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A B S T R A C T
Background
Self-harm (SH; intentional self-poisoning or self-injury) is common, often repeated, and associated with suicide. This is an update of
a broader Cochrane review first published in 1998, previously updated in 1999, and now split into three separate reviews. This review
focuses on psychosocial interventions in adults who engage in self-harm.
Objectives
To assess the effects of specific psychosocial treatments versus treatment as usual, enhanced usual care or other forms of psychological
therapy, in adults following SH.
Search methods
The Cochrane Depression, Anxiety and Neurosis Group (CCDAN) trials coordinator searched the CCDANClinical Trials Register (to
29 April 2015). This register includes relevant randomised controlled trials (RCTs) from: the Cochrane Library (all years), MEDLINE
(1950 to date), EMBASE (1974 to date), and PsycINFO (1967 to date).
Selection criteria
We included RCTs comparing psychosocial treatments with treatment as usual (TAU), enhanced usual care (EUC) or alternative
treatments in adults with a recent (within six months) episode of SH resulting in presentation to clinical services.
Data collection and analysis
We used Cochrane’s standard methodological procedures.
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Main results
We included 55 trials, with a total of 17,699 participants. Eighteen trials investigated cognitive-behavioural-based psychotherapy
(CBT-based psychotherapy; comprising cognitive-behavioural, problem-solving therapy or both). Nine investigated interventions for
multiple repetition of SH/probable personality disorder, comprising emotion-regulation group-based psychotherapy,mentalisation, and
dialectical behaviour therapy (DBT). Four investigated case management, and 11 examined remote contact interventions (postcards,
emergency cards, telephone contact). Most other interventions were evaluated in only single small trials of moderate to very low quality.
There was a significant treatment effect for CBT-based psychotherapy compared to TAU at final follow-up in terms of fewer participants
repeating SH (odds ratio (OR) 0.70, 95% confidence interval (CI) 0.55 to 0.88; number of studies k = 17; N = 2665; GRADE: low
quality evidence), but with no reduction in frequency of SH (mean difference (MD) -0.21, 95% CI -0.68 to 0.26; k = 6; N = 594;
GRADE: low quality).
For interventions typically delivered to individuals with a history of multiple episodes of SH/probable personality disorder, group-based
emotion-regulation psychotherapy and mentalisation were associated with significantly reduced repetition when compared to TAU:
group-based emotion-regulation psychotherapy (OR 0.34, 95% CI 0.13 to 0.88; k = 2; N = 83; GRADE: low quality), mentalisation
(OR 0.35, 95% CI 0.17 to 0.73; k = 1; N = 134; GRADE: moderate quality). Compared with TAU, dialectical behaviour therapy
(DBT) showed a significant reduction in frequency of SH at final follow-up (MD -18.82, 95% CI -36.68 to -0.95; k = 3; N = 292;
GRADE: low quality) but not in the proportion of individuals repeating SH (OR 0.57, 95% CI 0.21 to 1.59, k = 3; N = 247; GRADE:
low quality). Compared with an alternative form of psychological therapy, DBT-oriented therapy was also associated with a significant
treatment effect for repetition of SH at final follow-up (OR 0.05, 95% CI 0.00 to 0.49; k = 1; N = 24; GRADE: low quality). However,
neither DBT vs ’treatment by expert’ (OR 1.18, 95% CI 0.35 to 3.95; k = 1; N = 97; GRADE: very low quality) nor prolonged
exposure DBT vs standard exposure DBT (OR 0.67, 95% CI 0.08 to 5.68; k = 1; N =18; GRADE: low quality) were associated with
a significant reduction in repetition of SH.
Case management was not associated with a significant reduction in repetition of SH at post intervention compared to either TAU
or enhanced usual care (OR 0.78, 95% CI 0.47 to 1.30; k = 4; N = 1608; GRADE: moderate quality). Continuity of care by the
same therapist vs a different therapist was also not associated with a significant treatment effect for repetition (OR 0.28, 95% CI 0.07
to 1.10; k = 1; N = 136; GRADE: very low quality). None of the following remote contact interventions were associated with fewer
participants repeating SH compared with TAU: adherence enhancement (OR 0.57, 95% CI 0.32 to 1.02; k = 1; N = 391; GRADE:
low quality), mixed multimodal interventions (comprising psychological therapy and remote contact-based interventions) (OR 0.98,
95% CI 0.68 to 1.43; k = 1 study; N = 684; GRADE: low quality), including a culturally adapted form of this intervention (OR 0.83,
95% CI 0.44 to 1.55; k = 1; N = 167; GRADE: low quality), postcards (OR 0.87, 95% CI 0.62 to 1.23; k = 4; N = 3277; GRADE:
very low quality), emergency cards (OR 0.82, 95% CI 0.31 to 2.14; k = 2; N = 1039; GRADE: low quality), general practitioner’s
letter (OR 1.15, 95% CI 0.93 to 1.44; k = 1; N = 1932; GRADE: moderate quality), telephone contact (OR 0.74, 95% CI 0.42 to
1.32; k = 3; N = 840; GRADE: very low quality), and mobile telephone-based psychological therapy (OR not estimable due to zero
cell counts; GRADE: low quality).
None of the following mixed interventions were associated with reduced repetition of SH compared to either alternative forms of
psychological therapy: interpersonal problem-solving skills training, behaviour therapy, home-based problem-solving therapy, long-
termpsychotherapy; or to TAU: provision of information and support, treatment for alcohol misuse, intensive inpatient and community
treatment, general hospital admission, or intensive outpatient treatment.
We had only limited evidence on whether the intervention had different effects in men and women. Data on adverse effects, other than
planned outcomes relating to suicidal behaviour, were not reported.
Authors’ conclusions
CBT-based psychological therapy can result in fewer individuals repeating SH; however, the quality of this evidence, assessed using
GRADE criteria, ranged between moderate and low. Dialectical behaviour therapy for people with multiple episodes of SH/probable
personality disorder may lead to a reduction in frequency of SH, but this finding is based on low quality evidence. Case management and
remote contact interventions did not appear to have any benefits in terms of reducing repetition of SH. Other therapeutic approaches
weremostly evaluated in single trials of moderate to very low quality such that the evidence relating to these interventions is inconclusive.
P L A I N L A N G U A G E S U M M A R Y
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Psychosocial interventions for self-harm in adults
Why is this review important?
Self harm (SH), which includes non-fatal intentional self-poisoning/overdose and self-injury, is a major problem in many countries and
is linked to risk of future suicide. It is distressing for both patients and their families and friends, and places large demands on clinical
services. It is therefore important to assess the evidence on treatments for SH patients.
Who will be interested in this review?
Clinicians working with people who engage in SH, policy makers, people who themselves have engaged in SH or may be at risk of
doing so, and their families and relatives.
What questions does this review aim to answer?
This review is an update of a previous Cochrane review from 1999, which found little evidence of beneficial effects of psychosocial
treatments on repetition of SH. This update aims to further evaluate the evidence for the effectiveness of psychosocial treatments for
patients with SH with a broader range of outcomes.
Which studies were included in the review?
To be included in the review, studies had to be randomised controlled trials of psychosocial interventions for adults who had recently
engaged in SH. We searched electronic databases to find all such trials published up until 29 April 2015, and found 55 that met our
inclusion criteria.
What does the evidence from the review tell us?
There have now been a number of investigations of psychosocial treatments for SH in adults, with greater representation in recent years
of low- and middle-income countries such as China, Iran, Pakistan, and Sri Lanka.
Some moderate quality evidence shows that cognitive-behavioural-based (CBT-based) psychotherapy (a psychotherapy intended to
change unhelpful thinking, emotions and behaviour) may help prevent repetition of SH, although it did not reduce overall frequency
of SH. There were encouraging results (from small trials of moderate to very low quality) for other interventions aimed at reducing the
frequency of SH in people with probable personality disorder, including group-based emotion-regulation psychotherapy, mentalisation
(a psychosocial therapy intended to increase a person’s understanding of their own and others’ mental state), and dialectical behaviour
therapies (DBT; psychosocial therapies intended to assist with identification of triggers that lead to reactive behaviours and to provide
individuals with emotional coping skills to avoid these reactions). Whilst DBT was not associated with a significant reduction in
repetition of SH at final follow-up as compared to usual treatment, there was evidence of low quality suggesting a reduction in frequency
of SH.
There was no clear evidence supporting the effectiveness of prolonged exposure to DBT, case management, approaches to improve
treatment adherence, mixed multimodal interventions (comprising both psychological therapy and remote contact-based interven-
tions), remote contact interventions (postcards, emergency cards, and telephone contact), interpersonal problem-solving skills training,
behaviour therapy, provision of information and support, treatment for alcohol misuse, home-based problem-solving therapy, intensive
inpatient and community treatment, general hospital admission, intensive outpatient treatment, or long-term psychotherapy.
We had only limited evidence from a subset of the studies relating to whether the intervention had different effects in men and women.
The trials did not report on side effects other than suicidal behaviour.
What should happen next?
The promising results forCBT-based psychological therapy anddialectical behaviour therapywarrant further investigation to understand
which patients benefit from these types of interventions. There were only a few, generally small trials on most other types of psychosocial
therapies, providing little evidence of beneficial effects; however, these cannot be ruled out. There is a need for more information about
whether psychosocial interventions might work differently between men and women.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
CBT-based psychotherapy vs treatment as usual for self-harm in adults
Patient or population: adults who engage in SH
Settings: outpat ients
Intervention: CBT-based psychotherapy
Comparison: t reatment as usual (TAU)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
TAU CBT-based
psychotherapy
Repetition of SH at
post- intervention
Study population OR 0.66
(0.36 to 1.21)
313
(1 RCT)
⊕⊕©©
Lowa,b
We downgraded quality
as, due to the nature
of the intervent ion, it
is unlikely part icipants
and clinical personnel
would have been blind
to treatment allocat ion.
We further downgraded
quality as the conf i-
dence interval for the
treatment ef fect size is
wide
190 per 1000 134 per 1000
(78 to 221)
Repetition of SH at 6
months
Study population OR 0.54
(0.34 to 0.85)
1317
(12 RCTs)
⊕⊕⊕©
Moderatea
We downgraded qual-
ity as, due to the na-
ture of the interven-
t ion, it is unlikely part ic-
ipants and clinical per-
sonnel would have been
blind to treatment al-
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locat ion. For some tri-
als, addit ionally, part ic-
ipants were also not
blinded to treatment al-
locat ion
280 per 1000 173 per 1000
(117 to 248)
Repetition of SH at 12
months
Study population OR 0.80
(0.65 to 0.98)
2232
(10 RCTs)
⊕⊕⊕©
Moderatea
We downgraded qual-
ity as, due to the na-
ture of the interven-
t ion, it is unlikely part ic-
ipants and clinical per-
sonnel would have been
blind to treatment al-
locat ion. For some tri-
als, addit ionally, part ic-
ipants were also not
blinded to treatment al-
locat ion
272 per 1000 230 per 1000
(196 to 268)
Repetition of SH at 24
months
Study population OR 0.31
(0.14 to 0.69)
105
(2 RCTs)
⊕⊕⊕©
Moderatea
We downgraded quality
as, due to the nature
of the intervent ion, it
is unlikely part icipants
and clinical personnel
would have been blind
to treatment allocat ion.
For 1 trial, addit ionally,
part icipants were also
not blinded to treat-
ment allocat ion
563 per 1000 285 per 1000
(153 to 470)
Repetition of SH at fi-
nal follow-up
Study population OR 0.70
(0.55 to 0.88)
2665
(17 RCTs)
⊕⊕©©
Lowa,c
We downgraded quality
as, due to the nature
of the intervent ion, it
is unlikely part icipants
and clinical personnel
would have been blind
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to treatment allocat ion.
For 1 trial, addit ionally,
part icipants were also
not blinded to treat-
ment allocat ion. We fur-
ther downgraded qual-
ity due to the inconsis-
tency in the magnitude
of the ef fect size est i-
mates across trials
262 per 1000 199 per 1000
(163 to 238)
Frequency of SH at fi-
nal follow-up
The mean f requency of episodes of SH in the
experimental group was, on average, 0.21 lower
(0.68 lower to 0.26 higher)
- 597
(6 RCTs)
⊕⊕©©
Lowa,c
We downgraded quality
as, due to the nature
of the intervent ion, it
is unlikely part icipants
and clinical personnel
would have been blind
to treatment allocat ion.
For 1 trial, addit ionally,
part icipants were also
not blinded to treat-
ment allocat ion. We fur-
ther downgraded qual-
ity due to the inconsis-
tency in the magnitude
of the ef fect size est i-
mates across trials
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI)
CBT : cognit ive behavioural therapy; CI: conf idence interval; OR: odds rat io; RCT : randomised controlled trial: SH: self -harm; TAU: t reatment as usual.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
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a We rated risk of bias as SERIOUS as the nature of the intervent ion means that clinical personnel could not have remained blind
to treatment allocat ion. Addit ionally, for some trials, part icipants were not blinded to treatment allocat ion. Performance
and detect ion bias therefore may have been present.
b Imprecision was rated as SERIOUS as the conf idence interval is wide
c We rated inconsistency as SERIOUS due to notable dif f erences in the magnitude of the ef fect size est imates between trials
on visual inspect ion of the forest plot.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
The term ’self-harm’ is used to describe all non-fatal intentional
acts of self-poisoning or self-injury, irrespective of degree of sui-
cidal intent or other types of motivation (Hawton 2003a). Thus
it includes acts intended to result in death (’attempted suicide’),
those without suicidal intent (e.g., to communicate distress, to
temporarily reduce unpleasant feelings), and those with mixed
motivation (Hjelmeland 2002; Scoliers 2009). The term ’parasui-
cide’ was introduced by Kreitman 1969 to include the same range
of behaviour. However, clinicians in the USA have used ’parasui-
cide’ to refer specifically to acts of self-harm without suicidal in-
tent (Linehan 1991), and the term has largely fallen into disuse in
the UK and other countries. The Diagnostic and Statistical Man-
ual of Mental Disorders, fifth edition (DSM-5) includes two types
of self-harming behaviour as conditions for further study, namely
non-suicidal self-injury (NSSI) and suicidal behaviour disorder
(SBD). Many researchers and clinicians, however, believe this to
be an artificial and somewhat misleading categorisation (Kapur
2013). We have therefore used the approach favoured in the UK
and some other countries where all intentional self-harm is con-
ceptualised in a single category, namely self-harm (SH). Within
this category, suicidal intent is regarded as a dimensional rather
than a categorical concept. Readers more familiar with the NSSI
and SBD distinction may regard SH as an umbrella term for these
two behaviours (although it should be noted that neither NSSI
nor SBD include non-fatal self-poisoning).
SH has been a growing problem in most countries over the past
40 years. In the UK, researchers estimate that there are now more
than 200,000 presentations to general hospitals per year (Hawton
2007). In addition, self-harm often occurs in adults in the commu-
nity and does not come to the attention of clinical services or other
helping agencies (Borges 2011). SH consumes considerable hospi-
tal resources in both developed and developing countries (Carter
2005; Claassen 2006; Fleischmann 2005; Gibbs 2004; Kinyanda
2005; Parkar 2006; Schmidtke 1996; Schmidtke 2004).
Unlike suicide, in most countries SH usually occurs more com-
monly in females than males, although this gap decreases over
the life cycle (Hawton 2008). It has also decreased in recent years
(Perry 2012). SH predominantly occurs in young people, with
60% to 70% of individuals in many studies aged under 35 years.
In females, rates tend to be particularly high among those aged 15
to 24, whereas in males the highest rates are usually among those
in their late 20s and early 30s. SH is also less common in older
people but then tends to be associated with high suicidal intent
(Hawton 2008), with consequent greater risk of future suicide
(Murphy 2012).
Many people who engage in SH are facing acute life problems,
often in the context of longer-term difficulties (Hawton 2003b).
Common problems include disrupted relationships, employment
difficulties, financial and housing problems, and social isolation.
Alcohol abuse and, to a lesser extent, drugmisuse are often present.
There may be a history of adverse experiences, such as physical
abuse, sexual abuse, or both. In older people, physical health prob-
lems, bereavement, and threatened loss of independence become
increasingly important.
Many patients who present to hospital following SH have psychi-
atric disorders, especially depression, anxiety, and substance mis-
use (Hawton 2013). These disorders frequently occur in combi-
nation with personality disorder (Haw 2001).
Both psychological and biological factors appear to increase vul-
nerability to SH. Psychological factors include difficulties in prob-
lem-solving and a tendency to show black and white (or all or
none) thinking patterns, low self-esteem, impulsivity, vulnerabil-
ity to having pessimistic thoughts about the future (i.e., hopeless-
ness) and a sense of entrapment (O’Connor 2012:Williams 2000;
Williams 2005). Biological factors include disturbances in the
serotonergic and stress-response systems (Van Heeringen 2014).
SH is often repeated, with 15% to 25% of individuals who present
to hospital with SH returning to the same hospital following a
repeat episode within a year (Carroll 2014; Owens 2002). Studies
from Asia suggest a lower risk of repetition (Carroll 2014). There
may be other repeat episodes that do not result in hospital presen-
tation.
The risk of death by suicide within one year amongst people who
attend hospital with SH varies across different studies, from nearly
1% to over 3% (Carroll 2014; Owens 2002). This variation re-
flects differences in the characteristics of the SH population and
background national suicide rates. During the first year after a SH
episode, the risk in the UK is 50 to 100 times that of the gen-
eral population (Cooper 2005; Hawton 1988; Hawton 2003b).
Of people who die by suicide, over half will have a history of SH
(Foster 1997), and at least 15% will have presented to hospital
with SH in the preceding year (Gairin 2003). A history of SH is
the strongest risk factor for suicide across a range of psychiatric
disorders (Sakinofsky 2000). Repetition of SH further increases
the risk of suicide (Zahl 2004).
Description of the intervention
Psychosocial interventions include a wide variety of treatments,
for example cognitive behavioural therapy (CBT), problem-solv-
ing therapy, behaviour therapy, and dialectical behaviour therapy
(DBT). Treatments may vary in relation to the initial manage-
ment; the location of treatment; the continuity, intensity or fre-
quency of contact with a therapist; and the mode of delivery (in-
dividual or group-based). We included treatments that focused on
specific subgroups of SH patients in this review. These subgroups
may be defined in terms of age, psychological characteristics or
psychiatric diagnoses, substance misuse, and history of repetition
of self-harm. We also included studies of strategies to maintain
contact with patients, such as visits to patients with poor thera-
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peutic adherence, and contact by telephone, post and electronic
means.
How the intervention might work
Themechanisms of action of psychosocial interventions might in-
clude helping people improve their coping skills and self-esteem,
tackle specific problems, overcome psychiatric disorders, increase
their sense of social connectedness, and reduce impulsivity, aggres-
sion and unhelpful reactions to distressing situations.
CBT-based psychotherapy
CBT aims to help patients identify and critically evaluate the way
in which they interpret and evaluate disturbing emotional experi-
ences and events and then change the way they deal with problems
(Westbrook 2011). The therapy has three steps. First, therapists
help patients change the way in which they interpret and evalu-
ate distressing emotions. Secondly, patients learn strategies to help
them change the way they think about the meaning and conse-
quences of these emotions. Lastly, with the benefit of modified
interpretation of emotions and events, the therapy helps patients
to change their behaviour and especially to develop positive func-
tional behaviour (Jones 2012).
Problem-solving therapy, which is an integral part of CBT, as-
sumes that psychopathological processes such as SH are ineffec-
tive and maladaptive coping behaviours. Patients might overcome
them by learning skills to actively, constructively and effectively
solve the problems they face in their daily life (Nezu 2010). Ther-
apists might achieve this by encouraging patients to consciously
and rationally appraise problems, reduce or modify the negative
emotions generated by problems, and develop a range of possible
solutions to address their problems (D’Zurilla 2010). Treatment
goals include helping patients to develop a positive problem-solv-
ing orientation, use rational problem-solving strategies, reduce the
tendency to avoid problem-solving, and reduce the use of impul-
sive problem-solving strategies (Washburn 2012).
Our rationale for including CBT and problem-solving therapy
approaches in a single category of CBT-based psychotherapy in
this review is that they share common elements. For example,
problem-solving therapy incorporates other elements of behaviour
therapy and constitutes a key part of cognitive behavioural therapy;
also, cognitive-behavioural strategies are important for effective
problem-solving therapy (Hawton 1989; Westbrook 2011)
Interventions for multiple repetition of SH/probable
personality disorder
The goal of emotion-regulation training is to help patients find
adaptive ways to respond to distress instead of trying to control,
suppress or otherwise avoid experiencing these emotions through
behaviours such as SH (Gratz 2007). Emotion-regulation training
therefore helps patients in four stages: first, to become more aware
and accepting of their emotional experiences; second, to engage
in goal-directed behaviours whilst inhibiting the expression of im-
pulsive ones; third, to use appropriate strategies to moderate the
intensity and duration of their emotional responses; and fourth, to
become more accepting of negative emotional experiences within
their daily life (Gratz 2004).
Dialectical behaviour therapy (DBT) combines problem-solving
training, skills training, cognitive modification training andmind-
fulness techniques to encourage patients to accept their thoughts,
feelings, and behaviours without necessarily attempting to change,
suppress, or avoid these experiences (Lynch 2006; Washburn
2012). Within this framework, the aim of DBT is to help patients
better regulate their emotions, achieve a sense of interpersonal ef-
fectiveness, becomemore tolerant of distressing thoughts and feel-
ings, and become better at managing their own thoughts and be-
haviours (Linehan 1993b; Linehan 2007). The primary treatment
goals of DBT are therefore threefold: to reduce SH, to reduce be-
haviours that interfere with treatment success (e.g., treatment non-
adherence), and to reduce any other factors that may adversely
affect the patient’s quality of life (e.g., frequency and duration of
psychiatric hospitalisations) (Linehan 1993b). As the aim of DBT
is to help patients change or adjust to significant personality char-
acteristics, treatment is intensive and relatively prolonged.
Mentalisation refers to the ability to understand the actions of
both the self and of others as meaningful given knowledge of the
desires, beliefs, feelings, emotions, and motivations that under-
score their behaviour (Bateman 2004; Choi-Kain 2008). During
times of interpersonal stress, however, individuals may fail to rep-
resent experiences in terms of mental states and instead become
overwhelmed with negative thoughts and feelings about the self
(Rossouw 2013). Behaviours such as SH may then represent an
escape from these negative self-evaluations. Mentalisation therapy
aims to improve patients’ ability to empathise with others in or-
der to develop the ability to see how their own behaviours may
have an impact on the feelings of others, and to regulate their own
emotions more effectively (Rossouw 2013).
Case management
Case management in mental health services has mainly been de-
veloped for more severely ill patients. “In its simplest form . . . case
management is a means of co-ordinating services. Each . . . person
is assigned a ’case manager’ who is expected to assess that person’s
needs; develop a care plan; arrange for suitable care to be provided;
monitor the quality of the care provided; and maintain contact
with the person (Holloway 1991)” (Marshall 2000a, p. 2). Case
management might have a significant role in the aftercare of self-
harmpatients because of the recognised problemof poor treatment
adherence in many patients and the heterogeneous nature of the
problems patients are often facing (Hawton 2003b; Lizardi 2010).
It has included, for example, provision of a care manager, crisis
intervention, problem solving, assistance with getting to clinical
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appointments, and assertive outreach, each provided according to
individual patient need (Morthorst 2012).
Treatment adherence enhancement approaches
These approaches include specific efforts to maintain contact with
patients, such as following up patients in the community who fail
to attend outpatient appointments (Van Heeringen 1995). It also
includes strategies to encourage adherence with treatment (Hvid
2011).
Having the same clinician who assessed a patient initially also pro-
viding any aftercare intervention may increase treatment adher-
ence and may also have an advantage in that the clinician is already
acquainted with the patient’s problems and needs.
Remote contact interventions
Remote contact interventions typically involve sending regular
letters or postcards to patients. Patients may view this kind of
intervention as a ’gesture of caring’ that may help to counteract
the sense of social isolation many SH patients experience (Cooper
2011). This sense of “social connectedness” may, in turn, have a
stabilising emotional effect (Motto 2001).
Another type of remote contact intervention involves the use of
emergency cards, which may encourage patients to seek help when
they feel distressed as well as offering provision for on-demand
emergency contact with psychiatric services (Kapur 2010).
The fact that in many countries most individuals have their own
general practitioner (GP) can also facilitate provision of care di-
rectly following SH. Interventions may include guidance for GPs
on treating andmanaging problems commonly experienced by SH
patients (e.g., depression, substance misuse, life problems). Such
advice may also include advising GPs on referral of SH patients to
local community services (Bennewith 2002).
Telephone contact with patients following discharge from hospital
can also help to ensure a continuing sense of contact with the
service and be used to provide advice and possibly psychotherapy.
The immediacy that psychotherapy by mobile telephone can
achieve, when compared with standard clinic-based psychother-
apy, may help with crisis management in times of distress
(Marasinghe 2012).
Why it is important to do this review
SH is a major social and healthcare problem. It is responsible for
significant morbidity, is often repeated, and has strong links to
suicide. It also leads to substantial healthcare costs (Sinclair 2011).
Many countries now have suicide prevention strategies (WHO
2014), which include a focus on improved management of pa-
tients presenting with SH due to their greatly elevated suicide
risk and their high levels of psychopathology and distress. The
National Suicide Prevention Strategy for England (Her Majesty’s
Government Department of Health 2012) and the US suicide
prevention strategy (Office of the Surgeon General 2012), for ex-
ample, highlight SH patients as a high risk group for special at-
tention.
In recent years there has been considerable focus on improving
the standards of general hospital care for SH patients. The Royal
College of Psychiatrists published consensus guidelines for such
services in 1994 and a further guideline in 2004 (Royal College
of Psychiatrists 1994; Royal College of Psychiatrists 2004). While
these guidelines focus particularly on organisation of services and
assessment of patients, there clearly also need to be effective treat-
ments for SH patients. These may include both psychosocial and
pharmacological interventions. In 2004 the National Institute for
Clinical Excellence (NICE) produced a guideline on self-harm,
which focused on its short-term physical and psychological man-
agement (NCCMH 2004). More recently, NICE produced a sec-
ond guide focused particularly on long-term management, using
some interim data from the present review as the evidence base for
therapeutic interventions (NICE 2011). A similar guideline was
produced in Australia and New Zealand (Boyce 2003). We had
previously conducted a systematic review of treatment interven-
tions for SHpatients in terms of reducing repetition of SH(includ-
ing suicide); this review highlighted the paucity of evidence for ef-
fective treatments, at least in terms of this outcome (Hawton 1998;
Hawton 1999). The first NICE guideline essentially reinforced
this conclusion (NCCMH 2004). However, there was emerging
evidence for beneficial effects of short-term psychological therapy
on other outcomes (depression, hopelessness, and problem reso-
lution) (Townsend 2001). Using interim data from the present
review, the second NICE guideline concluded that there was ev-
idence showing clinical benefit of CBT-based psychotherapeutic
interventions in reducing repetition of self-harm, compared with
routine care (NICE 2011).
We have now fully updated our original review in order to pro-
vide current evidence to guide clinical policy and practice. Previ-
ous versions of this review included SH patients of any age and
both psychosocial and pharmacological interventions. We have
now divided this research into three separate reviews, one of in-
terventions in children and adolescents (Hawton 2015a), another
of pharmacological interventions in adults (Hawton 2015b), and
this, the third, focused on psychosocial interventions in adults.We
have also now included data on treatment adherence, depression,
hopelessness, problem-solving, and suicidal ideation.
O B J E C T I V E S
To assess the effects of specific psychosocial treatments versus ei-
ther treatment as usual, enhanced usual care or other forms of
alternative psychotherapy, in adults following SH.
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M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials, including cluster-ran-
domised, multi-arm, and cross-over trials of specific psychoso-
cial interventions versus any comparator (e.g., treatment as usual
[TAU]/enhanced usual care [EUC]/other alternative forms of psy-
chotherapy) in the treatment of adult SH patients.
Types of participants
Participant characteristics
Participants were adult men and women (aged 18 and over) of all
ethnicities. We also included trials where there were a small mi-
nority (< 15%) of adolescent participants. However, we undertook
sensitivity analyses to assess the effect of including such studies.
Diagnosis
We included participants who had engaged in any type of non-fatal
intentional self-poisoning or self-injury in the six months prior to
trial entry resulting in presentation to clinical services. There were
no restrictions on the frequency with which patients engaged in
SH; thus, for example, we included trials where participants had
frequently repeated SH (e.g., those with self-harming behaviour
associated with borderline personality disorder).
We defined SH as any non-fatal intentional act of self-poisoning
or self-injury, irrespective of degree of suicidal intent or other types
of motivation. Thus we included acts intended to result in death
(attempted suicide), those without suicidal intent (e.g., to com-
municate distress, to temporarily reduce unpleasant feelings), and
those with mixed motivation. Self poisoning includes both over-
doses of medicinal drugs and ingestion of substances not intended
for consumption (e.g., pesticides). Self-injury includes acts such
as self-cutting, self-mutilation, attempted hanging, and jumping
in front of moving vehicles. We only included trials where partic-
ipants presented to clinical services as a result of SH.
Co-morbidities
Therewere no restrictions on includedpatients in terms ofwhether
or not they had psychiatric disorders nor with regard to the nature
of those disorders, with the exception of intellectual disability, as
any SH behaviour is likely to be repetitive (e.g., head banging),
and the purpose of this behaviour is usually different from that
involved in SH (NICE 2011).
Setting
Interventions delivered in inpatient or outpatient settings were
eligible for inclusion, as were trials from any country.
Subset data
We did not include trials in which only some participants had
engaged in SH or trials in people with psychiatric disorders where
SH was an outcome variable but not an inclusion criterion for
entry into the trial.
Types of interventions
Comparisons included in this review were between any psychoso-
cial intervention and any comparator (e.g., TAU/EUC/other al-
ternative forms of psychotherapy, or placebo). As the trials in-
cluded in this review assessed a wide variety of interventions, we
developed categories or groups of interventions. This categorisa-
tion was based on consensus discussions within the review team
and included decisions about combining trials in which there were
superficial differences between treatments but the key method-
ologies between trials were similar. In some cases we sought more
details of the therapy from authors to assist this process. Categori-
sation reflected both prior views on types of psychotherapy and
the types of interventions that were identified as a result of the
systematic review of the literature.
Experimental interventions
These included:
1. CBT-based psychotherapy;
2. interventions for multiple repetition of SH/probable
personality disorder;
3. case management;
4. treatment adherence enhancement approaches;
5. mixed multimodal interventions;
6. remote contact interventions;
7. other mixed interventions.
Comparator interventions
Treatment as usual
As treatment as usual (TAU) is likely to vary widely between set-
tings, following previous work we defined TAU as any care that
patient would receive had they not been included in the trial (i.e.,
routine care) (Hunt 2013).
Enhanced usual care
Enhanced usual care (EUC) refers to TAU that has in some way
been supplemented, for example through the provision of psycho-
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education, assertive outreach, or more regular contacts with case
managers.
Treatment by expert
This typically consists of a treatment by a widely recognised au-
thority with significant experience in treating individuals follow-
ing SH.
Other alternative forms of psychotherapy
This included other forms of psychotherapy designed to be of
lower duration or intensity than the experimental intervention and
could include:
1. brief or short-term psychotherapy;
2. standard case management;
3. standard dialectical behaviour therapy (DBT).
Discharge from hospital without further aftercare
Types of outcome measures
Primary outcomes
The primary outcome measure in this review was the occurrence
of repeated SH (defined above) over a maximum follow-up period
of two years. Repetition was identified through at least one of the
following: self-report, collateral report, clinical records, or research
monitoring systems. As we wished to incorporate the maximum
amount of data from each trial, we included both self-reported and
hospital records of SH where available. We also assessed frequency
of repetition of SH.
Secondary outcomes
1. Treatment adherence
Thiswas assessed using a range ofmeasures of adherence, including
the proportion of participants that both started and completed
treatment, pill counts, and changes in blood measures.
2. Depression
This was assessed either continuously, as scores on psychometric
measures of depression symptoms (for example total scores on
Beck Depression Inventory (BDI; Beck 1961) or scores on the
depression sub-scale of the Hospital Anxiety and Depression Scale
(HADS; Zigmond 1983)), or dichotomously, as the proportion
of patients reaching defined diagnostic criteria for depression. We
included both patient- and clinician-reported instruments.
3. Hopelessness
This was assessed as scores on psychometric measures of hope-
lessness, for example total scores on the Beck Hopelessness Scale
(BHS; Beck 1974). We included both patient- and clinician-re-
ported instruments.
4. Suicidal ideation
This was assessed suicidal ideation either continuously, as scores on
psychometric measures (for example total scores on the Beck Scale
for Suicidal Ideation (BSSI; Beck 1988)), or dichotomously, as the
proportion of patients reaching a defined cut-off for ideation. We
included both patient- and clinician-reported instruments.
5. Problem solving
Problem solving ability was assessed either continuously, as scores
on psychometric measures (for example total scores on the Prob-
lem-Solving Inventory (PSI; Heppner 1988)), or dichotomously,
as the proportion of patients with improved problems. We in-
cluded both patient- and clinician-reported instruments.
6. Suicide
This included both register-recorded deaths and reports from col-
lateral informants such as family or neighbours.
Timing of the outcome assessment
We reported outcomes for the following time points.
1. At the conclusion of the treatment period.
2. Between 0 and 6 months after the conclusion of the
treatment period.
3. Between 6 and 12 months after the conclusion of the
treatment period.
4. Between 12 and 24 months after the conclusion of the
treatment period.
Hierarchy of outcome assessment
Where a trial measured the same outcome (e.g., depression) in two
or more ways, we used the most common measure across trials
in any meta-analysis, but we also reported scores from the other
measure in the text of the review.
Search methods for identification of studies
Electronic searches
1. The Cochrane Depression, Anxiety and Neurosis Review
Group Specialised Register (CCDANCTR)
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The Cochrane Depression, Anxiety and Neurosis Group (CC-
DAN) maintains two clinical trials registers at their editorial base
in Bristol, UK: a references register and a studies-based register.
The CCDANCTR-References Register contains over 39,500 re-
ports of randomised controlled trials on depression, anxiety and
neurosis. Approximately 60% of these references have been tagged
to individual, coded trials. The coded trials are held in the CC-
DANCTR-Studies register and records are linked between the two
registers through the use of unique study ID tags. Coding of trials
is based on the EU-PSI Coding Manual. Please contact the CC-
DAN Trials Search Coordinator for further details.
Reports of trials for inclusion in the group’s registers are collated
from weekly generic searches of MEDLINE (1950 to date), EM-
BASE (1974 to date) and PsycINFO (1967 to date), as well as
quarterly searches of the Cochrane Central Register of Controlled
Trials (CENTRAL).
We searched the CCDANCTR (Studies and References) database
on 29 April 2015 using terms for self-harm (condition only), as
outlined in Appendix 1.
We applied no restrictions on date, language, or publication status
to the search.
2. Additional electronic database searches
Sarah Stockton, librarian at the University of Oxford, conducted
earlier searches (1998 toOctober 2013) ofMEDLINE, EMBASE,
PsycINFO and CENTRAL (The Cochrane Library), following the
search strategy outlined in Appendix 2. As the CCDANCTR al-
ready contains relevant reports of RCTs from these databases, it
was unnecessary to re-search these. Additionally, KW searched the
Australian Suicide Prevention RCTDatabase (Christensen 2014).
KW also conducted electronic searches of ClinicalTrials.gov and
the ISRCTN registry using the keywords random* AND suicide
attempt* OR self$harm* to identify relevant ongoing trials.
Both the original version of this review as well as an unpublished
version also incorporated searches of the following databases:
SIGLE (1980 to March 2005) and SocioFile (1963 to July 2006).
We updated the search of ClinicalTrials.gov and the ISRCTN
registry to 29 April 2015.
Searching other resources
Handsearching
For the original versionof this review the authors hand-searched10
specialised journals within the fields of psychology and psychiatry,
including all English language suicidology journals, as outlined in
Appendix 3. As these journals are now indexed in major electronic
databases, we did not repeat hand-searching for this update.
Reference lists
We checked the reference lists of all relevant papers known to our
review team as well as the reference lists of major reviews that in-
clude a focus on interventions for SH patients (Baldessarini 2003;
Baldessarini 2006; Beasley 1991; Brausch 2012; Burns 2000;
Cipriani 2005; Cipriani 2013; Comtois 2006; Crawford 2007a;
Crawford 2007b; Daigle 2011; Daniel 2009; Dew 1987; Gould
2003; Gray 2001; Gunnell 1994; Hawton 1998; Hawton 1999;
Hawton 2012; Hennen 2005; Hepp 2004; Hirsch 1982; Kapur
2010; Kliem 2010; Lester 1994; Links 2003b; Lorillard 2011a;
Lorillard 2011b; Luxton 2013; Mann 2005; McMain 2007b;
Milner 2015; Möller 1989; Möller, 1992; Montgomery 1995;
Muehlenkamp 2006; Müller-Oerlinghausen 2005; Nock 2007;
Ougrin 2011; Ougrin 2015; Tarrier 2008b; Tondo 1997; Tondo
2000; Tondo 2001; Townsend 2001; Van der Sande 1997b).
Correspondence
We consulted trial authors and other experts in the field of suicidal
behaviour to find out if they were aware of any ongoing or un-
published RCTs concerning the use of psychosocial interventions
for adult SH patients.
Data collection and analysis
For details of the data collection and analysis methods used in the
original version of this review, see Appendix 4.
Selection of studies
For this review update all review authors independently assessed
the titles of trials identified by the systematic search for eligibility.
A distinction was made between:
1. eligible trials that compared any psychosocial intervention
with a control (e.g., treatment as usual (TAU), enhanced usual
care (EUC), or other alternative forms of psychotherapy);
2. general treatment trials (without any control treatment).
All trials identified as potentially eligible for inclusion underwent a
second screening. Pairs of review authors, working independently
from one another, screened the full text of relevant trials to identify
whether the trials met our inclusion criteria.
We resolved disagreements following consultation with KH.
Where we could not resolve disagreements based on the informa-
tion reported within the trial, or where it was unclear whether
the trial satisfied our inclusion criteria, we contacted authors to
provide additional clarification.
Data extraction and management
In the current update, KW and one other author (TTS, EA, DG,
PH, ET or KvH) independently extracted data from included
trials using a standardised extraction form. In case of disagreement,
authors resolved them through consensus discussions with KH.
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Data extracted from each eligible trial included participant demo-
graphics, details of the treatment and control interventions, and
information on the outcomemeasures used to evaluate the efficacy
of the intervention. We contacted study authors to obtain raw data
for outcomes that were not reported in the full text of included
trials.
We extracted both dichotomous and continuous outcome data
from eligible trials. As the use of non-validated psychometric scales
is associated with bias, we extracted continuous data only if the
psychometric scale used to measure the outcome of interest had
been previously published in a peer-reviewed journal and was not
subjected to item, scoring, or other modification by the trial au-
thors (Marshall 2000b).
We planned the following main comparisons.
1. CBT-based psychotherapy versus TAU or other alternative
forms of psychotherapy.
2. Interventions for multiple repetition of SH/probable
personality disorder versus TAU or other alternative forms of
psychotherapy.
3. Case management versus TAU or other alternative forms of
psychotherapy.
4. Treatment adherence enhancement approaches versus TAU
or other alternative forms of psychotherapy.
5. Mixed multimodal interventions versus TAU or other
alternative forms of psychotherapy.
6. Remote contact interventions versus TAU or other
alternative forms of psychotherapy.
7. Other mixed interventions versus TAU or other alternative
forms of psychotherapy.
Assessment of risk of bias in included studies
Given that highly biased trials aremore likely to overestimate treat-
ment effectiveness (Moher 1998), KW and one of TTS, EA, DG,
PH, ET or KvH independently evaluated the quality of included
trials by using the criteria described in Higgins 2008a. This tool
encourages consideration of the following domains:
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Other bias.
We judged each source of potential bias as conferring low, high
or unclear risk of bias, and we incorporated a supporting quota-
tion from the report to justify this judgment. Where the original
report provided inadequate details of the randomisation, blind-
ing, or outcome assessment procedures, we contacted authors for
clarification. We resolved disagreements through discussion with
KH and reported risk of bias for each included trial in the text of
the review. For cluster-randomised and cross-over trials, we used
appropriate methods of assessing bias as outlined in Higgins 2011,
sections 16.3.2 and 16.4.3.
Measures of treatment effect
Dichotomous outcomes
We summarised dichotomous outcomes, such as the number of
participants engaging in a repeat SH episode and the number
of deaths by suicide, using summary odds ratios (OR) and the
accompanying 95% confidence interval (CI), as the OR is the
most appropriate effect size statistic for summarising associations
between two dichotomous groups (Fleiss 1994).
Continuous outcomes
For outcomes reported on a continuous scale, we used mean dif-
ferences (MD) and accompanying 95% CI where trials employed
the same outcome measure. Where studies used different scales to
assess a given outcome, we used the standardised mean difference
(SMD) and its accompanying 95% CI.
We only aggregated trials for the purposes of meta-analysis if treat-
ments were sufficiently similar. For trials that could not be in-
cluded in a meta-analysis, we have instead provided narrative de-
scriptions of the results.
Unit of analysis issues
Zelen design trials
Trials in this area increasingly employ Zelen’s method, in which
investigators obtain consent after randomisation and treatment
allocation. This design may lead to bias if, for example, partici-
pants allocated to one particular arm of the trial disproportionally
refuse to provide consent for participation or, alternatively, if par-
ticipants only provide consent provided they are allowed to cross
over to the active treatment arm (Torgerson 2004). We included
four trials that employed Zelen’s method in this review (Carter
2005; Hatcher 2011; Hatcher 2016a; Hatcher 2015). Given the
uncertainty of whether to use data for the primary outcome based
on all those randomised to the trial, or only those who consented
to participation, we extracted data for the primary outcome mea-
sure using both sources where possible. We also conducted sensi-
tivity analyses by excluding these trials to investigate what impact,
if any, their inclusion had on the pooled estimate of treatment
effectiveness.
Cluster-randomised trials
Cluster randomisation, for example by clinician or general prac-
tice, can lead to overestimation of the significance of a treatment
effect, resulting in an inflation of the nominal type I error rate,
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unless there is appropriate adjustment for the effects of cluster-
ing (Donner 2002; Kerry 1998). We planned to statistically ad-
just for the effects of clustering following the guidance outlined
in Higgins 2008b, section 16.3.4. Clustering was an issue in one
included study (Bennewith 2002); however, we were unable to
adjust for the effects of clustering in subsequent analyses as the
study authors could not provide us with either the intercluster co-
efficient or the design effect.
Cross-over trials
A primary concern with cross-over trials is the ’carry-over’ effect,
in which the effect of the intervention treatment (e.g., pharma-
cological, physiological, or psychological) influences the partic-
ipant’s response to the subsequent control condition (Elbourne
2002). As a consequence, on entry to the second phase of the trial
participants may differ systematically from their initial state de-
spite a wash-out phase. This, in turn, may result in a concomitant
underestimation of the effectiveness of the treatment intervention
(Curtin 2002a; Curtin 2002b). One trial included in the current
update used cross-over methodology (i.e., Marasinghe 2012). To
protect against the carry-over effect, we only extracted data from
the first phase of this trial, prior to cross-over.
Studies with multiple treatment groups
Two trials in the current review included multiple treatment
groups (Stewart 2009;Wei 2013). As both intervention arms in the
Stewart 2009 trial investigated the effectiveness of CBT-based psy-
chotherapy, we combined dichotomous data from these two arms
and compared them with data from the TAU arm. For outcomes
reported on a continuous scale, we combined data using the for-
mula given in Higgins 2011, section 7.7.3.8. Wei 2013 compared
two different psychotherapies with TAU, namely CBT-based psy-
chotherapy and telephone contact. Therefore we included this trial
in both categories of intervention using the data from the relevant
experimental arm. As we did not combine these interventions in
any meta-analysis, we used the same TAU data for both analyses.
Studies with adjusted effect size estimates
None of the trials included in the current update calculated ad-
justed effect sizes. In future updates of this review, however, where
trials report both unadjusted and adjusted effect sizes, we will in-
clude only unadjusted effect sizes.
Dealing with missing data
Weas review authors did not imputemissingdata, aswe considered
that the bias that would be introduced by doing this would have
outweighed any benefit (in terms of increased statistical power)
that may have been gained by the inclusion of imputed data. How-
ever, where authors omitted standard deviations (SD) for contin-
uous measures, we estimated these using the method described in
Townsend 2001.
Dichotomous data
Although many authors conducted their own intention-to-treat
analyses, few presented intention-to-treat analyses as defined by
Higgins 2008b. Therefore, we based outcome analyses for both
dichotomous and continuous data on all information available on
trial participants. For dichotomous outcomes, we included data
on only those participants whose results were known, using as the
denominator the total number of participants with data for the
particular outcome of interest, as recommended (Higgins 2008b).
Continuous data
For continuous outcomes, we included data only on observed
cases.
Missing data
Where data on outcomes of interest were incomplete or excluded
from the text of the trial, we contacted authors to request further
information.
Assessment of heterogeneity
It is possible to assess between-study heterogeneity using either
the Chi2 or I2 statistic. In this review, however, we used only the
I2 statistic to determine heterogeneity, as Higgins 2003 considers
this to be more reliable. The I2 statistic indicates the percentage
of between-study variation due to chance and can take any value
from 0% to 100% (Higgins 2003). We used the following val-
ues to denote unimportant, moderate, substantial, and consider-
able heterogeneity, respectively: 0% to 40%, 30% to 60%, 50%
to 90%, and 75% to 100% as per the guidance in the Cochrane
Handbook for Systematic Reviews of Interventions (Deeks 2008, sec-
tion 9.5.2). Where we found substantial levels of heterogeneity
(i.e., ≥ 75%), we explored possible reasons. We also planned to
investigate heterogeneity even when the I2 statistic was lower than
75% but either the direction or magnitude of a trial effect size was
clearly discrepant from that of other trials included in the meta-
analysis (see Subgroup analysis and investigation of heterogeneity
section for further information on these analyses).
We also report heterogeneity in the results section but only when
we observed substantial levels, as indicated by an I2 statistic of
75% or greater.
Assessment of reporting biases
Reporting bias occurs when the direction and significance of a
particular trial’s results influence the decision to publish a report
on it (Egger 1997). Research suggests, for example, that trials with
statistically significant findings aremore likely to be submitted and
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subsequently accepted for publication (Hopewell 2009), leading
to possible overestimation of the true treatment effect. To assess
whether trials included in any meta-analysis were affected by re-
porting bias, we entered data into a funnel plot but only, as recom-
mended, when a meta-analysis included results of at least 10 trials.
Where evidence of any small-study effects were identified, we ex-
plored reasons for funnel plot asymmetry, including the presence
of publication bias (Egger 1997).
Data synthesis
For the purposes of meta-analysis, we calculated the pooled OR
and accompanying 95% CI using the random-effects model, as
this is the most appropriate model for incorporating heterogeneity
between trials (Deeks 2008, section9.5.4). Specifically, we used the
Mantel-Haenszel method for dichotomous data and the inverted
variancemethod for continuous data.However, we also undertook
a fixed-effect analysis to investigate the potential effect of method
choice on the estimates of treatment effect.We descriptively report
any material differences in ORs between these two methods in the
text of the review. All analyses were conducted in ReviewManager,
version 5 (RevMan 2014).
Subgroup analysis and investigation of heterogeneity
Subgroup analyses
In the original version of this review, we planned to undertake sub-
group analyses by repeater status (i.e., history of multiple episodes
of SH vs first known episode of SH) and gender but found there
were insufficient data. Consequently, in this update we only un-
dertook a priori subgroup analyses by sex or repeater status where
there were sufficient data to do so.
Investigation of heterogeneity
Where meta-analyses were associated with substantial levels of be-
tween-study heterogeneity (i.e., as indicated by an I2 statistic ≥
75%), KH and KW first independently triple-checked the data to
ensure that the review team had correctly entered the data. Assum-
ing this was the case, we investigated the source of heterogeneity by
visually inspecting the forest plot and removing each trial that had
a very different result from the general pattern of the others until
homogeneity was restored as indicted by an I2 statistic < 75%.
We have reported the results of this sensitivity analysis in the text
of the review alongside hypotheses regarding the likely causes of
heterogeneity.
Sensitivity analysis
We undertook sensitivity analyses, where appropriate, as outlined
below.
1. Trial/s that used Zelen’s method of randomisation (see Unit
of analysis issues section).
2. Trial/s that contributed substantial levels of between-study
heterogeneity (see Subgroup analysis and investigation of
heterogeneity section).
3. Trial/s that included some adolescent participants.
4. Trial/s that specifically recruited individuals diagnosed with
borderline personality disorder.
Summary of findings table
We prepared a ’Summary of findings’ table for the primary out-
comemeasure, repetition of SH, following recommendations out-
lined in Schünemann 2008a, section 11.5. This table provides in-
formation concerning the overall quality of evidence from each
included trial. We prepared the ’Summary of findings’ table using
GRADEpro software (GRADE profiler). We assessed quality of
the evidence following recommendations in Schünemann 2008b,
section 12.2.
R E S U L T S
Description of studies
Results of the search
In this update, the search strategy outlined in Appendix 1 and
Appendix 2 yielded a total of 23,725 citations. We identified a
further 10 trials that were ongoing at the time of the systematic
search through correspondence and discussion with researchers in
the field. All have subsequently been published.
In consultation with CCDAN, we divided the original review
(Hawton 1998; Hawton 1999) into three separate reviews: the
present review focuses on psychosocial interventions for adults, a
second review deals with pharmacological interventions for adults
(Hawton 2015b), and the third assesses interventions for children
and adolescents (Hawton 2015a). Nine of the additional 10 trials
evaluated psychosocial interventions for adults, and were therefore
included in the present update. The remaining trial evaluated an
intervention for children and adolescents; this is included in the
related relevant review (i.e., Hawton 2015a).
After deduplication, the initial number of citations decreased to
16,700. Of these, we excluded 16,459 after screening the titles and
abstracts and a further 217 after reviewing the full texts (Figure
1).
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Figure 1. Search flow diagram of included and excluded studies for the 2014 update.
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Included studies
In the previous versions of this review (Hawton 1998; Hawton
1999; NICE 2011), we included 36 trials of psychosocial in-
terventions for adults following SH (Allard 1992; Bateman
2009; Bennewith 2002; Brown 2005; Carter 2005; Cedereke
2002; Clarke 2002; Dubois 1999; Evans 1999a; Evans 1999b;
Fleischmann 2008; Gibbons 1978; Gratz 2006; Guthrie 2001;
Hawton 1981; Hawton 1987a; Liberman 1981; Linehan 1991;
Linehan 2006; McLeavey 1994; McMain 2009; Morgan 1993;
Patsiokas 1985; Salkovskis 1990; Slee 2008; Stewart 2009;
Torhorst 1987; Torhorst 1988; Turner 2000; Tyrer 2003; Vaiva
2006; Van der Sande 1997a; Van Heeringen 1995; Waterhouse
1990; Weinberg 2006; Welu 1977). The present update in-
cluded information from an additional 19 trials (Beautrais 2010;
Crawford 2010; Davidson 2014; Gratz 2014; Harned 2014;
Hassanian-Moghaddam 2011; Hatcher 2016a; Hatcher 2015;
Hatcher 2011;Husain 2014;Hvid 2011;Kapur 2013a;Kawanishi
2014;Marasinghe 2012;McAuliffe 2014;Morthorst 2012; Priebe
2012; Tapolaa 2010; Wei 2013). The present review there-
fore included 55 non-overlapping trials. Five further follow-up
studies (i.e., Bertolote 2010; Hassanzadeh 2010; McMain 2012,
Vijayakumar 2011 and Xu 2012) provide additional data for two
of these trials (Fleischmann 2008; McMain 2009).
We obtained unpublished data from corresponding authors from
a further 36 trials (Bateman 2009; Beautrais 2010; Bennewith
2002; Brown 2005; Carter 2005; Cedereke 2002; Clarke 2002;
Crawford 2010; Davidson 2014; Dubois 1999; Fleischmann
2008; Gratz 2006; Gratz 2014; Guthrie 2001; Harned 2014;
Hassanian-Moghaddam 2011; Hatcher 2016a; Hatcher 2015;
Hatcher 2011; Husain 2014; Hvid 2011; Linehan 1991; Linehan
2006; Marasinghe 2012; McAuliffe 2014; McMain 2009;
Patsiokas 1985; Priebe 2012; Slee 2008; Stewart 2009; Tapolaa
2010; Turner 2000; Tyrer 2003; Vaiva 2006;Wei 2013;Weinberg
2006).
We also identified 16 ongoing trials of psychosocial interventions
following SH in adults (see Characteristics of ongoing studies sec-
tion for further information on these trials).
Design
Study authors described all 55 independent trials as randomised
controlled trials (RCTs). Most (number of studies k = 49; 89.1%)
employed a simple randomisation procedure based on individual
allocation to the intervention and control groups. Zelen’s post-
randomisation consent design was used in four trials (Carter 2005;
Hatcher 2016a;Hatcher 2015;Hatcher 2011), a cluster-randomi-
sation procedure in one (Bennewith 2002), and a matched pair
randomisation procedure in another (Cedereke 2002).
Participants
The included trials comprised a total of 17,699 participants. All
had engaged in at least one episode of SH in the six months prior
to randomisation.
Participant characteristics
In the 39 trials that recorded information on age, the average age
of participants at randomisation was 30.9 years (SD 4.6). Twenty
trials included a small number of adolescent participants (i.e., un-
der 18 years of age at randomisation) (Carter 2005; Dubois 1999;
Evans 1999b; Gibbons 1978; Hassanian-Moghaddam 2011;
Hatcher 2016a; Hatcher 2015; Hatcher 2011; Hawton 1987a;
Husain 2014; Hvid 2011; Marasinghe 2012; McLeavey 1994;
Morthorst 2012; Priebe 2012; Salkovskis 1990; Slee 2008; Van
der Sande 1997a; Van Heeringen 1995; Wei 2013). However, in-
vestigators did not record the precise number in any of them. As
the majority of participants in these trials were adults, we included
them in the present review rather than in the related review spe-
cific to interventions for children and adolescents (i.e., Hawton
2015a). The majority of the sample was female in the 46 trials that
recorded information on sex (k = 46; mean 69.2%), reflecting the
typical pattern for SH (Hawton 2008).
Diagnosis
In all trials, a recent episode of SHwas a requirement for trial entry.
SH includes intentional acts of self-harm (i.e., self-poisoning or
self-injury) and not acts such as recreational use of drugs that may
result in accidental harm.
A history of multiple episodes of SH was a requirement for par-
ticipation in 13 trials (Evans 1999b; Gratz 2006; Gratz 2014;
Harned 2014; Liberman 1981; Linehan 1991; Linehan 2006;
McMain 2009; Priebe 2012; Salkovskis 1990; Torhorst 1988;
Tyrer 2003; Weinberg 2006). For an additional 28 trials, over
half the sample had a history of multiple episodes of SH (Allard
1992; Bateman 2009; Beautrais 2010; Bennewith 2002; Brown
2005; Carter 2005; Cedereke 2002; Crawford 2010; Davidson
2014; Dubois 1999; Gibbons 1978; Guthrie 2001; Hatcher
2016a; Hatcher 2015; Hatcher 2011; Husain 2014; Kapur 2013a;
Marasinghe 2012; McAuliffe 2014; McLeavey 1994; Morthorst
2012; Patsiokas 1985; Slee 2008; Stewart 2009; Tapolaa 2010;
Turner 2000; Wei 2013; Welu 1977). In four further trials, just
under half of the sample had a history of multiple episodes of
SH (Clarke 2002: 47.0%; Evans 1999a: 47.6%; Kawanishi 2014:
49.2%; Van der Sande 1997a: 46.3%). We present the propor-
tion with a prior history of SH in the remaining eight trials in
Table 1. Morgan 1993 excluded those with a history of multiple
episodes of SH from participation, whilst Torhorst 1987 provided
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no information on the proportion of the sample with a history of
multiple episodes of SH.
In around half of the included trials (k = 25; 45.4%), the au-
thors stated either within the trial report or through correspon-
dence that they included participants irrespective of whether or
not the episode of SH involved suicidal intent (Bateman 2009;
Beautrais 2010; Bennewith 2002; Clarke 2002; Davidson 2014;
Fleischmann 2008; Harned 2014; Hatcher 2016a; Hatcher 2015;
Hatcher 2011; Hawton 1981; Hawton 1987a; Hvid 2011; Kapur
2013a; Liberman 1981; Linehan 2006; McAuliffe 2014; McMain
2009; Patsiokas 1985; Slee 2008; Tapolaa 2010; Torhorst 1987;
Turner 2000; Tyrer 2003; Van Heeringen 1995; Waterhouse
1990). Seven trials included participants following a ’suicide at-
tempt’ (i.e., suggestive of evidence of suicidal intent) (Allard 1992;
Cedereke 2002;Morthorst 2012; Salkovskis 1990; Torhorst 1988;
Van der Sande 1997a;Wei 2013). A further five trials included par-
ticipants only if there had been evidence of suicidal intent (Brown
2005; Kawanishi 2014; Marasinghe 2012; Stewart 2009; Welu
1977), whilst in an additional two, the majority of participants
(76.5% and 74.0% respectively) expressed a wish to die (Guthrie
2001; Husain 2014). Gratz 2014 included participants only if
there was no evidence of suicidal intent, whilst only 2.0% in one
trial expressed awish to die (Vaiva 2006). Thirteen trials did not re-
port information on suicidal intent (Carter 2005; Crawford 2010;
Dubois 1999; Evans 1999a; Evans 1999b; Gibbons 1978; Gratz
2006; Hassanian-Moghaddam 2011; Linehan 1991; McLeavey
1994; Morgan 1993; Priebe 2012; Weinberg 2006).
Twenty-five trials did not report information on the meth-
ods of SH for the index episode (Allard 1992; Bateman 2009;
Cedereke 2002; Davidson 2014; Dubois 1999; Evans 1999b;
Fleischmann 2008; Gratz 2006; Gratz 2014; Hvid 2011; Kapur
2013a; Linehan 1991; Linehan 2006;Marasinghe 2012;McMain
2009; Morthorst 2012; Patsiokas 1985; Priebe 2012; Salkovskis
1990; Stewart 2009; Tapolaa 2010; Turner 2000; Tyrer 2003;Wei
2013; Weinberg 2006). One trial provided information on the
methods used in all episodes of SH (including the index episode)
in the two years preceding trial entry (Liberman 1981). A total
of 55.7% of these episodes involved self-poisoning and 44.3% in-
volved self-injury. One additional trial provided information on
methods used in the three months prior to trial entry with a total
of 61 (67.8%) participants in this trial engaging in self-injury at
least once over this period; however, investigators did not specify
the methods that the remaining 29 participants used for SH (Slee
2008). We present methods of SH for the remaining 28 trials in
Table 2. In these trials, the majority of participants had engaged
in self-poisoning (k = 28; 79.9%). Two trials included only those
who engaged in self-injury (Harned 2014; Welu 1977), whilst in
a further trial the majority of participants (75.6%) had engaged
in self-poisoning using pesticides (Husain 2014).
Comorbidities
We present information on current psychiatric diagnoses for all 55
trials in Table 3. Eight trials focused specifically on participants
diagnosed with borderline personality disorder (Bateman 2009;
Gratz 2006; Gratz 2014; Linehan 1991; Linehan 2006; McMain
2009; Turner 2000; Weinberg 2006), three focused on partici-
pants diagnosed with any personality disorder (Davidson 2014;
Evans 1999b; Priebe 2012), one focused specifically on partici-
pants diagnosed with alcohol use (Crawford 2010), and one fo-
cused on participants with comorbid post-traumatic stress disor-
der and borderline personality disorder (Harned 2014).
Details on comorbid diagnoses were not reported in the majority
of trials (k = 49; 89.1%) (Allard 1992; Bateman 2009; Beautrais
2010; Bennewith 2002; Cedereke 2002; Clarke 2002; Crawford
2010; Dubois 1999; Evans 1999a; Evans 1999b; Fleischmann
2008; Gibbons 1978; Gratz 2006; Guthrie 2001; Harned 2014;
Hassanian-Moghaddam 2011; Hatcher 2016a; Hatcher 2015;
Hatcher 2011; Hawton 1981; Hawton 1987a; Husain 2014;
Hvid 2011; Kapur 2013a; Kawanishi 2014; Liberman 1981;
Linehan 1991; Linehan 2006;Marasinghe 2012;McAuliffe 2014;
McLeavey 1994; Morgan 1993; Morthorst 2012; Patsiokas 1985;
Priebe 2012; Salkovskis 1990; Stewart 2009; Tapolaa 2010;
Torhorst 1987; Torhorst 1988; Turner 2000; Tyrer 2003; Vaiva
2006; Van der Sande 1997a; Van Heeringen 1995; Waterhouse
1990; Wei 2013; Weinberg 2006; Welu 1977). In Brown 2005,
most participants (85.0%) were diagnosed with more than one
psychiatric disorder; however, the authors did not provide infor-
mation on specific diagnoses. In an additional three trials (Carter
2005; McMain 2009; Slee 2008), the median number of psychi-
atric diagnoses was greater than two, suggesting that participants
in these trials were also diagnosed with more than one psychiatric
disorder; however, none of the three reported further information
on specific diagnoses. In one trial, 45.0% of the participants were
diagnosed with comorbid personality disorder and substance mis-
use (Davidson 2014), whilst in another, just under half of the sam-
ple (45.9%) had a comorbid personality diagnosis (Gratz 2014).
Setting
Of the 55 independent RCTs included in this review, most took
place in the United Kingdom (k = 17) or the United States (k =
12), followed by New Zealand (k = 4), Australia (k = 2), Canada
(k = 2), Denmark (k = 2), France (k = 2), Germany (k = 2),
the Netherlands (k = 2), and one each from Belgium, China,
Finland, Iran, Japan, Pakistan, the Republic of Ireland, Sri Lanka,
and Sweden. One trial was a multicentre study conducted in a
number of countries.
Interventions
The trials included in this review investigated the effectiveness of
various forms of psychosocial intervention.
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1. CBT-based psychotherapy versus TAU (k = 18: Brown
2005; Davidson 2014; Dubois 1999; Evans 1999b; Gibbons
1978; Guthrie 2001; Hatcher 2011; Hawton 1987a; Husain
2014; McAuliffe 2014; Patsiokas 1985; Salkovskis 1990; Slee
2008; Stewart 2009; Tapolaa 2010; Tyrer 2003; Wei 2013;
Weinberg 2006).
2. Interventions for multiple repetition of SH versus TAU (k =
6: Bateman 2009; Gratz 2006; Gratz 2014; Linehan 1991;
McMain 2009; Priebe 2012) or other alternative forms of
psychotherapy (k = 3: Harned 2014; Linehan 2006; Turner
2000).
3. Case management versus TAU (k = 4: Clarke 2002; Hvid
2011; Kawanishi 2014; Morthorst 2012).
4. Treatment adherence enhancement approaches versus TAU
(k = 1: Van Heeringen 1995) or other alternative forms of
psychotherapy (k = 1: Torhorst 1987).
5. Mixed multimodal interventions versus TAU (k = 2:
Hatcher 2016a; Hatcher 2015).
6. Remote contact interventions versus TAU (k = 11:
Beautrais 2010; Bennewith 2002; Carter 2005; Cedereke 2002;
Evans 1999a; Hassanian-Moghaddam 2011; Kapur 2013a;
Marasinghe 2012; Morgan 1993; Vaiva 2006; Wei 2013).
7. Other mixed interventions versus TAU (k = 5: Allard 1992;
Crawford 2010; Fleischmann 2008; Van der Sande 1997a; Welu
1977) or other alternative forms of psychotherapy (k = 5:
Hawton 1981; Liberman 1981; McLeavey 1994; Torhorst 1988;
Waterhouse 1990).
Outcomes
Information on the primary outcome, repetition of SH, was avail-
able for all but one of the included trials (Patsiokas 1985). In
the case of four trials, we obtained information on this out-
come following correspondence with authors (Marasinghe 2012;
McAuliffe 2014; McMain 2009; Tapolaa 2010). For around half
of the trials (k = 24; 43.6%), information on repetition of SH
was based on self-report (Brown 2005; Cedereke 2002; Davidson
2014; Evans 1999b; Gratz 2006; Gratz 2014; Harned 2014;
Hassanian-Moghaddam 2011; Hawton 1981; Hawton 1987a;
Husain 2014; Liberman 1981; Linehan 1991; Linehan 2006;
McMain 2009; Priebe 2012; Slee 2008; Tapolaa 2010; Torhorst
1988; Turner 2000; Vaiva 2006; Van Heeringen 1995; Wei 2013;
Weinberg 2006), whilst in a further eight trials, collateral re-
ports, hospital/clinical records, or both supplemented the self-
reported information (Allard 1992; Bateman 2009; Bennewith
2002; Fleischmann 2008; Guthrie 2001; Hvid 2011; Morthorst
2012; Tyrer 2003). In 11 trials, information on repetition of SH
was based on hospital re-presentations (Beautrais 2010; Carter
2005; Clarke 2002; Crawford 2010; Evans 1999a;Hatcher 2016a;
Hatcher 2015; Hatcher 2011; Kapur 2013a; Waterhouse 1990;
Welu 1977), whilst in three others, investigators obtained the
information from hospital or medical records (Gibbons 1978;
Morgan 1993; Van der Sande 1997a). McLeavey 1994 used col-
lateral records supplemented by hospital records to determine
repetition of SH. McAuliffe 2014 used mixed methods to de-
termine repetition of SH, using self-reported information at the
post-intervention and six-month follow-up assessments and data
on hospital re-presentations at the 12 month follow-up assess-
ment. Patsiokas 1985 did not report information on repetition
of SH, and our review team was unable to obtain this infor-
mation through correspondence. The remaining seven trials pro-
vided no details about the source of the data on repetition of
SH (Dubois 1999; Kawanishi 2014;Marasinghe 2012; Salkovskis
1990; Stewart 2009; Torhorst 1987).
The 19 trials that recorded informationon treatment adherence as-
sessed this using a variety of methods, including: the proportion of
participants who completed the full course of treatment (Bateman
2009;Harned 2014;Husain 2014; Linehan 1991;McMain 2009;
Priebe 2012; Slee 2008; Torhorst 1987; Turner 2000), the propor-
tion of participants who attended at least one treatment session
(Bennewith 2002; Cedereke 2002; Hawton 1981), and the num-
ber of treatment sessions attended (Brown 2005; Evans 1999b;
Van Heeringen 1995). Three trials assessed treatment adherence
using both the proportion of participants that completed the full
course of treatment and the total number of treatment sessions at-
tended (McAuliffe 2014; McLeavey 1994; Torhorst 1988), whilst
the remaining trial assessed treatment adherence using both the
proportion of participants who attended at least one treatment
session and the total number of treatment sessions attended (Van
der Sande 1997a).
Investigators assessed depression using the BDI in 13 trials
(Bateman 2009; Fleischmann2008;Gibbons 1978;Guthrie 2001;
Hawton 1987a; Husain 2014; Linehan 1991; Marasinghe 2012;
McAuliffe 2014; McMain 2009; Salkovskis 1990; Slee 2008;
Tapolaa 2010), theHamiltonRating Scale forDepression (HRSD;
Hamilton 1960) in 3 trials (Harned 2014; Linehan 2006; Wei
2013), both the BDI and HRSD in 1 trial (Turner 2000), the De-
pression Anxiety Stress Scales (DASS; Lovibond 1995) in 2 trials
(Gratz 2006; Gratz 2014), the Montgomery-Åsberg Depression
Rating Scale (MADRS; Montgomery 1979) in 1 trial (Van der
Sande 1997a), the depression sub-scale of the HADS in 6 trials
(Davidson 2014; Evans 1999b; Hatcher 2016a; Hatcher 2015;
Hatcher 2011; Tyrer 2003), both the BDI and theHRSD in 1 trial
(Brown 2005), and both the BDI and the Zung Self-Rating De-
pression Scale (ZSRDS; Zung 1965) in a further trial (Liberman
1981). In one trial it was not clear what scale the researchers used
to assess depression (Torhorst 1988).
All 14 trials that recorded information on hopelessness assessed
this using the BHS (Brown 2005; Hatcher 2016a; Hatcher 2015;
Hatcher 2011; Husain 2014; Kawanishi 2014; Linehan 1991;
McAuliffe 2014; McLeavey 1994; Patsiokas 1985; Salkovskis
1990; Stewart 2009; Van der Sande 1997a; Waterhouse 1990).
Ten trials assessed suicidal ideation using the BSSI (Cedereke
2002; Davidson 2014; Guthrie 2001; Hatcher 2011; Husain
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2014;Marasinghe 2012;McAuliffe 2014; Patsiokas 1985; Stewart
2009; Turner 2000), two trials used the Suicide Behaviors Ques-
tionnaire (SBQ; Linehan 1981) (Linehan 2006; Weinberg 2006),
one trial used the Scale for Suicidal Ideators (SSI; Schotte 1982)
(Linehan 1991), and one the suicidal ideation sub-scale of the
Psychiatric Status Schedule (PSS; Spitzer 1970) (Waterhouse
1990). Three trials measured suicidal ideation dichotomously as
the proportion with self-reported suicidal ideation (Hassanian-
Moghaddam 2011; Liberman 1981; Wei 2013).
Hatcher 2011 assessed problem-solving using the Social Prob-
lem-Solving Inventory-Revised (SPSI-R; D’Zurilla 1996); Husain
2014 used the Coping Resource Inventory (CRI; Marting 1988);
Patsiokas 1985, the Means-Ends Problem Solving test (MEPS;
Maydeu-Olivares 1996); Salkovskis 1990, the Personal Ques-
tionnaire Rapid Scaling Technique (PQRST; Mulhall 1977);
McAuliffe 2014 and McLeavey 1994, both the MEPS and Self-
RatedProblemSolving Scale (SRPSS;McLeavey 1987); Slee 2008,
the oriented coping subscale of the Coping Inventory for Stress-
ful Situations (CISS; Endler 1994); and Fleischmann 2008 (at
one site of the World Health Organization’s (WHO) multisite
trial SUPRE-MISS, as reported in Xu 2012), the problem-solv-
ing sub-scale of an idiosyncratic problem-solving questionnaire.
Gibbons 1978 and Hawton 1987a measured problem-solving di-
chotomously as the proportion of participants self-reporting im-
proved problems at follow-up.
In about half of the 44 trials (k = 24; 54.5%) that recorded in-
formation on completed suicide, the method used to assess this
outcome was unclear (Bateman 2009; Beautrais 2010; Brown
2005; Clarke 2002; Davidson 2014; Dubois 1999; Gratz 2006;
Gratz 2014; Guthrie 2001; Harned 2014; Husain 2014; Kapur
2013a; Linehan 1991; Linehan 2006;Marasinghe 2012;McMain
2009; McLeavey 1994; Priebe 2012; Salkovskis 1990; Slee 2008;
Stewart 2009; Tapolaa 2010; Torhorst 1987; Weinberg 2006). In
the 20 remaining trials, investigators used a variety of methods to
assess completed suicide, including: collateral reports (Crawford
2010; Fleischmann 2008; Hawton 1987a; Wei 2013), Coroner’s
records (Hatcher 2016a; Hatcher 2015; Hatcher 2011; Hvid
2011; Tyrer 2003), hospital records, medical records or both
(McAuliffe 2014; Morthorst 2012), mortality statistics (Carter
2005; Cedereke 2002; Kawanishi 2014; Van Heeringen 1995),
collateral reports supplemented by medical records or Coroner’s
records (Allard 1992;Hassanian-Moghaddam 2011), collateral re-
port supplemented by mortality statistics (Van der Sande 1997a),
hospital records, medical records or both, supplemented by mor-
tality statistics (Vaiva 2006), or mortality statistics supplemented
by Coroner’s records (Evans 1999a).
Excluded studies
We excluded a total of 217 articles from this update: 94 in which
not all participants engaged in SH; 60 that used a non-randomised
clinical trial design; 27 that were reviews, editorials, letters to the
editor, or conference proceedings; 23 that were trial protocols; 11
where SH could have occurred at any point rather than within six
months of randomisation; one that only presented data from one
trial arm (although a related publication that presented data for
both the intervention and control arms was eligible for inclusion),
and one that reported data reported for a period beyond two years
(although articles reporting data for earlier follow-up periods for
this trial were eligible for inclusion).
We excluded one trial that had been included in the original ver-
sion of this review following advice from CCDAN due to bias in
themethod used to randomise participants to the intervention and
control groups (Chowdhury 1973). We also had to exclude one
further trial that otherwise met inclusion criteria for this review as
correspondence with authors revealed that information on non-
fatal SH could not be disaggregated from information on com-
pleted suicide (Chen 2013).
We provide details on the reasons for excluding 52 trials
clearly related to psychosocial interventions for suicidality in the
Characteristics of excluded studies section.
Ongoing studies
We identified a total of 20 ongoing trials of psychosocial inter-
ventions for SH in adults. We provide full details of these trials in
the Characteristics of ongoing studies section. We note that one of
these trials has subsequently been terminated owing to the resigna-
tion of key clinical staff and a lack of ongoing funding (Agyapong
2013).
Studies awaiting classification
Four potentially relevant trials are currently awaiting assessment
(see Characteristics of studies awaiting classification table), two of
DBT (Andreasson 2016; Linehan 2015), one of a mixed multi-
modal intervention combining face-to-face psychosocial therapy
with a remote contact intervention (Gysin-Maillart 2016) and one
trial testing the effectiveness of implementation intentions (vo-
litional help sheet) in reducing suicidal ideation and behaviour
(Armitage 2016).
Risk of bias in included studies
We present summaries of the overall risk of bias for the included
trials in Figure 2 and Figure 3. Risk of bias for each included trial
is also considered within the text of the review.
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Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Sequence generation
All of the 55 independent trials used random allocation. We
considered the majority (k = 40; 72.7%) to have a low risk
of bias for this item. In most trials a computer-generated ran-
domisation sequence was used to allocate adults to the experi-
mental and control groups (Beautrais 2010; Brown 2005; Carter
2005; Guthrie 2001; Hatcher 2016a; Hatcher 2015; Hatcher
2011; Husain 2014; Kapur 2013a; Kawanishi 2014; Linehan
1991; Linehan 2006; McAuliffe 2014; Morthorst 2012; Priebe
2012; Slee 2008; Tyrer 2003; Vaiva 2006; Van der Sande 1997a;
Wei 2013). In two trials a minimisation algorithm was used
to allocate participants to the experimental and control groups
(Bateman 2009; Harned 2014) whilst in one a pre-generated
block randomisation procedure was used (McMain 2009). In
the remaining trials a variety of other randomisation procedures
were used, including: a random numbers table (Bennewith 2002;
Clarke 2002; Crawford 2010;Davidson 2014; Fleischmann 2008;
Hassanian-Moghaddam 2011; Hawton 1981; Hawton 1987a;
Welu 1977), shuffled envelopes (Gibbons 1978; Morgan 1993;
Salkovskis 1990; Waterhouse 1990; Weinberg 2006), numbers
drawn from a hat (Stewart 2009), and coin tossing (Tapolaa 2010).
In one trial details on the method used to allocate participants to
the invention and control groups were not provided, but the au-
thors undertook post hoc analyses to investigate the distribution
of various pre-treatment factors and found no significant differ-
ence in the distribution of these factors between the two groups,
suggesting that the randomisation procedure used was unbiased
(Turner 2000). We therefore also rated this trial as having low risk
of bias for this item.
We rated 13 trials (23.6%) as having unclear risk of bias for se-
quence generation, as study authors provided no information on
the method used to allocate participants to the experimental and
control groups (Cedereke 2002; Dubois 1999; Gratz 2006; Gratz
2014; Hvid 2011; Liberman 1981; Marasinghe 2012; Patsiokas
1985; Torhorst 1987; Torhorst 1988). In an additional three trials
opaque, sealed envelopes were used, but it was unclear whether
these were shuffled to ensure random sequence generation (Allard
1992; Evans 1999a; Evans 1999b). We rated the two remaining
trials as having high risk of bias for this item, as investigators used
an open numbers table to allocate participants to the experimental
and control groups (McLeavey 1994; Van Heeringen 1995).
Allocation concealment (selection bias)
We considered just over half of the included trials to be at
low risk of bias for allocation concealment (k = 31; 56.4%). A
third-party researcher working independently of the trial team
handled allocation in nine trials (Beautrais 2010; Bennewith
2002; Clarke 2002; Guthrie 2001; Harned 2014; Hassanian-
Moghaddam 2011; Hvid 2011; Morthorst 2012; Vaiva 2006),
14 trials used opaque, sealed envelopes (Allard 1992; Cedereke
2002; Crawford 2010; Evans 1999a; Evans 1999b; Gibbons 1978;
Hawton 1981; Hawton 1987a; McMain 2009; Morgan 1993;
Salkovskis 1990; Waterhouse 1990; Weinberg 2006; Van der
Sande 1997a), and a remote/offsite researcher allocated partic-
ipants in six trials (Bateman 2009; Fleischmann 2008; Husain
2014; Kawanishi 2014; Slee 2008; Tyrer 2003). In the one re-
maining trial information was not provided on the method used
to conceal allocation, but correspondence with authors confirmed
that they had adequately concealed allocation (Linehan 1991).
We rated a total of 18 trials (32.7%) as having unclear risk of bias
for this item, as they provided no information on themethod used
to conceal allocation (Brown 2005; Davidson 2014; Dubois 1999;
Gratz 2006; Gratz 2014; Kapur 2013a; Liberman 1981; Linehan
2006; Marasinghe 2012; Patsiokas 1985; Priebe 2012; Stewart
2009; Tapolaa 2010; Torhorst 1987; Torhorst 1988; Turner 2000;
Wei 2013;Welu 1977).We also rated six trials as having a high risk
of bias for this item. For four trials this was because the Zelen’s de-
sign, in which participant consent is obtained after randomisation,
was used (Carter 2005; Hatcher 2016a; Hatcher 2015; Hatcher
2011), whilst for the remaining two trials, this was because ran-
domisation was via an open numbers table (McLeavey 1994; Van
Heeringen 1995).
Blinding
Blinding was assessed separately for participants, clinical person-
nel, and outcome assessors.
Blinding of participants
Overall, we classified the majority of trials (k = 53; 96.4%) as
having high risk of bias for blinding of participants, as it is gen-
erally not possible to blind participants to psychological therapy.
In Harned 2014, correspondence with study authors clarified that
allocation was concealed from participants until their first therapy
session, at which point the therapist informed participants as to
which treatment condition they had been allocated, confirming
that participants were not blind to treatment allocation. We rated
one trial as having low risk of bias for this item, as the authors
asserted that “[t]he subjects were blinded as to their assignment”
(Fleischmann 2008, p. 704). We rated the remaining trial as hav-
ing an unclear risk of bias for this item; although authors did not
provide any information on participant blinding, treatments were
so similar that participants might have been blind to which treat-
ment they were receiving (Liberman 1981).
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Blinding of personnel
We classified the majority of trials (k = 52; 94.5%) as having high
risk of bias for blinding of clinical personnel, as it is not possible
to blind clinicians to the psychological therapy they are delivering.
We rated one trial as having an unclear risk of bias for this item as,
although GPs received a copy of the green (emergency) card given
to participants randomised to the experimental group, it is unclear
whether GPs were aware which of their patients received this card
(Morgan 1993). We rated the two remaining trials as having a low
risk of bias for this item, as clinicians were masked to allocation
status (Beautrais 2010; Hassanian-Moghaddam 2011).
Blinding of outcome assessors
As outcome assessors were blind to treatment allocation in 30
(54.5%) of the trials included in this review, we rated the ma-
jority of trials as having low risk of bias for blinding of outcome
assessment. We rated 10 trials as having a high risk of bias for
this item, as outcome assessor blinding was not possible: in four
trials this was due to reliance on self-reported information from
participants who were not blind to treatment allocation (Guthrie
2001; Slee 2008; Torhorst 1987; Van Heeringen 1995), and in six
it was due to issues related to feasibility, implementation, or both
(Allard 1992; Brown 2005; Gratz 2006; Hassanian-Moghaddam
2011; Stewart 2009; Waterhouse 1990). We rated the remain-
ing 15 trials as having an unclear risk of bias for this item as
they did not provide information on outcome assessor blinding
(Bennewith 2002; Cedereke 2002; Dubois 1999; Fleischmann
2008; Liberman 1981; Morgan 1993; Morthorst 2012; Patsiokas
1985; Salkovskis 1990; Tapolaa 2010; Torhorst 1988; Tyrer 2003;
Van der Sande 1997a; Wei 2013; Welu 1977).
Incomplete outcome data
For most trials the authors reported having conducted analyses on
an intention-to-treat basis, earning thema rating of low risk for this
item (k = 33; 60.0%), although the method used to conduct these
analyses was not clear for the majority of these trials (Allard 1992;
Bateman 2009; Beautrais 2010; Carter 2005; Cedereke 2002;
Crawford 2010; Davidson 2014; Evans 1999a; Guthrie 2001;
Hassanian-Moghaddam 2011; Hawton 1987a; Husain 2014;
Hvid 2011; Kapur 2013a; Kawanishi 2014; Marasinghe 2012;
Morgan 1993; Morthorst 2012; Salkovskis 1990; Turner 2000;
Vaiva 2006; Van der Sande 1997a; Wei 2013; Weinberg 2006).
Three used regression methods (Bennewith 2002; Clarke 2002;
Priebe 2012), one used longitudinal modelling (Brown 2005),
and one used Bayesian Markov chain Monte Carlo simulation
(Gratz 2014). The remaining three trials combined intention-to-
treat with per protocol analyses (Harned 2014; Hatcher 2011;
McMain 2009; Slee 2008), so we also rated them as having low
risk of bias for this item. We rated seven trials as having unclear
risk, as insufficient information was provided to confirm whether
intention-to-treat or per protocol analyses had been undertaken
(Hawton 1981; Patsiokas 1985; Torhorst 1987; Torhorst 1988;
Tyrer 2003; Waterhouse 1990; Van Heeringen 1995). We classi-
fied the remaining 15 trials as having high risk of bias because per
protocol analyses were undertaken (Dubois 1999; Evans 1999b;
Fleischmann 2008; Gibbons 1978; Gratz 2006; Hatcher 2015;
Hatcher 2016a; Liberman 1981; Linehan 1991; Linehan 2006;
McAuliffe 2014; McLeavey 1994; Stewart 2009; Tapolaa 2010;
Welu 1977).
Selective reporting
As the review authors did not have access to trial protocols for the
trials included in this review, it is difficult to assess the extent to
which selective outcome reporting could have occurred. Conse-
quently, we classified themajority of trials as having an unclear risk
of bias for this item (k = 52; 94.5%). We rated the remaining three
trials as having high risk of bias for this outcome because data on
pre-specified outcomes were not reported in the text (Kawanishi
2014; McLeavey 1994; Torhorst 1987).
Other potential sources of bias
We classified most trials as having low risk of bias for this item as
no evidence of other bias was apparent (k = 47; 85.4%). We rated
seven trials as at high risk of bias for this item. Three had used Ze-
len’s post-consent randomisationprocedure to allocate participants
to the experimental and control groups (Hatcher 2011; Hatcher
2016a; Hatcher 2015). In an additional three there were substan-
tial imbalances between the experimental and control groups on a
number of putative risk factors for repetition of SH, despite ran-
domisation (Beautrais 2010; Davidson 2014; Torhorst 1987). We
rated the remaining trial as at high risk of other bias because a small
number of participants in the control group (n = 20; 5.1%) mis-
takenly received the intervention treatment and yet were included
in the control group for all subsequent analyses (Carter 2005).We
rated one further trial as having unclear risk of bias for this item,
as the participants were biased towards more compliant patients
who were willing and able to attend a psycho-education session at
the commencement of treatment and were able to attend hospital
regularly for case management sessions and follow-up face-to-face
interviews. Additionally, this trial excluded individuals who had
engaged in non-suicidal SH from participation (Kawanishi 2014).
Few trials used systematic means to investigate whether partici-
pants were able to guess if they had been allocated to the experi-
mental or control arm.
Thirteen trials did not indicate the source of funding (Allard
1992; Dubois 1999; Hatcher 2016a; Hatcher 2015; McLeavey
1994; Morgan 1993; Patsiokas 1985; Salkovskis 1990; Stewart
2009; Tapolaa 2010; Torhorst 1987; Turner 2000; Waterhouse
1990). Fifteen trials received funding from national medical as-
sociations, research organisations, or both (Brown 2005; Gratz
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2014; Harned 2014; Hawton 1987a; Kapur 2013a; Liberman
1981; Linehan 1991; Linehan 2006; McMain 2009; Priebe
2012; Slee 2008; Tyrer 2003; Van Heeringen 1995; Wei 2013;
Welu 1977). An additional nine trials received funding from
a health organisation (Bennewith 2002; Carter 2005; Clarke
2002; Davidson 2014; Evans 1999b; Fleischmann 2008; Gratz
2006; Guthrie 2001; Vaiva 2006). The remaining trials received
funding from a variety of sources, including: research organisa-
tions associated with specific diagnostic groups (Bateman 2009;
Weinberg 2006), charitable trusts (Crawford 2010), private re-
search foundations (Cedereke 2002), accident compensation or-
ganisations (Hatcher 2011), health insurance companies (Van der
Sande 1997a), government departments (Evans 1999a; Hawton
1981; Kawanishi 2014; Torhorst 1988), and university sources
(Marasinghe 2012). A number of trials also received joint fund-
ing, including from health and accident compensation organ-
isations (Beautrais 2010), health organisations and legal chari-
ties (Hassanian-Moghaddam 2011), university sources and edu-
cational institutes (Husain 2014), government departments and
health organisations (Gibbons 1978), government departments
and health insurance companies (Hvid 2011), government depart-
ments and charitable trusts (Morthorst 2012), and health organi-
sations and national research organisations (McAuliffe 2014).
Effects of interventions
See:Summaryoffindings for themain comparisonComparison
1: CBT-based psychotherapy vs treatment as usual; Summary of
findings 2 Comparison 2: Interventions for multiple repetition
of SH/probable personality disorder vs treatment as usual or
other alternative forms of psychotherapy; Summary of findings
3 Comparison 3: Case management vs treatment as usual or
other alternative forms of psychotherapy; Summary of findings 4
Comparison 4: Adherence enhancement approaches vs treatment
as usual or other alternative forms of psychotherapy; Summary
of findings 5 Comparison 5: Mixed multimodal interventions
vs treatment as usual; Summary of findings 6 Comparison 6:
Remote contact interventions vs treatment as usual; Summary of
findings 7Comparison 7:Othermixed interventions vs treatment
as usual or other alternative form of psychotherapy
Comparison 1: CBT-based psychotherapy vs
treatment as usual (TAU)
Eighteen trials assessed the effectiveness ofCBT-based psychother-
apy, in which participants in the experimental group were offered
some form of specific psychological therapy, such as cognitive be-
havioural therapy or problem-solving therapy (Brown 2005, N
= 120; Davidson 2014, N = 20; Dubois 1999, N = 102; Evans
1999b, N = 32; Gibbons 1978, N = 400; Guthrie 2001, N = 119;
Hatcher 2011, N = 1094; Hawton 1987a, N = 80; Husain 2014,
N = 221; McAuliffe 2014, N = 433; Patsiokas 1985, N = 15;
Salkovskis 1990, N = 20; Slee 2008, N = 82; Stewart 2009, N =
32; Tapolaa 2010, N = 16; Tyrer 2003, N = 480; Wei 2013, N =
162; Weinberg 2006; N = 30). One of these used Zelen’s design
(Hatcher 2011). In most trials, therapy was typically very brief
(i.e., less than 10 sessions), and it was delivered on an individual
basis in all but one (McAuliffe 2014). One trial included only
patients with borderline personality disorder (Weinberg 2006). In
Stewart 2009, there were separate treatment arms for cognitive
behavioural therapy and problem-solving therapy. We therefore
combined data from these two conditions using the formula out-
lined in section 7.7.3.8 of the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011).
Primary outcome
1.1 Repetition of SH
There was no evidence of a significant treatment effect for CBT-
based psychotherapy on repetition of SH by post-intervention in
McAuliffe 2014 (23/171 vs 27/142; OR 0.66, 95% CI 0.36 to
1.21; k = 1; N = 313; GRADE: low quality).
By the six-month follow-up assessment, however, on the basis of
data from 12 trials there was evidence of a significant treatment
effect for CBT-based psychotherapy on repetition of SH (Anal-
ysis 1.1; OR 0.54, 95% CI 0.34 to 0.85; k = 12; N = 1317),
with moderate quality of evidence (see Summary of findings for
the main comparison). OmittingWeinberg 2006, which included
only participants diagnosed with borderline personality disorder,
did not materially affect this result. There was, however, evidence
of a significant difference by modality (Analysis 1.1; test for sub-
group differences: Chi2= 7.32, degrees of freedom (df ) = 1, P =
0.007, I2 = 86.3%). Specifically, although individual CBT-based
psychotherapy was associated with a significant treatment effect
on repetition of SH by the six-month follow-up assessment (OR
0.52, 95% CI 0.36 to 0.75; k = 11; N = 1083), a group-based
approach was not associated with a significant treatment effect for
this outcome in one trial (OR 1.35, 95% CI 0.75 to 2.41; k = 1;
N = 234; McAuliffe 2014).
There was also evidence of a significant treatment effect for CBT-
based psychotherapy by the 12-month follow-up assessment in
10 trials (Analysis 1.2; OR 0.80, 95% CI 0.65 to 0.98; k =
10; N = 2142), again with a moderate quality of evidence (see
Summary of findings for themain comparison).Once again, omit-
ting Weinberg 2006 did not materially affect this result, nor did
omitting Hatcher 2011, which used Zelen’s design. Hatcher 2011
also reported numbers of participants self-reporting an episode of
SH rather than those admitted to hospital following an episode of
SH.Using these data, however, did not materially affect this result.
There was no evidence of a significant difference by modality for
this outcome (Analysis 1.2; test for subgroup differences: Chi2 =
1.68, df = 1, P = 0.19, I2 = 40.6%).
In two trials data on repetition of SH from 12 to 24 months
were reported. A significant treatment effect for this outcome was
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found (Analysis 1.3; OR 0.31, 95% CI 0.14 to 0.69; k = 2; N
= 105; GRADE: moderate quality) (see Summary of findings for
the main comparison).
Including all 17 trials that reported information on repetition of
SH suggested a significant treatment effect for CBT-based psy-
chotherapy by the final follow-up assessment (i.e., including data
for the last follow-up assessment available in each trial) (Analysis
1.4; OR 0.70, 95%CI 0.55 to 0.88; k = 17; N = 2665). Excluding
Hatcher 2011 or Weinberg 2006 did not materially affect these
results. Once again, using data on self-reported incidents of SH
for Hatcher 2011 did not materially affect this result, nor did us-
ing data for the randomised rather than consenting group. There
was also no evidence of a significant difference by modality for
this outcome (Analysis 1.4; test for subgroup differences: Chi2 =
3.08, df = 1, P = 0.08, I2 = 67.5%). However, quality of evidence,
as assessed by the GRADE criteria, was low for this outcome (see
Summary of findings for the main comparison).
With respect to frequency of SH, data from six trials indicated
no significant treatment effect for CBT-based psychotherapy on
frequency of repetition of SH by final follow-up (Analysis 1.5; k =
6; N = 594). Excluding Weinberg 2006 did not materially affect
this result. There was no evidence of a significant difference by
modality (Analysis 1.5; test for subgroup differences: Chi2 = 1.17,
df = 1, P =0.28, I2 =14.2%).However, this outcomewas associated
with lowquality of evidence (see Summary of findings for themain
comparison). One trial reported information on median, rather
than mean, number of episodes of SH at six months. However,
the authors found that although “[t]he rate of self-harm episodes
was lower in the [experimental] group . . . [it was not] significantly
so” (Evans 1999b, p.22). A further trial reported information on
mediannumber of episodes of SHat 12months’ follow-up, finding
that “[t]he median number of self-harm episodes was two in both
[the experimental and TAU] groups” (Tyrer 2003, p. 972).
Secondary outcomes
1.2 Treatment adherence
Data on adherence was reported for both the experimental and
control groups in one trial in which a significant treatment effect
for CBT-based psychotherapy on the proportion of participants
who completed all 12 sessions of therapy in addition to the three
follow-up appointments was found (40/40 vs 33/42; OR 22.97,
95% CI 1.29 to 409.37; k = 1; N = 82; Slee 2008).
Four trials reported adherence data for the experimental group
only (Brown 2005; Evans 1999b; Husain 2014; McAuliffe 2014).
Brown2005 found that “participants in the cognitive therapy (CT)
group participated in a mean (SD) of 8.92 (5.97) CT sessions
(range 0-24). Thirty participants (50%) received ten or more CT
sessions” (p. 568). In Evans 1999b, five participants in the exper-
imental group did not have specific sessions of manual-assisted
cognitive-behaviour therapy (MACT) and received almost all in-
put from the booklet component of CBT alone. Overall, 17 of the
18 participants in the experimental group received the booklets.
Husain 2014 found that “more than half of the (intervention)
group attended all six sessions (n= 56)” (p. 466).
McAuliffe 2014, in which a group-based approach was used, like-
wise found that “almost half of those assigned to [problem-solving
therapy] (103, 46.4%) attended all 6 therapy sessions” (p. 4).
1.3 Depression
There was no evidence of a significant treatment effect for CBT-
based psychotherapy on depression scores at the post-intervention
assessment in McAuliffe 2014 (mean 18.20, SD 14.80, n = 171
vs mean 20.60, SD 16.0, n = 142; MD -2.40, 95% CI -5.84 to
1.04; k = 1; N = 313).
Data on depression scores at six months’ follow-up suggested a
significant treatment effect for CBT-based psychotherapy on de-
pression scores (Analysis 1.6; SMD -0.30, 95% CI -0.50 to -0.10;
k = 11; N = 1668). Omitting Hatcher 2011, which used Zelen’s
design, did not materially affect this result. There was also no evi-
dence of a significant difference by modality (Analysis 1.6; test for
subgroup differences: Chi2 = 1.38, df = 1, P = 0.24, I2 = 27.3%).
Seven trials reported data on depression scores at 12 months, sug-
gesting evidence of a significant treatment effect for psychological
therapy (Analysis 1.7; SMD -0.36, 95% CI -0.64 to -0.07; k = 7;
N = 1130; I2 = 76%). This outcome was associated with substan-
tial levels of heterogeneity (I2 = 76%). Omitting Hatcher 2011
did not materially affect the result nor the heterogeneity. Visual
inspection of the forest plot did not clearly indicate which trial/s
contributed to this substantial level of heterogeneity.
Only two trials reported depression scores between 12 and 24
months’ follow-up; however, there was no evidence of a significant
treatment effect for CBT-based psychotherapy (Analysis 1.8; k =
2; N = 225). One trial also reported data on depression scores at
6 and 12 months’ follow-up (Hawton 1987a); however, there was
not enough information to enable calculation of the SD. Never-
theless, the authors reported that there were no significant differ-
ences between groups in BDI scores at any time point.
Analysis of all 14 trials at final follow-up indicated a signifi-
cant treatment effect for CBT-based psychotherapy on depression
(Analysis 1.9; SMD -0.31, 95% CI -0.48 to -0.14; k = 14; N =
1859). Omitting Hatcher 2011 did not materially affect this re-
sult.
1.4 Hopelessness
There was no evidence of a significant treatment effect for CBT-
based psychotherapy on hopelessness at the post-intervention as-
sessment in three trials, regardless of treatment modality (Analysis
1.10; test for subgroup differences: Chi2 = 2.06, df = 1, P = 0.15,
I2 = 51.5%).
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However, by the six-month follow-up assessment, CBT-based psy-
chotherapy was associated with a significant treatment effect in
four trials (Analysis 1.11; SMD -0.36, 95% CI -0.58 to -0.13; k
= 4; N = 968). There was evidence of a difference by treatment
modality for this outcome, however (Analysis 1.11; test for sub-
group differences: Chi2 = 8.11, df = 1, P = 0.004, I2 = 87.7%). A
group-based CBT-based psychotherapy approach was not associ-
ated with a significant treatment effect on hopelessness scores at
six months in one trial (MD -0.30, 95% CI -1.89 to 1.29; k = 1;
N = 234; McAuliffe 2014).
Three trials reported data on hopelessness scores at 12 months,
again showing evidence of a significant treatment effect for CBT-
based psychological therapy (Analysis 1.12; MD -1.89, 95% CI -
2.97 to -0.81; k = 3; N = 539). Omitting Hatcher 2011, which
used Zelen’s design, did not materially affect these results.
Analyses of all seven trials also suggested evidence of a significant
treatment effect at final follow-up (Analysis 1.13, SMD -0.31,
95%CI -0.51 to -0.10; k = 7; N = 1017). Omitting Hatcher 2011
did not materially affect this result. There was also no evidence
of a significant treatment difference by modality for this outcome
(Analysis 1.13; test for subgroup differences: Chi2 = 3.65, df = 1,
P = 0.06, I2 = 72.6%).
1.5 Suicidal ideation
There was no evidence of a significant treatment effect for CBT-
based psychotherapy in three trials at the post-intervention assess-
ment, regardless of treatment modality (Analysis 1.14; k = 3; N
= 360; test for subgroup differences: Chi2 = 1.84, df = 1, P =
0.17, I2 = 45.8%). However, sensitivity analyses using the fixed-
effect, rather than random-effects model, suggested evidence of a
significant treatment effect for CBT-based psychotherapy on this
outcome (fixed: MD -1.93, 95% CI -3.83 to -0.04).
By the six-month follow-up assessment, CBT-based psychother-
apy was associated with a significant treatment effect for suicidal
ideation scores (Analysis 1.15; SMD -0.32, 95% CI -0.51 to -
0.13; k = 6; N = 1011). Omitting Hatcher 2011, which used Ze-
len’s design, did not materially affect this result, nor did omitting
Weinberg 2006, in which participants had been diagnosed with
personality disorders. Therewas evidence of a significant difference
by treatment modality, however (Analysis 1.15; test for subgroup
differences: Chi2 = 6.69, df = 1, P = 0.010, I2 = 85.1%), with a
group-based CBT-based psychotherapy approach not appearing
to be associated with a significant treatment effect for this out-
come (Analysis 1.15; MD -0.20, 95%CI -2.49 to 2.09; McAuliffe
2014).
Data from Hatcher 2011 suggested that CBT-based psychother-
apy was not associated with a significant treatment effect for suici-
dal ideation scores at 12 months (mean 3.70, SD 6.70, n = 187 vs
mean 4.80, SD 7.40, n = 231; MD -1.10, 95% CI -2.45 to 0.25;
k = 1; N = 418).
Including all eight trials suggested evidence for a significant treat-
ment effect for psychological therapy on suicidal ideation scores at
final follow-up (Analysis 1.16; SMD-0.32, 95%CI -0.53 to -0.11;
k = 8; N = 1129). Omitting Hatcher 2011 or Weinberg 2006 did
not materially affect this result. However, once again there was ev-
idence of a significant difference by treatment modality (Analysis
1.16; test for subgroup differences: Chi2 = 4.61, df = 1, P = 0.03, I2
= 78.3%), with a group-based psychotherapy approach not associ-
ated with a significant treatment effect for this outcome (Analysis
1.16; MD -0.02, 95% CI -0.24 to 0.20; McAuliffe 2014).
Wei 2013 recorded data on the proportion of participants self-
reporting suicidal ideation. There was no evidence of a significant
treatment effect for CBT-based psychotherapy in this trial at the
six-month follow-up assessment (30/35 vs 32/40; OR 1.50, 95%
CI 0.44 to 5.10; k = 1; N = 75). Although data were also available
for the 12-month follow-up period, authors reported a greater
number of participants in the CBT arm who self-reported suicidal
ideation (n = 30) than were reported to have been followed-up by
this point (n = 25). As we were unable to clarify these numbers
with the authors, we have excluded this analysis from the review.
1.6 Problem solving
Two trials recorded dichotomous data on problem-solving as the
proportion of participants reporting improvement in problems.
There was evidence of a significant treatment effect for CBT-based
psychotherapy on problem-solving in these trial trials at the six-
month follow-up assessment (Analysis 1.17; OR 2.81, 95% CI
1.50 to 5.24; k = 2; N = 231). However, for the same dichotomous
outcome, there was no indication of any apparent treatment effect
at the 12-month follow-up assessment in Hawton 1987a (24/30
vs 26/35; OR 1.38, 95% CI 0.43 to 4.47; k = 1; N = 65). Gibbons
1978 reported data for problem-solving at the 24-month follow-
up assessment, with evidence of a significant treatment effect for
CBT-based psychotherapy (64/73 vs 40/73; OR 5.87, 95% CI
2.54 to 13.54; k = 1; N = 146). Analysis of both these trials at the
final follow-up assessment, however, suggested no overall evidence
of a significant treatment effect for CBT-based psychotherapy on
problem-solving (Analysis 1.18; k = 2; N = 211). On the other
hand, therewas a significant difference using the fixed-effectmodel
(fixed: OR 3.66, 95% CI 1.88 to 7.09).
Data on problem-solving scores at post-intervention indicated
no evidence of a significant treatment effect for CBT-based psy-
chotherapy with no evidence of a significant difference by treat-
ment modality (Analysis 1.19; test for subgroup differences: Chi
2 = 0.07, df = 1, P = 0.79, I2 = 0%). By the six-month follow-
up, however, there was evidence of a significant treatment effect
for CBT-based psychotherapy for this outcome (Analysis 1.20;
SMD 0.33, 95% CI 0.08 to 0.58; k = 4; N = 949). Omitting
Hatcher 2011, which used Zelen’s design, caused this effect to be-
come non-significant (MD 0.24, 95% CI -0.03 to 0.51). There
was also evidence of a significant difference by treatment modality
(Analysis 1.20; test for subgroup differences: Chi2 = 8.11, df = 1,
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P = 0.004, I2 = 87.7%), with a single trial of group-based psy-
chotherapy indicating no evidence of a significant treatment effect
for this outcome (MD 0.30, 95% CI -3.55 to 4.15; McAuliffe
2014). There was no apparent benefit for CBT-based psychother-
apy in a single trial at 12 months (mean 92.2, SD 18.1, n = 190 vs
mean 90.5, SD 18.9, n = 233; MD 1.70, 95% CI -1.84 to 5.24;
k = 1; N = 423; Hatcher 2011). Combining all five trials at final
follow-up suggested evidence of a significant treatment effect for
problem solving at the final follow-up assessment (Analysis 1.21;
SMD 0.26, 95% CI 0.02 to 0.50; k = 5; N = 958). Omitting
Hatcher 2011 caused the association to become non-significant
(SMD 0.35, 95% CI -0.00. to 0.69; k = 4; N = 535).
Finally, Salkovskis 1990 reported the severity of participants’ three
main problems using the Personal Questionnaire Rapid Scaling
Technique (PQRST) at one week, one month, three months,
six months and one year following entry to treatment. The au-
thors reported that “the problem-solving therapy group showed
significantly better overall results on their three main problems
when compared with the group who received ’treatment as usual’
” (Salkovskis 1990, p. 873).
1.7 Suicide
Fifteen trials reported data on suicides during follow-up; however,
there was no evidence of a significant treatment effect for CBT-
based psychotherapy on suicides by final follow-up (Analysis 1.22;
k = 15; N = 2354). In Tyrer 2003, there was one death in the
experimental group that medical staff considered to be a suicide,
although the coroner did not record a suicide verdict in this case.
Including this death as a suicide did not materially change the
overall result.
Comparison 2: Interventions for multiple episodes of
SH/probable personality disorder vs TAU or other
alternative forms of psychotherapy
A number of trials investigated provision of a specialised treatment
for patients with multiple episodes of SH and/ or probable per-
sonality disorder, including: group-based emotion-regulation psy-
chotherapy (two trials; Gratz 2006; Gratz 2014), mentalisation-
based therapy (MBT; one trial; Bateman 2009), DBT-oriented
therapy (one trial; Turner 2000), DBT (four trials; Linehan 1991;
Linehan 2006;McMain 2009; Priebe 2012), and DBT prolonged
exposure protocol (one trial; Harned 2014).
Group-based emotion-regulation psychotherapy vs TAU
Two trials assessed the effectiveness of group-based emotion-reg-
ulation psychotherapy in women diagnosed with borderline per-
sonality referred for outpatient treatment as a result of recurrent
SH (Gratz 2006, N = 22; Gratz 2014, N = 61). Correspondence
with authors suggested that this treatment did not require partic-
ipants to abstain from SH behaviour. Instead, participants were
encouraged to work on resisting urges to engage in SH and, when
SH occurred, to learn from the reasons for it.
Primary outcome
2.1 Repetition of SH
Group-based emotion-regulation psychotherapy was associated
with a significant treatment effect by the post-intervention assess-
ment (Analysis 2.1; OR 0.34, 95% CI 0.13 to 0.88; k = 2; N =
83). Quality of evidence for this outcome, however, was low (see
Summary of findings 2).
With respect to frequency of repetition of SH, there was no
evidence of a significant treatment effect for group-based emo-
tion-regulation psychotherapy by the post-intervention assess-
ment (Analysis 2.1; k = 2; N = 83). Once again, this was associated
with a low quality of evidence (see Summary of findings 2).
Secondary outcomes
2.2 Treatment adherence
No data available.
2.3 Depression
There was evidence of a significant treatment effect for group-
based emotion-regulation therapy on depression scores at the post-
intervention assessment (Analysis 2.8; MD -9.59, 95% CI -13.43
to -5.75; k = 2; N = 83).
2.4 Hopelessness
No data available.
2.5 Suicidal ideation
No data available.
2.6 Problem solving
No data available.
2.7 Suicide
There were no suicides in either group for either trial.
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Mentalisation vs TAU
Bateman 2009 (N = 134) assessed the effectiveness of mentalisa-
tion-based therapy in adults diagnosed with borderline personal-
ity disorder referred to a specialist personality disorder treatment
service following an attempted suicide or an episode of life-threat-
ening SH in the six months prior to trial entry.
Primary outcome
2.8 Repetition of SH
There was a significant treatment effect for mentalisation-based
therapy by the conclusion of the 18-month treatment period, with
fewer participants in the experimental group engaging in SHbased
on data obtained by correspondence (Analysis 2.1; 18/71 vs 31/
63; OR 0.35, 95% CI 0.17 to 0.73; k = 1; N = 134). However,
quality of evidence was moderate (see Summary of findings 2).
There was also evidence of a significant treatment effect for men-
talisation-based therapy on frequency of SH episodes by the post-
intervention assessment according to data obtained by correspon-
dence (Analysis 2.5; mean 0.38, SD 0.83, n = 71 vs mean 1.66,
SD 2.87, n = 63; MD -1.28, 95% CI -2.01 to -0.55; k = 1; N =
134). Once again, quality of evidence was moderate (see Summary
of findings 2).
Secondary outcomes
2.9 Treatment adherence
There was no evidence of a significant treatment effect for mental-
isation-based therapy on the proportion of participants who com-
pleted the full course of treatment (Analysis 2.7; k = 1; N = 134).
2.10 Depression
Mentalisation-based therapy was associated with a significant
treatment effect for depression at the post-intervention assessment
(Analysis 2.8; mean 14.80, SD 8.55, n = 71 vs mean 18.68, SD
8.76, n = 63; MD -3.88, 95% CI -6.82 to -0.94; k = 1; N = 134).
2.11 Hopelessness
No data available.
2.12 Suicidal ideation
No data available.
2.13 Problem solving
No data available.
2.14 Suicide
There had been no suicides in either treatment arm by the time
of the post-treatment assessment.
Dialectical behaviour-oriented psychotherapy vs other
alternative forms of psychotherapy
One small trial in participants diagnosed with borderline person-
ality disorder and referred to outpatient services following a sui-
cide attempt assessed the effectiveness of a DBT-oriented therapy
versus client-oriented therapy over a 12-month follow-up (Turner
2000, N = 24).
Primary outcome
2.15 Repetition of SH
There was evidence of a significant treatment effect for DBT-
oriented therapy for repetition of SHbypost-treatment assessment
(Analysis 2.1; 1/12 vs 8/12; OR 0.05, 95% CI 0.00 to 0.49; k =
1; N = 24). This result had low quality evidence (see Summary of
findings 2).
Data on number of repeat episodes of SH, obtained by corre-
spondence, also suggest a significant treatment effect for DBT-
oriented therapy by the post-treatment assessment (Analysis 2.5;
mean 0.75, SD 1.23, n = 12 vs mean 5.58, SD 5.28, n = 12; MD
-4.83, 95% CI -7.90 to -1.76; k = 1; N = 24). Once again, how-
ever, a low quality of evidence was associated with this outcome
(see Summary of findings 2).
Secondary outcomes
2.16 Treatment adherence
There was no evidence of a significant treatment effect for DBT-
oriented therapy on the number of participants who completed
the full course of treatment (Analysis 2.7; k = 1; N = 24).
2.17 Depression
DBT-oriented therapy was associated with a significant treatment
effect for depression scores according to both the BDI and the
HRSDby the post-treatment assessment (BDI: Analysis 2.8;mean
14.92, SD 8.26, n = 12 vs mean 24.08, SD 5.55, n = 12; MD -
9.16, 95% CI -14.79 to -3.53; k = 1; N = 24; HRSD: mean 7.50,
SD 5.96, n = 12 vs mean 12.58, SD 3.90, n = 12; MD -5.08,
95% CI -9.11 to -1.05; k = 1; N = 24).
2.18 Hopelessness
No data available.
2.19 Suicidal ideation
30Psychosocial interventions for self-harm in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
There was also evidence of a significant treatment effect for suicidal
ideation at the post-treatment assessment (Analysis 2.11; mean
3.83, SD 8.03, n = 12 vs mean 11.58, SD 9.21, n = 12; MD -
7.75, 95% CI -14.66 to -0.84; k = 1; N = 24).
2.20 Problem solving
No data available.
2.21 Suicide
No data available.
Dialectical behaviour therapy (DBT) vs TAU
Three trials investigated the effectiveness of dialectical behaviour
therapy (DBT) in adults diagnosed with personality disorders,
typically borderline personality disorder, referred to specialistDBT
services owing to recurrent SH (Linehan 1991, N = 63; McMain
2009, N = 180; Priebe 2012, N = 80).
Primary outcome
2.22 Repetition of SH
We obtained data on repetition of SH through correspondence for
all three trials. There was no clear evidence of a significant treat-
ment effect for DBT compared to TAU in terms of the proportion
of patients repeating SH in three trials by the post-intervention
assessment (Analysis 2.1; k = 3; N = 267). Similarly, there was
no evidence of a significant treatment effect for DBT by the 12-
month follow-up assessment in two trials (Analysis 2.3; k = 2; N =
172). Combining data from all three trials by the final assessment
period suggested no evidence of a significant treatment effect for
DBT versus TAU (Analysis 2.4; k = 3; N = 247). Quality of ev-
idence for these three outcomes was low, however (see Summary
of findings 2).
There was evidence of a significant treatment effect for DBT as
compared to TAU on frequency of SH by the post-intervention
assessment (Analysis 2.5; MD -18.82, 95% CI -36.68 to -0.95; k
= 3; N = 292). Once again quality of evidence for this outcome
was low (see Summary of findings 2).
Following a “naturalistic” follow-up period, data from Linehan
1993a (N = 39) indicated that the effectiveness of DBT in the
Linehan 1991 trial was maintained at 24 months; however, this
outcome was only investigated for a proportion of the original
participants (61.9%) who the researchers were able to contact at
24 months. Results have therefore not been reproduced in the
present review.
Secondary Outcomes
2.23 Treatment adherence
There was no evidence of a significant treatment effect forDBT for
the number of participants completing the full course of treatment
in one trial (McMain 2009) (55/90 vs 56/90; OR 0.95, 95% CI
0.52 to 1.74; k = 1; N = 180). Numbers completing treatment in
the control group for Priebe 2012 were not provided. Therefore
we could not incorporate the results of this trial in a meta-analysis.
Although Linehan 1991 did not provide numerical data on treat-
ment adherence, the authors did report that participants allocated
to the DBT group were “. . . significantly more likely to start indi-
vidual therapy . . . (100% versus 73%)” (Linehan 1991, p. 1062).
2.24 Depression
There was no evidence of a significant treatment effect for DBT
as compared to TAU on depression scores at the post-intervention
assessment (Analysis 2.8; k = 2; N = 198).
Data from McMain 2012 furthermore suggested there was no
evidence of a significant treatment effect for DBT on depression
at the 24-month assessment (mean 22.24, SD 16.40, n = 90 vs
mean 21.67, SD 14.82, n = 90; MD 0.57, 95% CI -4.00 to 5.14;
k = 1; N = 180).
2.25 Hopelessness
We obtained data on hopelessness by correspondence for one trial
(Linehan 1991). There was no evidence of a significant treat-
ment effect for DBT at the 24-month follow-up assessment (mean
10.86, SD 6.04, n = 7 vs mean 10.69, SD 6.18, n = 11; MD 0.17,
95% CI -5.61 to 5.95; k = 1; N = 18).
2.26 Suicidal ideation
One trial reported data on suicidal ideation (Linehan 1991).
Again, there was no significant treatment effect for DBT at the
post-intervention assessment (mean 24.01, SD 19.80, n = 46 vs
mean 31.92, SD 26.80, n = 35; MD -7.91, SD -18.47 to 2.65; k
= 1; N = 81).
2.27 Problem solving
No data available.
2.28 Suicide
Although a suicide occurred in the DBT arm of Linehan 1991
before the post-intervention assessment, there were no suicides in
Priebe 2012 or inMcMain 2009. There was therefore no evidence
of a significant treatment effect for this outcome (Analysis 2.13;
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k = 3; N = 317). There were no suicides in Priebe 2012 or in
McMain 2009 by the 24-month follow-up assessment.
Dialectical behaviour therapy vs other alternative forms of
psychotherapy
One trial compared the effectiveness of DBT versus psychological
treatment by ’experts’ (CBT-E) for women diagnosedwith border-
line personality disorder and referred to a specialist DBT service
owing to recurrent SH (Linehan 2006, N = 101). Community
mental health leaders (such as heads of inpatient psychiatric units
and clinical directors of mental health agencies) nominated pro-
fessionals who they considered experts in treating difficult clients.
These therapists described themselves as “eclectic but non behav-
ioral” or “mostly psychodynamic” in their treatment approach.
No therapists with experience of delivering cognitive behavioural
therapy were included, however.
Primary outcome
2.29 Repetition of SH
There was no evidence of a treatment effect for DBT versus treat-
ment by expert on repetition of SH by either the post-interven-
tion assessment (Analysis 2.1; k = 1; N = 97) or by the 12-month
follow-up period (Analysis 2.3; k = 1; N = 97). Quality of evidence
for this outcome at both time points, as assessed by the GRADE
criteria, was very low (see Summary of findings 2).
Study authors did, however, state that those allocated to the DBT
group had “ . . . half the rate of suicide attempts compared with the
CTB-E group (23.1% vs 46% . . . hazard ratio, 2.66, P = 0.005)”
(Linehan 2006, p. 761). Nevertheless, correspondence with au-
thors regarding the total number of parasuicidal acts across the
12-month follow-up period revealed no evidence of a significant
treatment effect for DBT (mean 8.79, SD 10.81, n = 52 vs mean
23.64, SD 77.34, n = 45; MD -14.85, 95% CI -37.64 to 7.94; k
= 1; N = 97). Quality of evidence for this outcome was also very
low (see Summary of findings 2).
Secondary outcomes
2.30 Treatment adherence
No data available.
2.31 Depression
There was no evidence of a significant treatment effect on depres-
sion scores either at the post-intervention assessment (Analysis 2.8;
k = 1; N = 89) or at the 12-month follow-up assessment (Analysis
2.10; k = 1 ; N = 81) in this trial.
2.32 Hopelessness
No data available.
2.33 Suicidal ideation
There was also no evidence of a significant treatment effect for
DBT for suicidal ideation scores at either the post-intervention
(Analysis 2.11; k = 1; N = 89) or 12-month follow-up assessments
(Analysis 2.12; k = 1; N = 81).
2.34 Problem solving
No data available.
2.35 Suicide
There were no suicides in either treatment arm by the end of the
12-month follow-up period.
Dialectical behaviour therapy prolonged exposure vs other
alternative forms of psychotherapy
The effectiveness of two forms of DBT were compared over a
three-month follow-up period in one small trial of women with
comorbid borderline personality disorder andpost-traumatic stress
disorder referred to clinical services due to recurrent SH (Harned
2014; N = 26). In the experimental arm, participants received, in
addition to the standard DBT protocol, additional weekly therapy
sessions involving in vivo and imaginal exposure to previously
traumatic experiences.
Primary outcome
2.36 Repetition of SH
Data obtained by correspondence suggested there was no evidence
of a significant treatment effect for theDBTprolongedprotocol on
repetition of SH either by the post-treatment assessment (Analysis
2.1; k = 1; N = 18) or by the three-month follow-up (Analysis 2.2;
k = 1; N = 18). Quality of evidence for both these time points was
low, however (see Summary of findings 2).
Data on frequency of SH, obtained following correspondence with
authors, also suggested no apparent benefit of the DBT prolonged
exposure protocol by either the post-treatment (Analysis 2.5; k =
1; N = 18) or three-month follow-up (Analysis 2.6; k = 1; N =
18) assessments. Quality of evidence, as assessed by the GRADE
criteria, was low (see Summary of findings 2). Data on frequency
of suicide re-attempts could not be analysed as there were no repeat
suicide attempts in the control group by the final three-month
follow-up assessment.
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Secondary outcomes
2.37 Treatment adherence
There was no significant difference between the experimental and
control groups regarding the number of participants who attended
the full one-year course of treatment (Analysis 2.7; k = 1; N = 26).
According to the authors, “. . . one therapist . . . was not adherent
to DBT and had a 100% dropout rate” (p. 12). Excluding the four
participants treated by this therapist did not, however, materially
affect this result.
2.38 Depression
There was no evidence of a significant treatment effect for the
DBT prolonged exposure protocol for depression scores at either
the post-treatment (Analysis 2.8; k = 1; N = 18) or three-month
follow-up (Analysis 2.9; k = 1; N = 18) assessments.
2.39 Hopelessness
No data available.
2.40 Suicidal ideation
No data available.
2.41 Problem solving
No data available.
2.42 Suicide
There was no evidence of a significant treatment effect on death by
suicide by the three-month follow-up assessment (Analysis 2.14:
0/17 vs 1/9; OR 0.16, 95% CI 0.01 to 4.41; k = 1; N = 26) in
this trial.
Comparison 3: Case management vs TAU
Four trials investigated the provision of case management for the
prevention of SH either compared to either treatment as usual
(TAU; Clarke 2002, N = 467; Hvid 2011, N = 133; Morthorst
2012, N = 243) or to enhanced usual care (EUC; Kawanishi 2014,
N = 914). Although the intervention inHvid 2011 andMorthorst
2012 also included aspects of problem-solving psychotherapy, this
component was not the primary or only element of the case man-
agement strategy adopted in these trials, so we felt these trials were
sufficiently similar to justify pooling within a meta-analysis.
Primary outcome
3.1 Repetition of SH
There was no evidence of a significant treatment effect for case
management on repetition of SH by the post-intervention assess-
ment (Analysis 3.1; k = 4; N = 1608). Supplementing hospital-
recorded episodes of SH with self-reported data for Morthorst
2012 did not materially affect this result. There was also no in-
dication of a significant difference by comparator condition (i.e.,
TAU vs EUC) for this outcome (Analysis 3.1; test for subgroup
differences: Chi2 = 0.20, df = 1, P = 0.66, I2 = 0%). Quality, as
assessed using theGRADE criteria, wasmoderate for this outcome
(see Summary of findings 3).
One trial disaggregated data on repetition of SH by sex (Hvid
2011). Although there was no evidence of a significant treatment
effect for males in this trial (4/20 vs 4/18; OR 0.88, 95% CI 0.18
to 4.17; k = 1; N = 38), case management was associated with a
significant reduction in repetition of SH in females (2/49 vs 10/
46; OR 0.15, 95% CI 0.03 to 0.74; k = 1; N = 95).
Multiple readmissions for SH were, however, significantly more
common in the case management group than in the control group
over the treatment period in one trial (Clarke 2002: 9/220 vs 2/
247; OR 5.23, 95% CI 1.12 to 24.45; k = 1; N = 467). Quality of
evidence for this outcome was moderate (see Summary of findings
3).
Secondary outcomes
3.2 Treatment adherence
The authors of one trial reported that “11 participants in the
assertive case management group did not receive the intervention”
(Kawanishi 2014, p. 197).However, as correspondingnumbers for
the enhanced usual care group were not reported, we were unable
to analyse the effect of assertive case management on treatment
adherence for this trial.
3.3 Depression
No data available.
3.4 Hopelessness
Although the Beck Hopelessness Scale was administered to par-
ticipants throughout the follow-up period in one trial (Kawanishi
2014), the authors did not report data on this outcome. Cor-
respondence, however, revealed that they are currently analysing
these data and will present them in a future report.
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3.5 Suicidal ideation
No data available.
3.6 Problem solving
No data available.
3.7 Suicide
There was no evidence of a significant treatment effect on sui-
cide by the post-intervention assessment (Analysis 3.2; k = 4; N =
1757), nor was there evidence of a significant difference by com-
parator condition (i.e., TAU vs EUC) for this outcome (Analysis
3.2; test for subgroup differences: Chi2 = 0.67, df = 1, P = 0.41, I
2 = 0%).
Comparison 4: Treatment adherence enhancement
approaches vs TAU or other alternative forms of
psychotherapy
Two trials investigated the effectiveness of treatment adherence en-
hancement approaches compared either to TAU (Van Heeringen
1995) or to other alternative forms of psychotherapy (Torhorst
1987) in patients admitted to hospital following an episode of SH.
Treatment adherence enhancement vs TAU
Van Heeringen 1995 (N = 516) investigated the effectiveness of
adherence enhancement, involving home visits by a nurse for those
patients who failed to attend outpatient appointments, over a 12-
month follow-up period in patients referred to accident and emer-
gency departments following an episode of SH, irrespective of sui-
cidal intent.
Primary outcome
4.1 Repetition of SH
There was no evidence of a significant treatment effect on repeti-
tion of SH by the 12-month follow-up assessment, although the
difference in repetition between groups was fairly marked (Analy-
sis 4.1; k = 1; N = 391). Quality of evidence for this outcome, as
assessed by theGRADE criteria, was low (see Summary of findings
4).
Secondary outcomes
4.2 Treatment adherence
There was, however, a significant treatment effect for adherence
with outpatient aftercare appointments in this trial (129/252 vs
102/256; OR 1.58, 95% CI 1.11 to 2.25; k = 1; N = 508).
4.3 Depression
No data available.
4.4 Hopelessness
No data available.
4.5 Suicidal ideation
No data available.
4.6 Problem solving
No data available.
4.7 Suicide
There was no evidence of a significant treatment effect for the
number of participants who died by suicide over the 12-month
follow-up period (Analysis 4.3; k = 1; N = 391) in this trial.
Continuity of care by the same therapist vs other alternative
forms of psychotherapy
One trial investigated the effectiveness of continuing aftercare
with the same therapist (defined as continued therapeutic contact
with the original hospital therapist in an outpatient setting) versus
changing to a different therapist (defined as receiving therapy in
a specialised suicide prevention centre, which involved changing
both therapist and institution) over a 12-month follow-up period
in adults admitted to hospital following an episode of self-poison-
ing (Torhorst 1987, N = 141).
Primary outcome
4.8 Repetition of SH
There was no evidence of a significant treatment effect for receiv-
ing continued therapeutic contact with the original hospital ther-
apist on repetition of SH by the 12-month follow-up assessment
(Analysis 4.1; k = 1; N = 136). A very low quality of evidence was
associated with this outcome (see Summary of findings 4).
Secondary outcomes
4.9 Treatment adherence
There was evidence of a significant treatment effect for treatment
adherence, favouring the same-therapist group (49/68 vs 36/73;
OR 2.65, 95% CI 1.32 to 5.34; k = 1; N = 141).
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4.10 Depression
Depression scores did not differ significantly between groups at
the 12-month follow-up assessment (Analysis 4.2: mean 6.20, SD
6.90, n = 65 vs mean 7.60, SD 9.20, n = 62; MD -1.40, 95% CI
-4.24 to 1.44; k = 1; N = 127).
4.11 Hopelessness
No data available.
4.12 Suicidal ideation
No data available.
4.13 Problem solving
No data available.
4.14 Suicide
Therewas no evidence of a significant treatment effect for receiving
continued therapeutic contact with the original hospital therapist
on suicide by the 12-month follow-up assessment (Analysis 4.3; k
= 1; N = 136).
Comparison 5: Mixed multimodal interventions vs
TAU
Two trials investigated the effectiveness of a package of interven-
tions, including problem-solving psychotherapy, postcards, and a
GP voucher entitling participants to one free visit to their GP in
adults admitted to emergency departments following an episode
of SH, irrespective of intent (Hatcher 2016a: Hatcher 2015).
Mixed multimodal interventions vs TAU
One large trial using Zelen’s post-randomisation consent design
investigated the effectiveness of a package of mixed multimodal
interventions in adults admitted to emergency departments fol-
lowing an episode of SH irrespective of intent over a 12-month
period (Hatcher 2015; N = 1474).
Primary outcome
5.1 Repetition of SH
There was no evidence of a significant treatment effect for this
package of interventions in terms of hospital-recorded episodes
of SH by 12-month post-intervention assessment (66/327 vs 73/
357; OR 0.98, 95% CI 0.68 to 1.43; k = 1; N = 684). This out-
come had a low quality of evidence (see Summary of findings 5).
Using data from the randomised (including both patients who,
following treatment allocation, subsequently consented to partic-
ipation and those who did not), rather than consenting, sample
did not materially affect these results.
Investigators also presented data on repetition of SH by repeater
status at trial entry. However, there was no evidence of a signifi-
cant treatment effect for those with no history of SH prior to the
index attempt compared to those with a history of multiple SH
episodes by the post-intervention assessment (those with a history
of multiple episodes of SH: 47/176 vs 56/194; OR 0.90, 95% CI
0.57 to 1.42; k = 1; N = 370; those without a history of multiple
episodes of SH: 19/151 vs 17/163; OR 1.24, 95% CI 0.62 to
2.48; k = 1; N = 314).
With respect to frequency of SH, the authors reported that
“[a]lthough there were 20% fewer episodes in the intervention
group, the difference was not statistically significant” (Hatcher
2015, p. 17).
Secondary outcomes
5.2 Treatment adherence
No data available.
5.3 Depression
There was no significant treatment effect for this intervention on
depression scores at the 12-month post-intervention assessment
(mean 6.8, SD 4.9, n = 211 vs mean 6.5, SD 5.1, n = 234; MD
0.30, 95% CI -0.63 to 1.23; k = 1; N = 445).
5.4 Hopelessness
There was also no apparent treatment effect for this intervention
on hopelessness scores at the 12-month post-intervention assess-
ment (mean 8.3, SD 6.3, n = 210 vs mean 8.4, SD 6.4, n = 233;
MD -0.10, 95% CI -1.28 to 1.08; k = 1; N = 443).
5.5 Suicidal ideation
No data available.
5.6 Problem solving
No data available.
5.7 Suicide
Correspondence with authors revealed there was no significant
treatment effect for this interventionpackage on suicides by the 12-
month post-intervention assessment (1/327 vs 2/357; OR 0.54,
95% CI 0.05 to 6.03; k = 1; N = 684). One death in the experi-
mental and one in the control group were due to uncertain causes
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as they had yet to be investigated by the Coroner. However, as-
suming these deaths were attributable to suicide did not materially
affect this result.
Culturally adapted multi-model interventions vs TAU
The effectiveness of a culturally-adapted mixed multimodal inter-
vention was investigated over a 12-month follow-up period in one
trial using Zelen’s post-randomisation consent design in adults ad-
mitted to emergency departments following SH and who identify
themselves as of M ori ethnicity (Hatcher 2016a; N = 365).
Primary outcome
5.8 Repetition of SH
There was no evidence of a significant treatment effect for this
intervention on re-presentation to hospital following an episode
of SH by the time of the post-intervention assessment (34/95 vs
29/72; OR 0.83, 95% CI 0.44 to 1.55; k = 1; N = 167). Using
data from the randomised sample only (including both patients
who, following treatment allocation, subsequently consented to
participation and those who did not) did notmaterially affect these
results. Both outcomes had a low quality of evidence, as assessed
using the GRADE criteria (see Summary of findings 5).
Investigators presented information on repetition of SH by re-
peater status; however, there was no significant difference in rep-
etition of SH between groups for either those with a history of
multiple episodes of SH (24/60 vs 21/40; OR 0.60, 95% CI 0.27
to 1.35; k = 1; N = 100) or for those without a history of multiple
episodes of SH (10/35 vs 8/32; OR 1.20, 95% CI 0.41 to 3.55; k
= 1; N = 67).
Secondary outcomes
5.9 Treatment adherence
No data available.
5.10 Depression
There was no treatment effect for this intervention on depression
scores at the 12-month post-intervention assessment (mean 5.80,
SD 4.50, n = 66 vs mean 6.30, SD 4.30, n = 48; MD -0.50, 95%
CI -2.13 to 1.13; k = 1; N = 114).
5.10 Hopelessness
There was also no apparent treatment effect for this intervention
on hopelessness scores at the post-intervention assessment (mean
5.00, SD 4.40, n = 66 vs mean 5.70, SD 4.80, n = 47; MD -0.70,
95% CI -2.43 to 1.03; k = 1; N = 113).
However, the authors note that “whilst there was a greater change
in [hopelessness] scores at . . . 12 months [i.e., the post-inter-
vention assessment] in the intervention group, the group had a
significantly lower baseline score . . . because of the significant
differences in baseline scores and missing follow up data we . .
. used a mixed linear model to estimate the differences in scores
at [the post-intervention assessment].” Using this model the au-
thors found “there was a decrease in [h]opelessness scores in the
treatment group compared to the usual care group but this was
statistically non-significant” (Hatcher 2016a, ePub version, p. 5).
5.11 Suicide ideation
No data available.
5.12 Problem solving
No data available.
5.13 Suicide
Correspondence with authors revealed there was no significant
treatment effect for this intervention on suicides by the time of
the post-intervention assessment (0/72 vs 1/95; OR 0.43, 95%
CI 0.02 to 10.82; k = 1; N = 167).
Comparison 6: Remote contact interventions vs TAU
A number of trials investigated the effectiveness of remote con-
tact interventions, including, postcards (Beautrais 2010; Carter
2005; Hassanian-Moghaddam 2011; Kapur 2013a), emergency
cards (Evans 1999a; Morgan 1993), general practitioner’s (GP)
letter (Bennewith 2002), telephone contact (Cedereke 2002; Wei
2013; Vaiva 2006), or mobile telephone-based psychotherapy
(Marasinghe 2012) for the prevention of repetition of SH.
Postcards vs TAU
Four trials assessed the effectiveness of sending postcards to
patients on a regular basis over a 12-month follow-up period
(Beautrais 2010, N = 327; Hassanian-Moghaddam 2011, N =
2113; Kapur 2013a, N = 66), including one that used Zelen’s post-
randomisation consent design and reported data only for the ran-
domised sample (Carter 2005, N = 772). The trials of Beautrais
2010, Carter 2005, and Kapur 2013a took place in three high-
income countries, whilst the Hassanian-Moghaddam 2011 trial
was in a low income country (i.e., Iran).
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Primary outcome
6.1 Repetition of SH
Due to the definition of SH used in the report for one trial of post-
cards, we obtained data for this trial on repetition of SH through
correspondence (Hassanian-Moghaddam 2011).
Overall, there was no evidence of a significant treatment effect
on the proportion of patients repeating SH by the post-interven-
tion assessment (Analysis 5.1; k = 4; N = 3277). Excluding Carter
2005, which used Zelen’s design, did not materially affect this re-
sult. Quality of evidence, as assessed using the GRADE criteria,
was very low for this outcome (see Summary of findings 6). Visual
examination of the forest plot suggested that the result for Kapur
2013a may have been an outlier. Removing this trial reduced het-
erogeneity to 0% and suggested a significant treatment effect for
postcards on repetition of SH (OR 0.78, 95% CI 0.62 to 0.97; k
= 3; N = 3212).
There was no evidence of a significant treatment effect for post-
cards on repetition of SH by the 12-month follow-up assessment
in two trials (Analysis 5.2; k = 2; N = 2885). The quality of ev-
idence for this outcome was moderate (see Summary of findings
6). Excluding Carter 2005, however, caused this result to become
significant (OR 0.67, 95% CI 0.52 to 0.86; k = 1; N = 2113) as
did a sensitivity analysis using the fixed-effect rather than random-
effects model (fixed: OR 0.75, 95% CI 0.61 to 0.91).
Combining data from both time points indicated no overall signif-
icant effect for postcards by the final follow-up assessment (Anal-
ysis 5.3; k = 4; N = 3277). Excluding Carter 2005 did not materi-
ally affect this result. However, as before, excluding Kapur 2013a
caused this result to become significant (OR 0.77, 95% CI 0.63
to 0.95) as did a sensitivity analysis using the fixed-effect model
(fixed: OR 0.79, 95% CI 0.66 to 0.95), quality of evidence was
again very low for this outcome (see Summary of findings 6).
Data on repetition of SH by the post-intervention assessment and
12-month follow-up were available by sex in one trial (Carter
2005;Carter 2007); however, therewas no evidence of a significant
treatment effect for postcards in either sex by either time point
(post-intervention: males 20/145 vs 16/102; OR 0.86, 95% CI
0.42 to 1.75; k = 1; N = 247 versus females 37/233 vs 51/291; OR
0.89, 95% CI 0.56 to 1.41; k = 1; N = 524; 12 months’ follow-
up: males 26/145 vs 19/102; OR 0.95, 95% CI 0.50; k = 1; N =
247 versus females 54/233 vs 59/291; OR 1.19, 95% CI 0.78 to
1.80; k = 1; N = 524).
With respect to frequency of SH, we obtained data on mean num-
ber of repeat SH episodes by correspondence for three of the four
trials of postcards (Carter 2005; Hassanian-Moghaddam 2011;
Kapur 2013a). For the one remaining trial (Beautrais 2010), the
available data indicated a reduced mean number of SH episodes
for the experimental group (0.57 vs 0.78); however, as no infor-
mation on SDs, t-test or F statistics were reported, we were unable
to impute SDs using the method outlined in Townsend 2001 to
calculate themean difference in frequency of SH episodes between
groups. Overall, there was no evidence of a significant treatment
effect for postcards on frequency of repetition of SH by the post-
intervention assessment (Analysis 5.4; k = 3; N = 1,097). Qual-
ity of evidence for this outcome was very low (see Summary of
findings 6).
By the 12-month follow-up assessment, there was similarly no
evidence of a significant treatment effect for postcards in two trials
(Analysis 5.5; k = 2; N = 984). One trial also provided data for the
24-month follow-up period; however, no evidence of a significant
treatment effect was apparent (mean 0.21, SD 0.75, n = 217 vs
mean 0.24, SD 0.68, n = 255; MD -0.03, 95% CI -0.16 to 0.10; k
= 1; N = 472; Hassanian-Moghaddam 2011). Quality of evidence
was very low to moderate for these outcomes (see Summary of
findings 6).
Through correspondence, we were also able to obtain post hoc
data on frequency of repetition of SH by the post-intervention
assessment by both sex and repeater status for three trials (Carter
2005; Hassanian-Moghaddam 2011; Kapur 2013a). There was
no evidence of a significant treatment effect for postcards on fre-
quency of repetition by the post-intervention assessment for ei-
ther sex (males: Analysis 5.4; k = 3; N = 401; females: Analysis
5.4; k = 3; N = 695), those with a history of multiple episodes of
SH (Analysis 5.4; k = 3; N = 339), or those without a history of
multiple episodes of SH (Analysis 5.4; k = 3; N = 758). There was
also no evidence of a significant treatment effect for postcards on
frequency of repetition for males (Analysis 5.5; k = 2; N = 336),
females (Analysis 5.5; k = 2; N = 647), those with a history of
multiple episodes of SH (Analysis 5.5; k = 2; N = 296), or those
without a history of multiple episodes of SH (Analysis 5.5; k =
2; N = 688) by the 12-month follow-up assessment in two trials.
Correspondence with study authors revealed no significant treat-
ment effect for postcards on frequency of repetition in eithermales
(mean 0.33, SD 1.07, n = 116 vs mean 0.29, SD 0.82, n = 104;
MD 0.04, 95% CI -0.21 to 0.29; k = 1; N = 220), females (mean
0.14, SD 0.52, n = 101 vs mean 0.21, SD 0.59, n = 151; MD -
0.07, 95% CI -0.21 to 0.07, k = 1; N = 252), those with a history
of multiple episodes of SH (mean 0.42, SD 1.06, n = 155 vs mean
0.51, SD 0.96, n = 183; MD -0.09, 95% CI -0.31 to 0.13; k = 1;
N = 338), or those without a history of multiple episodes of SH
(mean 0.09, SD 0.47, n = 62 vs mean 0.10, SD 0.41, n = 72; MD
-0.01, 95%CI -0.16 to 0.14; k = 1; N = 134) by the 24-month fol-
low-up assessment in one of these trials (Hassanian-Moghaddam
2011).
Secondary outcomes
6.2 Treatment adherence
No data available.
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6.3 Depression
No data available.
6.4 Hopelessness
No data available.
6.5 Suicidal ideation
One trial recorded information on suicidal ideation at both
the post-intervention assessment and 12-months’ follow-up (
Hassanian-Moghaddam 2011; Hassanian-Moghaddam 2015).
There was a significant treatment effect for the number of peo-
ple reporting suicidal ideation at the post-intervention assessment
(302/1043 vs 446/1070; OR 0.57, 95% CI 0.48 to 0.68; k = 1;
N = 2113). Data reported by the trial authors in a subsequent
follow-up paper suggested that this effect was maintained at the
12-month follow-up assessment (465/997 vs 588/1004; OR 0.62,
95% CI 0.52 to 0.74; k = 1; N = 2001; Hassanian-Moghaddam
2015).
6.6 Problem solving
No data available.
6.7 Suicide
There was no evidence of a significant treatment effect for post-
cards on suicide by the post-intervention assessment (Analysis 5.6;
k = 4; N = 3464). Excluding Carter 2005, however, suggested a
harmful effect of postcards on suicides (OR 3.74, 95% CI 1.04 to
13.51; k = 3; N = 2692).
Data on suicides by the 12-month follow-up assessment were avail-
able for one trial (i.e., Carter 2005); however, no significant treat-
ment effect was found (Analysis 5.7; k = 1; N = 772).
Emergency cards vs TAU
Two trials investigated the effectiveness of providing an emergency
contact card (’green card’) providing 24-hour access to emergency
advice from a psychiatrist in addition to TAU in adults admitted
to general hospitals following an episode of SH, most frequently
self-poisoning (Evans 1999a, N = 827; Morgan 1993, N = 212).
Evans 1999a reported data on repetition of SH in a secondary trial
publication (Evans 2005).
Primary outcome
6.8 Repetition of SH
There was no evidence of a significant treatment effect for emer-
gency cards on repetition of SH by the post-intervention assess-
ment (Analysis 5.1; k = 2; N = 1039). Quality of evidence for
this outcome was low (see Summary of findings 6). There was
also no evidence of a significant treatment effect for emergency
cards by the time of the 12-month follow-up assessment in Evans
1999a (Analysis 5.2; k = 1; N = 827). For this outcome, quality
of evidence as assessed by the GRADE criteria was moderate (see
Summary of findings 6).
Evans 1999a disaggregated data on repetition of SH by repeater
status (i.e., those without a history of multiple episodes of SH
versus those with a history of multiple episodes of SH) in post hoc
analyses. Whilst there was no evidence of a significant treatment
effect for emergency cards on repetition of SH in those without a
history of multiple episodes of SH (18/221 vs 25/206; OR 0.64,
95% CI 0.34 to 1.22; k = 1; N = 427), emergency cards were
associated with a significantly increased risk of repetition of SH
in those with a history of multiple episodes of SH (52/194 vs 33/
200; OR 1.85, 95% CI 1.14 to 3.03; k = 1; N = 394) in this trial.
Evans 1999a also reported data on frequency of repetition of SH as
the proportion with no episodes at follow-up, the proportion with
a single episode at follow-up, and the proportion of two or more
repeat episodes of SH by the 12-month follow-up assessment.
There was no significant difference between groups in the number
of participants who had none (347/417 vs 351/410; OR 0.83,
95% CI 0.57 to 1.21; k = 1; N = 827), one (46/417 vs 32/410;
OR 1.46, 95% CI 0.91 to 2.35; k = 1; N = 827), or two or more
(24/417 vs 27/410; OR 0.87, 95% CI 0.49 to 1.53; k = 1; N =
827) episodes of SH over the six-month follow-up period.
This authors also presented data on frequency of repetition of SH
by repeater status in post hoc analyses. For those without a history
of multiple episodes of SH, there was no significant difference
between groups in the number of participants who had none (203/
221 vs 181/206; OR 1.56, 95% CI 0.82 to 2.95; k = 1; N = 427),
one (13/221 vs 16/206; OR 0.74, 95% CI 0.35 to 1.58; k = 1;
N = 427), or two or more (5/221 vs 9/206; OR 0.51, 95% CI
0.17 to 1.54; k = 1; N = 427) repeat episodes of SH. For those
with a history of multiple episodes of SH, however, receipt of an
emergency card was associated with a significant reduction in the
number of participantswith no further episodes of SH (142/194 vs
167/200; OR 0.54, 95% CI 0.33 to 0.88; k = 1; N = 394) coupled
with a significant increase in the number of participants with one
repeat episode of SH (33/194 vs 15/200;OR2.53, 95%CI 1.33 to
4.82; k = 1; N = 394). There was no significant difference between
the experimental and control groups with respect to the number
of participants with or two or more subsequent episodes of SH for
those with a history of multiple episodes of SH, however (19/194
vs 18/200; OR 1.10, 95% CI 0.56 to 2.16; k = 1; N = 394).
Secondary outcomes
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6.9 Treatment adherence
No data available.
6.10 Depression
No data available.
6.11 Hopelessness
No data available.
6.12 Suicidal ideation
No data available.
6.13 Problem solving
No data available.
6.14 Suicide
Data on suicides were reported in only one trial (Evans 1999a).
There was no evidence of a significant treatment effect for emer-
gency cards on suicide by the time of the six-month follow-up
assessment (2/417 vs 1/410; OR 1.97, 95% CI 0.18 to 21.82; k
= 1; N = 827).
General practitioner’s letter vs TAU
A single, cluster-randomised controlled trial compared the effec-
tiveness of a letter from patients’ general practitioners following
discharge from hospital care offering an appointment and advice
on patient management versus TAU over a 12-month follow-up
period (Bennewith 2002, clusters = 98 practices, N = 1932).
We were unable to adjust for the effects of clustering in this anal-
ysis, as the study authors could not provide us with either the in-
tercluster coefficient or the design effect. Therefore the effects we
report for this intervention should be interpreted with caution.
Primary outcome
6.15 Repetition of SH
There was no evidence of a significant treatment effect for a letter
from patients’ general practitioners on repetition of SH by the 12-
month follow-up assessment (211/964 vs 189/968;OR1.15, 95%
CI 0.93 to 1.44; k = 1; N = 1932). A moderate quality of evidence
was associated with this outcome (see Summary of findings 6).
A post hoc analysis by sex, however, suggested that whilst there
was no significant treatment effect for males (82/383 vs 84/413;
OR 1.07, 95% CI 0.76 to 1.50; k = 1; N = 796), a GP letter was
associated with a significant treatment effect on repetition of SH
for females (30/581 vs 105/555; OR 0.23, 95% CI 0.15 to 0.36;
k = 1; N = 1136).
In a secondpost hoc analysis, the authors also analysed repetition of
SH by repeater status at trial entry and concluded that “[t]he odds
ratio for the effect of the intervention in patients with a history of
self-harm was 0.57 (0.33 to 0.98), indicating a beneficial effect,
and in those with no history was 1.32 (1.02 to 1.70), indicating
a harmful effect” (Bennewith 2002, p. 1258). As the raw data on
which these sub-group results were based is not reported, we were
unable to reproduce these results in this review.
Secondary outcomes
6.16 Treatment adherence
There was no significant treatment effect for the number of par-
ticipants with at least one contact with treatment services by the
time of the 12-month follow-up assessment (351/599 vs 387/681;
OR 1.08, 95% CI 0.86 to 1.34; k = 1; N = 1280).
6.17 Depression
No data available.
6.18 Hopelessness
No data available.
6.19 Suicidal ideation
No data available.
6.20 Problem solving
No data available.
6.21 Suicide
No data available.
Telephone contact vs TAU
Three trials investigated the effectiveness of telephone contact in
adults admitted to emergency departments following a ’suicide
attempt’ (i.e., suggestive of suicidal intent) (Cedereke 2002, N =
216; Vaiva 2006, N = 605; Wei 2013, N = 157).
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Primary outcome
6.22 Repetition of SH
There was no evidence of a significant treatment effect for tele-
phone contact on repetition of SH at the six-month follow-up
assessment in Wei 2013 (1/41 vs 4/40; OR 0.23, 95% CI 0.02
to 2.11; k = 1; N = 81), by the 12-month follow-up period in
Cedereke 2002(14/83 vs 15/89; OR 1.00, 95% CI 0.45 to 2.23;
k = 1; N = 172), or by the 24-month follow-up period in Vaiva
2006 (44/293 vs 59/312; OR 0.76, 95% CI 0.49 to 1.16; k = 1;
N = 605). Combining data for these three time points indicated
no significant treatment effect for telephone contact by the final
follow-up point (Analysis 5.3; k = 3; N = 840). Quality of evidence
for these three time points was very low to low (see Summary of
findings 6).
With respect to frequency of repetition of SH, the mean number
of episodes of SH was similar between treatment groups in both
Cedereke 2002 (0.31 vs 0.30) and Vaiva 2006 (0.15 vs 0.19).
However, as study authors did not report information on SDs, t-
test or F statistics, we were unable to impute SDs using themethod
outlined in Townsend 2001 to calculate the mean difference in
the number of repeat episodes of SH between groups in these two
trials.
Secondary outcomes
6.23 Treatment adherence
There was no evidence of a significant treatment effect on the
number of patients attending treatment at least once by 12-month
follow-up assessment in one trial (60/83 vs 58/89, OR 1.39, 95%
CI 0.73 to 2.67; k = 1; N = 172; Cedereke 2002).
6.24 Depression
There was no evidence of a significant treatment effect for tele-
phone contact on depression at either the six-month (mean 6.01,
SD 8.87, n = 41 vs mean 5.85, SD 8.16, n = 40; MD 0.16, 95%
CI -3.55 to 3.87; k = 1; N = 81) or the 12-month (mean 5.73, SD
8.71, n = 36 vs mean 5.84, SD 8.23, n = 27; MD -0.11, 95% CI
-4.32 to 4.10; k = 1; N = 63) follow-up assessments in the only
trial of telephone contact to report data on depression scores (Wei
2013).
6.25 Hopelessness
No data available.
6.26 Suicidal ideation
Suicidal ideation was recorded continuously in Cedereke 2002,
whereas Wei 2013 recorded data on suicidal ideation dichoto-
mously as the proportion self-reporting an episode of suicidal
ideation.
In Cedereke 2002, telephone contact was not associated with a
significant treatment effect on suicidal ideation scores by the 12-
month follow-up assessment (mean 5.80, SD 7.80, N = 5 vs mean
4.00, SD 6.20, N = 8; MD 1.80, 95% CI -6.27 to 9.87; k = 1; N
= 13).
Telephone contact was also not associated with a significant treat-
ment effect on the proportion of participants reporting suicidal
ideation by the six-month follow-up assessment in Wei 2013 (26/
41 vs 24/40; OR1.16, 95%CI 0.47 to 2.83; k= 1; N= 81). By the
12-month follow-up assessment, however, telephone contact was
associated with a significant treatment effect on the proportion of
participants reporting suicidal ideation in this trial (24/36 vs 25/
27; OR 0.16, 95% CI 0.03 to 0.79; k = 1; N = 63).
6.27 Problem solving
No data available.
6.28 Suicide
There was no evidence of a significant treatment effect for tele-
phone contact on suicides by either the 12-month (1/107 vs 1/
109; OR 1.02, 95% CI 0.06 to 16.50; k = 1; N = 216; Cedereke
2002) or 24-month (1/293 vs 2/312; OR 0.52, 95% CI 0.05 to
5.89; k = 1; N = 605; Vaiva 2006) follow-up assessments. Com-
bining data from these trials suggested no evidence of a signifi-
cant treatment effect by the time of the final follow-up assessment
(Analysis 5.8; k = 2; N = 821).
Mobile telephone-based psychotherapy vs TAU
One trial assessed the effectiveness of psychotherapy, including
elements of training in problem-solving therapy, meditation and
social support, delivered by mobile telephone over a six-month
follow-up period in adults admitted to general hospitals following
an episode of SH with significant suicidal intent (Marasinghe
2012; N = 68). As this trial used a cross-over design, we report only
data from the post-intervention assessment (i.e., prior to cross-
over) in this review.
Primary outcome
6.29 Repetition of SH
Data obtained by correspondence from the authors indicated there
were no repeat episodes of SH in either the treatment or control
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groups by the post-intervention assessment. It was therefore not
possible to calculate the pooled odds ratio and accompanying 95%
confidence interval owing to zero cell counts (Analysis 5.1; k = 1;
N = 68). A low quality of evidence was apparent for this outcome
(see Summary of findings 6).
Secondary outcomes
6.30 Treatment adherence
No data available.
6.31 Depression
There was evidence of a significant treatment effect for mobile
telephone-based psychotherapy for depression at the post-inter-
vention assessment (mean 7.00, SD 5.00, n = 34 vs mean 14.60,
SD 10.40, n = 34; MD -7.60, 95% CI -11.48 to -3.72; k = 1; N
= 68).
However, a priori analyses suggested that this effect varied by sex.
Mobile telephone-based psychotherapy was associated with a sig-
nificant treatment effect for depression at the post-intervention
assessment in males (mean 5.90, SD 2.40, n = 17 vs mean 13.30,
SD 6.10, n = 17; MD -7.40, 95% CI -10.52 to -4.28; k = 1; N
= 34) but not in females (mean 8.10, SD 6.30, n = 17 vs mean
11.60, SD 6.50, n = 17; MD -3.50, 95% CI -7.80 to 0.80; k = 1;
N = 34).
6.32 Hopelessness
No data available.
6.34 Suicidal ideation
There was evidence of a significant treatment effect for mobile
telephone-based psychotherapy for suicidal ideation at the post-
intervention assessment (mean 3.60, SD 1.60, n = 34 vs mean
7.30, SD 5.50, n = 34; MD -3.70, 95% CI -5.63 to -1.77; k = 1;
N = 68) in this trial.
When we analysed results separately by sex, however, there was
no evidence of a significant treatment effect for mobile telephone-
based psychotherapy for suicidal ideation at the post-intervention
assessment in males (mean 3.50, SD 1.80, n = 17 vs mean 6.20,
SD 5.50, n = 17; MD -2.70, 95% CI -5.45 to 0.05; k = 1; N =
34). There was, however, a significant treatment effect for females
(mean 3.80, SD 1.40, n = 17 vs mean 8.90, SD 6.20, n = 17; MD
-5.10, 95% CI -8.12 to -2.08; k = 1; N = 34).
6.35 Problem solving
No data available.
6.36 Suicide
Information obtained by correspondence indicated that there was
one suicide in the experimental group by the time of the post-
intervention assessment and none in the control group. Mobile
telephone-based psychotherapy was not associated with a signifi-
cant treatment effect for suicide by this time point (Analysis 5.6;
k = 1; N = 68).
Comparison 7: Other mixed interventions vs TAU or
other alternative forms of psychotherapy
A number of single, small trials investigated the effectiveness of
other types of heterogeneous interventions, including: interper-
sonal problem-solving skills training (vs TAU; McLeavey 1994),
behaviour therapy (vs other alternative forms of psychother-
apy; Liberman 1981), provision of information and support (vs
TAU; Fleischmann 2008), treatment for alcohol misuse (vs TAU;
Crawford 2010), home-based problem-solving therapy (vs other
alternative forms of psychotherapy; Hawton 1981), intensive in-
patient and community treatment (vs TAU; Van der Sande 1997a,
general hospital admission (vs other alternative forms of psy-
chotherapy;Waterhouse 1990), intensive outpatient treatment (vs
TAU; Allard 1992; Welu 1977), and long-term therapy (vs other
alternative forms of psychotherapy; Torhorst 1988).
Interpersonal problem-solving skills training vs other
alternative forms of psychotherapy
One small trial compared the effectiveness of interpersonal prob-
lem-solving skills training (IPSST) with brief problem-oriented
therapy in adults admitted to accident and emergency facilities
following an episode of self-poisoning (McLeavey 1994; N = 39).
Primary outcome
7.1 Repetition of SH
There was no evidence of a significant treatment effect for repeti-
tion of SH, defined as a ’self-poisoning act’, within the 12-month
follow-up period (2/17 vs 4/16; OR 0.40, 95% CI 0.06 to 2.57;
k = 1; N = 33) in this trial. A very low quality of evidence was
associated with this outcome (see Summary of findings 7).
Secondary outcomes
7.2 Treatment adherence
There was no evidence of a significant treatment effect on the
number of participants who completed the full course of treatment
(2/19 vs 3/20; OR = 0.67, 95% CI 0.10 to 4.51; k = 1; N =
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39).There was, however, evidence for a significant treatment effect
in terms of the number of treatment sessions attended (mean 5.30,
SD 0.48, n = 17 vs mean 4.20, SD 1.32, n = 16; MD 1.10, 95%
CI 0.41 to 1.79; k = 1; N = 33).
7.3 Depression
No data available.
7.4 Hopelessness
There was no evidence of a significant treatment effect for hope-
lessness at the six-month follow-up assessment (mean 6.12, SD
4.61, n = 19 vs mean 4.35, SD 4.39, n = 20; MD 1.77, 95% CI
-1.06 to 4.60; k = 1; N = 39).
7.5 Suicidal ideation
No data available.
7.6 Problem solving
Analysis of means estimated by the review authors from graph-
ics in the original report suggests that, at the post-intervention
assessment, participants allocated to the experimental group had
scores within the normal range whilst those allocated to the con-
trol group remained impaired according to both the Means-Ends
Problem-Solving Scale (estimated means 6.4 vs 2.9) and the Self-
Rated Problem Solving Scale (estimated means 89.8 vs 78.0). Ad-
ditionally, participants in the experimental group reported feeling
more confident in solving problems post-treatment according to
scores on the Perceived Ability to Solve Current Problems scale
(estimatedmeans 0.9 vs 1.9). Lastly, both groups reported a reduc-
tion in self-reported number of problems (estimated means 1.1 vs
1.5).
Results reported by the trial authors suggest an equal benefit of
both treatments in reducing the “number of presenting problems .
. .” (McLeavey 1994, p. 382). However, the authors conclude that
IPSST was “significantly more effective . . . as determined by other
outcome measures . . .” including measures of interpersonal cogni-
tive problem-solving, self-rated personal problem-solving ability,
and perceived ability to cope with ongoing problems (McLeavey
1994, p.382).
7.7 Suicide
There were no suicides in either group during the 12-month fol-
low-up period.
Behaviour therapy vs other alternative forms of
psychotherapy
One small trial compared the effectiveness of behaviour therapy
versus insight-oriented therapy in adults referred for inpatient
treatment following a suicide attempt (Liberman 1981; N = 24).
Primary outcome
7.8 Repetition of SH
There was no evidence of a significant treatment effect with regards
to the number of patients repeating SH by the 24-month follow-
up period (2/12 vs 3/12; OR 0.60, 95% CI 0.08 to 4.45; k = 1; N
= 24). This outcome was associated with a low quality of evidence
(see Summary of findings 7)
Secondary outcomes
7.9 Treatment adherence
No data available.
7.10 Depression
Depression was measured using both the BDI and the ZSRDS in
this trial. There was evidence of a significant treatment effect for
behaviour therapy at the post-treatment assessment according to
both measures (BDI: mean 4.00, SD 4.00, n = 12 vs mean 14.00,
SD 12.00, n = 12; MD -10.00, 95% CI -17.16 to -2.84; k = 1; N
= 24; ZSRDS: mean 32.00, SD 8.00, n = 12 vs mean 43.00, SD
14.00, n = 12; MD -11.00, 95% CI -20.12 to -1.88; k = 1; N =
24).
At the six-month (24-week) follow-up assessment, although there
was no significant treatment effect for depression according to the
ZSRDS (mean 34.00, SD 8.00, n = 12 vs mean 41.00, SD 13.00,
n = 12; MD -7.00, 95% CI -15.64 to 1.64; k = 1; N = 24), BDI
scores did show an effect (mean 4.00, SD 6.00, n = 12 vs mean
13.00, SD 11.00, n = 12; MD -9.00, 95% CI -16.09 to -1.91; k
= 1; N = 24).
7.11 Hopelessness
No data available.
7.12 Suicidal ideation
There was no evidence of a significant effect for behaviour therapy
on the number of patients reporting suicidal ideation at the 24-
month follow-up assessment (5/12 vs9/12;OR 0.24, 95%CI 0.04
to 1.36; k = 1; N = 24).
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7.13 Problem solving
No data available.
7.14 Suicide
No data available.
Provision of information and support vs TAU
The effectiveness of providing a one-off hospital-based informa-
tion session combined with regular home visits and/or telephone
contact in addition toTAUover an18month follow-up periodwas
investigated in one multicentre trial (SUPRE-MISS) conducted
in ten countries, although data from only five of these countries
are reported in Bertolote 2010 (N = 1,663) and Fleischmann
2008 (N = 1,699). Data from three of the individual countries (
Hassanzadeh 2010, N = 632; Vijayakumar 2011, N = 680; Xu
2012, N = 111) were also included for some outcomes.
Correspondence with authors indicted that the term ’attempted
suicide’ in this trial was used to refer to SH both with and without
suicidal intent.
Primary outcome
7.15 Repetition of SH
For the overall SUPRE-MISS cohort, data from Bertolote 2010
indicated there was no evidence for a significant treatment effect
for information and support on repetition of SH by the 18-month
follow-up assessment (66/863 vs 60/800; OR 1.02, 95% CI 0.71
to 1.47; k = 1; N = 1663). This outcome was associated with
low quality of evidence according to the GRADE criteria (see
Summary of findings 7).
Data on repetition of SH were also available for males and females
separately. Overall, across all five sites, there was no evidence of a
significant treatment effect on repetition of SH by the 18-month
follow-up assessment in either males (30/349 vs 27/340; OR 1.09,
95% CI 0.63 to 1.88; k = 1; N = 689) or females (36/514 vs 33/
460; OR 0.97, 95% CI 0.60 to 1.59; k = 1; N = 974).
Data on repetition of SH by the 18-month follow-up assessment
were also available for each of the five countries separately. Al-
though there was no significant difference between groups for the
individual sites in Campinas, Brazil (21/71 vs 10/64; OR 2.27,
95% CI 0.97 to 5.28; k = 1; N = 135), Colombo, Sri Lanka (3/
130 vs 5/121; OR 0.55, 95% CI 0.13 to 2.34; k = 1; N = 251),
Karaj, Iran (33/303 vs 28/298; OR 1.18, 95% CI 0.69 to 2.00;
k = 1; N = 601), and Yuncheng, China (1/58 vs 0/38; OR 2.01,
95% CI 0.08 to 50.60; k = 1; N = 96), significantly fewer par-
ticipants in the experimental group had repeated SH by the 18-
month follow-up period at the Chennai, India site (8/301 vs 17/
260; OR 0.39, 95% CI 0.17 to 0.92; k = 1; N = 561). Quality
of evidence for these five sites varied from very low to low (see
Summary of findings 7).
Breaking results down by gender revealed no significant effect for
information and support on repetition of SH by the 18-month
follow-up assessment for either gender at either of the five study
sites [Campinas, Brazil: males 4/21 vs. 3/25; OR 1.73, 95% CI
0.34 to 8.76; k = 1; N = 46 versus females 17/50 vs. 7/39; OR
2.35, 95% CI 0.86 to 6.44; k = 1; N = 89; Chennai, India: males
5/148 vs. 7/125; OR 0.59, 95% CI 0.18 to 1.91; k = 1; N = 273
versus females 3/153 vs. 10/153; OR 0.29, 95% CI 0.08 to 1.06;
k = 1; N = 306; Colombo, Sri Lanka: males 1/54 vs. 3/53; OR
0.31, 95% CI 0.03 to 3.12; k = 1; N = 107 versus females 2/76
vs. 2/68; OR 0.89, 95% CI 0.12 to 6.51; k = 1; N = 144; Karaj,
Islamic Republic of Iran: males 19/109 vs. 14/118; OR 1.57, 95%
CI 0.74 to 3.31; k = 1; N = 227 versus females 14/194 vs. 14/
180; OR 0.92, 95% CI 0.43 to 1.99; k = 1; N = 374; Yuncheng,
China: males: 1/17 vs. 0/19; OR 3.55, 95% CI 0.14 to 93.01; k
= 1; N = 36 versus females 0/41 vs. 0/38; OR not calculable; k =
1; N = 79].
Hassanzadeh 2010 reported data on frequency of SH for one sub-
sample at the six-month follow-up assessment inKaraj, Iran. In this
sample, there was evidence of a significant increase in frequency
of repetition of SH in the information and support group relative
to the TAU group (mean 1.63, SD 1.19, n = 319 vs mean 1.17,
SD 0.38, n = 310; MD 0.46, 95% CI 0.32 to 0.60; k = 1; N =
629). Quality of evidence for this outcome was low (see Summary
of findings 7).
Secondary outcomes
7.16 Treatment adherence
No data available.
7.17 Depression
Correspondence with authors revealed that information on de-
pression was recorded at one site only: Yuncheng, China (reported
by Xu 2012). Information and support was associated with a sig-
nificant treatment effect for depression scores at this site by the
18-month follow-up assessment (mean 2.51, SD 3.25, n = 57 vs
mean 5.60, SD 9.25, n = 54; MD -3.09, 95% CI -5.70 to -0.48;
k = 1; N = 111).
7.18 Hopelessness
No data available.
7.19 Suicidal ideation
No data available.
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7.20 Problem solving
Correspondence with authors revealed that information on prob-
lem solving was reported for one site only: Yuncheng, China (re-
ported in Xu 2012). There was evidence of a significant treatment
effect for information and support at this site by the 18-month
follow-up assessment (mean 0.64, SD 0.29, n = 57 vs mean 0.52,
SD 0.30, n = 54; MD 0.12, 95% CI 0.01 to 0.23; k = 1; N = 111).
7.21 Suicide
In the overall SUPRE-MISS cohort, as reported in the primary
study reference (Fleischmann 2008), there was evidence of a sig-
nificant treatment effect for information and support on suicide
by the 18-month follow-up period (2/872 vs 18/827; OR 0.10,
95% CI 0.02 to 0.45; k = 1; N = 1699).
Data on suicides were also available for three of the five study
sites in related publications: Vijayakumar 2011 reported data from
Chennai, India, Hassanzadeh 2010 from Karaj, Iran, and Xu
2012 from Yuncheng, China. There was evidence of a significant
treatment effect for information and support on suicides by the
18-month follow-up assessment at the Chennai, India site (1/302
vs 9/320; OR 0.11, 95% CI 0.01 to 0.91; k = 1; N = 622) but not
at either the Karaj, Iran (2/319 vs 2/310; OR 0.97, 95% CI 0.14
to 6.94; k = 1; N = 629) or the Yuncheng, China (0/57 vs 2/54;
OR 0.18, 95% CI 0.01 to 3.89; k = 1; N = 111) sites.
Notably, the number of completed suicides in the experimental
group reported for these three subsamples is greater than the num-
ber reported for the overall SUPRE-MISS cohort in the primary
study reference (i.e., Fleischmann 2008). We were unable to con-
firm the correct number of completed suicides in the experimental
group with the authors. Including the one additional suicide for
the experimental group identified from the three subsample pub-
lications with the data reported in the primary study reference,
however, did not materially affect the result obtained for the over-
all SUPRE-MISS cohort.
Treatment for alcohol misuse vs TAU
One trial investigated the effectiveness of a brief intervention for
alcohol misuse on repetition of SH over a six-month follow-up
period in adults who were misusing alcohol and were admitted
to emergency departments following an episode of SH (Crawford
2010; N = 103).
Primary outcome
7.22 Repetition of SH
There was no evidence of a significant treatment effect for treat-
ment for alcohol misuse on repetition of SH by the six-month
follow-up period (7/52 vs11/51; OR 0.57, 95% CI 0.20 to 1.60;
k = 1; N = 103). This was associated with a moderate quality of
evidence (see Summary of findings 7).
Secondary outcomes
7.23 Treatment adherence
The study authors report that only 47.1% of those randomised to
the experimental group attended the brief alcohol treatment ses-
sion (Crawford 2010, p.1826). However, as corresponding num-
bers were not available for the control group, who did not receive
an invitation to a brief alcohol treatment session, we could not
calculate treatment effect sizes for this outcome.
7.24 Depression
No data available.
7.25 Hopelessness
No data available.
7.26 Suicidal ideation
No data available.
7.27 Problem solving
No data available.
7.28 Suicide
Correspondence with authors confirmed that no participants died
by suicide in either group over the course of the six-month follow-
up period. However, the authors warn that as they were unable to
track participants via their National Health Service (NHS) iden-
tity numbers, they were unable to confirm numbers of suicides
from national mortality data. Thus, there may have been suicides
amongst those participants whom the authors were unable to con-
tact by the six-month follow-up assessment.
Home-based problem-solving therapy vs other alternative
forms of psychotherapy
Hawton 1981 (N = 96) investigated the effectiveness of brief prob-
lem-oriented counselling delivered in two different ways, namely
as a flexibly-timed home-based therapy, combined with open ac-
cess via telephone services to the general hospital psychiatric ser-
vice, versus treatment in weekly outpatient clinics, in adults re-
ferred to the psychiatric department of a general hospital following
admission for self-poisoning, irrespective of intent.
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Primary outcome
7.29 Repetition of SH
There was no evidence of a significant treatment effect for home-
based problem-solving therapy on repetition of SH by the 12-
month follow-up assessment (5/48 vs 7/48; OR 0.68; 95% CI
0.20 to 2.32; k = 1; N = 96). Quality of evidence, as assessed
using the GRADE criteria, was moderate for this outcome (see
Summary of findings 7).
Secondary outcomes
7.30 Treatment adherence
There was, however, a significant treatment effect for home-based
problem-solving therapy on the number of participants who at-
tended at least one treatment session over the course of the 12-
month follow-up period (45/48 vs 35/48; OR 5.57, 95% CI 1.47
to 21.08; k = 1; N = 96).
7.31 Depression
Although this trial included data on depression, the authors mod-
ified the scale used (Lorr and McNair Mood Scale; McNair 1964;
Lorr 1967), thereby precluding inclusion of this data in this re-
view.
7.32 Hopelessness
No data available.
7.33 Suicidal Ideation
Data obtained by correspondence suggested there was no signifi-
cant treatment effect for suicidal ideation at either the post-treat-
ment assessment (Mann-WhitneyU=984, P = 0.29) or six-month
follow-up (Mann-Whitney U = 726, P = 0.14). As only median,
rather than mean, scores were available for this outcome, we were
unable to reproduce themean difference in suicidal ideation scores
between the experimental and control groups in this review.
7.34 Problem solving
No data available.
7.35 Suicide
No data available.
Intensive inpatient and community treatment vs TAU
One trial compared the effectiveness of brief psychiatric inpatient
admission followed by regular outpatient appointments and 24-
hour access to the psychiatric unit with TAU over a 12-month
follow-up period in adults admitted to a general hospital following
a ’suicide attempt’ (i.e., suggestive of suicidal intent) (Van der
Sande 1997a, N = 274).
Primary outcome
7.36 Repetition of SH
Therewas no evidence of a significant treatment effect for intensive
inpatient and community treatment on repetition of SH by the
12-month follow-up (24/140 vs 20/134; OR 1.18, 95% CI 0.62
to 2.25; k = 1; N = 274). Quality of evidence, according to the
GRADE criteria, was low for this outcome (see Summary of
findings 7).
With respect to frequency of repetition of SH, there was also no
evidence of a significant treatment effect for intensive inpatient
and community treatment (mean 0.23, SD 0.57, n = 140 vs mean
0.23, SD 0.81, n = 134; MD 0.00, 95% CI -0.17 to 0.17, k = 1;
N = 274). Quality of evidence for this outcome was also low (see
Summary of findings 7).
Secondary outcomes
7.37 Treatment adherence
There was a significant treatment effect for treatment adherence.
More patients in the experimental group attended at least one out-
patient treatment session by the 12-month follow-up assessment
(119/140 vs 64/134; OR 6.99, 95% CI 3.69 to 12.36; k = 1; N
= 274). However, there was no difference in the total number of
treatment sessions attended (mean 14.30, SD 24.20, n = 140 vs
mean 11.40, SD 27.70, n = 134; MD 2.90, 95%CI -3.27 to 9.07;
k = 1; N = 274).
7.38 Depression
There was no significant treatment effect for intensive inpatient
and community treatment on depression scores by the 12-month
follow-up assessment (mean 30.80, SD 15.90, n = 94 vs mean
35.80, SD 16.20, n = 50; MD -5.00, 95% CI -10.52 to 0.52; k =
1; N = 144).
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7.39 Hopelessness
There was no significant treatment effect for intensive inpatient
and community treatment onhopelessness scores by the 12-month
follow-up assessment (mean 6.10, SD 5.00, n = 94 vs mean 7.50,
SD 5.90, n = 50; MD -1.40, 95% CI -3.32 to 0.52; k = 1; N =
144).
7.40 Suicidal ideation
No data available.
7.41 Problem solving
No data available.
7.42 Suicide
There was also no evidence of a significant treatment effect for
suicide by the 12-month follow-up assessment (1/140 vs 2/134;
OR 0.47, 95% CI 0.04 to 5.30; k = 1; N = 274).
General hospital admission vs other alternative forms of
psychotherapy
One trial investigated the effectiveness of general hospital admis-
sion versus non-admission over a four-month follow-up period
in a group of adults attending an emergency room following an
episode of self-poisoning, who had no immediate medical or psy-
chiatric treatment needs (Waterhouse 1990, N = 77). In this trial,
admission was described as consisting of little more than admis-
sion to an inpatient bed. The investigators did not attempt to in-
fluence referral to psychiatric or other treatment services. The me-
dian length of admission for those allocated to the experimental
group was 17 hours.
Primary outcome
7.43 Repetition of SH
There was no evidence of a significant treatment effect for hospital
admission on repetition of SH at the post-intervention assessment
(2/38 vs 2/39; OR 1.03, 95% CI 0.14 to 7.69; k = 1; N = 77) or
by the four-month follow-up assessment (3/38 vs 4/39; OR 0.75,
95% CI 0.16 to 3.60; k = 1; N = 77). Quality of evidence for these
time points was low (see Summary of findings 7).
Secondary outcomes
7.44 Treatment adherence
No data available.
7.45 Depression
No data available.
7.46 Hopelessness
The authors state that there was no significant difference in hope-
lessness scores at the post-intervention assessment (mean 10.29,
SD 5.68 vs mean 10.21, SD 4.97); however, they did not provide
the numbers of patients in each group, thus precluding calculation
of the MD and its associated 95% CI.
7.47 Suicidal ideation
There was no evidence of a significant treatment effect for hospital
admission on suicidal ideation scores by the four-month follow-
up assessment (mean 0.22, SD 0.85, n = 27 vs mean 0.04, SD
0.20, n = 25; MD 0.18, 95% CI -0.15 to 0.51; k = 1; N = 52).
7.48 Problem solving
No data available.
7.49 Suicide
No data available.
Intensive outpatient treatment vs TAU
Two trials compared the effectiveness of intensive outreach inter-
ventions with standard outpatient care in adults admitted to emer-
gency departments following a ’suicide attempt’ (i.e., suggestive
of suicidal intent) (Allard 1992, N = 150; Welu 1977, N = 119).
Allard 1992 compared an intensive intervention, involving psychi-
atrists and a social worker, a schedule of visits including at least one
home visit, therapy provided where needed, reminders (telephone
or written), and home visits with treatment by regular personnel
in the same hospital over a 12-month treatment period. Thera-
pies in the experimental group varied, and drug therapy was also
an option. Welu 1977 compared a specialist, intensive outreach
programme in which a community mental health team contacted
participants immediately after discharge and arranged home visits
and weekly or bi-weekly contact with therapists alongside routine
psychiatric consultation.
Primary outcome
7.50 Repetition of SH
Therewas no evidence of a significant treatment effect for intensive
intervention on repetition of SH by either the four-month (Welu
1977: 3/62 vs 9/57; OR 0.27, 95% CI 0.07 to 1.06; k = 1; N =
119) or 24-month (Allard 1992: 22/63 vs 19/63; OR 1.24, 95%
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CI 0.59 to 2.62; k = 1; N = 126) follow-up assessments. For both
follow-up periods, quality of evidence was low(see Summary of
findings 7). We combined the results of these two trials, and again
there was no evidence of a significant treatment effect for intensive
outpatient intervention by the final follow-up point (Analysis 6.1;
k = 2; N = 245). The quality of evidence was very low for this
outcome (see Summary of findings 7).
In the one trial that reported information on frequency of SH over
the course of the 24-month follow-up period (i.e., Allard 1992),
“the experimental subjects did not make fewer attempts than the
comparison subjects” (Allard 1992, p. 310).
Secondary outcomes
7.51 Treatment adherence
Data on treatment adherence were only available for Allard 1992.
However, as the authors did not report information on SDs, t-test
or F statistics we were unable to impute SDs using the method
outlined in Townsend 2001 to calculate themean difference in the
number of treatment sessions attended. Nevertheless, the authors
themselves report that “[t]he mean numbers of encounters with
psychiatrists were 12.35 versus 1.54 (P < 0.001) in the first year
and 2.11 versus 0.64 (P = 0.071) in the second year” (Allard 1992,
p. 311).
7.52 Depression
No data available.
7.53 Hopelessness
No data available.
7.54 Suicidal ideation
No data available.
7.55 Problem solving
No data available.
7.56 Suicide
Allard 1992 reported data on suicide during follow-up. There
was no evidence of a significant treatment effect for the intensive
outpatient intervention on suicides, however, by the 24-month
follow-up assessment (3/76 vs 1/74; OR 3.00, 95% CI 0.30 to
29.52; k = 1; N = 150) in this trial.
Long-term psychotherapy vs other alternative forms of
psychotherapy
One trial investigated the effectiveness of long-term (one session
per month over 12 months) versus short-term (one session per
week over 12weeks) outpatient psychotherapy on repetition of SH
over a 12-month follow-up period in adults admitted to hospital
due to repeated episodes of self-poisoning (Torhorst 1988, N =
80). The content of therapywas not specified in this trial, however.
Primary outcome
7.57 Repetition of SH
There was no evidence of a significant treatment effect for long-
term therapy on repetition of SHby the post-treatment assessment
(9/40 vs 9/40; OR 1.00, 95% CI 0.35 to 2.86; k = 1; N = 80).
A low quality of evidence was associated with this outcome (see
Summary of findings 7).
Secondary outcomes
7.58 Treatment adherence
The authors did not provide numerical data on treatment adher-
ence, although they state, “[a]ttendance at the first session was
about equal for both groups (about 60%)” (Torhorst 1988, p.
420). However, the authors further state that “participation of the
12-month (long-term therapy) group dropped drastically by the
second session to under 40%, while the participation of the pa-
tients in the 3-month (intensive short-term therapy) program re-
mained higher” (Torhorst 1988, p. 420). It is unclear whether this
difference was significant.
Overall adherence also appears to have been very low in both
groups as the “average number of sessions was 3.9 (out of a possible
12 sessions) in the three-month group and 2.6 (out of a possible 12
sessions) for the 12-month group” (Torhorst 1988, p.420). Again,
it is unclear whether this difference is significant. Additionally, as
neither SDs, nor t-test, nor F statistics were reported, we were
unable to impute SDs using the method outlined in Townsend
2001 to calculate the mean difference in the number of treatment
sessions attended by the experimental and control groups.
7.59 Depression
Although numerical data on depression scores were not available,
means estimated by the review authors from a graph in the orig-
inal report suggest there was little difference in depression scores
between those allocated to long-term therapy and those allocated
to short-term therapy by the 12-month follow-up assessment (es-
timated means 9.3 vs 6.7).
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The study authors, however, stated that “self-evaluated depressivity
. . . improved considerablymore for the patients of the three-month
program than for those of the 12-month program” (Torhorst
1988, p. 421). This improvement was described by the authors as
significant.
7.60 Hopelessness
No data provided.
7.61 Suicidal ideation
No data provided.
7.62 Problem solving
No data provided.
7.63 Suicide
No data provided.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Interventions for multiple repetition of SH/ probable personality disorder vs treatment as usual or other alternative forms of psychotherapy
Patient or population: adults who engage in SH
Settings: outpat ients
Intervention: intervent ions for mult iple repet it ion of SH/ probable personality disorder
Comparison: t reatment as usual (TAU) or other alternat ive forms of psychotherapy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evi-
dence
(GRADE)
Comments
Assumed risk Corresponding risk
TAU/ other alterna-
tive forms of psy-
chotherapy
Interventions for
multiple repetition
of SH/ probable per-
sonality disorder
Emotion- regulation group-based psychotherapy vs TAU
Repetition of SH at
post- intervention
Study population OR 0.34
(0.13 to 0.88)
83
(2 RCTs)
⊕⊕©©
Lowa
We down-
graded quality as the
nature of this inter-
vent ion means it is
unlikely part icipants
and clinical person-
nel would have been
blind to treatment
allocat ion. Addit ion-
ally, for 1 trial,
outcome assessors
were also not blind
to treatment allo-
cat ion. We further
downgraded quality
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as study invest iga-
tors did not ade-
quately describe de-
tails on sequence
generat ion and allo-
cat ion concealment
775 per 1000 539 per 1000
(309 to 752)
Frequency of SH at
post- intervention
Study population - 83
(2 RCTs)
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Lowb,c
We down-
graded quality as the
nature of this inter-
vent ion means it is
unlikely part icipants
and clinical person-
nel would have been
blind to treatment al-
locat ion. Study in-
vest igators also did
not adequately de-
scribe details on se-
quence generat ion
and allocat ion con-
cealment. Addit ion-
ally, for 1 trial,
outcome assessors
were also not blind
to treatment alloca-
t ion As the conf i-
dence interval for
the treatment ef fect
size is wide, we
further downgraded
quality due to impre-
cision
The mean f requency of episodes of SH in
the experimental group was, on average,
12.76 lower (34.92 lower to 9.40 higher)
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Repetition of SH at
post- intervention
Study population OR 0.35
(0.17 to 0.73)
134
(1 RCT)
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Moderateb
We down-
graded quality as the
nature of this inter-
vent ion means it is
unlikely part icipants
and clinical person-
nel would have been
blind to treatment al-
locat ion
492 per 1000 253 per 1000
(141 to 414)
Frequency of SH at
post- intervention
Study population - 133
(1 RCT)
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graded quality as the
nature of this inter-
vent ion means it is
unlikely part icipants
and clinical person-
nel would have been
blind to treatment
allocat ion. Addit ion-
ally, as the conf i-
dence interval for
the treatment ef fect
size is wide, we
further downgraded
quality
The mean f requency of episodes of SH in
the experimental group was, on average,1.
28 lower (2.01 lower to 0.55 lower)
DBT-oriented therapy vs Alternative forms of psychotherapy
Repetition of SH at
post- intervention
Study population OR 0.05
(0.00 to 0.49)
24
(1 RCT)
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downgraded quality
as the sample size
is small
667 per 1000 91 per 1000
(0 to 495)
Frequency of SH at
post- intervention
Study population - 24
(1 RCT)
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We down-
graded quality as the
nature of this inter-
vent ion means it is
unlikely part icipants
and clinical person-
nel would have been
blind to treatment al-
locat ion. We further
downgraded quality
as the sample size
is small
The mean f requency of episodes of SH in
the experimental group was, on average,4.
83 lower (7.90 lower to 1.76 lower)
DBT vs TAU
Repetition of SH at
post- intervention
Study population OR 0.59
(0.16 to 2.15)
267
(3 RCTs)
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graded quality as the
nature of this inter-
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due to notable dif -
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nitude of the ef fect
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tween trials on vi-
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sual inspect ion of
the forest plot
667 per 1000 541 per 1000
(242 to 811)
Repetition of SH at
12 months’ follow-
up
Study population OR 0.36
(0.05 to 2.47)
172
(2 RCTs)
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Lowb,c
We down-
graded quality as the
nature of this inter-
vent ion means it is
unlikely part icipants
and clinical person-
nel would have been
blind to treatment al-
locat ion. We further
downgraded quality
due to notable dif -
ferences in the mag-
nitude of the ef fect
size est imates be-
tween trials on vi-
sual inspect ion of
the forest plot
495 per 1000 260 per 1000
(47 to 707)
Repetition of SH at
final follow-up
Study population OR 0.57
(0.21 to 1.59)
247
(3 RCTs)
⊕⊕©©
Lowb,c
We down-
graded quality as the
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tween trials on vi-
sual inspect ion of
the forest plot
620 per 1000 482 per 1000
(255 to 722)
Frequency of SH at
post- intervention
Study population - 292
(3 RCTs)
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We down-
graded quality as the
nature of this inter-
vent ion means it is
unlikely part icipants
and clinical person-
nel would have been
blind to treatment al-
locat ion. We further
downgraded quality
due to imprecision
of the ef fect size es-
t imate
The mean f requency of episodes of SH in
the experimental group was, on average,
18.82 lower (36.68 lower to 0.95 lower)
DBT vs treatment by expert
Repetition of SH at
post- intervention
Study population OR 1.66
(0.53 to 5.20)
97
(1 RCT)
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conf idence interval
for the treatment ef -
fect size is wide, we
further downgraded
quality
822 per 1000 885 per 1000
(710 to 960)
Repetition of SH at
12 months
Study population OR 1.18
(0.35 to 3.95)
97
(1 RCT)
⊕©©©
Very lowa,c
We
downgraded quality
as the nature of this
intervent ion means
it is unlikely par-
t icipants and clini-
cal personnel would
have been blind
to treatment alloca-
t ion. Study authors
did not adequately
describe details on
allocat ion conceal-
ment. Last ly, as the
conf idence interval
for the treatment ef -
fect size is wide, we
further downgraded
quality
867 per 1000 885 per 1000
(695 to 963)
Frequency of SH at
post- intervention
Study population - 97
(1 RCT)
⊕©©©
Very lowa,c
We
downgraded quality
as the nature of this
intervent ion means
it is unlikely par-
t icipants and clini-
cal personnel would
have been blind
to treatment alloca-
t ion. Study authors
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did not adequately
describe details on
allocat ion conceal-
ment. Last ly, as the
conf idence interval
for the treatment ef -
fect size is wide, we
further downgraded
quality
The mean f requency of episodes of SH in
the experimental group was, on average,
14.85 lower (37.64 lower to 7.94 higher)
DBT prolonged exposure vs DBT standard exposure
Repetition of SH at
post- intervention
Study population OR 0.67
(0.08 to 5.68)
18
(1 RCT)
⊕⊕©©
Lowb,c
We
downgraded quality
as details on par-
t icipant and clinical
personnel blinding
were not adequately
described. However,
given the sim ilar-
ity between the in-
tervent ion and con-
trol treatment in this
trial, it is possible
that blinding could
have been achieved.
We further down-
graded quality as the
conf idence interval
for the treatment ef -
fect size is wide
333 per 1000 251 per 1000
(38 to 740)
Repetition of SH at
6 months’ follow-up
Study population OR 0.67
(0.08 to 5.68)
18
(1 RCT)
⊕⊕©©
Lowb,c
We
downgraded quality
as details on par-
t icipant and clinical
personnel blinding5
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were not adequately
described. However,
given the sim ilar-
ity between the in-
tervent ion and con-
trol treatment in this
trial, it is possible
that blinding could
have been achieved.
We further down-
graded quality as the
conf idence interval
for the treatment ef -
fect size is wide
333 per 1000 251 per 1000
(38 to 740)
Frequency of SH at
post- intervention
Study population - 18
(1 RCT)
⊕⊕©©
Low b,c
We
downgraded quality
as details on par-
t icipant and clinical
personnel blinding
were not adequately
described. However,
given the sim ilar-
ity between the in-
tervent ion and con-
trol treatment in this
trial, it is possible
that blinding could
have been achieved.
We further down-
graded quality as the
conf idence interval
for the treatment ef -
fect size is wide
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The mean f requency of episodes of SH in
the experimental group was, on average,0.
25 lower (2.47 lower to 1.97 higher)
Frequency of SH at
6 months’ follow-up
Study population - 18
(1 RCT)
⊕⊕©©
Lowb,c
We
downgraded quality
as details on par-
t icipant and clinical
personnel blinding
were not adequately
described. However,
given the sim ilar-
ity between the in-
tervent ion and con-
trol treatment in this
trial, it is possible
that blinding could
have been achieved.
We further down-
graded quality as the
conf idence interval
for the treatment ef -
fect size is wide
The mean f requency of episodes of SH in
the experimental group was, on average,0.
34 higher (0.61 lower to 1.29 higher)
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95%
conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI)
CI: conf idence interval; OR: odds rat io; RCT : randomised controlled trial: SH: self -harm; TAU: t reatment as usual.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
a Risk of bias was rated as VERY SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel could
not have remained blind to treatment allocat ion, suggest ing that performance and detect ion bias may have been present.
For 1 trial, outcome assessors were not blind to treatment allocat ion. Addit ionally, as details on sequence generat ion and
allocat ion concealment were not adequately described, select ion bias may have been present.
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b Risk of bias was rated as SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel could not
have remained blind to treatment allocat ion suggest ing that performance and detect ion bias may have been present.
c Imprecision was rated as SERIOUS as the conf idence interval is wide or there are notable dif f erences in the magnitude of
the ef fect size between trials on visual inspect ion of the forest plot.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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Case management vs treatment as usual or other alternative forms of psychotherapy
Patient or population: adults who engage in SH
Settings: outpat ients
Intervention: case management
Comparison: t reatment as usual (TAU) or other alternat ive forms of psychotherapy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
TAU/ other alternative
forms of psychother-
apy
Case management
Repetition of SH at
post- intervention
Study population OR 0.78
(0.47 to 1.30)
1608
(4 RCTs)
⊕⊕⊕©
Moderatea
We downgraded quality
as the nature of this
intervent ion means it
is unlikely part icipants
and clinical personnel
would have been blind
to treatment allocat ion
114 per 1000 91 per 1000
(57 to 143)
M ultiple readmissions
for SH at post- inter-
vention
Study population OR 5.23
(1.12 to 24.45)
469
(1 RCT)
⊕⊕⊕©
Moderatea
We downgraded quality
as the nature of this
intervent ion means it
is unlikely part icipants
and clinical personnel
would have been blind
to treatment allocat ion
8 per 1000 41 per 1000
(9 to 166)
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI)
CI: conf idence interval; OR: odds rat io; RCT : randomised controlled trial: SH: self -harm; TAU: t reatment as usual.
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
a Risk of bias was rated as SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel could not
have remained blind to treatment allocat ion.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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Adherence enhancement approaches vs treatment as usual or other alternative forms of psychotherapy
Patient or population: adults who engage in SH
Settings: outpat ients
Intervention: Adherence enhancement approaches
Comparison: t reatment as usual (TAU) or other alternat ive forms of psychotherapy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
TAU/ other alternative
forms of psychother-
apy
Adherence enhance-
ment approaches
Compliance enhancement vs TAU
Repetition of SH at 12
months’ follow-up
Study population OR 0.57
(0.32 to 1.02)
391
(1 RCT)
⊕⊕©©
Lowa
We downgraded qual-
ity as an open ran-
dom numbers table was
used to generate the al-
locat ion sequence and,
as allocat ion was not
concealed, there is pos-
sible select ion bias.
We further downgraded
quality as the nature of
this intervent ion means
it is unlikely part ici-
pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion
174 per 1000 107 per 1000
(63 to 177)
Continuity of care by the same therapist vs other alternative forms of psychotherapy (i.e. , care by a different therapist)
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Repetition of SH at 12
months’ follow-up
Study population OR 0.28
(0.07 to 1.10)
136
(1 RCT)
⊕©©©
Very lowb,c
We downgraded qual-
ity as neither part ici-
pants, clinical person-
nel, nor outcome asses-
sors were blind to treat-
ment allocat ion. We fur-
ther downgraded qual-
ity as study authors did
not specif y the method
used to allocate par-
t icipants to the ex-
perimental and control
groups, nor did they re-
port details on alloca-
t ion concealment. Fi-
nally, we downgraded
quality three grades, as
there was signif icant
imbalance between the
experimental and con-
trol group for some pu-
tat ive risk factors for
repet it ion of SH despite
randomisat ion
136 per 1000 42 per 1000
(11 to 148)
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI)
CI: conf idence interval; OR: odds rat io; RCT : randomised controlled trial: SH: self -harm; TAU: t reatment as usual.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
a Risk of bias was rated as VERY SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel
could not have remained blind to treatment allocat ion, suggest ing that performance and detect ion bias may have been
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present. As an open numbers table was used the generate the allocat ion sequence, and as allocat ion was not concealed,
select ion bias also may have been present.
b Risk of bias was rated as VERY SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel
could not have remained blind to treatment allocat ion, suggest ing that performance and detect ion bias may have been
present. Addit ionally, as no details on the method used to allocate part icipants to the intervent ion and control groups or on
allocat ion concealment were reported, select ion bias also may have been present.
c There was signif icant imbalance between the intervent ion and control groups for a number of putat ive risk factors for
repet it ion of SH despite randomisat ion.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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M ixed multimodal interventions vs treatment as usual
Patient or population: adults who engage in SH
Settings: outpat ients
Intervention: m ixed mult imodal intervent ions
Comparison: t reatment as usual (TAU)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
TAU M ixed multimodal In-
terventions
M ixed multimodal interventions vs TAU
Repetition of SH at
post- intervention
Study population OR 0.98
(0.68 to 1.43)
684
(1 RCT)
⊕⊕©©
Lowa,b
We downgraded quality
as, due to the nature
of the intervent ion, it
is unlikely part icipants
and clinical personnel
would have been blind
to treatment allocat ion.
Addit ionally, use of Ze-
len’s post-consent de-
sign would indicate that
part icipants were also
not blind to treatment
allocat ion. We further
downgraded quality as
the conf idence interval
for the treatment ef fect
size is wide
204 per 1000 201 per 1000
(149 to 269)
Culturally-adapted mixed multimodal interventions vs TAU
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Repetition of SH at 12
months
Study population OR 0.83
(0.44 to 1.55)
167
(1 RCT)
⊕⊕©©
Lowa,b
We downgraded quality
as, due to the nature
of the intervent ion, it
is unlikely part icipants
and clinical personnel
would have been blind
to treatment allocat ion.
Addit ionally, use of Ze-
len’s post-consent de-
sign would indicate that
part icipants were also
not blind to treatment
allocat ion. We further
downgraded quality as
the conf idence interval
for the treatment ef fect
size is wide
403 per 1000 359 per 1000
(229 to 511)
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI)
CI: conf idence interval; OR: odds rat io; RCT : randomised controlled trial: SH: self -harm; TAU: t reatment as usual.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
a Risk of bias was rated as SERIOUS, as the nature of the intervent ion means that part icipants and clinical personnel could not
have remained blind to treatment allocat ion. Addit ionally, the use of Zelen’s post-consent design indicates that part icipants
would not have been blind to treatment allocat ion. Performance and detect ion bias therefore may have been present.
b Imprecision was rated as SERIOUS as the conf idence interval is wide.
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Remote contact interventions vs treatment as usual
Patient or population: adults who engage in SH
Settings: outpat ients
Intervention: remote contact intervent ions
Comparison: t reatment as usual
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
TAU Remote contact inter-
ventions
Postcards vs TAU
Repetition of SH at
post- intervention
Study population OR 0.87
(0.62 to 1.23)
3277
(4 RCTs)
⊕©©©
Very lowa,b
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely that par-
t icipants and clinical
personnel would have
been blind to treat-
ment allocat ion. We fur-
ther downgraded qual-
ity due to signif icant dif -
ferences in the direc-
t ion of the ef fect size
est imate between trials
on visual inspect ion of
the forest plot
132 per 1000 117 per 1000
(86 to 157)
Repetition of SH at 12
months
Study population OR 0.76
(0.57 to 1.02)
2885
(2 RCTs)
⊕⊕⊕©
Moderatea
We downgraded quality
as the nature of this
intervent ion means it
is unlikely that part ici-
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pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion
175 per 1000 139 per 1000
(108 to 178)
Repetition of SH at fi-
nal follow-up
Study population OR 0.88
(0.62 to 1.25)
3277
(4 RCTs)
⊕©©©
Very lowa,b
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely that par-
t icipants and clinical
personnel would have
been blind to treat-
ment allocat ion. We fur-
ther downgraded qual-
ity due to signif icant dif -
ferences in the direc-
t ion of the ef fect size
est imate between trials
on visual inspect ion of
the forest plot
185 per 1000 167 per 1000
(123 to 221)
Frequency of SH at
post- intervention
Study population - 1097
(3 RCTs)
⊕©©©
Very lowa,b
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely that par-
t icipants and clinical
personnel would have
been blind to treat-
ment allocat ion. We fur-
ther downgraded qual-
ity due to signif icant dif -
ferences in the direc-
t ion of the ef fect size
est imate between trials
on visual inspect ion of
the forest plot
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The mean f requency of episodes of
SH in the experimental group was, on average, 0.
07 lower (0.32 lower to 0.18 higher)
Frequency of SH at 12
months
Study population - 984
(2 RCTs)
⊕©©©
Very lowa,b
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely that par-
t icipants and clinical
personnel would have
been blind to treat-
ment allocat ion. We fur-
ther downgraded qual-
ity due to signif icant dif -
ferences in the direc-
t ion of the ef fect size
est imate between trials
on visual inspect ion of
the forest plot
The mean f requency of episodes of
SH in the experimental group was, on average, 0.
19 lower (0.58 lower to
0.20 higher)
Frequency of SH at 24
months
Study population - 472
(1 RCT)
⊕⊕⊕©
Moderatea
We downgraded quality
as the nature of this
intervent ion means it
is unlikely that part ici-
pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion
The mean f requency of episodes of
SH in the experimental group was, on average, 0.
03 lower (0.16 lower to
0.10 higher)
Emergency cards vs TAU
Repetition of SH at
post- intervention
Study population OR 0.82
(0.31 to 2.14)
1039
(2 RCTs)
⊕⊕©©
Lowa,d
We downgraded quality
as the nature of this
intervent ion means it
is unlikely part icipants
and clinical personnel
were bind to treat-6
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ment allocat ion. Addi-
t ionally, quality was fur-
ther downgraded due to
notable dif f erences in
the direct ion of the ef -
fect size est imate be-
tween trials on visual
inspect ion of the forest
plot
171 per 1000 145 per 1000
(60 to 306)
Repetition of SH at 12
months’ follow-up
Study population OR 1.19
(0.85 to 1.67)
827
(1 RCT)
⊕⊕⊕©
Moderate a
We downgraded quality
as the nature of this
intervent ion means it
is unlikely part icipants
and clinical personnel
were bind to treatment
allocat ion
188 per 1000 216 per 1000
(164 to 279)
General practitioner’s (GP) letter vsTAU
Repetition of SH at
post-intervent ion
Study population OR 1.15
(0.93 to 1.44)
1932
(1 RCT)
⊕⊕⊕©
Moderatea
We downgraded quality
as the nature of this
intervent ion means it
is unlikely that part ici-
pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion
195 per 1000 218 per 1000
(184 to 259)
Telephone contact vs TAU
Repetition of SH at 6
months’ follow-up
Study population OR 0.23
(0.02 to 2.11)
81
(1 RCT)
⊕⊕©©
Lowa,e
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely that par-
t icipants and clinical
personnel would have7
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been blind to treatment
allocat ion. We further
downgraded quality as
the conf idence interval
for the treatment ef fect
size is wide
100 per 1000 25 per 1000
(2 to 190)
Repetition of SH at 12
months’ follow-up
Study population OR 1.00
(0.45 to 2.23)
172
(1 RCT)
⊕⊕©©
Low a,e
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely that par-
t icipants and clinical
personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
the conf idence interval
for the treatment ef fect
size is wide
169 per 1000 169 per 1000
(84 to 311)
Repetition of SH at 24
months’ follow-up
Study population OR 0.76
(0.49 to 1.16)
605
(1 RCT)
⊕⊕⊕©
Lowa,e
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely that par-
t icipants and clinical
personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
the conf idence interval
for the treatment ef fect
size is wide
189 per 1000 151 per 1000
(103 to 213)
Repetition of SH at fi-
nal follow-up
Study population OR 0.74
(0.42 to 1.32)
840
(3 RCTs)
⊕©©©
Very lowa,b
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely that par-
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t icipants and clinical
personnel would have
been blind to treat-
ment allocat ion. We fur-
ther downgraded qual-
ity due to signif icant dif -
ferences in the direc-
t ion of the ef fect size
est imate between trials
on visual inspect ion of
the forest plot
185 per 1000 143 per 1000
(87 to 230)
M obile telephone-based psychotherapy vs TAU
Repetition of SH at
post- intervention
Study population Not estimable 68
(1 RCT)
⊕⊕©©
Lowa,e
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely that par-
t icipants and clinical
personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
the sample size is small
0 per 1000 0 per 1000
(0 to 0)
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI)
CI: conf idence interval; OR: odds rat io; RCT : randomised controlled trial: SH: self -harm; TAU: t reatment as usual.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
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a Risk of bias was rated as SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel could not
have remained blind to treatment allocat ion. Addit ionally, for some trials, no details on outcome assessor blinding were
reported. Performance and detect ion bias therefore may have been present.
b Inconsistency was rated as VERY SERIOUS as the conf idence interval is wide or there are signif icant dif f erences in the
magnitude of the ef fect size between trials on visual inspect ion of the forest plot.
c Risk of bias was rated as VERY SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel
could not have remained blind to treatment allocat ion. Addit ionally, for some trials, no details on outcome assessor blinding
were reported. Performance and detect ion bias therefore cannot be ruled out. Addit ionally, as a number of part icipants
randomised to the control group mistakenly received the intervent ion, and yet were included in the control group for all
subsequent analyses, other bias may have been present.
d Inconsistency was rated as SERIOUS as the conf idence interval is wide or there are notable dif f erences in the magnitude of
the ef fect size between trials on visual inspect ion of the forest plot.
e Imprecision was rated as SERIOUS as the conf idence interval is wide and/ or the sample size is small.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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Heterogeneous other interventions vs treatment as usual or other alternative forms of psychotherapy
Patient or population: adults who engage in SH
Settings: m ixture of in- and outpat ients
Intervention: other mixed intervent ions
Comparison: t reatment as usual or other alternat ive forms of psychotherapy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
TAU or other alter-
native forms of psy-
chotherapy
Heterogenous other in-
terventions
Interpersonal problem-solving skills training vs other alternative forms of psychotherapy
Repetition of SH at 12
months
Study population OR 0.40
(0.06 to 2.57)
33
(1 RCT)
⊕©©©
Very lowa,b
We downgraded quality
as the nature of this
intervent ion means it
is unlikely part icipants
and clinical personnel
would have been blind
to treatment allocat ion.
We further downgraded
quality as an open ran-
dom numbers table was
used to generate the al-
locat ion sequence and,
as allocat ion was not
concealed, there is pos-
sible select ion bias.
We further downgraded
quality as the sample
size is small
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250 per 1000 118 per 1000
(20 to 461)
Behaviour therapy vs other alternative forms of psychotherapy
Repetition of SH at 12
months
Study population OR 0.60
(0.08 to 4.45)
24
(1 RCT)
⊕⊕©©
Lowb,c
We downgraded qual-
ity as clinical person-
nel were not blind
to treatment alloca-
t ion. Addit ionally, de-
tails on sequence gen-
erat ion, allocat ion con-
cealment, part icipant
blinding, and outcome
assessor blinding were
not adequately de-
scribed. Last ly, as the
conf idence interval for
the treatment ef fect
size is wide, we further
downgraded quality
250 per 1000 167 per 1000
(26 to 597)
Information and support vs TAU
Repetition of SH at fi-
nal follow-up for the
overall cohort
Study population OR 1.02
(0.71 to 1.47)
1663
(1 RCT)
⊕⊕©©
Lowd
We downgraded qual-
ity as the nature of the
intervent ion means it
is unlikely that clinical
personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
attrit ion bias may have
been present
75 per 1000 76 per 1000
(54 to 106)
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Repetition of SH at fi-
nal follow-up for the
Campinas, Brazil site
Study population OR 2.27
(0.97 to 5.28)
135
(1 RCT)
⊕©©©
Very lowb,c
We downgraded qual-
ity as the nature of
the intervent ion means
it is unlikely that clin-
ical personnel would
have been blind to treat-
ment allocat ion. We fur-
ther downgraded qual-
ity as attrit ion bias
may have been present.
We downgraded qual-
ity three grades for this
site as the conf idence
interval for the treat-
ment ef fect size is wide
156 per 1000 296 per 1000
(152 to 494)
Repetition of SH at fi-
nal follow-up for the
Colombo, Sri Lanka
site
Study population OR 0.55
(0.13 to 2.34)
251
(1 RCT)
⊕©©©
Very lowb,d
We downgraded qual-
ity as the nature of the
intervent ion means it
is unlikely that clinical
personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
attrit ion bias may have
been present. We fur-
ther downgraded qual-
ity for this site as
the conf idence interval
for the treatment ef fect
size is wide
41 per 1000 23 per 1000
(6 to 92)
Repetition of SH at fi-
nal follow-up for the
Karaj, Iran site
Study population OR 1.18
(0.69 to 2)
601
(1 RCT)
⊕⊕©©
Lowd
We downgraded qual-
ity as the nature of the
intervent ion means it
is unlikely that clinical
personnel would have
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been blind to treatment
allocat ion. We further
downgraded quality as
attrit ion bias may have
been present
94 per 1000 109 per 1000
(67 to 172)
Repetition of SH at fi-
nal follow-up for the
Yuncheng, China site
Study population OR 2.01
(0.08 to 50.6)
96
(1 RCT)
⊕©©©
Very lowb,d
We downgraded qual-
ity as the nature of the
intervent ion means it
is unlikely that clinical
personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
attrit ion bias may have
been present. We fur-
ther downgraded qual-
ity for this site as
the conf idence interval
for the treatment ef fect
size is wide
0 per 1000 0 per 1000
(0 to 0)
Repetition of SH at fi-
nal follow-up for the
Chennai, India site
Study population OR 0.39
(0.17 to 0.92)
561
(1 RCT)
⊕⊕©©
Lowd
We downgraded qual-
ity as the nature of the
intervent ion means it
is unlikely that clinical
personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
attrit ion bias may have
been present
65 per 1000 27 per 1000
(12 to 60)
Frequency of SH at fi-
nal follow-up for the
Karaj, Iran site
The f requency of episodes of SH for the Karaj,
Iran site in the experimental group was, on aver-
age, 0.46 higher (0.32 higher to 0.32 higher)
- 629
(1 RCT)
⊕⊕©©
Lowd
We downgraded qual-
ity as the nature of the
intervent ion means it
is unlikely that clinical
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personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
attrit ion bias may have
been present
Treatment for alcohol misuse vs TAU
Repetition of SH at 6
months
Study population OR 0.57
(0.20 to 1.60)
103
(1 RCT)
⊕⊕©©
Lowb,c
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely clinical
personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
the conf idence interval
for the treatment ef fect
size is wide
216 per 1000 136 per 1000
(52 to 306)
Home-based problem-solving therapy vs other alternative forms of psychotherapy
Repetition of SH at 12
months
Study population OR 0.68
(0.20 to 2.32)
96
(1 RCT)
⊕⊕©©
Lowb,c
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely clinical
personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
the conf idence interval
for the treatment ef fect
size is wide
146 per 1000 104 per 1000
(33 to 284)
Intensive inpatient and community treatment vs TAU
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Repetition of SH at 12
months
Study population OR 1.18
(0.62 to 2.25)
274
(1 RCT)
⊕⊕©©
Low b,c
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely clinical
personnel would have
been blind to treatment
allocat ion. We further
downgraded quality as
the conf idence interval
for the treatment ef fect
size is wide
149 per 1000 172 per 1000
(98 to 283)
Frequency of SH at 12
months
Study population - 274
(1 RCT)
⊕⊕⊕©
Moderatec
We downgraded quality
as the nature of this in-
tervent ion means it is
unlikely clinical person-
nel would have been
blind to treatment allo-
cat ion
The mean f requency of
SH at 12 months in the
control group was 0.23
episodes
The mean f requency of
SH at 12 months in
the experimental group
was 0 higher (0.17
lower to 0.17 higher
General hospital admission vs other alternative forms of psychotherapy
Repetition of SH at
post- intervention
Study population OR 1.03
(0.14 to 7.69)
77
(1 RCT)
⊕⊕©©
Lowb,c
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely clinical
personnel would have
been blind to treatment
allocat ion. Last ly, as
the conf idence interval
for the treatment ef fect
size is wide, quality was
further downgraded
51 per 1000 53 per 1000
(8 to 294)
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Repetition of SH at 6
months’ follow-up
Study population OR 0.75
(0.16 to 3.60)
77
(1 RCT)
⊕⊕©©
Lowb,c
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely clinical
personnel would have
been blind to treatment
allocat ion. Last ly, as
the conf idence interval
for the treatment ef fect
size is wide, quality was
further downgraded
103 per 1000 79 per 1000
(18 to 291)
Intensive outpatient intervention vs TAU
Repetition of SH at
post- intervention
Study population OR 0.27
(0.07 to 1.06)
119
(1 RCT)
⊕⊕⊕©
Low b,c
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely clinical
personnel would have
been blind to treatment
allocat ion. Last ly, as
the conf idence interval
for the treatment ef fect
size is wide, quality was
further downgraded
158 per 1000 48 per 1000
(13 to 166)
Repetition of SH at 24
months
Study population OR 1.24
(0.59 to 2.62)
126
(1 RCT)
⊕⊕©©
Low b,c
We downgraded qual-
ity as the nature of
this intervent ion means
it is unlikely clinical
personnel would have
been blind to treatment
allocat ion. Last ly, as
the conf idence interval
for the treatment ef fect
size is wide, quality was
further downgraded8
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302 per 1000 349 per 1000
(203 to 531)
Repetition of SH at fi-
nal follow-up
Study population OR 0.65
(0.15 to 2.85)
245
(2 RCTs)
⊕©©©
Very lowb,e
We downgraded quality
as the nature of this
intervent ion means it
is unlikely clinical per-
sonnel could have been
blind to treatment allo-
cat ion. Addit ionally, for
1 trial, part icipants also
were not blind to treat-
ment allocat ion. We fur-
ther downgraded qual-
ity due to signif icant dif -
ferences in the direc-
t ion of the ef fect size
est imate between trials
on visual inspect ion of
the forest plot
233 per 1000 165 per 1000
(44 to 464)
Long term vs other alternative forms of psychotherapy
Repetition of SH at 12
months
Study population OR 1.00
(0.35 to 2.86)
80
(1 RCT)
⊕⊕©©
Low b,c
We downgraded quality
as the nature of this in-
tervent ion means it is
unlikely clinical person-
nel would have been
blind to treatment allo-
cat ion, addit ionally, the
method used to allo-
cate part icipants to the
treatment and interven-
t ions groups was not
specif ied and as no de-
tails on allocat ion con-
8
1
P
sy
c
h
o
so
c
ia
l
in
te
r
v
e
n
tio
n
s
fo
r
se
lf-h
a
rm
in
a
d
u
lts
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
6
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
cealment was reported.
We further downgraded
quality as the sample
size was small and
the conf idence interval
for the treatment ef fect
size is wide
225 per 1000 225 per 1000
(92 to 454)
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI)
CI: conf idence interval; OR: odds rat io; RCT : randomised controlled trial: SH: self -harm; TAU: t reatment as usual.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
a Risk of bias was rated as VERY SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel
could not have remained blind to treatment allocat ion, suggest ing that performance and detect ion bias may have been
present. As an open numbers table was used the generate the allocat ion sequence, and as allocat ion was not concealed,
select ion bias also may have been present.
b Imprecision was rated as SERIOUS as the conf idence interval is wide and/ or the sample size is small.
c Risk of bias was rated as SERIOUS as clinical personnel were not blind to treatment allocat ion, suggest ing that performance
and detect ion bias may have been present. Addit ionally, although details on part icipant blinding and outcome assessor
blinding were not adequately described, the nature of the intervent ion means that part icipants could not have remained blind
to treatment allocat ion. Finally, authors of some studies did not adequately describe details on sequence generat ion and
allocat ion concealment. Select ion bias therefore may also have been present.
d Risk of bias was rated as VERY SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel
could not have remained blind to treatment allocat ion, suggest ing that performance and detect ion bias may have been
present. Addit ionally, attrit ion bias may have been present.
e Inconsistency was rated as VERY SERIOUS due to signif icant dif f erences in the magnitude of the ef fect size between trials
on visual inspect ion of the forest plot.
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D I S C U S S I O N
This systematic review represents an update of previous versions
(Hawton 1998; Hawton 1999; NICE 2011). Whilst those ver-
sions included psychosocial and pharmacological interventions as
well as data for adults, children and adolescents who engage in SH,
this update focused solely on psychosocial treatments for adults. In
the previous versions of this review, we only focused on a limited
number of clinical outcomes, namely repetition of SH and suicide.
In this update we have considerably expanded the range of clini-
cally relevant outcomes examined to include treatment adherence,
depression, hopelessness, problem-solving, and suicidal ideation
where available. We also reported frequency of SH where data on
this outcome were available. For the primary outcome of SH, we
have included SH episodes with any type of motivation, including
suicidal. Where we clarified suicidal intent with study authors a
number reported including all episodes of SH irrespective of sui-
cidal intent despite inclusion criteria suggesting that only those
indicating intent to die were eligible to participate, highlighting
the problems in attempting to ascertain suicidal intent.
Recently there has been a considerable increase in the number
of trials conducted in this field and in the types of interventions
evaluated, reflecting the international concern about self-harm,
the increased attention to suicide prevention in particular, and the
involvement of newer countries in this research, especially in Asia.
Previously we commented on the fact that the majority of trials
included either patients who had all taken overdoses, or samples
where themajority had, reflecting the types of patients who present
to general hospitals following SH (Hawton 2007). However, there
are other important patient subgroups, especially those who en-
gage in self-mutilation. Some of the more recent trials in this re-
view included such participants, particularly those that focused
on patients who had a history of multiple episodes of SH at trial
entry (e.g., Gratz 2006; Gratz 2014; Harned 2014; Linehan 1991;
Linehan 2006; McMain 2009; Priebe 2012; Weinberg 2006). It
should be noted that people who repeat SHmay change the meth-
ods they use (Owens 2015; Lilley 2008). It is also important to
note that multiple repetition of SH is associated with increased
suicide risk (Zahl 2004).
None of the trials included information on adverse effects of these
interventions, other than further suicidal behaviour.
We have used the intention-to-treat method where data allowed.
This was usually possible when examining the outcomes of repe-
tition of SH and suicide. Where outcomes relied on patient inter-
view, this was generally not possible and we have instead used all
available case data.
Summary of main results
CBT-based psychotherapy
There were 18 trials that compared CBT-based psychotherapy,
comprising cognitive behavioural therapy, problem-solving ther-
apy, or both, versus treatment as usual (TAU) (Brown 2005;
Davidson 2014; Dubois 1999; Evans 1999b; Gibbons 1978;
Guthrie 2001; Hatcher 2011; Hawton 1987a; Husain 2014;
McAuliffe 2014; Patsiokas 1985; Salkovskis 1990; Slee 2008;
Stewart 2009; Tapolaa 2010; Tyrer 2003; Wei 2013; Weinberg
2006). Meta-analysis of these trials provided evidence to suggest
a reduction in repetition of SH at both 6 and 12 months after
trial entry and at final follow-up. However, we did not find any
significant treatment effect for CBT-based psychotherapy on the
frequency of SH at final follow-up. On the basis of data from 15
trials, there was no evidence of a significant effect of psychological
therapy on suicides, although relatively few events (i.e., 24) were
recorded.We also found beneficial effects for depression and hope-
lessness at 6 and 12 months as well as at final follow-up. Few trials
assessed suicidal ideation, although there was an apparent benefit
for CBT-based psychotherapy at three months, six months, and
at final follow-up. Relatively few trials reported findings for treat-
ment adherence, and they did so in different ways, so we cannot
draw firm conclusions for this outcome.
Interventions for multiple repetition of SH/probable
personality disorder
Group-based emotion-regulation psychotherapy
On the basis of two trials, conducted by the same research group,
emotion-regulation therapy for patients with borderline personal-
ity disorder provided in a group-based setting was associated with
a reduction in the proportion of patients repeating SH in the final
two months of the initial treatment period, but not with an overall
reduction in the frequency of SH over the whole treatment period
(Gratz 2006; Gratz 2014). There was also no effect for this type
of therapy on depression.
Mentalisation
In a single trial, mentalisation therapy for patients diagnosed with
borderline personality disorder was associated with fewer partici-
pants repeating both SH and suicide attempts by the post-inter-
vention assessment (Bateman 2009). There were also beneficial
effects for frequency of repetition of suicide attempts and for de-
pression scores.
Dialectical behaviour therapy
Three trials compared DBT with TAU in patients diagnosed with
borderline personality disorder, with no apparent overall effect on
the proportion of patients repeating SH at 12 and 24 months
following trial entry (Linehan 1991;McMain 2009; Priebe 2012).
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There was, however, a significant treatment effect for DBT on
frequency of repetition of SH.
A single trial compared DBT versus psychological treatment by
’experts’ (CBT-E; Linehan 2006). There was no evidence of dif-
ferences in outcomes for patients in the two groups in terms of
the proportion repeating SH or in the total number for ’parasui-
cidal’ acts, although the authors stated that there was a beneficial
effect for DBT on suicide re-attempts. There were no differences
between the DBT and CBT-E groups for depression and suicidal
ideation, however.
There was no difference in terms of repetition of SH, depression,
or treatment adherence in a single small trial between two forms of
DBT, an experimental one in which participants were given signif-
icantly longer cognitive exposure to stressful events coupled with
the standard DBT protocol and a control one in which partici-
pants received the standard DBT protocol as devised by Linehan
1991 (Harned 2014).
Dialectical behaviour-oriented therapy
In a single small trial (Turner 2000), DBT-oriented therapy ap-
peared to be more effective than client-oriented therapy in terms
of the proportion of patients repeating SH and the frequency of
SH. There were also benefits for depression and suicidal ideation.
Case management
In a single trial comparing case management versus TAU, there
was no effect for the experimental treatment on the proportion
of participants repeating SH, but it was associated with fewer
multiple admissions (Clarke 2002).
Two trials compared case management with added assertive out-
reach versus TAU (Hvid 2011; Morthorst 2012). There was no
evidence of a significant treatment effect for repetition of SH, but
there was a reduction in the proportion of females repeating SH
in the experimental group in one of these trials (Hvid 2011).
A single large trial compared case management plus assertive out-
reach versus enhanced usual care (Kawanishi 2014). There was no
difference between groups for repetition of SH or for suicide by
the 24-month follow-up period, although the study authors state
that are undertaking further analyses and also data for hopeless-
ness.
Treatment adherence enhancement approaches
Adherence enhancement
In a single trial that made efforts to improve adherence with treat-
ment by having nurses make home visits to participants who had
not attended initial outpatient appointments, there were increased
rates of attendance at the outpatient clinic in the group receiving
the experimental intervention. However, in spite of a marked re-
duction in subsequent repetition of SH in this group, the differ-
ence was non-significant (Van Heeringen 1995).
Continuity of care by the same therapist
In a single trial, continuity of care (i.e., where the clinician who
assessed each participant in hospital also provided aftercare for
them) resulted in better treatment attendance thanwhere different
therapists treated participants (Torhorst 1987). However, there
was no beneficial effect on repetition of SH.
Mixed multimodal interventions
Mixed multimodal interventions
A single large trial compared a package of interventions including
problem-solving therapy, postcards, and vouchers entitling partic-
ipants toGP care versus TAU (Hatcher 2015). However, there was
no beneficial effect for the experimental treatment on repetition
of SH, depression, or hopelessness.
Culturally-adapted mixed multimodal interventions
Hatcher 2016a adapted the treatment package developed by
Hatcher 2015 for participants self-identifying as ofM ori ethnic-
ity. There were no apparent benefits of this intervention in terms
of repetition of SH (including in subgroups of those with only a
single episode of SH prior to trial entry and those with a history
of multiple episodes of SH), depression, or hopelessness.
Remote contact interventions
Postcards
Four trials compared the effectiveness of postcards sent on a reg-
ular basis over a 12-month period with TAU (Beautrais 2010;
Carter 2005; Hassanian-Moghaddam 2011; Kapur 2013a). How-
ever, there was no benefit for this intervention in terms of pro-
portion of patients repeating SH. Substantial heterogeneity was
associated with this analysis, and removing Kapur 2013a (a small
pilot trial which may have been an outlier) resulted in a signifi-
cant treatment effect. The single largest trial of this intervention
did find fewer patients repeating SH in the experimental group
(Hassanian-Moghaddam 2011). This result is notable because the
control treatment used in this trial would have consisted of little
more than discharge because of the paucity of psychiatric services
in Iran as compared toAustralia, NewZealand, and theUK,which
have well-developed services. This raises the possibility that such
an intervention may be more effective in such settings. Addition-
ally, the postcards used in this trial included religious and philo-
sophical messages in addition to general support, which may also
explain their apparent efficacy in reducing suicidal behaviour.
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There was also no evidence of a significant treatment effect for
postcards on frequency of repetition of SH at either post-inter-
vention or at 12 or 24 months’ follow-up in three of the four trials
of postcards (Carter 2005; Hassanian-Moghaddam 2011; Kapur
2013a). It should be noted that the positive effect on frequency of
repetition reported in Carter 2005 was, according to the study’s
author, largely accounted for by difference in repetition in a small
subsample (less than 3% of the total sample) of women with a
history of three or more episodes of SH prior to trial entry.
Emergency cards
On the basis of two trials, there was no evidence that provision
of an emergency contact card allowing emergency access to a psy-
chiatrist on demand had an impact on repetition of SH (Evans
1999a; Morgan 1993). In the original report, however, a post hoc
subgroup analysis indicated that receipt of the emergency card was
associated with an increased risk of repetition of SH in those with
a history of multiple episodes of SH prior to the index episode
(Evans 1999a).
General practitioner’s letter
In a single trial in which general practitioners sent a letter to par-
ticipants following their discharge from hospital after SH offering
an appointment coupled with specialist advice on the manage-
ment of SH patients (Bennewith 2002), there was no apparent
beneficial effect on repetition of SH, although there was evidence
of a substantial beneficial effect in females. When analysed by re-
peater status, furthermore, there appeared to be a beneficial effect
in those with a history of multiple episodes of SH at trial entry,
but the reverse was true in those with only a single episode of SH
at trial entry.
Telephone contact
In three trials telephone contact with patients after discharge from
hospital did not produce any apparent benefits in terms of repe-
tition of SH compared with standard care (Cedereke 2002; Vaiva
2006; Wei 2013). There was also no evidence of any impact of
telephone contact on depression, suicidal ideation, or on the pro-
portion of participants attending at least one treatment session
during the 12-month follow-up period.
Mobile telephone-based psychotherapy
A single trial delivered psychotherapy, which included elements
of problem-solving therapy, meditation, and social support, by
mobile telephone (Marasinghe 2012), but there was no effect of
this intervention on repetition of SH. In the mobile phone psy-
chotherapy group, however, depression improved more in males
compared to those assigned to the wait list control group, whereas
suicidal ideation improved more in females.
Other mixed interventions
Interpersonal problem-solving skills training
In a single trial, interpersonal problem-solving skills training
(IPSST) was no better than brief problem-oriented therapy in
terms of repetition of SH, suicide and hopelessness (McLeavey
1994), although patients in the IPSST group may have had better
scores after treatment with regard to measures of problem-solving.
Treatment adherence also did not differ between groups, although
patients in the IPSST group did attend more treatment sessions.
Behaviour therapy
In a single trial, although behaviour therapy appeared to lead to
significant reductions in depression at the 10-week post-treatment
assessment, by the nine-month follow-up assessment there was
no apparent benefit for behaviour therapy compared to insight-
oriented therapy (Liberman 1981). Behaviour therapy was also
associated with mixed findings with respect to suicidal ideation.
There was no apparent effect of behaviour therapy in reducing the
proportion of participants reporting suicidal ideation at the two-
year follow-up period, although there was some evidence of a sig-
nificant treatment effect for shorter follow-up periods. Behaviour
therapy was also not associated with a significant treatment effect
for repetition of SH over a two-year follow-up period.
Provision of information and support
In a single trial conducted in five countries, a hospital-based infor-
mation service combined with regular home support, telephone
support, or both, appeared to have no extra benefit compared to
TAU in terms of repetition of SH (Bertolote 2010). However,
when results were analysed separately by site, although no ap-
parent benefit for information and support was found for four
of the five sites, this intervention package was associated with a
significant reduction in repetition of SH at the Chennai, India
site. There was evidence of significant reduction in suicide for the
overall cohort (Fleischmann 2008) and for the Chennai, India site
(Vijayakumar 2011), but not for the remaining two sites for which
data on suicides were available (Karaj, Iran: Hassanzadeh 2010
and Yuncheng, China: Xu 2012). We have noted that there is a
discrepancy between the findings for the overall cohort and those
reported from the individual sites, in that the number of suicides
reported for the overall cohort for the experimental group is less
than that presented in three local site reports (i.e., two vs three,
respectively).
Treatment for alcohol misuse
Evaluation in a single trial of a brief intervention for alcoholmisuse
in SHpatients showed no significant effect for this intervention on
repetition of SH, although the proportion of participants repeat-
ing SH was somewhat lower in the experimental group (Crawford
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2010). However, only 47.1% of those randomised to the experi-
mental group attended the alcohol treatment session. The original
trial report did, however, observe a non-significant trend towards
reduced alcohol consumption per drinking day in those allocated
to the experimental arm.
Home-based problem-solving psychotherapy
In a single trial, home-based problem-solving psychotherapy re-
sulted in better treatment adherence than outpatient problem-
solving therapy, but there was no difference in repetition of SH, de-
pression, or suicidal ideation between the groups (Hawton 1981).
Intensive inpatient and community treatment
A single trial compared an intervention involving brief psychiatric
admission followed by regular outpatient appointments plus 24-
hour access to a treatment service versus TAU (Van der Sande
1997a). There was no difference between the two groups in repe-
tition of SH, depression, or hopelessness, although more patients
in the experimental groups attended at least one outpatient ap-
pointment.
General hospital admission
In a single trial, there was no beneficial effect of general hospital
admission on repetition of SH or on hopelessness compared with
discharge from hospital (Waterhouse 1990). However, as this trial
was limited to low-risk participants, only around 15% of the pre-
senting patients were included.
Intensive outpatient intervention
Two trials compared a combination of intensive therapies, includ-
ing psychotherapy, behaviour therapy and family therapy, versus
standard outpatient care (Allard 1992; Welu 1977). There was no
effect of this treatment package on repetition of SH.
Long-term psychotherapy
In a single trial that compared long-term therapy (the nature of
which was unspecified) versus short-term intensive therapy, there
was no difference in repetition of SH (Torhorst 1988). Estimates
of scores from graphs also suggests little difference in depression
scores.
Overall completeness and applicability of
evidence
Completeness of evidence
There have now been a considerable number of trials of psychoso-
cial interventions for adult SH patients (we identified 55 indepen-
dent trials). There have been multiple trials of CBT-based psy-
chotherapy, dialectical behaviour therapy, case management, and
postcards. Investigators have also evaluated a wide range of other
types of interventions, including attempts to increase adherence
with treatment and specific aftercare interventions; however,many
of these evaluations have been limited to single trials.
It is important to note that we identified no trials of psychosocial
interventions for older (> 60/65 years) adults.
Most trials evaluated a range of relevant primary and secondary
outcomes (e.g., repetition of SH, hopelessness, depression). How-
ever, they infrequently reported information on suicide, and we
had to request it from many authors. In 11 trials, information
on repetition of SH was based only on hospital re-presentations,
whereas in a large number of trials this information came from
self-reported data, which in some cases was supplemented by in-
formation from clinical and other sources. More episodes of SH
will be identified through self-report compared with information
from clinical records, as much SH occurs in the community and
does not result in presentation to clinical services (Borges 2011).
However, these differences in the recording of SH would not have
affected the overall results, as whatever approach was used in the
individual trials would have affected the experimental and con-
trol arms equally. Also, some trials only assessed repetition during
the period in which participants received therapy (e.g., Bateman
2009), whereas for most trials there were further post-treatment
follow-up assessments.
Acceptability of evidence
The proportions of participants from the two sexes in these
trials appears to be in accord with SH patients more gener-
ally (Hawton 2007). A number of trials focused on those with
a history of multiple episodes of SH, including patients diag-
nosed with borderline personality disorder; this focus is welcome
given that a history of multiple episodes of SH is associated
with a particularly high risk of subsequent suicide (Zahl 2004).
A number of trials did not record information on suicidal in-
tent of participants (e.g., Carter 2005; Crawford 2010; Dubois
1999; Evans 1999a; Evans 1999b; Gibbons 1978; Gratz 2006;
Hassanian-Moghaddam 2011; Linehan 1991; McLeavey 1994;
Morgan 1993; Priebe 2012; Weinberg 2006), which is surprising
given the association of SH with future risk of suicide (Carroll
2014; Owens 2002).
Compared to previous versions of this review (Hawton 1998;
Hawton 1999; NICE 2011), there is now a greater representation
of trials from low- to middle-income countries, including China
(Wei 2013;Xu2012), India (Vijayakumar 2011), Iran (Hassanian-
Moghaddam 2011; Hassanzadeh 2010), Pakistan (Husain 2014),
and Sri Lanka (Marasinghe 2012).
It is worth noting that this review focused exclusively on patients
who had previously engaged in SH. As a result, we excluded pa-
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tients with conditions such as borderline personality disorder who
had not engaged in SH and mixed trials of patients with either SH
or suicidal ideation in the absence of actual SH.
Quality of the evidence
Apart from trials of CBT-based psychotherapy (18 trials), group-
based emotion-regulation psychotherapy (two trials), dialectical
behaviour therapy (three trials in which DBT was compared with
TAU), case management (four trials) and postcards (four trials),
all the included trials compared specific interventions, thus limit-
ing the robustness of possible conclusions about their effectiveness
compared with routine care (TAU). Also, many trials were too
small to detect significant differences in proportions of patients
experiencing the primary outcome, namely repetition of SH. Ad-
ditionally, quality of evidence, as assessed using the GRADE ap-
proach, was generally low to moderate, suggesting that further re-
search is likely to have an important impact on our confidence
in the estimate of treatment effectiveness and may, in some cases,
change the estimates.
Limitations in design and implementation
All 55 included trials were rated as at high risk of bias in rela-
tion to at least one aspect of trial design, especially with respect to
blinding of both participants and clinical personnel. In part this
may reflect the fact that the focus of the present review was on
the effectiveness of psychological interventions, and we believe it
is generally not possible to blind participants or clinical personnel
to psychological therapy. Nevertheless, we cannot rule out perfor-
mance or detection bias.
Indirectness of evidence
Repetition of SHwasmeasured using either self-reported informa-
tion, medical records, or re-presentation to hospital in all 55 trials
included in this review. It is possible that self-reported information
might over- or underestimate the real recurrence of SH. On the
other hand, use of medical records, hospital presentations, or both
may underestimate the real recurrence of SH, as many episodes
of SH occur in the community and do not result in presentation
to clinical services (Borges 2011). However, these differences in
the recording of SH would not have affected the overall results,
as whatever approach was used in the individual trials would have
affected the experimental and control arms equally.
Trials assessed secondary outcomes using widely validated psycho-
metric measures (e.g., BDI, BHS), which authors did not typically
modify in scoring.
Unexplained heterogeneity or inconsistency of results
One meta-analysis included in the review, effectiveness of CBT-
based psychotherapy on depression scores at 12 months, was asso-
ciated with substantial levels of heterogeneity (I2 = 76%). Exclud-
ing Hatcher 2011, which used Zelen’s method of randomisation,
did not materially affect heterogeneity.
We also conducted sensitivity analyses where visual inspection of
the forest plot indicated that one or more trials may have been
outliers. For this reason, we excluded the postcard trial by Kapur
2013a from meta-analyses for repetition of SH both at post-inter-
vention and at 12-month follow-up. In both cases, exclusion of
this trial caused the overall estimate of treatment effectiveness for
postcard-based interventions to obtain significance. This could be
due to the fact that Kapur 2013a was a small pilot investigation.
We also undertook sensitivity analyses where one or more trials
included adolescent participants. Excluding trials for this reason,
however, did not appear to systematically explain heterogeneity.
Imprecision of results
Results of the individual trials included in this review were asso-
ciated with a high level of imprecision as indicated by the wide
confidence intervals around the effect size estimates for many of
the outcomes reported in this review.
Probability of publication bias
We could only formally evaluate the presence of publication bias
for CBT-based psychotherapy with respect to repetition of SH at
six months (Figure 4), 12 months (Figure 5), and final follow-
up (Figure 6), and for depression scores at final follow-up (Figure
7). In all four cases, some funnel plot asymmetry was evident
and particularly seemed to affect the right side of the plot. It
is therefore possible that there are unpublished trials in which
experimental treatment was ineffective. However, it should also be
noted that funnel plot asymmetry could also be due to high levels
of heterogeneity.
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Figure 4. Funnel plot of comparison 1: CBT-based psychotherapy vs treatment as usual for repetition of SH
at six months
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Figure 5. Funnel plot of comparison 1: CBT-based psychotherapy vs treatment as usual for repetition of SH
at 12 months
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Figure 6. Funnel plot of comparison 1: CBT-based psychotherapy vs treatment as usual for repetition of SH
at final follow-up
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Figure 7. Funnel plot of comparison 1: CBT-based psychotherapy vs Treatment as usual for depression
scores at final follow-up.
For one trial of provision of information and support, investiga-
tors have not published data from two of the seven study sites
(Fleischmann 2008; Bertolote 2010). Therefore we cannot rule
out publication bias for this intervention. We are also aware of one
further unpublished trial of CBT-based psychotherapy for which
we were unable to obtain the results from the authors. All other
trials included in this review have been published in full in peer-
reviewed journals. We therefore believe that publication bias is
unlikely to have been a major cause of heterogeneity. Instead, we
believe either poor methodological design or true heterogeneity
between trials may be responsible for this result (Sterne 2011).
Potential biases in the review process
We have no reason to believe we have not identified all relevant
published trials of psychosocial interventions for SH in adults.
Nevertheless, by using the random-effectsmodel in all analyses our
results possess greater generalisability than if we had used the fixed-
effect model (Erez 1996). However, because our review criteria
included trials in people who had all engaged in SH and presented
to clinical services in the preceding six months, we excluded trials
where only some of the participants had engaged in SH and also
trials where SH was an outcome measured in general psychoso-
cial interventions for patients with psychiatric disorders. Data on
repetition of SH were available for all but one of the included
trials (Patsiokas 1985). Information on suicides was available for
43 (78.2%) of the trials included in this review, although for most
trials this information had to be obtained via correspondence with
authors.
Owing to uncertainties about the impact of using Zelen’s design,
for trials using this approach we analysed data for the primary
outcome of repetition of SH using data for both the randomised
sample (including both those patients who, following treatment
allocation, subsequently consented to participation and those who
did not) and the consenting sample only (seeUnit of analysis issues
section). This typically had little impact on the pattern of results
observed.
Due to the large number and varied nature of the interventions in-
cluded in the earlier versions of this review (Hawton1998;Hawton
1999) we decided, with agreement of the editors, to divide the re-
view into three (the others reviews being of pharmacological inter-
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ventions in adults (Hawton 2015b) and both pharmacological and
psychosocial interventions for children and adolescents (Hawton
2015a)). Because of the fact that we approached this review with
a view to identifying the types of psychosocial interventions that
had been evaluated to date in this clinical population, we used a
consensus approach to grouping the interventions. This process
might have been subject to bias, but in general, there was very
good agreement between members of the review group, who have
considerable experience in research and clinical practice in relation
to SH in adults.
Risk of bias for selective outcome reporting was based on the
analyses undertaken by the study authors. As we were unable to
include data that had been statistically adjusted for missingness in
the present review, we believe it would be unfair to rate trials that
made use of statistical adjustments to account for missing data
at follow-up as having high risk of bias for this outcome simply
because of our choice of outcome.
Agreements and disagreements with other
studies or reviews
There have been several reviews of the efficacy of psychosocial in-
terventions for adult SH patients. None of those that used system-
atic review methodology to identify all relevant treatment inter-
ventions also presentmeta-analyses of treatment efficacy (Comtois
2006; Crawford 2007a; Daigle 2011; Hepp 2004; Van der Sande
1997b), aside from Inagaki 2015 and NICE 2011; however, this
latter reviewwas conducted using data supplied by our review team
during a previous update of the present review. Of two further
meta-analyses, one specifically focused on cognitive behavioural
interventions (Tarrier 2008b) and one examined remote contact-
based interventions (Milner 2015).
Inagaki 2015 combined trials of case management, treatment
adherence enhancement, and remote contact interventions into
one category which the authors termed “active contact and fol-
low-up” interventions. They concluded that these interventions
show promise in reducing repetition at 12 months’ follow-up but
not at 24 months’ follow-up. Combining trials of such different
treatment approaches, however, is potentially misleading given
their very different mechanisms of action. Crawford 2007a also
combined different treatment approaches (e.g., CBT-based psy-
chotherapy, DBT, and adherence enhancement), as well as inter-
ventions specifically developed for children and adolescents (e.g.,
Spirito 2002; Wood 2001). The authors concluded there was no
evidence of a preventive effect of psychosocial interventions for the
prevention of suicide. However, they only assessed efficacy with
respect to completed suicide, which few trials are adequately pow-
ered to evaluate. Repetition of SH, on the other hand, is a much
more common outcome for which a greater number of trials are
powered to evaluate.
There is general agreement amongst these reviews concerning the
efficacy of CBT-based psychotherapy. Comtois 2006, for example,
concluded there were positive effects for psychotherapy and out-
reach interventions. However, conclusions concerning the latter
type of intervention in this review were particularly influenced by
the findings of a single trial in which regular letters were mailed to
suicidal patients discharged frompsychiatric inpatient care (Motto
2001). As not all participants included in this trial had engaged
in SH behaviour, this trial did not meet inclusion criteria for the
present review. Tarrier 2008b, moreover, concluded there was evi-
dence for the effectiveness of CBT-based psychotherapy but only
when compared against TAU rather than another form of active
psychosocial therapy. Benefits of psychological therapy have re-
cently been reported by findings of a national, non-randomised
naturalistic study in Denmark (Erlangsen 2015).
A recent meta-analysis of contact-based interventions found no
significant reduction in terms of repetition of SH (both proportion
andnumber of episodes per person) for these interventions (Milner
2015). Surprisingly, however, the review pooled together several
different types of contact-based intervention, including letters,
emergency cards, and postcards. Additionally, despite the stated
focus of the review being on interventions following SH, it also
included trials in which not all participants had engaged in SH
prior to inclusion (e.g., Motto 2001; Robinson 2012). Also, for
one of the trials included in this review, our correspondence with
the original trial authors revealed that data on non-fatal repetition
of SH could not be disaggregated from information on completed
suicide (e.g., Chen 2013).
Other reviews have focused specifically on interventions for pa-
tients with personality disorder, particularly borderline personality
disorder (McMain 2007b; Kliem 2010). They, along with the re-
view by Comtois 2006, concluded that dialectical behaviour ther-
apy was effective for the prevention of SH, although these reviews
included some trials in which not all participants had engaged
in SH prior to trial entry. Further reviews by Luxton 2013 and
Kapur 2010 of postcard, telephone, emergency card, and face-to-
face interventions concluded they may be effective in preventing
suicidal behaviour, although again, these reviews included some
trials in which not all participants had engaged in SH at trial entry.
The inclusion of these participants means that the focus of the
intervention in such trials, and hence the specificity of the findings
for SH patients and planning of clinical services for these patients,
will be unclear.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Evidence drawn from an earlier version of this review has been in-
corporated in guidance for commissioners of clinical services in the
United Kingdom, which states that brief CBT-based psychother-
apy should be available in self-harm services (NICE 2011). Our
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updated findings would reinforce the view that there is some evi-
dence to suggest that CBT-based psychotherapy is effective in re-
ducing repetition of SH compared with treatment as usual (TAU).
There is a lack of evidence with respect to the prevention of sui-
cide, however, although there was a relatively small number of
such events in these trials, precluding a firm conclusion.
In most trials CBT-based psychotherapy was typically very brief
(i.e., less than 10 sessions). It was delivered on an individual basis
in all trials except one (i.e., McAuliffe 2014).
While dialectical behaviour therapy (DBT) did not reduce the
proportion of participants with borderline personality disorder
who engaged in a repeated episode of SH as compared with TAU,
it did appear to reduce the frequency of repetition. Arguably, where
patients are multiple repeaters of SH and much of their SH will
have included acts such as superficial self-cutting, reduction in the
frequency of SH could be viewed as a key outcome.
Less intensive remote contact-based interventions, such as sending
regular postcards to patients in the year following an episode of SH,
did not appear to reduce the proportion of patients repeating SH.
However, these interventions may hold promise in settings where
there are very limited psychiatric services (where the alternative
may be no provision of little or no aftercare). Case management
approaches also did not appear to be effective in reducing the
proportion of patients who repeat SH.
Other interventions havemostly been evaluated in single trials. In a
trial of DBT-oriented therapy, for example, there was a significant
reduction in both the number of patients repeating SH and the
total number of repeat episodes, as well as significant reductions in
depression and suicidal ideation. Mentalisation therapy was asso-
ciated with reduced repetition of SH and depression in the latter
stages of follow-up in patients with borderline personality disor-
der. Group-based emotion-regulation psychotherapy was associ-
ated with a reduction in the proportion of patients repeating SH
in the final two months of the treatment period, but there was no
apparent effect on depression. Provision of information and sup-
port was associated with reduced numbers of completed suicides
in a single multicentre trial conducted in five low- and middle-
income countries, but not with reduced repetition of SH. There is,
however, some inconsistency in the reporting of numbers of sui-
cides in the experimental group for the overall cohort as reported
in Fleischmann 2008 and those from three of the five individual
study sites (in Karaj, Iran (Hassanzadeh 2010); Chennai, India
(Vijayakumar 2011); and Yuncheng, China (Xu 2012)). Home-
based problem-solving psychotherapy and continuity of treatment
by the same therapist from assessment to aftercare appeared to
improve treatment adherence, but without clear benefit in terms
of repetition of SH.
Where possible, we analysed results separately by sex. Whilst one
trial indicated reduced benefit for the intervention on depression
in females as compared to males (Marasinghe 2012), in the few
trials where a subgroup analysis by sex was possible, the majority
suggested a significant treatment effect of psychosocial interven-
tions for females but not males.
In terms of repeater status, it appears that somemore limited inter-
ventions (emergency cards) may have negative effects in patients
with a history of multiple episodes of SH. However, trials of some
more intensive interventions (e.g., group-based emotion-regula-
tion psychotherapy, mentalisation, DBT) appear to have positive
benefits on repetition of SH, and particularly for participants who
were multiple repeaters of SH at trial entry, which would mostly
have included participants diagnosed with borderline personality
disorder.
Implications for research
Given the apparent positive benefits of CBT-based psychother-
apy and some other treatment approaches, future trials should
identify which types of patients are most likely to benefit from
these interventions. Although we were only able to undertake sub-
group analyses by sex in five trials (Bennewith 2002; Carter 2005;
Fleischmann 2008; Hvid 2011;Marasinghe 2012), evidence from
the present review would suggest that some psychosocial inter-
ventions, particularly remote contact-based interventions and case
management, tend to be of greater benefit for female patients.
There should therefore be a greater focus on sex-specific interven-
tions, especially to identify treatments most likely to benefit male
SH patients.
We could only undertake subgroup analyses by repeater status (i.e.,
with or without a history of multiple episodes of SH) in five trials
(Bennewith 2002; Evans 1999a; Hatcher 2011; Hatcher 2016a;
Hatcher 2015). Nevertheless, there is limited evidence that whilst
some forms of psychosocial interventions may be more effective in
those with a history of multiple episodes of SH (e.g., CBT-based
psychotherapy) other forms of contact-based interventions, such
as emergency cards, may lead to an increased risk of repetition of
SH in those with a history of multiple episodes of SH prior to
trial entry. For these reasons, history of prior SH should be clearly
identified in future trials, with stratified randomisation according
to repeater status being desirable.
Researchers investigating psychosocial treatments should endeav-
our to investigatewhether the intervention results in changes in the
psychological or socialmechanisms that are the targets of treatment
(e.g., problem-solving, emotion-regulation, interpersonal skills)
and the extent to which such changes relate to positive outcomes
(Arensman 2001). Such knowledge will help clarify the mediators
of treatment efficacy and allow therapists to modify interventions
so that they may be more effective.
In view of the apparent effectiveness of CBT-based psychother-
apy in reducing repetition of SH and the development of online
therapy for a range of psychological problems (Andersson 2014;
Griffiths 2006), and the introduction online means of provid-
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ing this therapy should be a priority, particularly given the find-
ings of some short-term benefits of online self-help for suicidal
thoughts (Van Spijker 2014) and behaviours (Franklin 2016), al-
though these effects may not be maintained at longer-term follow-
ups. The longer term effectiveness of these interventions is there-
fore yet to be determined.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Allard 1992
Methods Allocation: random assignment using sealed and numbered envelopes
Follow-up period: 24 months after trial entry
N lost to follow-up: 24/150 (16%) for repetition data
Participants Inclusion criteria: i) resident in catchment area of hospital; ii) able to speak French or
English; iii) no physical handicap preventing attendance; iv) not already in institutional
care; v) capacity to give informed consent; vi) not sociopathic; vii) suicide attempt was
made within one week prior to trial entry
Exclusion criteria: i) no fixed address; ii) expecting to move out of the catchment area;
iii) in the care of an institution that ensures follow-up after all suicide attempts; iv)
diagnosed with a physical disability that would prevent attendance at follow-up sessions;
v) unable to provide informed consent; vi) diagnosed with sociopathy and presents a
physical threat to hospital personnel; vii) suicide attempt occurred a week or more prior
to randomisation
Numbers: Of the 150 participants, 76 were allocated to the experimental arm and 74 to
the control arm
Profile: 55% (n = 83) were female. 50% (n = 75) were repeaters. 87% (n = 131) had
diagnosis of depression, 53% (n = 80) substance abuse diagnosis, and 45% (n = 68) were
diagnosed with a personality disorder
Source of participants: patients presenting to hospital following a suicide attempt
Location: Montreal, Canada
Interventions Experimental: intensive intervention involving a schedule of visits, including at least one
home visit. Therapy providedwhere needed. Reminders (telephone or written) and home
visits were made in case of missed appointments
Control: treatment by the regular personnel within the same hospital
Therapist: 1 social worker
Type of therapy offered: various interventions offered to participants in the experimental
arm, including: psychoanalytic psychotherapy, psychosocial, drug therapy, behavioural
therapy, or a combination of these
Length of treatment: 12 months
Outcomes Included: i) repetition of SH according to hospital records, Coroner’s office records, in-
terviews with participants or collateral informants, or a combination of these; ii) suicide;
iii) compliance measured as encounters with therapist
Excluded: none
Notes Sources of funding: no details on funding are provided
Declaration of author interests: no details on author interests are provided
Risk of bias
Bias Authors’ judgement Support for judgement
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Allard 1992 (Continued)
Random sequence generation (selection
bias)
Unclear risk Quote: “Subjects were randomly assigned
either to the intensive intervention group
or to the comparison group, using sealed
and numbered envelopes” (p. 306)
Comment: No mention of how the se-
quence was generated or how envelopes
were numbered. It is therefore unclear if the
allocation sequence was adequately gener-
ated
Allocation concealment (selection bias) Low risk Quote: “Subjects were randomly assigned
either to the intensive intervention group
or to the comparison group, using sealed
and numbered envelopes” (p. 306)
Comment: No mention of whether the en-
velopes were opaque or not, although they
probably were
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “If in the experimental group, sub-
jects . . . were put under the care of the
project team (two staff psychiatrists and a
social worker); if in the comparison group,
they were treated by other personnel” (p.
306)
Comment: It is not known whether the par-
ticipantswere aware theywere being treated
by a different team or not, although the na-
ture of the intervention means it is likely
participants were aware of which treatment
group they had been assigned to
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “If in the experimental group, sub-
jects . . . were put under the care of the
project team (two staff psychiatrists and a
social worker); if in the comparison group,
they were treated by other personnel” (p.
306)
Comment: Personnel would have been
aware ofwhich team they hadbeen assigned
to
Blinding (performance bias and detection
bias)
Of outcome assessors
High risk Quote: “For most of the study, patients in
the experimental group were interviewed at
12 months by their psychiatrist (instead of
the research assistant)” (p. 307)
Comment: If personnel were also acting
as outcome assessors they would not have
beenblinded to allocation for the above rea-
son
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Allard 1992 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All comparisons between groups
were made on an intention-to-treat basis”
(p. 307)
Comment: Within the section on ’Losses to
follow-up’, the authors state that follow-
up information was not available for 24
participants. No reasons for dropouts were
provided in this section. The authors do,
however, assert these losses were unlikely to
introduce bias and “unlikely to affect the
comparisons between the two groups” (pp.
308-309) as dropouts (who shared a simi-
lar demographic profile) were “equally dis-
tributed between groups”
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not reported; however, in the
absence of the trial protocol this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Bateman 2009
Methods Allocation: offsite random assignment made using a stochastic minimisation programme
(MINIM) balanced for age (18-25, 26-30, and > 30 years), sex, and diagnosis of antisocial
personality disorder
Follow-up period: 6, 12, and 18 months
N lost to follow-up: 8/134 (6.0%) at the 18-month follow-up period
Participants Inclusion criteria: i) diagnosed with borderline personality disorder; ii) made a suicide
attempt or an episode of SH within 6 months prior to randomisation; iii) aged 18-65
years
Exclusion criteria: i) currently in long-term psychotherapeutic treatment; ii) met DSM-
IV criteria for any psychosis or bipolar I disorder; iii) dependent on any opiate to such
a degree that specialist treatment was required; iv) presence of a mental impairment or
evidence of an organic brain disorder
Numbers: Of the 134 participants, 71 were allocated to the experimental arm and 63 to
the control arm
Profile: 80% (n = 107) were female,100% (n = 134) were multiple repeaters, 56% (n =
75) were diagnosed with major depression, 77% (n = 103) were diagnosed with a milder
depressive disorder such as dysthymia, 14% (n = 19) were diagnosed with post-traumatic
stress disorder, 61% (n = 82) were diagnosed with an anxiety disorder, 54% (n = 72)
were diagnosed with a substance use disorder, 28% (n = 37) were diagnosed with an
eating disorder, 13% (n = 17) were diagnosed with somatoform disorder, and 28% (n =
37) were diagnosed with comorbid antisocial personality disorder
Source of participants: consecutive referrals to 1 of 2 community outpatient psychiatric
facilities, 1 of which provides specific treatment for personality disorder
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Bateman 2009 (Continued)
Location: London, UK
Interventions Experimental: mentalisation-based treatment involving weekly individual and group ses-
sions of psychotherapy. Participants were also prescribed medication (e.g., antidepres-
sants, antipsychotics, mood stabilisers, minor tranquillizers) as needed
Control: structured case management involving 3 monthly individual and group sessions
based on a counselling model resembling a supportive approach combined with case
management, advocacy support, and problem-solving psychotherapy. Participants were
also prescribed any medication (e.g., antidepressants, antipsychotics, mood stabilisers,
minor tranquillizers) as needed
Therapist: 2 psychotherapists
Type of therapy offered: mentalisation-based psychotherapy
Length of treatment: 18 months
Outcomes Included: i) repetition of SH, ii) repetition of suicide attempts; iii) suicides; iv). compli-
ance; v) depression scores
Excluded: i) psychiatric readmissions; ii) length of psychiatric readmissions; iii) medica-
tion use; iv) social functioning scores; v) symptom distress scores; vi) social adjustment
scores; vii) interpersonal functioning scores
Notes Sources of funding: “Supported by a grant from the Borderline Personality Disorder
Research Foundation” (p. 1363)
Declaration of author interests: none stated
Other: repetition data for SH, suicide attempts, and completed suicides was obtained
through correspondence with Dr Fonagy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Treatment allocation was made
offsite via telephone randomisation us-
ing a stochastic minimization program
(MINIM)” (p. 1356)
Comment: Use of a computerised algorithm
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Low risk Quote: “Treatment allocationwasmade off-
site” (p. 1356).
Comment: Use of offsite allocation is likely
to have ensured allocation was adequately
concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: nomentionof participant blind-
ing; however, the nature of the trial means
it is likely participants were aware of which
treatment group they had been assigned to
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Bateman 2009 (Continued)
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: No mention of personnel blind-
ing is made; however, the nature of the trial
means it is likely that therapists knewwhich
treatment they were providing
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Independent evaluators blind to
treatment allocation conducted assess-
ments.” (p. 1355)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All results were analysed using an
intention-to-treat analysis based on treat-
ment assignment” (p. 1359)
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not reported; however, in the
absence of the trial protocol this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Beautrais 2010
Methods Allocation: randomisation using a predetermined computer-generated random number
procedure
Follow-up period: 12 months
N lost to follow-up: 0/327 (0%) for repetition of SH
Participants Inclusion criteria: i) aged 16 or older; ii) admitted to a psychiatric emergency service
following an episode of SH or attempted suicide; iii) resident in New Zealand; iv) able
to understand English well enough to provide informed consent
Exclusion criteria: none stated
Numbers: Of the 327 participants, 153 were allocated to the experimental arm and 174
were allocated to the control arm
Profile: 66.0% (n = 216) were female, 17.7% (n = 58) were multiple repeaters
Source of participants: patients admitted to a psychiatric emergency service following an
episode of SH or attempted suicide
Location: Christchurch, New Zealand
Interventions Experimental: postcards mailed at 2 and 6 weeks and 3, 6, 9, and 12 months after
discharge in addition to usual care
Control: TAU involving crisis assessment and referral to inpatient community-based
mental health services as required
Therapist: none
Type of therapy offered: outreach through the mailing of frequent postcards encouraging
participants to make contact with the service
Length of treatment: 12 months
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Beautrais 2010 (Continued)
Outcomes Included: i) repetition of SH; ii) suicide
Excluded: i) number of re-presentations to psychiatric emergency services
Notes Source of funding: “This study was supported by grants from the Canterbury District
HealthBoard and theAccidentCompensationCorporation (ACC). S.J.G.was supported
by a University of Otago Postgraduate Publishing Bursary” (p. 59)
Declaration of author interests: none stated.
Other: Data on repetition of SH were obtained from psychiatric emergency service
records, hospital medical records, or both. Data on suicides were obtained following
correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants were randomised 1:1
. . . using predetermined computer-gener-
ated random numbers . . . The number se-
quence was computer-generated in SAS 9.1
for Windows using a uniform distribution
to generate a sequence of random numbers
between 0 and 1. Numbers of 0.5 or above
were classified as the intervention group;
numbers below 0.5 were classified as the
control group.” (p. 56)
Comment: Use of a computer-generated list
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Low risk Quote: “Randomisation was performed . . .
by research staff who were not involved in
the recruitment or clinical care of partici-
pants” (p.56)
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
Low risk Quote: “Participants’ randomisation status
was not conveyed to clinical . . . staff ” (p.
56)
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Participants’ randomisation status
was not conveyed to . . . data-collection
staff ” (p. 56)
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Beautrais 2010 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “ . . . results of the trial were analysed
using the intention-to-treat design” (p. 56)
Selective reporting (reporting bias) Unclear risk Comment: Data on suicides had to be re-
quested fromauthors, suggesting that selec-
tive reporting bias may have been present.
In the absence of the trial protocol; how-
ever, the degree of selective reporting can-
not be ascertained
Other bias High risk Quote: “[T]here was a significant differ-
ence between the groups in the number of
prior attendances for self-harm in the [12
months prior to randomisation] with the
number of prior attendances being lower
in the intervention than in the control
group . . . the reduced number of re-pre-
sentations for self-harm in the intervention
group . . . may reflect a pre-existing ten-
dency for those in the intervention group
to have lower numbers of prior hospital at-
tendances for self-harm . . . Adjusting for
the number of prior hospital visits for self-
harm reduced, and in many cases removed,
the effect of the intervention on re-presen-
tation for self-harm” (pp. 57-58)
Bennewith 2002
Methods Allocation: Primary care practices were stratified into 4 groups according to rate of SH.
Practices were divided again into 2 groups (8 groups total) according to practice size.
Allocation was then made using a random numbers table
Follow-up period: 12 months
N lost to follow-up: 0/1932 (0%) for repetition data
Participants Inclusion criteria: for primary care practices: i) based in geographical area whose patients
lived in catchment area of 4 general hospitals. For participants: i) found in general
hospital case register for SH; ii) recruitment data collected weekly from hospitals’ A&
E sites; iii) not an alcohol (taken alone) or illicit drug overdose, except where casualty
officer felt purpose was SH or suicide; iv) aged 16 years and older; v) of fixed residence
Exclusion criteria: i) imprisoned; ii) made a request that no one be informed of SH
episode; iii) SH occurred in direct response to a hallucination or delusion; iv) SH episode
managed entirely in primary care
Numbers: Of the 98 primary care practices, 49 were assigned to the experimental arm and
49 to the control arm. Of the 1932 participants, 964 were assigned to the experimental
arm, and 968 to the control arm
Profile: 59% (n = 1140) female, 12.6% (n = 244) were repeaters (based on case register
information)
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Bennewith 2002 (Continued)
Source of participants: patients presenting to hospital following an episode of SH and
who are also registered with one of the participating primary care practices
Location: Avon, Wiltshire, and Somerset, UK
Interventions Experimental: letter from GP inviting patient to a consultation with GP (provided with
management guideline)
Control: usual care involving GP, psychiatric or other referral
Therapist: GPs
Type of therapy offered: one-off consultation in GP practice
Length of treatment: one-off consultation
Outcomes Included: i) repetition of SH according to hospital case registers; ii) contact with services
Excluded: i) initiation of contact from GP; ii) days to first repeat SH episode
Notes Sources of funding: “National Health Service South West Research and Development
Directorate” (p. 1260)
Decalartion of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “98 general practices were assigned
in equal numbers to an intervention or a
control group” (p. 1254)
Comment: correspondence with authors
confirmed that a random numbers table
had been used to generate the allocation se-
quence
Allocation concealment (selection bias) Low risk Comment: Correspondence with authors
confirmed that primary care practices were
stratified into 4 groups according to rate of
SH, were divided again into 2 groups (8
groups total) according to practice size, and
were then allocated using random numbers
tables by individuals blind to identity of
practices. It is likely this process was ade-
quately concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “The intervention comprised a let-
ter from the general practitioner inviting
the patient to consult” (p. 1254)
Comment: It is therefore likely that partici-
pants aware of their allocation to the inter-
vention arm
119Psychosocial interventions for self-harm in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bennewith 2002 (Continued)
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “The intervention comprised a let-
ter from the general practitioner inviting
the patient to consult” (p. 1254)
Comment: It is therefore likely that GPs
were aware of which arm a participant had
been assigned
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: no details on blinding of out-
come assessors were provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “For the primary analysis, which
compared the intervention and control
groups on an intention to treat basis, we
carried out a logistic regression analysis
with repeat episodes of deliberate self-harm
within 12 months of the index event as the
outcome variable. This analysis controlled
for practice size (two categories) and quar-
tile of rates of deliberate self-harm by prac-
tice at baseline and allowed for clustering by
practice, using random effects logistic re-
gression.We used a Poisson regression anal-
ysis to compare the intervention and con-
trol groups in terms of differences in the
number of repeat episodes. We used Cox’s
proportional hazards regression for time (in
days) to first repeat episode. Clustering was
taken into account for both of these (inten-
tion-to-treat) analyses” (p. 1255)
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Brown 2005
Methods Allocation: randomisation using a computer randomisation sequence programmed to
prohibit more than 7 consecutive assignments in the same treatment group
Follow-up period: 18 months
N lost to follow-up: 35/120 (29%) for repetition data
Participants Inclusion criteria: i) attempted suicide and receivedmedical/psychiatric evaluation within
48 hours of attempt; ii) able to provide at least 2 verifiable contacts; iii) 16 years or older;
iv) able to speak English; v) able to complete baseline assessment; vi) able to provide
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Brown 2005 (Continued)
informed consent
Exclusion criteria: i) diagnosedwith anymedical disorder thatwould prevent participation
in an outpatient clinical trial
Numbers: Of the 120 participants, 60 were allocated to the experimental arm, and 60 to
the control arm
Profile: 61% (n = 73) female. 74% (n = 89) were repeaters. 68% (n = 82) were diagnosed
with substance abuse, and 77% (n = 92) were diagnosed with major depressive disorder
Source of participants: patients presenting to hospital after suicide attempt
Location: Pennsylvania, USA
Interventions Experimental: 10 sessions of cognitive therapy in addition to treatment as usual
Control: TAU
Therapist: outpatient sessions were delivered by trial therapists
Type of therapy offered: cognitive therapy
Length of treatment: 10-20 weeks
Outcomes Included: i) repetition of SH according to self-report; ii) suicide; iii) suicidal ideation
scores; iv) depression scores; v) hopelessness scores
Excluded: i) adherence (due to nature of data reported)
Notes Sources of funding: “This research was supported by grants R01 MH60915 and P20
MH71905 from the National Institute of Mental Health and grant R37 CCR316866
from the Centers for Disease Control and prevention” (p. 570)
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A computerized randomization se-
quence programmed to prohibit more than
7 consecutive assignments in either treat-
ment group was used” (p. 564)
Comment: Use of a computerised algorithm
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment provided
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “Participants . . . were randomly as-
signed to cognitive therapy or usual care”
(p. 564)
Comment: Due to the nature of the in-
tervention treatment, it is unlikely partic-
ipants could have been blinded to which
treatment they had been assigned
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Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: Due to the nature of the inter-
vention treatment, it is unlikely therapists
could have been blinded to which treat-
ment they were delivering
Blinding (performance bias and detection
bias)
Of outcome assessors
High risk Quote: “Although blinded assessmentswere
conducted at baseline, blinded follow-up
evaluations were not possible” (p.5 64)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All effectiveness analyses were con-
ducted using the intent-to-treat (ITT)
principle” (p. 565) Additionally, “[t]ests
and estimates of ITT differences for both
continuous and binary outcomes were
based on longitudinal models with random
effects” (p. 566)
Comment: of the 120 randomised partici-
pants, 2 dropped out during the interven-
tion and 35 were lost to follow-up at 18
months. Reasons were given for dropouts
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of
bias. Care was taken to test for differ-
ences between groups with respect to other
care, including psychotropic medications
and treatments for substance misuse, but
no significant differences were found
Carter 2005
Methods Allocation: randomisation based on Zelen’s method using a computer generated ran-
domisation schedule
Follow-up period: 24 months
N lost to follow-up: 0/772 (0%) for repetition data
Participants Inclusion criteria: i) aged over 16 years; ii) presented to a toxicology service with deliber-
ate self-poisoning; iii) able to provide informed consent; iv) fixed address; v) sufficient
English; vi) did not pose a potential threat to the interviewer
Numbers: Of the 772 participants, 378 were allocated to the experimental arm, and 394
to the control arm
Profile: 68% (n = 525) female, 17% (n = 131) were repeaters. 43% (n = 333) were
diagnosed with any affective disorder, 13% (n = 104) with alcohol abuse or dependence,
40% (n = 311) with other substance-related disorders, and 22% (n = 169) with any
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personality disorder
Source of participants: patients presenting to hospital toxicology service
Location: Hunter Valley, NSW, Australia
Interventions Experimental: postcards mailed at 1, 2, 3, 4, 6, 8, 10, and 12 months after discharge in
addition to usual care
Control: usual care
Therapist: none
Type of therapy offered: outreach through the mailing of frequent postcards encouraging
participants to make contact with the service
Length of treatment: 12 months
Outcomes Included: i) repetition of SH according to hospital databases; ii) suicide
Excluded: none
Notes Sources of funding: “KC is funded by the NSW Health, Burdekin Mental Health En-
hancement Strategy” (p. 4)
Declaration of author interests: none stated
Other: data on suicides obtained following correspondence with the authors. 20 control
group participants received intervention due to clerical errors but were included by the
authors in the control group for all intention-to-treat analyses
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomisation was by database
(HanDBase, version 2.0, DDH Softwards,
FL, USA) on a personal digital assistant
(Palm III, Palm, CA, USA) that was pop-
ulated with a pre-generated randomisation
schedule (in blocks of 10) . . . ” (p. 2)
Comment: Use of a computerised program
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) High risk Comment: As consent was obtained using
Zelen’smethod, participants were given the
option to change treatment arms follow-
ing allocation. Therefore, allocation cannot
have been concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Quote:“We used a randomised consent de-
sign, using the single consent version (Ze-
len’s design). This design is a variation on
the standard randomised controlled exper-
imental design, where participants are ran-
domised to control or intervention before
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consent is sought. In the single consent
version, written informed consent to re-
ceive the intervention (eight non-obliga-
tory postcards) was sought from partici-
pants randomised to the intervention.” (p.
2)
Comment: As participants were required to
give consent to the treatment they were re-
ceiving, blinding to allocation status could
not have been maintained
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “ [The] secretary responsible for
managing the mailing database and post-
cards [was] not blind to allocation status”
(p. 4)
Comment: As personnel knew whether or
not a postcard had been sent, they could
not have been blinded to allocation status
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “All other . . . research staff remained
blinded to allocation.” (p. 2)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “We assessed the outcomes by an
intention to treat analysis on the basis of
allocation” (p. 2)
Selective reporting (reporting bias) Unclear risk Comment: Data on completed suicides had
to be obtained through correspondence
with the authors. In the absence of the trial
protocol, the degree of selective reporting
cannot be ascertained
Other bias High risk Quote: “Twenty participants in the control
group received the intervention due to cler-
ical errors but were included in the control
group for the intention to treat analyses.”
(p. 2)
Comment: The inclusion of participants
who received the treatment intervention
within the control group may lead to bias
in the estimation of the treatment effect
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Cedereke 2002
Methods Allocation: randomisation in groups of 2 or 4 using sealed envelopes
Follow-up period: 12 months
N lost to follow-up: 44/216 (20%) for repetition data
Participants Inclusion criteria: i) individuals treated after suicide attempt
Numbers: Of the 216 participants, 107 were allocated to the experimental arm and 109
to the control arm
Profile: 66% (n = 143) were female, 52% (n = 112) were repeaters, and 91% (n = 197)
were diagnosed with a mood disorder
Source of participants: patients treated in hospital after suicide attempt
Location: Lund, Sweden
Interventions Experimental: telephone contact (20-45 minutes) at 4 and 8 months to increase motiva-
tion in addition to usual care
Control: usual care
Therapist: therapists with at least 10 years’ experience working with suicidal individuals
Type of therapy offered: motivational therapy
Length of treatment: 8 months
Outcomes Included: i) repetition of SH according to self-report checked against both patient records
and admission charts; ii) suicide; iii) suicidal ideation scores; iv) compliance
Excluded: i) global functioning scores; ii) psychiatric symptoms scores
Notes Sources of funding: “This study was supported by grants from The Axson Johnsons
foundation and from the Vardal Foundation (V97 341)” (p. 90)
Declaration of author interests: No details on author interests are provided.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Random allocation” and “personal
(sic) . . . performed the randomisation” (p.
83)
Comment: The trialists appear to have con-
ducted randomisation using the matched
pair design, as blocks of 2 or 4 patients
were randomised. Although it is likely the
random sequence was adequately gener-
ated, without further information on the
method used, we cannot ascertain this
Allocation concealment (selection bias) Low risk Quote: “Random allocation (sealed enve-
lope)” (p. 83)
Comment: no mention of whether the en-
velopes were opaque or not, although they
probably were
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Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “The patients did not knowwhether
they would be contacted at 4 and 8months
or not” (p. 83)
Comment: The nature of this trial means
that participants could have known to
which group they had been allocated when
they received the telephone call
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: As telephone interventions were
made by therapists, personnel could not be
blinded to treatment allocation
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Quote: “[A]ll study participants were inter-
viewed again after 12 months at a personal
meeting” (p.84)
Comment: It is unclear if outcome asses-
sors conducted these meetings and, if so,
whether they were blinded to treatment al-
location or not
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “An intent-to-treat analysis was per-
formed on all patients who were followed
up (n = 178) and the results were the same
as in those 172 patients who got at least one
intervention” (p.86)
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Clarke 2002
Methods Allocation: random numbered lists stratified for sex and admitting hospital; constructed
independently of research team; administrator provided clinician with allocation by
telephone after patient details given
Follow-up period: 12 months
N lost to follow-up: 0/467 (0%) for repetition data
Participants Inclusion criteria: i) resident in catchment area; ii) aged 16 years or older; iii) not aged
16-19 years and still in full-time secondary education; iv) overdoses did not include
recreational or problematic substance use
Exclusion criteria: i) aged less than 16 years; ii) aged between 16-19 years and still en-
rolled in full-time secondary education; iii) overdose episode occurred as the result of
recreational or problematic substance use
Numbers: Of the 467 participants, 220 were allocated to the experimental arm and 247
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to the control arm
Profile: 56% (n = 263) were female, 47% (n = 104) were repeaters, 17% (n = 80) had a
history of psychiatric treatment, 13% (n = 60) had alcohol problems, and 3% (n = 12)
were diagnosed with schizoaffective disorder
Source of participants: patients presenting to hospital for SH
Location: East London and Essex, UK
Interventions Experimental: case management involving psychosocial assessment, a negotiated care
plan, and ’open access’ to case manager who helped patient identify and access suitable
services in addition to usual care
Control: usual care involving triage, and medical and psychosocial assessment and treat-
ment as required
Therapists: assessing researchers, case managers or both
Type of therapy offered: case management
Length of treatment: up to 6 months, reviewable
Outcomes Included: i) repetition of SH according to hospital admission records; ii) suicide
Excluded: none
Notes Sources of funding: “Funded by the participating health authority” (p. 167)
Declaration of author interests: no details on author interests provided
Other:data on suicides obtained following correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomisation was conducted us-
ing random numbered lists, stratified for
sex and admitting hospital . . . The re-
searchers were required to telephone an ad-
ministrator with possible candidates’ de-
tails and were then informed of the treat-
ment group” (p. 169)
Comment: Use of a random numbers table
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Low risk Quote: “The random number lists were
constructed independently of the research
team and they did not have sight of them.
” “The researchers were required to tele-
phone an administrator with possible can-
didates’ details and were then informed of
the treatment group” (p. 169)
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Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “Case management as deployed in
the trial comprised a psychosocial assess-
ment, a negotiated care plan and ’open ac-
cess’ to the assessing researcher (the case
manager) via a dedicated (mobile) tele-
phone contact number” (p. 169)
Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “Case management as deployed in
the trial comprised a psychosocial assess-
ment, a negotiated care plan and ’open ac-
cess’ to the assessing researcher (the case
manager) via a dedicated (mobile) tele-
phone contact number” (p. 169)
Comment: As the intervention was deliv-
ered by therapists, personnel could not be
blinded to treatment allocation
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Comment: Authors report no details on
blinding of outcome assessors. However,
as readmission rates were the primary out-
come and other adverse outcomes during
follow-up were assessed fromA&E records,
it would not appear that blinding of out-
come assessors would have been problem-
atic
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Data analysis proceeded on an in-
tention to treat basis using the unpaired t
test procedure, Yates corrected chi-square
and univariate and multivariate logistic re-
gression. The analysis was carried out with
SPSS 9 for Windows” (p. 170)
Comment: In addition, the trial profile pro-
vided on p. 171 does not suggest there were
any dropouts, as all patients were followed
up at 12 months via A&E records
Selective reporting (reporting bias) Unclear risk Comment: We had to request data on sui-
cides from authors, suggesting that selec-
tive reporting bias may have been present
Other bias Low risk Comment: no other apparent sources of bias
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Crawford 2010
Methods Allocation: randomisation using a random numbers table and delivered using prepared,
sealed, opaque envelopes
Follow-up period: 6 months
N lost to follow-up: 0/103 (0%) for repetition of SH; 65/103 (63.1%) for secondary out-
comes not included in this review (e.g., alcohol consumption, mental health problems,
and satisfaction with treatment)
Participants Inclusion criteria: i) aged 18 or older; ii) admitted to an emergency department following
an episode of SH; iii) diagnosed with alcohol misuse according to scores on the Padding-
ton Alcohol Test
Exclusion criteria: i) unwilling to provide informed consent; ii) unable to provide in-
formed consent (e.g., due to an inability to communicate in English or impaired con-
sciousness); iii) no fixed address in the greater London area; iv) already receiving treat-
ment from alcohol misuse services; v) made a specific request to receive treatment from
alcohol misuse services at index presentation
Numbers: Of the 103 participants, 51 were allocated to the experimental arm and 52
were allocated to the control arm
Profile: 48.5% (n = 50) were female, 100% (n = 103) were diagnosed with alcohol misuse
Source of participants: consecutive admissions to an emergency department following an
episode of SH and who were diagnosed with alcohol misuse according to scores on the
Paddington Alcohol Test
Location: London, UK
Interventions Experimental: a one-off appointment with an alcohol nurse specialist involving assess-
ment and discussion of both current and previous drinking behaviours delivered accord-
ing to the FRAMES approach in addition to a health information leaflet advising on the
damaging effects of excessive alcohol consumption, recommended limits of alcohol con-
sumption, and the contact details of nationally-based alcohol misuse help lines (Miller
1993). Participants could also be referred by the alcohol nurse specialist to individual
alcohol counselling or detoxification services as required
Control: TAU involving a health information leaflet advising on the damaging effects of
excessive alcohol consumption, recommended limits of alcohol consumption, and the
contact details of nationally-based alcohol misuse help lines
Therapist: 1 alcohol nurse specialist
Type of therapy offered: alcohol-specific therapy
Length of treatment: approximately 30 minutes
Outcomes Included: i) repetition of SH; ii) suicide
Excluded: i) alcohol consumption; ii) alcohol involved in SH episode; iii) diagnosis of
probably personality disorder; iv) satisfaction with treatment
Notes Sources of funding: “This study was funded by St Mary’s Paddington Charitable Trust”
(p. 1827)
Declaration of author interests: none stated
Other: Data on suicides were obtained following correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Quote: “We used simple randomization
with an experimental to control treatment
ratio of 1:1 . . . using random numbers ta-
bles” (p. 1822)
Comment: Use of a random numbers table
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Low risk Quote: “Sealed opaque envelopes” (p. 1822)
Comment: Use of sealed opaque envelope
containing either an appointment card or a
blank piece of card would ensure adequate
allocation concealment
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: This was a single-blind study
and only “researchers collecting follow-up
data were masked to allocation status” (p.
1825), suggesting that participants were
not blind to allocation status
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: This was a single-blind trial and
only “researchers collecting follow-up data
were masked to allocation status” (p. 1825)
, suggesting that personnel were not blind
to allocation status
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “[R]esearchers collecting follow-up
data were masked to allocation status” (p.
1825)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Our primary analysis [repetition of
SH] was conducted using an intention-to-
treat principle” (p.1823)
Selective reporting (reporting bias) Unclear risk Comment: We had to request data on sui-
cides from authors, suggesting that selec-
tive reporting bias may have been present
Other bias Low risk Comment: no other apparent sources of bias
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Methods Allocation: randomisation using a random numbers table
Follow-up period: 3 months
N lost to follow-up: 6/20 (30.0%) at the 3 month follow-up period
Participants Inclusion criteria: i) aged 18-65 years; ii) diagnosed with any personality disorder accord-
ing to the SCID-II; iii) score 3 or greater on the Standardised Assessment of Personality
Abbreviated Scale
Exclusion criteria: i) unable to provide informed consent
Numbers: Of the 20 participants, 14 were allocated to the experimental arm and 6 to the
control arm
Profile: 100% (n = 20) were diagnosed with a personality disorder; 45.0% (n = 9) were
diagnosed with comorbid substance misuse
Source of participants: patients admitted to the medical receiving ward of the A&E de-
partment following an episode of SH
Location: Glasgow, UK
Interventions Experimental: manualised cognitive therapy involving psycho-education to help partic-
ipants understand SH, potential alternatives to resolving problems, and referral to ap-
propriate mental health services where required
Control: TAU involving referral to community mental health teams, appointments with
psychiatrists and a community psychiatric nurse, and inpatient psychiatric treatment as
required
Therapist: 2 therapists: 1 doctoral-level clinical psychologist and 1 psychiatrist who re-
ceived weekly training in manualised cognitive therapy
Type of therapy offered: cognitive behavioural therapy
Length of treatment: no details on length of treatment were provided
Outcomes Included: i) repetition of SH; ii) suicide; iii) suicidal ideation; iv) depression
Excluded: i) alcohol use; ii) anxiety and depression severity
Notes Source of funding: “This work was supported by NHS Greater Glasgow and the Scottish
Mental Health Research Network” (p. 4)
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomised . . . using
a random numbers table with an allocation
of 2:1 in favour of [the intervention]” (p.
2)
Comment: Use of a random numbers table
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Unclear risk Comment: nodetails on allocation sequence
provided
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Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “The research assistant, who as-
sessed patients at baseline and outcome,
remained masked to treatment allocation
throughout the study” (p. 2)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “[T]he intention-to-treat principle
[was] applied, i.e. analyses [were] based
on the initial treatment intent, not on the
treatment eventually administered” (p. 2)
Selective reporting (reporting bias) Unclear risk Comment: We had to request data on repe-
tition of SH and depression from authors,
suggesting that selective reporting bias may
have been present
Other bias High risk Comment: This was a very small trial with
substantial imbalances between interven-
tion and control groups with respect to lev-
els of non-suicidal self-harm, anxiety, and
depression at baseline. Follow-up analyses
did not adjust for these baseline imbal-
ances. This is likely to result in exaggerated
treatment effects as, in all cases, the control
group had higher levels of self-harm, anxi-
ety, and depression
Dubois 1999
Methods Allocation: random assignment using an unknown method
Follow-up period: 12 months
N lost to follow-up: 18/102 (17.6%) for repetition of SH data
Participants Inclusion criteria: i) attended emergency department following a suicide attempt; ii) aged
15-34 years
Exclusion criteria: i) hospitalised for more than 24 hours; ii) currently being treated by a
psychiatrist
Numbers: Of the 102 participants, 51 were randomised to the experimental arm and 51
to the control arm
Profile: 80% (n = 82) female
Source of participants: patients attending emergency department
132Psychosocial interventions for self-harm in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Dubois 1999 (Continued)
Location: Bohars, France
Interventions Experimental: Brief psychotherapy involving 5 sessions during first month following the
index episode. These sessions followed a specific therapeutic model
Control: TAU involving an assessment by a clinical psychiatrist. Upon leaving, these
participants were followed-up by a psychiatrist or psychologist
Therapists: participants continued to receive treatment from the same therapist who
initially saw them at hospital
Type of therapy offered: brief psychotherapy
Length of treatment: 1 month
Outcomes Included: i) repetition of SH according to unknown source; ii) suicide
Excluded: i) compliance
Notes Source of funding: no details on funding provided
Declaration of author interests: no details provided
Other: As compliance data were not reported for the control group, this outcome had to
be excluded from subsequent analyses
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Two groups, with 51 patients each,
[were] distributed by randomisation” (p.
557)
Comment: Although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Unclear risk Comment: No details on allocation conceal-
ment are reported.
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of this trial means
that personnel are likely to have known
which participant was receiving which
treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Quote: “Patients were evaluated by a clini-
ciandifferent to their therapist (translation)
” (p. 558)
Comment: However, it is not statedwhether
this clinician was blind to treatment allo-
cation
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Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: Of the 70 participants, 34 re-
fused to attend follow-up and 12 were lost
to follow-up (could not be found). No fur-
ther reasons for dropouts given. The au-
thors, in addition, note that less than 2/3 of
patients attended all 3 appointments. De-
spite this, they did not attempt ITT analy-
ses
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Evans 1999a
Methods Allocation: randomisation using a sealed envelope which contained either an emergency
green card or a ’dummy’ card
Follow-up period: 12 months
N lost to follow-up: 0/827 (0%) for repetition data
Participants Inclusion criteria: i) admitted to emergency departments following an episode of SH;
ii) referred for routine psychiatric evaluation; iii) resident in catchment area; iv) judged
likely to use intervention appropriately; v) made contact with and used mental health
services; vi) acceptable level of aggressive behaviour
Exclusion criteria: i) inappropriate substance abuse leading to repetitive presentation in
which the participant was aggressive or unable to engage in treatment
Numbers: Of the 827 participants, 417 were allocated to the experimental arm and 410
to the control arm
Profile: 55.4% (n = 458) female, 42% (n = 349) were multiple repeaters
Source of participants: patients admitted to general hospital following SH episode
Location: Bristol, UK
Interventions Experimental: emergency card in addition to TAU. Participants were provided with an
emergency card offering 24-hour service for crisis telephone consultation with an on-
call psychiatrist
Control: TAU
Therapist: on-duty trainee psychiatrist
Type of therapy offered: emergency card offering 24-hour service for crisis telephone con-
sultation with an on-call psychiatrist in addition to TAU
Length of treatment: 6 months
Outcomes Included: i) repetition of SH according to A&E and hospital admissions records; ii)
suicide
Excluded: none
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Evans 1999a (Continued)
Notes Sources of funding: “Funding was provided by a grant from the Department of Health”
(p. 23)
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Randomised on a 1:1 basis . . . using
the sealed envelope technique” (p. 23)
Comment: although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Low risk Quote: “Randomised . . . using the sealed
envelope technique, ensuring that it was
impossible to tell from feeling or looking
at the envelopes whether they contained a
green card or a ’dummy card’ (which was
not given out)” (p. 23)
Comment: Use of opaque sealed envelope
containing either a green card or a ’dummy’
card would ensure adequate allocation con-
cealment
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “Those randomised to receive a
green card were offered the card immedi-
ately after the psychiatric assessment” (p.
23)
Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of this trial means
that personnel (e.g., GPs and psychia-
trists on telephone duty) are likely to have
known which participant was receiving
which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “All subjects’ repeat hospital atten-
dances for SH within 6 months of ran-
domisation were monitored (blind to their
study group) by means of a computerised
case register based on routine accident and
emergency admission data” (p. 24)
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Evans 1999a (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “ . . . all analyses were conducted on
an intention-to-treat basis.” (p. 24)
Selective reporting (reporting bias) Unclear risk Comment: No reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Evans 1999b
Methods Allocation: randomised using opaque sealed envelopes opened sequentially
Follow-up period: 6 months
N lost to follow-up: 2/34 (6%) for repetition data
Participants Inclusion criteria: i) personality disturbance (antisocial, dissocial, impulsive or borderline)
; ii) at least 1 episode of SH in 12 months preceding entry to trial
Exclusion criteria: i) diagnosed with alcohol or drug dependence, schizophrenia, or or-
ganic psychiatric disorder
Numbers: Of the 34 participants, 18 were allocated to the experimental arm and 16 to
the control arm
Profile: 62% (n = 21) were female, 100% (n = 34) were repeaters, 100% (n = 34) had a
diagnosis of a personality disorder
Source of participants: patients admitted after an episode of SH to 1 of 2 hospitals in the
London area (Paddington and Chelsea, Westminster)
Location: London, UK
Interventions Experimental: 2-6 sessions of manual assisted cognitive behavioural therapy including
basic cognitive techniques, problem-solving, techniques for managing emotions and
thoughts, and relapse prevention plans in individuals with personality disorders
Control: TAU. 5 participants had contact with a psychiatrist, 3 saw a community mental
health team, 4 saw a specialist social worker, and 2 saw no mental health professional
Therapist: 1 psychiatrist, 2 nurses, and 2 social workers. The type of therapy recieved by
the remaining 2 participants in the control group was not specified
Type of therapy offered: cognitive behavioural therapy
Length of treatment: varied
Outcomes Included: i) repetition of SH according to self-report and hospital records; ii) depression;
iii) compliance
Excluded: i) time to repetition of SH; ii) cost of care; iii) social functioning; iv) anxiety
Notes Sources of funding: “This workwas supported by a grant from theNorthThamesRegional
Health Authority” (p. 24)
Declaration of author interests: no details on author interests provided
Other: 5 participants in the experimental group did not see a therapist and instead
received therapy from the booklets. 1 participant in the experimental group did not
receive any intervention
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Patients were allocated by open-
ing opaque sealed envelopes sequentially at
each centre” (p. 20)
Comment: Although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Low risk Quote: “Patients were allocated by open-
ing opaque sealed envelopes sequentially at
each centre” (p. 20)
Comment: Use of opaque sealed envelope
would have ensured adequate allocation
concealment
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of this trial means
that personnel (a psychiatrist, 2 nurses and
2 social workers) would not have been
blinded to the type of treatment they were
giving
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Baseline assessments, before ran-
domization, and follow-up assessments, at
6 months, were completed by an indepen-
dent assessor, who had no contact with the
clinical teams during the trial and made as-
sessments without any knowledge of treat-
ment received” (p. 20)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: Of the 34 participants, 2
dropped out after initial assessment and
randomisation but “prior to knowledge of
treatment allocation”. They were subse-
quently excluded from all analyses, which
the authors felt was appropriate, as no ser-
vice had been provided to them following
the initial assessment
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
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ascertained
Other bias Low risk Comment: no other apparent sources of bias
Fleischmann 2008
Methods Allocation: random number table using opaque sealed envelopes
Follow-up period: 18 months
N lost to follow-up: 204/1867 (11%) for repetition data
Participants Inclusion criteria: i) diagnosis of self-harm/self-poisoning by medical staff
Exclusion criteria: i) died on the ward; ii) presence of clinical conditions which would
disallow interview; iii) left hospital against medical order; iv) resident in a different
catchment area; v) had language difficulties
Numbers: Of the 1867 participants, 922 were allocated to the experimental arm and 945
to the control arm
Profile: 58% (n = 1086) were female
Source of participants: patients presenting to emergency care settings following an episode
of self-harm/self-poisoning within a defined catchment area with a population of at least
250,000
Location: Brazil, India, Sri Lanka, Iran, and China
Interventions Experimental: brief cognitive behavioural intervention involving “information about sui-
cidal behaviour as a sign of psychological and/or social distress, risk and protective factors,
basic epidemiology, repetition, alternatives to suicidal behaviours, and referral options”
(p. 705) and contact via telephone or home visits to provide referral support in addition
to TAU
Control: TAU “according to the norms prevailing in the respective emergency depart-
ments” (p. 704). This typically involved only acute treatment for somatic problems only
Therapist: clinician (e.g., psychiatrist, nurse, doctor)
Type of therapy offered: information and support
Length of treatment: 18 months
Outcomes Included: i) repetition; ii) suicide
Excluded: i) compliance; ii) depression; iii) hopelessness; iv) impulsiveness; v) social
support; vi) suicidal intent; vii) anger; viii) well-being
Notes Sources of funding: “The study was funded by the Department of Mental Health and
Substance Abuse, WHO. Some field research sites obtained additional funding from the
following agencies: Campinas: Fundação de Amparo à Pesquisa do Estado de São Paulo
(FAPESP), grant no 02/08288-9, São Paulo, Brazil; Durban: Medical Research Council
(MRC), Tygerberg, Cape Town, South Africa; Karaj: Tehran Psychiatric Institute, Men-
tal Health Research Centre (IUMS), Tehran, Iran; Tallinn: Estonian Health Insurance
Fund, Tallinn, Estonia; the Swedish National and Stockholm County Centre for Suicide
Research and Prevention of Mental Ill-Health (NASP),WHOColloborating Centre for
Research and Training in Suicide Prevention, Department of Public Health Sciences,
Karolinska Institute, Stockholm, Sweden” (p. 708)
Declaration of author interests: none stated
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Other:We obtained data on repetition of SH and suicides following correspondence with
authors. Excluded outcomes are taken from the trial protocol
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “An allocation sequence based on
a random-number table was used to ran-
domly assign all enrolled subjects” (p. 704)
Comment: Use of a random numbers table
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Low risk Quote: “ . . . the allocation sequence was
maintained in a separate location toprevent
clinician bias” (p. 704)
Blinding (performance bias and detection
bias)
Of participants
Low risk Quote: “The subjects were blinded as to
their assignment” (p. 704)
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: No details on personnel blind-
ing are provided; however, the nature of
the trial means personnel are likely to have
known which participant was receiving
which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: No details on outcome assessor
blinding are provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: Authors report the number of
participants lost to follow-up; however,
they did not provide reasons for dropout,
nor did they attempt to use intention-to-
treat analyses
Selective reporting (reporting bias) Unclear risk Comment: Authors collected additional
outcome information, including adher-
ence, depression, hopelessness, impulsive-
ness, social support, suicidal intent, anger,
and well-being. They did not reportit ,
but they report some of these outcomes
in related trials (i.e., Hassanzadeh 2010;
Vijayakumar 2011; Xu 2012).
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Other bias Low risk Comment: no apparent sources of other bias
Gibbons 1978
Methods Allocation: Correspondence with authors confirmed that participants were randomly
assigned using sequentially numbered, sealed, opaque envelopes
Follow-up period: 12 months
N lost to follow-up: 0/400 (0%) for repetition data
Participants Inclusion criteria: i) over 17 years old
Exclusion criteria: i) immediate suicide risk; ii) no formal psychiatric illness
Numbers: Of the 400 participants, 200 were allocated to the experimental arm and 200
to the control arm
Profile: Self poisoning patients, including both multiple repeaters and first-timers. 71%
(n = 284) were female, 44% (n = 176) were diagnosed with depressive neurosis, 2% (n
= 8) with phobic neurosis, 2% (n = 8) with affective psychosis, and 1% (n = 4) with
schizophrenia
Source of participants: patients presenting to an A&E department following an episode
of deliberate self-poisoning
Location: Southampton, UK
Interventions Experimental: crisis-oriented, time-limited, task-centred social work provided at home,
which included problem-solving intervention for personal relationships, emotional dis-
tress, practical problems, etc
Control: TAU. 54% (n = 108) were referred to their GP, 33% (n = 66) received a
psychiatric referral, and 13% (n = 26) received an unspecified referral
Therapist: 2 social workers
Type of therapy offered: task-centred case management alongside problem-solving therapy
Length of treatment: 3 months
Outcomes Included: i) repetition of SH according to hospital records; ii) depression; iii) social
problems
Excluded: i) satisfaction with service
Notes Sources of funding: “The study was supported by the Department of Health and Social
Security, and the Wessex Regional Health Authority” (p. 117)
Declaration of author interests: no details on author interests were provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: Correspondence with authors
confirmed that participants were ran-
domly assigned using sequentially num-
bered, sealed, opaque envelopes
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Allocation concealment (selection bias) Low risk Comment: Correspondence with authors
confirmed that participants were ran-
domly assigned using sequentially num-
bered, sealed, opaque envelopes. Use of
opaque sealed envelopewould have ensured
adequate allocation concealment
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: No details on personnel blind-
ing are provided; however, the nature of
the trial means personnel are likely to have
known which participant was receiving
which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “The follow-up interviews were car-
ried out by three experienced interviewers
. . . [who] had had no connection with the
project and did not know what treatment
patients had received” (pp. 113-114)
Comment: Additionally, reliability between
outcome assessors was also assessed on p.
116
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “ . . . there were no differences in
age and sex distribution between the inter-
viewed sample and the missing cases” (p.
114)
Comment: Given there were no difference
in age and sex distribution between the in-
terviewed and missing cases, missing data
were unlikely to have affected the outcome
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
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Methods Allocation: random assignment using an unknown method
Follow-up period: 14 weeks
N lost to follow-up: 2/24 (8%) for repetition data
Participants Inclusion criteria: i) diagnosis of borderline personality disorder; ii) history of deliberate
self-harm, with at least 1 episode in the past 6 months; iii) have an individual therapist;
iv) aged 18 to 60 years; v) female
Exclusion criteria: i) diagnosis of a psychotic disorder, bipolar I disorder, or substance
dependence; ii) suicide attempt rated as having a ’high’ risk of death or greater within past
6 months; iii) at risk of attempting suicide within the next year; iv) received dialectical
behaviour therapy in the past 6 months
Numbers: Of the 24 participants, 13 were allocated to the experimental arm and 11 to
the control arm
Profile: 100% (n = 24) were female, 100% (n = 24) were multiple repeaters
Source of participants: clinician referrals and self referrals from advertisements posted at
a hospital and on 2 websites
Location: Boston, MA, USA
Interventions Experimental: weekly emotion regulation group intervention and individual therapy
sessions in addition to TAU
Control: TAU, including individual therapy sessions
Therapists: group and individual emotion regulation therapists
Type of therapy offered: emotion regulation group intervention
Length of treatment: 14 weeks
Outcomes Included: i) repetition of SH according to self report; ii) depression
Excluded: i) emotion regulation; ii) emotional avoidance; iii) impairment due to BPD;
iv) anxiety; v) stress
Notes Sources of funding: ”This research was supported by the Psychosocial Fellowship of
McLean Hospital, awarded to the first author“ (p. 25)
Declaration of author interests: Although no details on author interests were provided,
Prof Gratz developed emotion regulation group therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: ”“Random assignment” (p. 30)
Comment: Although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Unclear risk Comment: No details on allocation conceal-
ment were provided.
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Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
High risk Quote: “Research team members were not
blind to condition” (p. 30)
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “Two participants dropped out of
the study (one from each condition)” (p.
27)
Comment: Despite this, authors did not at-
tempt ITT analyses.
Selective reporting (reporting bias) Unclear risk Comment: No reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Gratz 2014
Methods Allocation: stratified randomisation procedure matching for i) emotion dysregulation; ii)
number of lifetime episodes of SH; iii) Global Assessment of Functioning scores; iv) age
Follow-up period: 3 and 9 months
N lost to follow-up: 12/61 (23.5%)
Participants Inclusion criteria: i) females; ii) aged 18-60 years; iii) diagnosed with threshold or sub-
threshold borderline personality disorder; iv) history of repeated SH with at least 1
episode in the past 6 months; v) have one or more of the following: individual therapist,
psychiatrist, case manager
Exclusion criteria: i) diagnosed with psychosis or bipolar I disorder; ii) current (past
month) substance use
Numbers: Of the 61 participants, 31 were allocated to the intervention arm and 30 to
the control arm
Profile: 100% (n = 61) were female; 100% (n = 61) were multiple repeaters; 62.3% (n
= 38) had previously made a suicide attempt; 50.0% (n = 31) were diagnosed with any
mood disorder; 62.3% (n = 38) were diagnosed with an anxiety disorder; 36.0% (n =
22) were diagnosed with PTSD; 13.3% (n = 8) were diagnosed with an eating disorder;
1.6% (n = 1) were diagnosed with substance use disorder
Source of participants: referrals from clinicians to the emotion regulation group therapy
and from self referrals in response to an advertisement posed both online and in the
community
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Location: Jackson, MS, USA
Interventions Experimental: emotion-regulation group therapy involving psycho-education to develop
awareness, understanding, and acceptance of emotions, the ability to engage in goal-
directed behavior whilst inhibiting impulsive behaviours without experiencing negative
emotions, use of situationally appropriate strategies to moderate either the intensity or
duration of emotions, and the willingness to experience some negative emotions as a
consequence of daily life
Control: TAU involving outpatient treatment with individual therapists. Some partici-
pants also received group therapy as part of TAU, although this was not emotion-regu-
lation group therapy
Therapist: 2 doctoral-level therapists who received at least 4 months of training in deliv-
ering emotion-regulation group therapy
Type of therapy offered: emotion-regulation group therapy
Length of treatment: 14 weeks
Outcomes Included: i) repetition of SH; ii) depression
Excluded: i) non-acceptance of emotions; ii) impulsiveness with respect to emotions; iii)
goal-directed emotions; iv) awareness of emotions; v) emotion strategies; vi) emotional
clarity; vii) acceptance and action; viii) borderline personality disorder severity; ix) in-
terpersonal problems; x) anxiety; xi) stress; xii) disability severity; xiii) quality of life
Notes Sources of funding: “This research was supported by National Institute of Mental Health
Grant R34 MH079248, awarded to Dr. Gratz” (p. 2110)
Declaration of author interests: Although no details on author interests were provided,
Prof Gratz developed emotion-regulation group therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Participants . . . were matched
on four prognostic variables [emotion dys-
regulation, number of lifetime incidents
of SH, global assessment of functioning
(GAF) scores, and age] and randomly as-
signed . . . using a stratified randomization
procedure” (p. 2100)
Comment: although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Unclear risk Comment: No details on allocation conceal-
ment were provided.
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
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Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “All assessments were conducted
by trained assessors masked to participant
condition” (p. 2103)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “We adopted a Bayesian approach . .
. using theMarkov chainMonte Carlo rou-
tines . . . This approach implements a mul-
tiple imputation strategy to handle missing
data . . . enabling an analysis of the intent-
to-treat (ITT) sample” (p. 2104)
Selective reporting (reporting bias) Unclear risk Comment: No reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Guthrie 2001
Methods Allocation: After consent, recruiting member of research team referred to an allocation
sequence provided by the trial statistician and based on a computer-generated list of
random numbers to assign participants
Follow-up period: 6 months
N lost to follow-up: 0/119 (0%) for repetition data
Participants Inclusion criteria: i) aged 18-65 years; ii) presenting with episode of deliberate self-
poisoning; iii) able to read and write English; iv) living in the catchment area of the
hospital; v) registered with a GP
Exclusion criteria: i) requiring psychiatric treatment
Numbers: Of the 119 participants, 58 were allocated to the experimental arm and 61 to
the control arm
Profile: 55.5% (n = 66) were female, 60% (n = 71) were multiple repeaters, 55% (n =
65) had a history of psychiatric treatment
Source of participants: patients presenting to hospital after deliberate self-poisoning
Location: Manchester, UK
Interventions Experimental: weekly 50-minute sessions of an individual home-based psychodynamic
interpersonal therapy involving identification of personal difficulties. Participants were
left to resolve interpersonal difficulties causing distress through a conversational approach
focused on the identification of feelings and relating these to problems and relationships
to develop shared understanding and approaches to family problems
Control: TAU. In most cases this involved assessment by doctor in the emergency de-
partment and referral to psychiatry outpatient treatment, addiction services, or GP
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Therapists: nurse therapists
Type of therapy offered: psychodynamic interpersonal therapy
Length of treatment: 4 weeks
Outcomes Included: i) repetition of SH according to self report and hospital records; ii) suicide; iii)
suicidal ideation; iv) depression
Excluded: i) patient satisfaction
Notes Sources of funding: “North West Regional Health Authority and the NHS Research and
Development Levy” (p. 4)
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “block randomised design” (p. 5).
Comment: Correspondence with the au-
thors further clarified that after consent, re-
cruiting member of research team referred
to an allocation sequence, provided by the
trial statistician and based on a computer-
generated list of random numbers to assign
participants in groups of 12 participants
(stratified according to whether or not par-
ticipants had a history of SH). Use of a ran-
dom numbers table is likely to have min-
imised the role of bias in the generation of
the randomisation sequence
Allocation concealment (selection bias) Low risk Comment: Correspondence with authors
clarified that allocation was concealed from
the recruiting member of the research team
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel (e.g., nurse therapists, GPs) are
likely to have known which participant was
receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
High risk Quote: “Follow up assessments were con-
ducted by one of two research assistants,
who were blind to treatment groups” (p. 2)
Comment: Data on repetition of SH, how-
ever, were obtained from participant self re-
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port
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “ [W]e included in the analysis all
patients who completed the assessments at
the end of treatment or at six month fol-
low up assessments. Comparisons between
groups were made on an intention to treat
basis” (p. 2)
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Harned 2014
Methods Allocation: randomisation using a minimisation procedure matched for: i) number of
suicide attempts in the past year; ii) number of episodes of NSSI in the past year; iii)
PTSD symptom severity; iv) dissociation symptom severity; v) current use of any SSRI
medication
Follow-up period: 3 months
N lost to follow-up: 8/26 (30.8%)
Participants Inclusion criteria: i) female; ii) aged 18-60 years; iii) diagnosedwith borderline personality
disorder; iv) diagnosed with post-traumatic stress disorder (PTSD); v) satisfactory recall
of at least part of the index trauma; vi) recent and recurrent engagement in SH (at least
2 suicide attempts or episodes of NSSI in the previous 5 years with at least 1 occurring
within the past 8 weeks); vii) lives within commuting distance of the specialist clinic
Exclusion criteria: i) diagnosed with psychosis, bipolar disorder, or mental retardation;
ii) receiving treatment under a legal mandate; iii) require treatment for another life-
threatening condition (e.g., anorexia nervosa)
Numbers: Of the 26 participants, 19 were allocated to the intervention arm and 7 were
allocated to the control arm
Profile: 100% (n = 26) were female; 100% (n = 26) were diagnosed with borderline
personality disorder; 100% (n = 26) were diagnosed with PTSD
Source of participants: patients seeking treatment from a specialist treatment service for
suicidal individuals with comorbid borderline personality disorder and PTSD, flyers,
and from outreach services within the catchment area
Location: Seattle, WA, USA
Interventions Experimental: dialectical behaviour therapy with the prolonged exposure protocol in-
volving individual psychotherapy, group skills training, phone consultations as required,
and weekly therapist consultation sessions. The prolonged exposure protocol enabled
participants to receive longer individual therapy sessions per week
Control: dialectical behaviour therapy involving individual psychotherapy, group skills
training, phone consultations as required, and weekly therapist consultation sessions
Therapists: masters’ level clinicians with an average of 2 years of clinical experience. Most
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were doctoral-level students in training (52.6%), followed by licensed professionals (36.
8%), and postdoctoral fellows (10.5%). Clinicians had received training in DBT for at
least 1 day
Type of therapy offered: dialectical behaviour therapywith the prolonged exposure protocol
Length of treatment: 12 months
Outcomes Included: i) repetition of SH; ii) suicides; iii) suicide attempts; iv) depression; v) compli-
ance
Excluded: i) repetition of SH and suicide attempts combined; ii) treatment sessions
attended; iii) adjunct skills sessions attended; iv) PTSD symptom severity; v) dissociation
symptom severity; vi) trauma-related guilt cognitions severity; vii) shame severity; viii)
anxiety; ix) global symptomatology
Notes Source of funding: “This work was supported by grant R34MH082143 from theNational
Institute of Mental Health” (p. 16)
Declaration of author interests: “Drs. Harned, Korslund, and Linehan are trainers and
consultants for Behavioral Tech, LLC” (p. 16)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A minimization randomization
procedure was used to match participants
on the five primary prognostic variables:
(1) number of suicide attempts in the last
year; (2) number of NSSI episodes in the
last year; (3) PTSD severity; (4) dissocia-
tion severity; and (5) current use of SSRI
medication” (pp. 8-9)
Comment: Use of a minimisation randomi-
sation algorithm is likely to haveminimised
the role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) Low risk Comment: Correspondence with authors
clarified that allocation was concealed from
assessors as randomisation was completed
by a staff member not involved in assess-
ments. Furthermore, there was no way to
foresee the outcome of the randomisation
algorithm
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: Correspondence with authors
clarified that allocation was concealed from
participants until their first therapy session,
at which point their therapist informed
them as to which treatment condition they
had been allocated
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Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: Correspondence with authors
clarified that allocation was concealed from
participants until their first therapy session,
at which point their therapist informed
them as to which treatment condition they
had been allocated, suggesting that person-
nel were aware of which participant had
been allocated to which treatment condi-
tion
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “[A]ssessments were conducted by
independent clinical assessors who were
blind to treatment condition” (p. 9)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: both intention-to-treat and per
protocol analyses provided
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Hassanian-Moghaddam 2011
Methods Allocation: randomisation using a block randomisation procedure using a random digit
table
Follow-up period: 12 months
N lost to follow-up: 187/2300 (8.1%) for repetition of SH at 12 months
Participants Inclusion criteria: i) aged 12 or older; ii) admitted or transferred to a specialist hospital
for the treatment of poisoning following an episode of deliberate self-poisoning
Exclusion criteria: i) treated in the emergency department of a regular hospital; ii) diag-
nosed with psychosis; iii) unable to provide informed consent (e.g., unable to commu-
nicate in Farsi); iv) of no fixed address; v) potential threat to interviewers; vi) episode
of self-poisoning was classified by the attending toxicologist as recreational, habitual,
accidental, or iatrogenic
Numbers: Of the 2300 participants, 1150 were allocated to the experimental arm and
1150 to the control arm
Profile: 66.4% (n = 1402) were female, 31.4% (n = 723) were multiple repeaters
Source of participants: patients admitted or transferred to a specialist hospital for the
treatment of poisoning following an episode of deliberate self-poisoning
Location: Tehran, Iran
Interventions Experimental: postcards mailed at 1, 2, 3, 4, 6, 8, 10, and 12 months after discharge in
addition to TAU
Control: TAU. Although no specific details are provided, the authors note that “[f ]ollow-
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up care for self-poisoning in Tehran is generally poor . . . Contact is mainly hospital- or
office-based, and community-based programs are almost non-existent. Psychiatric beds
are often at 100% occupancy, with short admissions and frequent readmissions.” (pp.
310-311)
Therapist: none
Type of therapy offered: outreach through the mailing of frequent postcards encouraging
participants to make contact with the service
Length of treatment: 12 months
Outcomes Included: i) repetition of SH according to self report; ii) suicide; iii) suicide attempts
according to self report cross-validated against hospital records; iv) suicidal ideation
Excluded: ii) number receiving postcard; ii) number finding postcard helpful in the
prevention of SH; iii) death from any cause
Notes Sources of funding: “This study was supported by a grant from the Legal Medicine Orga-
nization of Iran and the Loghman-Hakim ResearchDevelopment Unit, Shahid Beheshti
Medical University” (p. 315)
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Block randomisation (blocks of
100) was undertaken using a random digit
table” (p. 310)
Comment: the authors note that although “
. . . this older form of randomisation is po-
tentially liable to interference . . . no imbal-
ances at baseline suggest that the randomi-
sation was likely to have been successful”
(p. 314)
Allocation concealment (selection bias) Low risk Quote: “Tomaintain masking to allocation,
randomisation was not revealed to the re-
cruiting toxicologist until all information
was entered and eligibility determine” (p.
310)
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
Low risk Quote: “Other staff were masked to alloca-
tion status during hospital treatment” (p.
310)
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Blinding (performance bias and detection
bias)
Of outcome assessors
High risk Quote: “The research psychologist was not
masked to allocation status at follow-up”
(p. 310)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All outcomeswere analysed on ran-
domisation status at baseline for 12-month
follow-up” (p. 311)
Selective reporting (reporting bias) Unclear risk Comment: We had to obtain data on sui-
cides following correspondence with au-
thors, suggesting that selective reporting
bias may have been present
Other bias Low risk Comment: no other apparent sources of bias
Hatcher 2011
Methods Allocation: randomisation based on Zelen’smethod using a computer-generated numbers
list
Follow-up period: 12 months for primary outcome (i.e., repetition of SH) and 3 and
12 months for secondary outcomes (i.e., suicidal ideation, depression, hopelessness, and
problem-solving)
N lost to follow-up: 158/1094 (14.4%) by the 1-year follow-up period
Participants Inclusion criteria: i) 16 years or older; ii) admitted to hospital following an episode of SH
Exclusion criteria: i) still enrolled full time in school; ii) currently receiving dialectical
behaviour therapy for the treatment of borderline personality disorder; iii) had a treat-
ment management plan which precluded receiving short-term therapy; iv) cognitively
impaired; v) admitted to a psychiatric care unit following the index episode of SH for a
minimum period of 48 h
Numbers: Of the 552 participants who provided informed consent, 253 were allocated
to the experimental arm and 299 were allocated to the control arm
Profile: 68.8% (n = 380) were female, 44.7% (n = 247) were multiple repeaters
Source: patients admitted to hospital following an episode of SH
Location: Auckland and Wellington, New Zealand
Interventions Experimental: problem-solving therapy based on D’Zurilla 1971 involving problem ori-
entation, problem listing, definition, brainstorming of alternative solutions, devising an
action plan, and reviewing the plan in addition to TAU
Control: TAU involving a one-off psychosocial assessment by amental health professional
Therapist: clinicians without extensive clinical experience working in the mental health
care setting who received 1 week of training in problem-solving therapy
Type of therapy offered: problem-solving therapy
Length of treatment: 3 months
Outcomes Included: i) repetition of SHaccording tohospital records; ii) suicide; iii) suicidal ideation;
iv) depression; v) hopelessness; vi) problem-solving
Excluded: i) anxiety
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Notes Sources of funding: “This study was funded by the Accident Compensation Corporation
of New Zealand” (p. 316)
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “[P]atients were randomised (1:1)
using computer-generated random num-
bers . . . ” (p. 311)
Comment: Use of a computer-generated list
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) High risk Quote:“patients were randomised (1:1) us-
ing computer-generated random numbers
(from an independent statistician) con-
tained in sealed envelopes” (p. 311)
Comment: Use of opaque sealed envelope
could have ensured that allocation was con-
cealed; however, use ofZelen’s designmakes
it unlikely that participants and clinical
personnel would have remained unaware of
allocation
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: As consent was obtained using
Zelen’smethod, participants were given the
option to change treatment arms following
allocation. Therefore, participants cannot
have been blinded as to treatment alloca-
tion
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Researchers masked to treatment
allocation subsequently interviewed con-
senting participants by telephone” (p. 311)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “For the primary outcome we could
obtain information on repetition of self-
harm for everyone who was randomised, so
the analysis . . . is a true intention-to treat
analysis . . . For the analysis of secondary
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outcomes we used data from just those peo-
ple who consented to take part in the study
and we have called this a per protocol anal-
ysis” (p. 312)
Comment: mixture of intention-to-treat
and per protocol analyses.
Selective reporting (reporting bias) Unclear risk Comment: data on suicides had to be re-
quested fromauthors, suggesting that selec-
tive reporting bias may have been present
Other bias High risk Comment: Use of Zelen’s design may have
led to bias.
Hatcher 2015
Methods Allocation: randomisation based on Zelen’s method using a centrally generated randomi-
sation sequence. A stratified minimisation procedure was also used to ensure balance in
key prognostic factors (i.e., history of SH and method of SH) between the 4 sites
Follow-up period: 12 months for primary outcome (i.e., hospital recorded repetition of
SH) and 3 and 12 months for secondary outcomes (i.e., self reported repetition of SH,
depression, and hopelessness)
N lost to follow-up: 0/1474 (0%) for the primary outcome measure of hospital re-presen-
tations for SH
Participants Inclusion criteria: i) presented to the emergency department at 1 of the 4 participating
hospitals following an episode of SH
Exclusion criteria: i) aged less than 17 years; ii) still enrolled full-time in school; iii) unable
to provide informed consent; iv) self identified as M ori (these participants were instead
invited to participate in the Hatcher 2016a trial).
Numbers: Of the 684 participants who provided informed consent, 327 were allocated
to the experimental arm and 357 were allocated to the control arm
Profile: Of those who consented to participation 67.8% (n = 464) were female, 54.1%
(n = 370) were multiple repeaters
Source: patients admitted to hospital following an episode of SH
Location: Waitemata, Manukau, Northland, and Waikato regions, New Zealand
Interventions Experimental: 4-6 sessions of problem-solving therapy in the 4 weeks following the
index SH episode; postcards mailed at 1,2,3,4,6,8,10 and 12 months following the
index SH episode; 1-2 face-to-face or telephone patient support sessions over the 2-
week period following discharge from hospital to ensure patients were adhering to their
agreed discharge plan; improved access to primary care via the provision of a voucher
that could be used to access 1 free GP consultation; development of a risk management
strategy; and a cultural assessment focused on identifying patients’ sense of belonging
and identification with their ethnic group
Control: TAU involving referral to multidisciplinary teams for psychiatric/psychological
assessment, intervention, or both; referral to crisis teams; or referral to community-based
drug or alcohol treatment teams as necessary
Therapist: research clinicians (no further details on qualifications or experience were pro-
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vided), mental health crisis and community mental health clinicians (no further details
on qualifications or experience were provided), GPs, and substance misuse counsellors
(no further details on qualifications or experience were provided)
Type of therapy offered: mixture of brief psychosocial therapy, telephone contact, and
postal intervention
Length of treatment: 12 months
Outcomes Included: i) repetition of SH; ii) suicide; iv) depression; v) hopelessness
Excluded: i) anxiety; ii) quality of life; iii) sense of belonging; iv) ethnic identification
Notes Sources of funding: none stated
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “All eligible participants were allo-
cated randomly to the intervention or usual
care groups using a central computerised
randomisation system at the Clinical Trials
Research Unit (subsequently the National
Institute for Health Innovation) . . . Strati-
fied minimisation randomization was used
to ensure a balance in key prognostic fac-
tors between the study groups” (p. 6 of the
manuscript)
Comment: Use of a computerised randomi-
sationprocedure is likely to haveminimised
the role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) High risk Quote: “[P]articipants were allocated ran-
domly . . . using a central computerised
randomisation system at the Clinical Trials
Research Unit (subsequently the National
Institute for Health Innovation)” (p. 6 of
the manuscript)
Comment: Use of offsite randomisation
could have ensured that allocation was con-
cealed; however, use ofZelen’s designmakes
it unlikely that participants and clinical
personnel would have remained unaware of
allocation
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “ [T]he introduction to the study
differed depending on whether [the partic-
ipant was] randomised to the control or in-
tervention group” (p. 3 of the manuscript)
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Comment: As consent was obtained using
Zelen’smethod, participants were given the
option to change treatment arms following
allocation. Therefore, participants cannot
have been blinded as to treatment alloca-
tion
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “The research assistants were blind
to treatment allocation” (p. 6 of the
manuscript)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “Analysis of the primary outcome
was in everyone who was randomised . .
. The secondary outcomes were analysed
only in those people who had consented to
be in the study” (p. 6 of the manuscript)
Comment: mixture of intention-to-treat
and per protocol analyses
Selective reporting (reporting bias) Unclear risk Comment: We had to request data on sui-
cides from authors, suggesting that selec-
tive reporting bias may have been present
Other bias High risk Comment: Use of Zelen’s design may have
led to bias.
Hatcher 2016a
Methods Allocation: randomisation based on Zelen’s method using a centrally-generated randomi-
sation sequence. A stratified minimisation procedure was also used to ensure balance in
key prognostic factors (i.e., history of SH and method of SH) between the 3 sites
Follow-up period: 12 months for primary outcome (i.e., hospital recorded repetition of
SH) and 3 and 12 months for secondary outcomes (i.e., self reported repetition of SH,
depression, and hopelessness)
N lost to follow-up: 0/365 (0%) for hospital re-presentations for SH.
Participants Inclusion criteria: i) presented to the emergency department at 1 of the 3 participating
hospitals following an episode of SH; ii) self identified asM ori; iii) able to communicate
effectively in Te Reo Maori (M ori language)
Exclusion criteria: i) aged less than 17 years; ii) still enrolled full-time in school; iii) unable
to provide informed consent
Numbers: Of the 167 participants who provided informed consent, 95 were allocated to
the experimental arm and 72 were allocated to the control arm
Profile: Of those who consented to participation 65.3% (n = 109) were female, 59.9%
(n = 100) were multiple repeaters
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Source: patients admitted to hospital following an episode of SH
Location: Waitemata, Manukau, and Northland regions, New Zealand
Interventions Experimental: a culturally sensitive treatment framework consisting of 4-6 sessions of
problem-solving therapy in the 4weeks following the index SH episode; postcardsmailed
at 1,2,3,4,6,8,10 and 12 months following the index SH episode, 1-2 face-to-face or
telephone patient support sessions over the 2 week period following discharge from
hospital to ensure patients were adhering to their agreed discharge plan, improved access
to primary care via the provision of a voucher that could be used to access 1 free GP
consultation, development of a risk management strategy, and a cultural assessment
focused on identifying patients’ sense of belonging and identification withM ori culture
Control: TAU involving referral to multi-disciplinary teams for psychiatric/psychological
assessment, intervention, or both; referral to crisis teams; or referral to community-based
drug or alcohol treatment teams as necessary
Therapist: research clinicians (no further details on qualifications or experience were
provided), mental health crisis and community mental health clinicians (no further
details on qualifications or experience were provided), GPs, and addiction counsellors
(no further details on qualifications or experience were provided)
Type of therapy offered: mixture of brief psychosocial therapy, telephone contact, and
postal intervention
Length of treatment: 12 months
Outcomes Included: i) repetition of SH; ii) suicide; iv) depression; v) hopelessness
Excluded: i) anxiety; ii) quality of life; iii) sense of belonging; iv) ethnic identification; v)
cultural impact
Notes Sources of funding: none stated
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “All eligible participants were allo-
cated randomly to the intervention or usual
care groups using a central computerised
randomization system at the Clinical Trials
Research Unit (subsequently the National
Institute for Health Innovation) . . . Strati-
fied minimisation randomization was used
to ensure a balance in key prognostic fac-
tors between the study groups” (p. 7 of the
manuscript)
Comment: Use of a computerised randomi-
sationprocedure is likely to haveminimised
the role of bias in the generation of the ran-
domisation sequence
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Allocation concealment (selection bias) High risk Quote: “ [P]articipants were allocated ran-
domly using a central computerised ran-
domisation system at theClinical Trials Re-
search Unit (subsequently the National In-
stitute for Health Innovation) . . . ” (p. 7 of
the manuscript)
Comment: Use of offsite randomisation
could have ensured that allocation was con-
cealed; however, use ofZelen’s designmakes
it unlikely that participants and clinical
personnel would have remained unaware of
allocation
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “[T]he introduction to the study
differed depending on which arm of the
trial [the participant was] randomised to”
(p. 3 of the manuscript)
Comment: As consent was obtained using
Zelen’smethod, participants were given the
option to change treatment arms following
allocation. Therefore, participants cannot
have been blinded as to treatment alloca-
tion
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “The research assistants were blind
to treatment allocation” (p. 6 of the
manuscript)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: mixture of intention-to-treat
and per protocol analyses. Hospital-
recorded episodes of repeated SH, for ex-
ample, were available for all 365 partici-
pants who were enrolled, whereas data on
outcomes measured on a continuous scale
(e.g., depression, hopelessness) are available
for the 167 participants who provided in-
formed consent
Selective reporting (reporting bias) Unclear risk Comment: We had to request data on sui-
cides from authors, suggesting that selec-
tive reporting bias may have been present
Other bias High risk Comment: Use of Zelen’s design may have
led to bias.
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Methods Allocation: random number method using sealed, opaque envelopes
Follow-up period: 12 months
N lost to follow-up: 0/96 (0%) for repetition of SH data
Participants Inclusion criteria: i) aged over 16 years; ii) suitable for randomisation (e.g., fixed abode)
Exclusion criteria: i) in psychiatric care; ii) residing outside of catchment area; iii) requiring
treatment for alcohol or dug addiction; iv) in need of inpatient psychiatric care
Numbers: Of the 96 participants, 48 were allocated to the experimental arm and 48 to
the control arm
Profile: 70% (n = 67) were female, 32% (n = 31) were multiple repeaters
Source of participants: patients admitted to a general hospital following an episode of
deliberate self-poisoning
Location: Oxford, UK
Interventions Experimental: domiciliary (home-based) therapy, where the frequency of treatment ses-
sions was flexible according to therapists’ ’assessment of needs’. Open telephone access
to the general hospital service was also available
Control: outpatient therapy once a week in an outpatient clinic in a general hospital
Therapist: 2 junior psychiatrists, 1 psychiatric nurse, and 1 social worker
Type of therapy offered: brief problem-oriented psychological therapy
Length of treatment: up to 3 months
Outcomes Included: i) repetition of SH according to hospital records, self report, and from a GP
questionnaire; ii) compliance; iii) improvement in problems; iv) suicidal ideation
Excluded: i) mood; ii) social adjustment; iii) GP questionnaire
Notes Sources of funding: “The project was supported by a grant from theDepartment of Health
and Social Security” (p. 177)
Declaration of author interests: no details on author interests provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A random number method was
used to select subjects” and “each patient
was then allocated to 1 of the 2 treatment
conditions by a randomized procedure” (p.
172)
Comment: Use of a random numbers
method is likely to have minimised the role
of bias in the generation of the randomisa-
tion sequence
Allocation concealment (selection bias) Low risk Comment: Correspondence with authors
clarified that sealed, opaque envelopes were
used to conceal allocation. Use of opaque
sealed envelope would ensure adequate al-
location concealment
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Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “The assessor remained blind to the
treatment offered” (p. 172)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: 6%of patientswere not available
for post-treatment assessment and 15%
were not available for 6-month assessment.
No further details on whether intention-
to-treat analyses were undertaken are pro-
vided, however
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Hawton 1987a
Methods Allocation: randomisation using opaque envelopes according to a random number table
in blocks of 8 with equal allocation to the experimental and control arms
Follow-up period: 12 months
N lost to follow-up: 0/80 (0%) for repetition of SH data
Participants Inclusion criteria: i) aged over 16; ii) registered with a general practitioner; iii) living up to
15 miles away from hospital; iv) suitable for outpatient counselling; iv) willing to accept
aftercare offered
Exclusion criteria: i) in need of psychiatric care (day-patient or inpatient); ii) currently in
psychiatric care
Numbers: Of the 80 participants, 41 were allocated to the experimental arm and 39 to
the control arm
Profile: 66% (n = 53) were female, 31% (n = 25) were multiple repeaters
Source of participants: patients admitted to a general hospital following an episode of self-
poisoning
Location: Oxford, UK
Interventions Experimental: up to 8 sessions, each lasting on average 54minutes, of outpatient problem-
solving therapy delivered by non-medical clinicians
Control: GP care including individual support, marriage counselling, psychiatric referral,
159Psychosocial interventions for self-harm in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hawton 1987a (Continued)
etc
Therapist: 5 counsellors from clinical team in the general hospital psychiatric service
Type of therapy offered: problem-solving therapy
Length of treatment: not stated
Outcomes Included: i) repetition of SHaccording tohospital records, self report, collateral informant
report, or from interviews with the participants’ GP; ii) suicide; iii) depression; iv)
improvement in problems
Excluded: i) social adjustment; ii) attitudes to treatment; iii) General Health Question-
naire; iv) GP interview; v) compliance
Notes Sources of funding: “This study was supported by a grant from the Medical Research
Council” (p. 760)
Declaration of author interests: no details on author interests provided
Other: As compliance data were not reported for the control group, this outcome had to
be excluded from subsequent analyses
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote:“Patients were allocated by a ran-
domized procedure” (p. 752).
Comment: Correspondence with authors
clarified that the allocation sequence was
generated using a random number table in
blocks or 8 with equal allocation to the
experimental and control groups. Use of
a random numbers table is likely to have
minimised the role of bias in the generation
of the randomisation sequence
Allocation concealment (selection bias) Low risk Comment: Correspondence with authors
clarified that sealed, opaque envelopes were
used to conceal allocation. Use of opaque
sealed envelope would ensure adequate al-
location concealment
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Assessment interviews were con-
ducted by research interviewers, who, until
towards the end of the second follow-up,
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remained blind to which treatment group
the patients had been allocated” (p. 753)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: combineduse of hospital records
and GP reports would enable information
on all clinically treated SH episodes to
be obtained, suggesting intention-to-treat
analyses were undertaken
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Husain 2014
Methods Allocation: randomisation using a computer-generated allocation sequence
Follow-up period: 3 and 6 months
N lost to follow-up: 4/221 (1.8%) by the 3-month follow-up period; 8/221 (3.6%) by
the 6-month follow-up period
Participants Inclusion criteria: i) aged 16-64 years; ii) living within the catchment area of 1 of the 3
participating university hospitals
Exclusion criteria: i) requiring inpatient psychiatric treatment; ii) temporarily resident in
the catchment area of 1 of the 3 participating university hospitals; iii) diagnosed with a
mental disorder due to a general medical condition, substance misuse, dementia, delir-
ium, substance dependence, schizophrenia, bipolar disorder, or an intellectual disability
according to DSM-IV criteria
Numbers: Of the 221 participants, 108 were allocated to the intervention arm and 113
were allocated to the control arm
Profile: 68.8% (n = 152) were female; 4.1% (n = 9) were multiple repeaters
Source of participants: patients admitted to the medical unit a university hospitals follow-
ing an episode of SH
Location: Karachi, Sindh province, Pakistan
Interventions Experimental:manualised culturally adapted problem-solving therapy based onprinciples
of cognitive behavioural therapy involving an evaluation of the SHattempt, development
of crisis management skills, use of problem-solving and cognitive-behavioural techniques
to improve emotion regulation skills, negative thinking, interpersonal relationships, and
to improve relapse prevention strategies
Control: TAU. The authors further clarify that “[p]atients are not routinely referred to
psychiatric or psychological services” (p. 464)
Therapist: qualified, Masters-level psychologists with a minimum of 3 years postqualifi-
cation clinical experience. Clinicians also received training in delivering the intervention
treatment
Type of therapy offered: problem-solving therapy
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Length of treatment: 3 months
Outcomes Included: i) repetition of SH; ii) suicide; iii) suicidal ideation; iv) depression; v) hope-
lessness; vi) problem-solving; vii) compliance
Excluded: i) quality of life; ii) help-seeking behaviours; iii) days spent in inpatient treat-
ment; iv) attendances at outpatient clinics; v) GP consultations; vi) consultations with
any other doctors; vii) consultations with non-medical religious healers; viii) consulta-
tions with non-medical homeopathic healers
Notes Source of funding: “This study was jointly funded by the University of Manchester and
Pakistan Institute of Learning and Living” (p. 469)
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “ [A]n allocation sequence . . .
was based on a computer-generated list
of random numbers . . . Randomisation
was performed using www.randomization.
com. Participantsmeeting the entry criteria
were randomly allocated to each condition
in a 1:1 ratio using permuted blocks of 6”
(p.463)
Comment: Use of a computer-generated list
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Low risk Quote: “ [A]n allocation sequence . . . was
provided by the off-site statistician (inde-
pendent of the research team)” (p. 463)
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “It was not possible to keep the .
. . participants themselves masked to the
group allocation” (p. 463)
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “It was not possible to keep the clin-
icians at participating centres . . . masked
to the group allocation” (p.463)
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Research assistants [were] masked
to treatment allocation” (p. 463)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Comparisons between groups were
made on an intention-to-treat basis” (p.
465)
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Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Hvid 2011
Methods Allocation: randomisation stratifying for: i) history ofmultiple suicide attempts; ii) history
of previous psychiatric treatment; iii) use of alcohol during the index suicide attempt
Follow-up period: 6 months
N lost to follow-up: 8/133 (6.0%) for repetition of SH
Participants Inclusion criteria: i) admitted to an emergency department or clinical department fol-
lowing an episode of SH
Exclusion criteria: i) less than 12 years old; ii) diagnosed with anymajor psychiatric illness,
including: schizophrenia, other psychoses, bipolar disorder, major depression, psychotic
depression, mental retardation, and severe dementia; iii) unable to communicate in
Danish without an interpreter
Numbers: Of the 133 participants, 69 were allocated to the experimental arm and 64 to
the control arm
Profile: 71.4% (n = 95) were female, 38.3% (n = 51) were multiple attempters
Source of participants: patients admitted to an emergency or clinical department following
an episode of SH
Location: Amager, Denmark
Interventions Experimental: assertive outreach delivered according to the Baerum model involving as-
sertive outreach via home visits, telephone calls, email messages, and text messages, so-
lution-focused problem-solving therapy, adherence therapy, and treatment continuity as
participants were contacted by the same psychiatric nurse (as far as practical) throughout
the course of treatment (Dieserud 2000)
Control: TAU involving encouraging participants to contact their GP who could, where
required, refer the participant on to further psychiatric or psychological treatment
Therapist: 1 consultant-level psychiatrist and 2 psychiatric nurses
Type of therapy offered: assertive outreach and compliance enhancement
Length of treatment: maximum period of 6 months
Outcomes Included: i) repetition of SH according to hospital records; ii) suicide according to coro-
ner’s records
Excluded: none
Notes Sources of funding: “The trial has been funded by a grant from the Danish Ministry of
Social Affairs, the Lundbeck Foundation and theHealth Insurance Foundation” (p. 297)
Declaration of author interests: none stated
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “We applied a stratified randomiza-
tion procedure . . . this stratified random-
ization procedure . . . created eight cate-
gories and randomization was performed
for each independently” (p. 293)
Comment: Although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Low risk Quote: “Randomisation was performed by
an independent office” (p. 293)
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “The patient . . . knew who was a
case and who was a control” (p. 293)
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “[I]ntervention staff knew who was
a case and who was a control” (p. 293)
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “ [I]ndependent assessors (three psy-
chiatrists) who reviewed all incidents did
not have this information” on who had
been allocated to the experimental or con-
trol arms (p. 294)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Outcomes were measured by an
intent-to-treat design in which all patients
were followed until the end of the trial, ir-
respective of whether the patient was still
receiving or complying with the assigned
treatment” (p. 294)
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
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Methods Allocation: randomisation using web-based randomisation software
Follow-up period: 12 months
N lost to follow-up: 0/66 (0%) by the 12-month follow-up period
Participants Inclusion criteria: i) aged 18 or older; ii) resident in Manchester, UK; iii) admitted to
emergency departments following an episode of SH
Exclusion criteria: i) required admission to a psychiatric unit; ii) not in possession of a
telephone; iii) required admission to a general hospital for a period of greater than 7
days; iv) lived outside of the catchment area; v) experienced deterioration in psychosis
symptoms; vi) denied having engaged in SH; vii) declined to participate
Numbers: Of the 66 participants, 33 were allocated to the intervention arm and 33 to
the control arm
Profile: no details are provided, although the authors note “[i]ntervention and usual
treatment groups were similar in terms of age, gender” (p. 73)
Source of participants: admissions to emergency departments following an episode of SH
Location: Manchester, UK
Interventions Experimental: outreach involving mailing of an information leaflet listing both local and
national sources of support, 2 semi-structured telephone calls, and a series of letters
mailed at 1, 2, 4, 6, 8, and 12 months designed to facilitate referral to appropriate
specialist treatment as required
Control: TAU involving referral to mental health services, social services, or voluntary-
sector services as required
Therapist: clinical researchers. No other details on qualifications or experience were pro-
vided
Type of therapy offered: outreach through telephone contact and the mailing of frequent
letters encouraging participants to make contact with the service
Length of treatment: 12 months
Outcomes Included: i) repetition of SH; ii) suicide
Excluded: i) number of emergency department attendances; ii) number of days on a
medical inpatient ward; iii) number of face-to-face contacts with mental health services;
iv) number of admissions to psychiatric inpatient services
Notes Source of funding: “commissioned by the National Institute for Health Research (NIHR)
under its Program Grants for Applied Research scheme (RP-PG-0606-1247)” (p. 74)
Declaration of author interest: “N.K. chaired the Naitonal Institute for Health and Clin-
ical Excellence (NICE) guideline development group and evidence for the longer-term
management of self-harm. N.K., D.G., K.H. are members of the National Suicide Pre-
vention Strategy Advisory Group” (p. 73)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomisation was conducted via
a remote Internet-based service (www.
sealedenvelope.com)” (p. 73)
Comment: Use of computer-based ran-
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domisation software is likely to have min-
imised the role of bias in the generation of
the randomisation sequence
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment provided
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “All outcome data were collected by
researchers masked to allocation status” (p.
73)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Primary analysis was on an inten-
tion-to-treat basis” (p. 73)
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Kawanishi 2014
Methods Allocation: randomisation using web-based randomisation software using minimisation
to ensure balance between the treatment and control groups with respect to site, sex, age,
and history of episodes of SH prior to the index episode
Follow-up period: 18 months to 5 years
N lost to follow-up: 0/914 (0%) by the 18-month follow-up period
Participants Inclusion criteria: i) aged 20 years or older; ii) admitted to the emergency department at 1
of 17 hospitals following a suicide attempt; iii) have at least 2 prior suicide attempts rated
as having definite suicidal intent as determined by scores on the Suicide Intent Scale;
iv) diagnosed with any axis I psychiatric disorder according to DSM-IV-TR criteria; v)
able to understand the trial procedure; vi) provide informed consent; vii) attend a face-
to-face interview; viii) attend a psychoeducation session during their hospital admission
Exclusion criteria: i) diagnosed with any psychiatric disorder which did not meet DSM-
IV-TR criteria
Numbers: Of the 914 participants, 460 were allocated to the intervention arm and 454
to the control arm
Profile: 56.2% (n = 514) were females, 49.2% (n = 450) had multiple episodes of at-
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tempted suicide
Source of participants: admissions to emergency departments following a suicide attempt
Location: various locations around Japan
Interventions Experimental: assertive outreach and case management involving contact with patients
at week 1 and 1, 2, 3 , 6, 12, and 18 months after the index suicide attempt with a view
to collecting information about the participant’s treatment status and any problems that
could interfere with treatment adherence, providing encouragement to remain adherent
with treatment, coordination and referral to appointments with psychiatrists and any
other primary care physicians, outreach for those who had dropped out of treatment,
referral to social services and other support organisations as needed, psycho-education,
and access to a dedicated website designed to provide participants with information and
resources
Control: enhanced usual care. No further details on treatment content provided
Therapist: mixture of psychiatrists, nurses, social workers, and clinical psychologists
Type of therapy offered: assertive outreach
Length of treatment: 18 months
Outcomes Included: i) repetition of SH; ii) suicide
Excluded: none
Notes Source of funding: “This study was funded by theMinistry of Health, Labour, andWelfare
of Japan” (p. 200)
Declaration of author interest: no conflicts of interest reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants were randomly as-
signed (1:1) by and Internet-based system
. . . to either the intervention group (as-
sertive case management) or the control
group (enhanced usual care). Assignment
was by theminimisationmethod, with four
factors: participating hospital, sex, age . . .
and history of previous suicide attempts be-
fore the current episode. We regarded these
as factors that could affect the study out-
comes.” (p. 194)
Comment: Use of computer-based ran-
domisation software is likely to have min-
imised the role of bias in the generation of
the randomisation sequence
Allocation concealment (selection bias) Low risk Quote:“Participants were randomly as-
signed . . . by an Internet-based system op-
erated by a central, independent data cen-
tre” (p. 194)
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Comment: use of offsite randomisation
would have ensured that allocation was
concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “Outcome assessors were masked to
group assignment, but patients . . . were
not” (p. 194)
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “Outcome assessors were masked to
group assignment, but . . . case managers
who provided the interventions were not”
(p. 194)
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Outcome assessors were masked to
group assignment . . . The assessors did not
know the participants’ assigned groups, the
status of implementation of the interven-
tion or information about events obtained
by other on-site staff ” (p. 194)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Analyses were done in accordance
with the intention-to-treat principle” (p.
196)
Selective reporting (reporting bias) High risk Comment: outcomes determined ad hoc.
In addition, data on some protocol-speci-
fied outcomes (e.g., number of repeat SH
episodes, hopelessness) are yet to be pub-
lished
Other bias Unclear risk Comment: sample was biased towards more
compliant patients who were willing and
able to attend a psycho-education session
seminar at the commencement of treat-
ment and were able to attend hospital reg-
ularly for face-to-face interviews and case
management sessions. Additionally, those
individuals who had engaged in non-suici-
dal SH were excluded from participation
Liberman 1981
Methods Allocation: random assignment
Follow-up period: 24 months
N lost to follow-up: 0/24 (0%) for repetition data
Participants Inclusion criteria: i) at least 1 previous suicide attempt
Exclusion criteria: i) diagnosed with psychosis; ii) addicted to drugs and alcohol; ii)
diagnosed with organic brain syndrome
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Numbers: Of the 24 participants, 12 were assigned to the experimental arm and 12 to
the control arm
Profile: 16 (67%) were female, 24 (100%) were multiple repeaters, 24 (100%) were
diagnosed with depressive neurosis, most met criteria for personality disorder
Source of participants: patients referred by psychiatric emergency services or hospital A&
E departments following an episode of SH
Location: Los Angeles, CA, USA
Interventions Experimental: inpatient treatment involving behaviour therapy. Treatment consisted of
social skills training, anxiety management, and family therapy. A therapeutic milieu with
a token economy was also established. Aftercare at a community mental health centre or
with a private therapist was also used as required
Control: inpatient treatment involving insight oriented therapy. Treatment consisted of
individual therapy, group therapy and psychodrama, and family therapy. A therapeutic
milieu with a token economy was also established. Aftercare at a community mental
health centre or with a private therapist was also used as required
Therapist: 1 psychologist assisted by 2 bachelor level technicians
Type of therapy offered: behavioural therapy
Length of treatment: 10 days
Outcomes Included: i) repetition of SH according to self report; ii) suicidal ideation; iii) depression
Excluded: i) reinforcement; ii) assertiveness; iii) fear
Notes Source of funding: “The project was made possible by grant MH 22804 from the Clinical
Research Branch of the National Institute of Mental Helath toMichael Serber, MD, and
R.P.L., the co-principal investigators.” (p. 1130)
Declaration of author interests: no details on author interests provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Patients were randomly assigned”
(p. 1127).
Comment: Although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Unclear risk Comment: No details on allocation conceal-
ment were provided.
Blinding (performance bias and detection
bias)
Of participants
Unclear risk Comment: No information on participant
blinding was provided. However, both
treatments were so similar that it is possible
participants were unaware of which treat-
ment they were receiving
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Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: no details on outcome assessor
blinding provided
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 4 participants dropped out dur-
ing the early stages of the trial (2 in each
arm) and were not included in any subse-
quent analyses, suggesting researchers un-
dertook per protocol analyses
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Linehan 1991
Methods Allocation: randomised allocation via computer programme
Follow-up period: 24 months
N lost to follow-up: 24/63 (38.1%) participants were deliberately not included in the 24-
month follow-up
Participants Inclusion criteria: i) female; ii) diagnosed with borderline personality disorder; iii) at least
2 suicide attempts in the last 5 years, with at least 1 in the previous 8 weeks; iv) aged 18-
45 years; v) agree to trial conditions
Exclusion criteria:
Numbers: Of the 63 participants, 32 were allocated to the experimental arm and 31 to
the control arm
Profile: 63 (100%)were female, 63 (100%)weremultiple repeaterswithmultiple episodes
of SH each and who were at high risk of further episodes of SH, 63 (100%) were
diagnosed with borderline personality disorder
Source of participants: clinically referred patients who had at least 1 episode of SH in the
last 8 weeks
Location: Seattle, WA, USA
Interventions Experimental: dialectical behaviour therapy involving cognitive behavioural treatment
developed specifically for the treatment of for suicidal patients with borderline person-
ality disorder (see Linehan 1993a), which targets increasing behavioural capabilities and
motivation for treatment whilst also reinforcing functional behaviour. The manualised
treatment consisted of 1 h per week of individual psychotherapy, 2.5 h per week of group
skills training, telephone consultation as required (within each therapists’ limitations),
and weekly therapist team meetings
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Control: TAU involving referral to alternative therapy
Therapist: 5 psychologists, 1 clinical psychology graduate, and 1 psychiatrist
Type of therapy offered: dialectical behaviour therapy
Length of treatment: 12 months
Outcomes Included: i) repetition of SH according to self report; ii) suicide; iii) compliance; iv)
depression; v) suicidal ideation; vi) hopelessness
Excluded: i) psychiatric admissions; ii) reasons for living
Notes Sources of funding: ”This research was supported by grant MH34486 from the National
Institute of Mental Health, Bethesda, Md (Dr Linehan)
Declaration of author interests: Although no details on author interests were provided, Dr.
Linehan was developed dialectical behaviour therapy
Other: Half (50%) of the self reported episodes of SH were checked against medical
records, therapist records, and observer/nurse/physician ratings
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “randomized” (p. 1060; 1991 arti-
cle).
Comment: Correspondence with authors
clarified that they used a computer pro-
gramme to generate the random sequence.
Use of a computerised randomisation se-
quence is likely to have minimised the role
of bias in the generation of the randomisa-
tion sequence
Allocation concealment (selection bias) Low risk Comment: Correpondence with authors
clarified that allocation had been concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Every effort was made to keep the
assessors blind about treatment condition”
(p. 1061)
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: subsequent analyses appear to be
based on those participants with available
information at each follow-up period, sug-
gesting investigators undertook per proto-
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col analyses
Selective reporting (reporting bias) Unclear risk Comment: No reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Linehan 2006
Methods Allocation: randomisation using a computerised adaptive minimisation procedure
whereby participants were matched using 5 primary prognostic variables: i) number of
lifetime suicide attempts or non-suicidal self injuries combined; ii) number of psychi-
atric hospitalisations; iii) history of only suicide attempts, only non-suicidal self-injury,
or both; iv) age; v) Beck Depression Inventory score > 30 or a Global Assessment of
Functioning score < 45 for any comorbid condition
Follow-up period: 24 months
N lost to follow-up: 0/101 (0%) for repetition data
Participants Inclusion criteria: i) 18-45 years; ii) female; iii) met criteria for borderline personality
disorder; iv) at least 2 suicide attempts or episodes of SH in the past 5 years, with at least
1 in the past 8 weeks
Exclusion criteria: i) lifetime diagnosis of schizophrenia, schizoaffective disorder, bipolar
disorder, psychotic disorder not otherwise specified, or mental retardation; ii) seizure
disorder requiringmedication; iii)mandate to treatment; iv) requiring primary treatment
for another debilitating condition
Numbers: Of the 101 participants 52 were allocated to the experimental arm and 49 to
the control arm
Profile: 101 (100%) were female, 97 (96%) had a lifetime diagnosis of a depressive disor-
der, 73 (72.3%) were diagnosed with major depression, and 30 (29.7%) had substance
abuse
Source of participants: clinical referrals and individuals attending inpatient units, emer-
gency rooms and outpatient clinics
Setting: Seattle, WA, USA
Interventions Experimental: dialectical behavior therapy involving cognitive behavioural treatment de-
veloped specifically for the treatment of for suicidal patients with borderline personal-
ity disorder (see Linehan 1993a), which targets increasing behavioural capabilities and
motivation for treatment whilst also reinforcing functional behaviour. The manualised
treatment consisted of 1 h weekly individual psychotherapy, 2.5 h weekly group skills
training, telephone consultation as required (within each therapists’ limitations), and
weekly therapist team meetings
Control: community treatment by experts specifically designed for the trial to control for
factors previously uncontrolled in DBT trials. Whilst similar to TAU, as therapists were
free to decide on type and dose of therapy they believed was most suited to the patient
(minimum of 1 scheduled individual session per week), the characteristics of therapists
were controlled via selection of therapists and supervisory arrangements
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Therapists: specially trained to provide either experimental or control therapy
Type of therapy offered: dialectical behaviour therapy
Length of treatment: 1 year
Outcomes Included: i) repetition of SH according to the Suicide Attempt Self-Injury Interview; ii)
suicide; iii) suicidal ideation; iv) depression; v) compliance
Excluded: i) severity of SH episode; ii) importance of reasons for living; iii) use of addi-
tional service (e.g., re-presenting to A&E)
Notes Sources of funding: “This study was supported by grants MH34486 and MH01593 from
the National Institute of Mental Health” (p. 765)
Declaration of author interests: although no details on author interests were provided, Dr
Linehan developed dialectical behaviour therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Computerized adaptive minimiza-
tion randomization procedure” (p. 758)
Comment: Use of a computerised randomi-
sation sequence is likely to have minimised
the role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) Unclear risk Comment: No details on allocation conceal-
ment provided
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “Initial assessments were done be-
fore informing subjects of treatment assign-
ment” (p. 758)
Comment:suggests participants were subse-
quently informed of treatment allocation
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Assessments were conducted by
blinded independent clinical assessors” (p.
758)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “[W]e examined the effects of differ-
ential missing data and treatment dropout
on each of ourmajor outcome variables and
found no evidence that the findings were
biased by these differences” (p. 760)
Comment: 111 participants were ran-
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domised, 10were pilot cases (not analysed),
20were lost to follow-up, and21discontin-
ued interventions. 101 were analysed over-
all
Selective reporting (reporting bias) Unclear risk Comment: No reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Marasinghe 2012
Methods Allocation: randomisation using an unknown method
Follow-up period: as this was a cross-over trial, only data from the first follow-up period
at 6 months was extracted
N lost to follow-up: 0/68 (0%) for the 6-month follow-up period
Participants Inclusion criteria: i) aged 15-74 years; ii) admitted to hospital following an episode of
SH; iii) episode of SH was associated with significant suicidal intent as reported either
at the intake interview or according to scores on Beck’s Scale for Suicidal Ideation; iv)
considered likely to be discharged fromhospital within 2 days or able to be re-approached
if admitted for longer than 2 days; v) able to provide informed consent
Exclusion criteria: i) currently receiving ongoing psychiatric treatment; ii) diagnosed with
psychosis; iii) diagnosed with dementia
Numbers: Of the 68 participants, 34 were allocated to the intervention arm and 34 to
the control arm
Profile: 50.0% (n = 34) were female
Source of participants: patients admitted to hospital following an episode of SH
Location: Colombo, Sri Lanka
Interventions Experimental: brief mobile treatment involving an assessment of mental health, medi-
tation, problem-solving therapy, interventions to increase social support, interventions
to address alcohol or other substance misuse problems, a series of 10 telephone calls to
reaffirm techniques learnt during treatment, the ability to access telephone messages to
reaffirm techniques learnt during treatment, and a series of up to 26 text messages to
encourage the participant to practice meditation techniques, problem-solving skills, to
seek social support, to avoid alcohol and other drugs, and to use the telephone helpline
to get individual support in times of crisis
Control: wait list
Therapist: no details on qualifications or experience provided
Type of therapy offered: brief problem-solving treatment via mobile telephone
Length of treatment: up to 26 weeks
Outcomes Included: i) repetition of SH; ii) suicide reattempts; iii) suicide; iv) suicidal ideation; v)
depression
Excluded: i) medical outcomes; ii) alcohol use; iii) drug use; iv) substance use severity
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Notes Sources of funding: “We are grateful for funding from the Improving Relevance and Qual-
ity of Undergraduate Education (IRQUE) project of the University of Jeyewardenepura,
Sri Lanka” (p. 155)
Declaration of author interests: no details on author interests provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The participants were randomly al-
located” (p. 152).
Comment: Although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment provided
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “The assessor was blind to the treat-
ment” (p. 152).
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Intention to treat analyses . . . ” (p.
152).
Selective reporting (reporting bias) Unclear risk Comment: We had to request data on rep-
etition of SH, suicide reattempts, and sui-
cide from authors, suggesting that selective
reporting bias may have been present
Other bias Low risk Comment: no other apparent sources of bias
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Methods Allocation: randomisation using a computer-generated sequence of numbers stratified
by: i) sex; ii) repeater status; iii) site
Follow-up period: 6 and 12 months
N lost to follow-up: 107/433 (24.7%) by the 6-month follow-up period
Participants Inclusion criteria: i) aged 18-64 years; ii) engaged in SH in the previous 3 days
Exclusion criteria: i) diagnosed with psychosis, intellectual disability, sensory disability, or
an organic cognitive impairment; ii) currently substance dependent according to scores
on the Short Alcohol Dependent Data questionnaire; iii) imprisoned; iv) of no fixed
abode
Numbers: Of the 433 participants, 222 were allocated to the experimental arm and 211
to the control arm
Profile: 64.4% (n = 279) were female; 29.3% (n = 127) were multiple repeaters
Source of participants: admissions to the emergency department following an episode
of SH, or patients engaging in SH on acute psychiatric facilities even if this did not
necessitate admission to the emergency department
Location: Cork and Limerick, Republic of Ireland
Interventions Experimental: problem-solving skills training involving manualised, group-therapy ses-
sions of interpersonal problem-solving skills training
Control: TAU involving assessment by mental health professional staff and by crisis staff,
and referral to acute mental health or community-based services, psychotherapy, and
pharmacotherapy as necessary
Therapist: 1 therapist and 1 co-therapist who received training in the delivery of problem-
solving skills training
Type of therapy offered: problem-solving group therapy
Length of treatment: 6 weeks
Outcomes Included: i) repetition of SH; ii) suicides; iii) suicidal ideation; iv) depression; v) hope-
lessness; vi) problem-solving; vii) compliance
Excluded: i) anxiety; ii) impulsiveness; iii) generalised self efficacy; iv) social life confiding/
emotions skills; v) social life practical support skills; vi) social life negative skills
Notes Source of funding: “This work was supported by funding from the Health Service Exec-
utive (HSE) South, HSE Mid-West, the HSE National Office for Suicide Prevention,
the Health Research Board and Pobal-Dormant Accounts Fund in Ireland” (p. 389)
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “[P]articipants were randomly as-
signed to treatment conditions on the basis
of a computer generated sequence of num-
bers” (p. 384)
Comment: Use of a computerised randomi-
sation sequence is likely to have minimised
the role of bias in the generation of the ran-
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domisation sequence
Allocation concealment (selection bias) Low risk Quote: “Allocation was concealed using
sealed opaque envelopes”
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: Correspondence with authors
confirmed that participants were not
blinded to treatment allocation
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: Correspondence with authors
confirmed that personnel were not blinded
to treatment allocation
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “ [R]esearchers [were] masked to
participant treatment allocation” (p. 384)
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: subsequent analyses appear to be
based on those participants with available
information at each follow-up period, sug-
gesting per protocol analyses were under-
taken
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
McLeavey 1994
Methods Allocation: randomisation using an open random number table
Follow-up period: 12 months
N lost to follow-up: 6/39 (15.4%) for repetition data
Participants Inclusion criteria: i) aged 15-45 years
Exclusion criteria: i) history of psychosis, mental retardation, or organic cognitive im-
pairment; ii) requiring psychiatric treatment (day care or inpatient)
Numbers: Of the 39 participants, 19 were allocated to the experimental arm and 20 to
the control arm
Profile: 29 (74%) were female, 14 (35.6%) were multiple repeaters, 9 (23%) were diag-
nosed with dysthymia, 6 (15%) had dependent personality disorder, and 5 (13%) had
alcohol abuse
Source of participants: patients admitted to an A&E department following an episode of
self-poisoning
Location: Cork, Republic of Ireland
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Interventions Experimental: interpersonal problem-solving skills training involving a manualised train-
ing regimen including instruction, active discussion, reflective listening, modelling, cop-
ing strategy, role playing, sentence completion, and prompting
Control: brief problem-solving therapy involving therapy focused on patients’ current
problems and prevention by helping patients gain insight into problems. No specific
skills training
Therapist: clinical psychologists and psychiatry registrars
Type of therapy offered: interpersonal problem-solving therapy
Length of treatment: 5 weeks
Outcomes Included: i) repetition of SH according to hospital records and a GP questionnaire; ii)
suicide; iii) compliance; iv) hopelessness; v) problem-solving; vi) number of problems
Excluded: i) self perception; ii) Optional Thinking Test; iii) awareness of consequences
Notes Sources of funding: no details on funding provided
Declaration of author interests: Although no details on author interests were provided, Dr
McLeavey was the developer of interpersonal problem-solving skills training
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “ [P]articipants were assigned on a
random basis to the two treatment groups
using an open random number table” (p.
384)
Comment: As the numbers table was open,
it is possible there may have been bias in
the generation of the random sequence
Allocation concealment (selection bias) High risk Comment: As an open numbers table was
used, it is possible there was bias in alloca-
tion
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “An independent assessor, blind
to the treatment conditions in which
the patients had participated, adminis-
tered both pretreatment and post-treat-
ment measures” (p. 385)
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Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: Of the 50 randomised partici-
pants, 5 dropped out of treatment before
completion and 6 were lost to follow-up.
Only the 39 participants that completed
the trial were included in all subsequent
analyses, however, suggesting that analyses
were per protocol
Selective reporting (reporting bias) High risk Comment: Numerical data on problem-
solving were not reported, suggesting that
selective reporting bias may have been
present
Other bias Low risk Comment: no other apparent sources of bias
McMain 2009
Methods Allocation: randomisation using pre-generated block procedure
Follow-up period: outcomes after 1 year of active treatment are reported in this review
N lost to follow-up: unclear
Participants Inclusion criteria: i) met DSM-IV criteria for borderline personality disorder;ii) 18-60
years old; iii) at least 2 episodes of suicidal or non-suicidal self injurious acts in the past
5 years with at least 1 in the 3 months proceeding enrolment
Exclusion criteria: i) meeting DSM-IV criteria for a psychotic disorder, bipolar I disorder,
delirium, dementia, or mental retardation; ii) diagnosed with substance dependence in
the preceding 30 days; iii) live outside of a 40-mile radius of Toronto; iv) have a serious
medical condition likely to require hospitalisation within the next year (e.g., cancer); v)
have plans to leave the province of Ontario within the next 2 years
Numbers: of the 180 participants, 90 were allocated to the experimental arm and 90 to
the control arm
Profile: 155 (86.1%) were female, 180 (100%) were multiple repeaters, 180 (100%) met
criteria for Borderline Personality Disorder, 135 (75%) had a current diagnosis of any
anxiety disorder, 17 (9.4)% had a current diagnosis of substance abuse, 88 (48.9%) had
a current diagnosis of major depression, 39 (21.7%) had a current diagnosis of panic
disorder, and 71 (37.4%) had a current diagnosis of PTSD
Source of participants: patients attending a specialised Centre for Addiction and Mental
Health, hospital or both
Location: Toronto, ON, Canada
Interventions Experimental: manualised dialectical behaviour therapy involving 1 h weekly sessions of
individual therapy, 2 h weekly sessions of skills group training, and 2 h weekly of tele-
phone-based coaching aimed at providing psycho-education about borderline person-
ality disorder, improving personal relationships, and providing validation and empathy,
within a ’here and now’ focus on the prevention of self-harm and suicidal behaviour.
Additionally, therapists’ attended weekly therapist team meetings
Control: general psychiatric management involving 1 h weekly sessions of individual
therapy focused on improving medication management through the use of a structured
179Psychosocial interventions for self-harm in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
McMain 2009 (Continued)
drug algorithm. Participants also received psycho-education about borderline personality
disorder, improvingpersonal relationships, andproviding validation and empathy,within
a ’here and now’ focus. Additionally, therapists’ attended weekly therapist teammeetings
Therapists: 7 doctoral-level clinicians and 1 board-certified psychiatrist
Type of therapy offered: dialectical behaviour therapy
Length of treatment: 12 months
Outcomes Included: i) repetition of SH; ii) suicide; iii) depression; iv) number completing full 1
year course of treatment
Excluded: i) repetition of NSSI
Notes Sources of funding: “Supported by grant 200204MCT-101123 from the Canadian Insti-
tutes for Health Research” (p. 1373)
Declaration of author interests: “Dr. Links has received an unrestricted educational grant
from Eli Lilly Canada Inc. All other authors report no competing interests” (p. 1373)
Other: data on hospital admissions for self-harm obtained from self report following
clinician interview
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Eligible participants were ran-
domly assigned to treatment arms using a
pre-generated block randomization scheme
developed and held by the statistician” (p.
1366)
Comment: Use of a pre-generated block ran-
domisation sequence is likely to have min-
imised the role of bias in the generation of
the randomisation sequence
Allocation concealment (selection bias) Low risk Quote: “[T]he statistician, who prepared
45 sealed envelopes, each containing the
group allocations in random order for four
participants” (p. 1366)
Comment: although no details on whether
the envelopes were opaque is not provided,
it is likely they were thereby ensuring ade-
quate allocation concealment
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: As this was a single blind trial,
participants were aware of the treatment
group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “The study coordinator… was not
blind to treatment assignment” (p. 1366)
Comment: As this was a single blind trial,
all personnel, not just the trial coordinator,
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are likely to have known which participant
was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Assessors . . . were . . . blind to treat-
ment assignment” (p. 1366). Additionally,
“Assessors were polled after the treatment
phase to ascertain whether they could cor-
rectly guess participants’ treatment assign-
ment; they did not know treatment assign-
ment for 86% of the cases, suggesting that
blinding was largely maintained” (p. 1366)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All results were analysed using an
intent-to-treat analysis (n = 180). We also
conducted a per-protocol analysis based on
’treated’ participants, defined as those who
were in treatment for at least 8 weeks from
initial session to last session. This included
a total of 167 patients (dialectical behavior
therapy, n = 85; general psychiatric man-
agement, n = 82)” (p. 1370)
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Morgan 1993
Methods Allocation: randomisation using a supply of sealed envelopes, half of which contained an
emergency green card
Follow-up period: 12 months
N lost to follow-up: 0/212 (0%) for repetition data
Participants Inclusion criteria: i) no previous episode of SH; ii) resident within healthcare trust catch-
ment area
Exclusion criteria: none stated
Numbers: of the 212 participants, 101 were allocated to the experimental arm and 111
to the control arm
Profile: 25% (n = 53) were diagnosed with any depressive disorder, 100% (n = 212) were
non-repeaters
Source of participants: patients admitted to hospital following first episode of SH
Location: Bristol, UK
Interventions Experimental: emergency green card in addition to TAU. The green card outlined that a
doctor was available by telephone and how to contact them
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Control: TAU involving referral to the primary healthcare team, and psychiatric or inpa-
tient admissions if required
Therapist: telephone contact, face-to-face interviews, or both conducted by a doctor on-
call
Type of therapy offered: emergency green card
Length of treatment: 12 months
Outcomes Included: i) repetition of SH according to hospital, psychiatric, and GP records
Excluded: i) use of the green card; ii) admission to psychiatric hospital; iii) use of psychi-
atric services
Notes Source of funding: no details on funding were provided
Declaration of author interests: no details on author interests provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Allocation to experimental or con-
trol group was carried out by random se-
lection from a supply of closed envelopes,
half of which contained the green card” (p.
111)
Comment: Randomisation using sealed en-
velopes is likely to have minimised the role
of bias in the generation of the randomisa-
tion sequence
Allocation concealment (selection bias) Low risk Quote: “closed envelopes” (p. 111)
Comment: Although authors provide node-
tails onwhether the envelopeswere opaque,
it is likely they were, thereby ensuring ade-
quate allocation concealment
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “[Patients] receive[ed] the green
card” (p. 111)
Comment: suggests participants would have
known to which treatment arm they had
been allocated
Blinding (performance bias and detection
bias)
Of personnel
Unclear risk Quote: “GPs were also sent copies of the
green card” (p. 111)
Comment: It is unclear if they knew which
of their patients received the intervention
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: no details on outcome assessor
blinding provided
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Data concerning outcomewere ob-
tained for all patients included in the study”
(p. 111)
Comment: Subsequent analyses include all
those randomised to the experimental and
control groups, suggesting intention-to-
treat analyses were undertaken
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Morthorst 2012
Methods Allocation: randomisation using computer-based software and stratified by: i) history
of suicide attempts; ii) history of psychiatric treatment or hospitalisation; iii) alcohol
consumption at the time of the index suicide attempt
Follow-up period: 12 months
N lost to follow-up: 0/243 for primary outcomes (suicide reattempts, suicide). 74/243
(30.4%) for secondary outcomes (depression, compliance)
Participants Inclusion criteria: i) 12 years or older; ii) admitted to acute emergency units, intensive care
units, paediatric units, or psychiatric emergency room units following a suicide attempt
Exclusion criteria: i) living in an institution; ii) admitted to a psychiatric unit for more
than 14 days; iii) diagnosed with a schizophrenia-spectrum disorder; iv) diagnosed with
severe depression, bipolar disorder, or dementia; v) currently receiving outreach services
from social service agencies
Numbers: Of the 243 participants, 123 were allocated to the intervention arm and 120
to the control arm
Profile: 75.7% (n = 184) were female; 53.5% (n = 130) were multiple repeaters
Source of participants: patients admitted to acute emergency units, intensive care units,
paediatric units, or psychiatric emergency room units following a suicide attempt
Location: Copenhagen, Denmark
Interventions Experimental: assertive intervention involving case management, crisis intervention as
required, problem-solving therapy, and assertive outreach based on motivational support
to encourage patients to attend treatment sessions, assist patients to attend these sessions,
and to improve adherence to after-treatment in addition to TAU
Control: TAU involving referral to a range of different treatments depending on diag-
nosis, clinical, and social needs. Treatment included a psychiatric assessment and may
also incorporate substance abuse treatment, psychological therapy, and GP referral as
required. Pharmacological treatment was also provided where necessary
Therapist: psychiatric nurses who had received training in suicidology
Type of therapy offered: assertive outreach
Length of treatment: 6 months
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Outcomes Included: i) suicide reattempts; ii) suicide; iii) depression; iv) compliance
Excluded: none
Notes Sources of funding: “This study received funding from theMinistry of Health and Internal
Affairs, Denmark, the National Board of Social Services, and independent subdivision of
TheMinistry of Social Affairs and Integration, TrygFoden, and Aase og Ejnar Danielsens
Foundation” (p. 6)
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Computer randomisation was
done . . . stratified by whether the patient
had previously attempted suicide (first at-
tempt v previous attempt), previous psy-
chiatric contacts or hospitalisations (none v
previous contacts), and alcohol consump-
tion at the time of suicide attempt (none v
alcohol consumption . . . The randomisa-
tion procedure ensured adequate sequence
generation . . . ” (p. 3)
Comment: Use of a computer-based ran-
domisation procedure is likely to havemin-
imised the role of bias in the generation of
the randomisation sequence
Allocation concealment (selection bias) Low risk Quote: “Computer randomisation was
done by an independent research assistant
. . . The randomisation procedure ensured
adequate . . . allocation concealment” (p.
3)
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “[P]articipants were immediately
informed of the outcome [i.e., allocation]”
(p. 3)
Comment: suggests participants were not
blind as to treatment allocation
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “Owing to the nature of the study
design, the intervention staff were not
blinded” (p. 3)
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Quote: “An external medical evaluation
committee conducted a blinded outcome
assessment using medical records” (p. 3).
However, authors later state that: “The re-
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searcher conducting the analyses on self-re-
ported outcomes was . . . not blinded.” (p.
3)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All participants were included in
the analysis regardless of subsequent adher-
ence to treatment, according to the inten-
tion to treat principle” (p. 3)
Selective reporting (reporting bias) Unclear risk Comment: No reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Patsiokas 1985
Methods Allocation: random allocation
Follow-up period: 3 weeks
N lost to follow-up: no details provided
Participants Inclusion criteria: i) admitted to a psychiatric ward following a suicide attempt
Exclusion criteria: ii) diagnosed with psychosis; ii) diagnosed with substance abuse
Numbers: Of the 15 participants, 10 were allocated to the experimental arms (5 to the
cognitive restructuring arm and 5 to the problem-solving arm), and 5 were allocated to
the control arm
Profile: no details provided
Source of participants: patients admitted to a psychiatric ward following a suicide attempt
Location: Charleston, SC, USA
Interventions Experimental: 10 one-hour sessions of cognitive restructuring with a focus on suicidal
ideation or problem-solving
Control: non-directive therapy involving opendiscussions about suicidal behaviour, prob-
lems, and daily life
Therapist: The same therapist conducted therapy sessions for all 3 arms
Type of therapy offered: i) cognitive therapy; ii) problem-solving therapy
Length of treatment: 3 weeks
Outcomes Included: i) repetition of SH according to an unknown source; ii) suicidal ideation
(measured in 2 ways); iii) hopelessness; iv) problem-solving; v) problem-solving skills
Excluded: i) flexibility of thinking
Notes Sources of funding: no details provided
Declaration of author interests: none stated
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Subjects were randomly assigned”
(p. 282).
Comment: Although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment provided
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: As the same therapist provided
therapy for all 3 arms, personnel would
have known which participant was receiv-
ing which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: no details on outcome assessor
blinding provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: no details provided on whether
intention-to-treat analyses were conducted
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Priebe 2012
Methods Allocation: randomisation using a computer-generated algorithm
Follow-up period: 12 months
N lost to follow-up: 10/80 (12.5%) by the 12-month follow-up period
Participants Inclusion criteria: i) aged 16 years or older; ii) engaged in SH on 5 or more days in the
year prior to randomisation; iii) diagnosed with at least 1 personality disorder
Exclusion criteria: i) diagnosed with a severe learning disability that would interfere with
the ability to benefit from DBT; ii) unable to read or write in English
Numbers: Of the 80 participants, 40 were allocated to the intervention arm and 40 to
the control arm
Profile: 87.5% (n = 70) were female
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Source of participants: referrals to a specialist DBT service
Location: London, UK
Interventions Experimental: dialectical behaviour therapy delivered according to Linehan (i.e., Linehan
1993b) involving both individual and group-based cognitive behavioural therapy, mind-
fulness, validation, supportive therapeutic techniques, and skills training. Out-of-hours
telephone skills training was also available as required
Control: TAU involving referral back to the referee agency where the participant was
encouraged to engage with any treatment other than DBT, including psychotherapy,
referral to psychiatrists, mental health teams, counsellors, GPs, or other user-run support
services
Therapist: no details on qualifications or clinical experience reported
Type of therapy offered: dialectical behaviour therapy
Length of treatment: 12 months
Outcomes Included: i) repetition of SH; ii) suicide; iii) compliance.
Excluded: i) days with SH; ii) borderline personality disorder symptom severity; iii)
psychiatric disorder symptom severity; iv) quality of life
Notes Sources of funding: “This paper . . . [was] funded by the National Institute for Health
Research (NIHR) under its Research for Patient Benefit Programme (grant reference No.
PB-PG-0906-10540). All authors were funded by this grant with the exception of K.B.
whose contribution was funded by the NIHR Doctoral Research Fellowship Scheme”
(p. 364).
Declaration of author interests: no author interests provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomisation was computer gen-
erated with a 1:1 allocation . . . using 6
blocks of 12 randomly permuted treatment
allocation sequences, with a final block of
8.” (p. 358)
Comment: Use of a computerised randomi-
sation sequence is likely to have minimised
the role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment provided
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
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Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “[T]he data analyst remained
masked throughout the study period” (p.
358)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote:“[M]issing covariate values were . . .
[estimated using] maximum likelihood es-
timation [to] ensure . . . unbiased parameter
estimates. We . . . [also] conducted a sensi-
tivity analysis with last observation carried
forward.” (p. 358)
Selective reporting (reporting bias) Unclear risk Comment: We had to obtain data on rep-
etition of SH and suicides from authors,
suggesting that selective reporting bias may
have been present
Other bias Low risk Comment: no other apparent sources of bias
Salkovskis 1990
Methods Allocation: predetermined random allocation using sampling without replacement and
sealed envelopes
Follow-up period: 12 months
N lost to follow-up: 0/20 (0%) for repetition data
Participants Inclusion criteria: i) aged 16-65 years; ii) of fixed abode and livingwithinHealth Authority
boundary; iii) antidepressants were taken as part of the self-poisoning episode; iv) a
history of 2 or more previous suicide attempts; v) Buglass and Horton Risk of Repetition
Scale score of at least 4. Participants had to fulfil at least 2 criteria to be included
Exclusion criteria: i) not requiring immediate psychiatric treatment; ii) diagnosed with
psychosis; iii) diagnosed with a serious organic illness
Numbers: of the 20 participants, 12 were allocated to the experimental arm and 8 to the
control arm
Profile: 10 (50%) were female, 20 (100%) were multiple repeaters with a high risk of
further repetition
Source of participants: patients referred by the duty psychiatrist following an episode of
self-poisoning using antidepressant and assessed in an A&E department
Setting: Leeds, UK
Interventions Experimental: 5 one-hour sessions of domiciliary (home-based) cognitive-behavioural
problem-solving treatment
Control: TAU
Therapist: community psychiatric nurse
Type of therapy offered: problem-solving therapy
188Psychosocial interventions for self-harm in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Salkovskis 1990 (Continued)
Length of treatment: 1 month
Outcomes Included: i) repetition of SHaccording tohospital records; ii) depression; iii) hopelessness;
iv) suicide; v) suicidal ideation (measured in 2 ways); vi) severity of 3 main problems;
vii) problem-solving
Excluded: i) mood
Notes Sources of funding: no details provided
Declaration of author interests: no details provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Predetermined random allocation”
(p. 872)
Comment: Correspondence with authors
clarified that the method used was “sam-
pling without replacement using en-
velopes”
Allocation concealment (selection bias) Low risk Comment: Correspondence with authors
clarified that sealed envelopes were used to
conceal allocation. Use of sealed envelopes
would ensure adequate allocation conceal-
ment
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: Although it is possible that out-
come assessors could have rated data on
repetition of self-poisoning from hospital
records blind, other assessments were gath-
ered by the same psychiatric nurse who de-
livered the intervention
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “There were no treatment drop
outs” (p. 872)
Selective reporting (reporting bias) Unclear risk Comment: We had to request data on sui-
cides from authors, suggesting that selec-
tive reporting bias may have been present
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Other bias Low risk Comment: no other apparent sources of bias
Slee 2008
Methods Allocation: randomisation by computer and random number generator
Follow-up period: 3 months, 6 months and 9 months
N lost to follow-up: 8/90 (21%) for repetition of SH data
Participants Inclusion criteria: i) recently engaged in self-harm; ii) aged 15-35; iii) Dutch-speaking;
iv) live in the Leiden region
Exclusion criteria: i) diagnosed with a psychiatric disorder requiring intensive inpatient
treatment; ii) diagnosed with a cognitive impairment
Numbers: Of the 90 participants, 48 were allocated to the experimental arm and 42 to
the control arm
Profile: Of the 82 participants who received the intervention, 77 (93.9%) were female
Source of participants: patients presenting to hospital/mental health centre following an
episode of self-harm
Setting: Leiden, the Netherlands
Interventions Experimental: 12 sessions of CBT in addition to TAU
Control: TAU involving psychotropic medication, psychotherapy, or hospitalisation as
required
Therapist: experienced CBT practitioners
Type of therapy offered: cognitive-behavioural therapy
Length of treatment: 5.5 months
Outcomes Included: i) repetition of SH from self report; ii) suicide; iii) depression; iv) compliance;
iv) problem-solving
Excluded: i) anxiety; ii) self esteem; iii) suicidal cognition; iv) use of psychological and
psychiatric services
Notes Sources of funding: “Support for the study was provided by TheNetherlandsOrganisation
for Health Research and Development (AonMw) (contract grant number: 2100.0068)
” (p. 210).
Declaration of author interests: none stated
Other: Repetition data provided by participants was subjected to reliability analysis by
comparing self reports to hospital records and information from treatment sessions
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomisation to treatment was
accomplished using a computer program
and a random-number generator provided
by an independent investigator” (p. 203)
Comment: use of a random-number gener-
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ator is likely to have minimised the role of
bias in the generation of the randomisation
sequence
Allocation concealment (selection bias) Low risk Comment: Correspondence with authors
clarified that computerised, central alloca-
tion had been used to conceal allocation
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “Masking of follow up assessments
was not possible because participants were
asked about their use of healthcare services
at each assessment” (p. 203)
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “Masking of follow up assessments
was not possible because participants were
asked about their use of healthcare services
at each assessment” (p. 203)
Comment: As personnel were required to
question participants about their use of
healthcare services, this would suggest that
personnel would have known which partic-
ipant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
High risk Comment: all measures were self reports.
Participants were not blinded at follow-up
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: of the 90 participants ran-
domised, 8 did not receive their allocated
intervention and 9 were lost to follow-up.
Analyses are conducted both including and
excluding these participants, suggesting a
combinationof per protocol and intention-
to-treat analyses (using the LOCFmethod)
Selective reporting (reporting bias) Unclear risk Comment: We had to request data on sui-
cides from authors, suggesting that selec-
tive reporting bias may have been present
Other bias Low risk Comment: no other apparent sources of bias
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Methods Allocation: randomisation using the method of drawing names from a hat
Follow-up period: 2 months
N lost to follow-up: unknown as no apparent attempt was made to follow-up patients
who did not complete treatment
Participants Inclusion criteria: i) suicide attempt with self reported suicide intent; ii) admitted to 1 of
the 2 participating hospitals
Exclusion criteria: i) diagnosed with an intellectual disability; ii) current diagnosis of
mania, psychosis, or both; iii) under 18 years. Correspondence with authors further
clarified that 1 participant was subsequently excluded after randomisation due to being
a frequent repeater of SH, possibly due to borderline personality disorder
Numbers: Of the 32 participants, 11 were allocated to the CBT arm, 12 were allocated
to the PST arm, and 9 were allocated to the control arm
Profile: 53.1% (n = 17) were female
Source of participants: patients admitted to 1 of 2 participating hospitals following a
suicide attempt
Location: Brisbane (QLD), Australia
Interventions Experimental: 4 weekly individual sessions of cognitive-behavioural therapy or 7 weekly
individual sessions of problem-solving therapy. Cognitive-behavioural therapy was of-
fered as a manualised treatment involving elements of both Beck’s cognitive behaviour
therapy and Ellis’ theory of rational emotive therapy (Ellis 1986; Ellis 1996). Problem-
solving therapy was also manualised and was based on the 6-step model of D’Zurilla
1971
Control: TAU involving treatment by the hospital acute care team
Therapist: treatment was provided by “the researcher” (p. 542). No further details on
qualifications, training, or experience provided
Type of therapy offered: i) cognitive-behavioural therapy; ii) problem-solving therapy
Length of treatment: 2 months
Outcomes Included: i) suicide reattempts; ii) suicides; iii) suicidal ideation; iv) hopelessness; v)
problem-solving; vi) compliance
Excluded: i) satisfaction with treatment
Notes Sources of funding: no details provided
Declaration of author interests: no details provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: Correspondence with authors
clarified that “[n]ames of treatment groups
were drawn from a container and partici-
pants were allocated to a treatment group.
”
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment were provided
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Blinding (performance bias and detection
bias)
Of participants
High risk Comment: correspondence with authors
clarified that the “treatment condition was
offered to the client via a phone call”, sug-
gesting that participantswould have known
to which treatment arm they had been al-
located
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: Correspondence with authors
clarified that the therapist running the re-
search was aware of which treatment con-
dition the participant was being offered
Blinding (performance bias and detection
bias)
Of outcome assessors
High risk Comment: Correspondence with authors
clarified that the “therapist collected out-
come data via self-report measures and
chart audits.” Neither participants nor per-
sonnel were blinded as to which treatment
arm participants had been allocated
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: Correspondence with authors
clarified that 10 participants dropped out
of the TAU arm, 12 dropped out of the
CBT arm, and 11 dropped out of the PST
arm. It would appear that data were only
collected on patients who completed treat-
ment and that no intention-to-treat analy-
ses were attempted
Selective reporting (reporting bias) Unclear risk Comment: We had to obtain data on sui-
cidal ideation, hopelessness, problem-solv-
ing (for TAU arm), repetition of suicide at-
tempts (for TAU and PST arms), and sui-
cides (for TAU, CBT, and PST arms) fol-
lowing correspondence with authors, sug-
gesting that selective reporting bias may
have been present
Other bias Low risk Comment: no other apparent sources of bias
Tapolaa 2010
Methods Allocation: randomisation using a coin toss
Follow-up period: 4 and 6 months
N lost to follow-up: 3/16 (18.7%) for incidence of SH during the 6-month follow-up
period
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Participants Inclusion criteria: i) aged 18-65 years; ii) able to communicate effectively in Finnish,
including reading and writing; iii) living within the hospital catchment area
Exclusion criteria: none stated
Numbers: Of the 16 participants, 9 were allocated to the experimental arm and 7 were
allocated to the control arm
Profile: 100% (n = 16) were female
Source of participants: admissions to an emergency department following a episode of SH
Location: Jyväskylä, Finland
Interventions Experimental: acceptance commitment therapy and solution-focused brief therapy in-
volving meditation, identification of problems, strategies to solve these problems, re-
flection on alternative methods of problem-solving, providing motivation to solve these
problems, frustration tolerance exercises, and identity assimilation exercises
Control: Correspondence with authors clarified that TAU involved psychiatric outpatient
treatment in the form of supportive sessions with a mental health nurse in addition to
pharmacological treatment as required
Therapist: advanced level psychology students who received 36 h of training in acceptance
and commitment therapy and solution-focused brief therapy
Type of therapy offered: brief psychological therapy
Length of treatment: 4 weeks
Outcomes Included: i) repetition of SH; ii) suicide; iii) depression
Excluded: i) anxiety; ii) health-related quality of life; iii) action and acceptance; iv) diffi-
culties in emotion regulation
Notes Source of funding: no details provided
Declaration of author interests: no details provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: Correspondence with authors
clarified that randomisationwaswith a sim-
ple coin toss
Allocation concealment (selection bias) Unclear risk Comment: no details provided
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
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Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Quote: “The assessor was not blind to
conditions; however, all outcome measures
were self-reported, and there was limited
interaction between participants and the
assessor.” (p. 97)
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: participants who did not receive
treatment appear to have been excluded
from all subsequent analyses, suggesting
that investigators undertook per protocol
analyses
Selective reporting (reporting bias) Unclear risk Comment: We had to request data on rep-
etition of SH and suicides from authors,
suggesting that selective reporting bias may
have been present
Other bias Low risk Comment: no other apparent sources of bias
Torhorst 1987
Methods Allocation: randomisation using an unknown method
Follow-up period: 12 months
N lost to follow-up: 11/141 (5.7%) for repetition of SH data
Participants Inclusion criteria: i) admitted to the toxicology department of a hospital following a
suicide attempt by acute intoxication
Exclusion criteria: i) diagnosed with psychosis
Numbers: Of the 141 participants, 68 were allocated to the experimental arm and 73 to
the control arm
Profile: 63.1% (n = 89) were female, 48.2% (n = 68) were multiple repeaters, 100% (n
= 141) had engaged in self-poisoning
Source of participants: patients hospitalised following a suicide attempt
Location: Munich, Germany
Interventions Experimental: short crisis intervention during hospital stay followed by a fixed outpatient
appointment with the same therapist. Treatment involved a motivational interview, as
well as a letter and assessment of motivation towards therapy
Control: short crisis intervention during hospital stay followed by a fixed outpatient
appointment with a different therapist. Treatment involved a motivational interview, as
well as a letter and assessment of motivation towards therapy
Therapist: 3 therapists trained in psychotherapy and 1 therapist trained in behaviour
therapy
Type of therapy offered: compliance enhancement plus therapy delivered by the same
therapist as in hospital
Length of treatment: 3 months
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Outcomes Included: i) repetition of SH according to self report; ii) suicide; iii) compliance; iv)
depression
Excluded: none
Notes Sources of funding: no details provided
Declaration of author interests: no details provided
Other: in the first phase of this trial, the efficacy of standard care was assessed in terms of
compliance. 85 participants were not randomly assigned to this group but were instead
“referred routinely” (p. 53)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Patientswere randomly offered [in-
tervention or control treatment]” (p.54)
Comment: Although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment provided
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
High risk Comment: no details on outcome asses-
sor blinding provided. However, most out-
come measures, with the exception of data
on suicides, were self reported. Given the
nature of this trial, participants could have
known to which group they had been allo-
cated
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: 11 participants were lost to fol-
low-up. A greater number of participants in
the control arm (n = 7) dropped out com-
pared to number in the experimental arm
(n = 4). No details on whether intention-
to-treat analyses were conducted was pro-
vided
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Torhorst 1987 (Continued)
Selective reporting (reporting bias) Unclear risk Comment: No reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias High risk Quote: “There is some evidence that pa-
tients of the experimental group . . . had
more risk factors for further suicidal behav-
ior than did patients of the control group
. . . despite randomization. In the exper-
imental group there were more older pa-
tients . . . more men . . . more divorced per-
sons . . . and more had been hospitalised in
psychiatry in the past . . . Also, there were
more parasuicides in the 12 months before
index parasuicide . . . Most differences did
not reach statistical significance; neverthe-
less, they can indicate some unequal dis-
tribution of risk factors between treatment
groups” (p. 56)
Torhorst 1988
Methods Allocation: randomisation using an unknown method
Follow-up period: 12 months
N lost to follow-up: 0/80 (0%) for repetition of SH data
Participants Inclusion criteria: i) able to understand German; ii) living within travelling distance of
research centre; iii) previous episodes of SH
Exclusion criteria: i) diagnosed with endogenous psychosis; ii) already in psychothera-
peutic treatment; iii) already in inpatient psychiatric treatment; iv) overdose involved
use of illicit drugs
Numbers: Of the 80 participants, 40 were allocated to the experimental arm and 40 to
the control arm
Profile: 100% (n = 80) were multiple repeaters
Source of participants: patients who were hospitalised following an episode of deliberate
self-poisoning and who were referred to the liaison service of toxicological ward
Location: Munich, Germany
Interventions Experimental: long-term therapy involving 1 therapy session per month over a period of
12 months in addition to a brief crisis intervention delivered 3 days after admission
Control: short-term therapy involving 12 weekly therapy sessions over a period of 3
months in addition to a brief crisis intervention delivered 3 days after admission
Therapist: 3 psychiatric attendants.
Type of therapy offered: no further details on the content of therapy sessions provided
Length of treatment: for the experimental arm, 12 months; for the control arm, 3 months
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Outcomes Included: i) repetition of SH according to an unknown source; ii) compliance; iii) de-
pression
Excluded: i) complaints; ii) psychopathology
Notes Sources of funding: “Supported by a grant from the FRG Ministry for Research and
Technology” (p. 419)
Declaration of author interests: no details provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Randomly assigned” (p. 419)
Comment: Although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment were provided.
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: no details on outcome assessor
blinding provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: Of the 80 participants, data on
50-67% were available at 3 months, and
data on 97.5%were available at 12months.
Self and experts’ ratings data from personal
follow-up were available for 85% of par-
ticipants. No details provided on whether
intention-to-treat analyses were conducted
Selective reporting (reporting bias) High risk Comment: numerical data on depression
scores not reported, suggesting that selec-
tive reporting bias may have been present
Other bias Low risk Comment: no other apparent sources of bias
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Turner 2000
Methods Allocation: randomised using an unknown method
Follow-up period: 12 months
N lost to follow-up: 0/24 (0%) for repetition of SH at the 6- and 12-month follow-up
assessments
Participants Inclusion criteria: i) diagnosed with borderline personality disorder according to both the
Diagnostic Interview for Borderlines and the Personality Disorders Examination criteria
; ii) admitted to hospital following a suicide attempt; iii) able to provide written informed
consent; iv) consent to randomised assignment
Exclusion criteria: i) diagnosed with schizophrenia, schizoaffective disorder, bipolar dis-
order, organic mental disorder, mental retardation
Numbers: Of the 24 participants, 12 were allocated to the intervention arm and 12 were
allocated to the control arm
Profile: 79.2% (n = 19) were female, 95.8% (n = 23) met criteria for a comorbid Axis
I disorder, including: dysthymia with a comorbid generalised anxiety disorder (n = 17)
, major depression (n = 3), and dysthymia (n = 3). 95.8% (n = 23) met criteria for a
comorbid Axis II disorder, including: dependent personality disorder (n = 9), histrionic
personality disorder (n = 6), narcissistic personality disorder (n = 6), schizotypal per-
sonality disorder (n = 3), antisocial personality disorder (n = 2), paranoid personality
disorder (n = 2), and compulsive personality disorder (n = 1). 75.0% (n = 18) had alcohol
misuse, 83.3% (n = 20) had substance misuse
Source of participants: patients admitted to hospital following a suicide attempt
Location: Philadelphia, PA, USA
Interventions Experimental: dialectical behaviour therapy involving elements of Linehan’s manualised
DBT protocol (see Linehan 1993a) but modified to include: i) psychodynamic tech-
niques to conceptualise patients’ behavioural, emotional, and relationship schema. Addi-
tionally, no group skills training sessions were provided. Instead, skills training occurred
during individual therapy. The 6 sessions intended to be used as group skills training
sessions were instead used for interpersonal skills training focusing on the identification
of significant persons in the participants’ environment, including problems in relation-
ships, with family, etc
Control: client-centred therapy based on Carkhuff ’s model involving emphatic under-
standing of the patients’ sense of aloneness and the provision of a supportive atmosphere
to enable individuation (Carkhuff 1969; Carkhoff 1976). Carkhuff ’s manual provides
directions for increasing the therapeutic relationship through emphatic and supportive
elements. The primary focus of treatment was to provide support to enable participants
to deal with everyday stress and prevent relapse. Participants also received 6 sessions of
interpersonal skills training focusing on the identification of significant persons in the
participants’ environment, including problems in relationships, with family, etc. Treat-
ment also included the creation and signing of a contract by the therapist and patient
stipulating that the patient would not engage in SH or make a suicide attempt during
the 12-month treatment period
Therapist: 4 therapists with an average of 22 years’ clinical experience in family systems,
client-centred, and psychodynamic treatment therapies. All therapists also received 12
sessions of training in dialectical behaviour therapy delivered over a 3-month period
prior to randomisation
Type of therapy offered: dialectical behavioural therapy
Length of treatment: 12 months
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Turner 2000 (Continued)
Outcomes Included: i) suicide reattempts according to self report; ii) suicides; iii) suicidal ideation
according to self report; iv) depression according to self report
Excluded: i) impulsiveness; ii) anger; iii) anxiety; iv) psychiatric symptomatology; v) days
in hospital
Notes Sources of funding: no details provided
Declaration of author interests: no details provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants [were] randomly as-
signed . . . ” (p. 414).
Comment: the authors further note that “To
determine if the random assignment pro-
cedure worked, we examined the pretreat-
ment values of the dependent variables for
each . . . outcome . . . there were no signif-
icant differences between the groups” (pp.
416-417), suggesting that the random se-
quence generation was unbiased
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment provided
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “The independent assessor was un-
aware of the patients’ treatment condition
. . . ” (p. 415)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All 24 patients participated in the
6 month and 12 month assessments and
composed the intention-to-treat sample for
the analyses” (p. 414)
Comment: no additional details provided
on the method used to perform intention-
to-treat analyses
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Turner 2000 (Continued)
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Tyrer 2003
Methods Allocation: central independent telephone randomisation system using a computer allo-
cation sequence composed of randomly permuted blocks of sizes 2, 4, and 6 in a non-
systematic sequence. Randomisation stratified by hospital and parasuicide risk
Follow-up period: 12 months
N lost to follow-up: 50/480 (10%) for repetition of SH data
Participants Inclusion criteria: i) aged 16-65 years; ii) previous history of SH; iii) able to provide
informed consent; iv) sufficient English to provide informed consent; v) live in the
catchment area; vi) likely to be available for follow-up
Exclusion criteria: ii) have an ICD-10 diagnosis within the organic, alcohol and drug
dependence, schizophrenia or bipolar affective disorder group of codes; viii) psychiatric
hospitalisation required
Numbers: Of the 480 participants, 239 were allocated to the experimental arm and 241
to the control arm
Profile: 67.9% (n = 326) were female, 42.1% (n = 202) were diagnosed with a personality
disorder
Source of participants: patients presenting to hospital following an episode of SH
Location: Glasgow, Edinburgh, Nottingham, West London, and South London, UK
Interventions Experimental: manual-assisted cognitive-behavioural therapy involving an evaluation of
the most recent suicide attempt, crisis skills problem-solving therapy, cognitive tech-
niques for emotional, and negative thinking management, and the development of re-
lapse prevention strategies
Control: TAU involving psychiatric assessment, outpatient care, occasional day-patient
care, referral to GP, or a combination of these
Therapist: therapists from the existing services
Type of therapy offered: cognitive-behavioural therapy
Length of treatment: 3 to 6 months
Outcomes Included: i) repetition of SH according to self report and verified by GP notes, hospital
records, or both; ii) suicide; iii) depression
Excluded: i) anxiety; ii) social functioning; iii) quality of life; iv) global functioning; v)
future thinking
Notes Sources of funding: “The POPMACT study is funded by the Medical Research Council
of the United Kingdom” (p. 67)
Declaration of author interests: no details provided
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “After initial research assessments,
participants were randomised to either
MACT or TAU using a central indepen-
dent telephone randomising system so that
patients could be allocated to treatment
immediately . . . Stata software was used
to generate allocation using randomly per-
muted blocks of sizes two, four and six in a
non-systematic sequence. Random alloca-
tion was stratified by participating hospi-
tal and parasuicide risk status (high versus
low)” (p. 60)
Comment: Use of a computerised randomi-
sation sequence is likely to have minimised
the role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) Low risk Quote: “After initial research assessments,
participants were randomised to either
MACT or TAU using a central indepen-
dent telephone randomising system . . . ”
(p. 60)
Comment: Use of central allocation means
that allocation was probably concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: no details on outcome assessor
blinding provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: of the 480 participants ran-
domised, we could not obtain 12-month
data for 78 (16.2%) for the following rea-
sons: i) could not be traced (n = 27); ii)
refused follow-up assessment (n = 19); iii)
did not attend follow-up assessment (n =
9); iv) died (n = 8); v) withdrew (n = 4);
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vi) other reasons (n = 11). No details pro-
vided on whether intention-to-treat analy-
ses were conducted
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Vaiva 2006
Methods Allocation: randomisation using a computer-generated list of pseudo-random numbers
in opaque sealed envelopes
Follow-up period: 13 months
N lost to follow-up: 0/605 (0%) for suicide reattempts data
Participants Inclusion criteria: i) aged 18-65 years; ii) hospitalised following a suicide attempt by drug
overdose; iii) examined by a psychiatrist who agreed to patients’ discharge; iv) able to
provide name of GP; v) able to be be contacted by phone; vi) able to provide written
consent
Exclusion criteria: i) homeless; ii) addicted to illicit drugs
Numbers: of the 605 participants, 293 were allocated to the experimental arm and 312
to the control arm
Profile: 72.9% (n = 441) were female, 9% (n = 54) had history of more than 4 suicide
attempts in the past 3 years, 49% (n = 296) had experienced a stressful life event in past
6 months
Source of participants: patients presenting to hospital following a drug overdose
Setting: Lille, France
Interventions Experimental: telephone contact involving a review of the emergency department rec-
ommended treatment in addition to TAU. Where participants found the the treatment
recommended during their hospitalisation too difficult to follow, a new regimen was
suggested. For those at high risk of suicide, an urgent appointment was made at the
emergency department where the patient initially received treatment. No therapy other
than support was provided
Control: TAU typically involving referral to the participants’ GP.
Therapist: psychiatrists with at least 5 years of experience in managing suicidal crises
Type of therapy offered: supportive therapy by telephone
Length of treatment: 1 telephone call at 1 or 3 months postdischarge
Outcomes Included: i) suicide reattempts according to both self report and hospital records; ii)
suicide
Excluded: none
Notes Sources of funding: “This studywas funded by a hospital clinical research grant (PHRC98)
, a state region contract plan, a subsidy from the regional hospitalization agency” (p.
1245)
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Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomised . . . on
the basis of a computer generated list of
pseudo-random numbers. We used two
strata for the randomisation process: one
for patients who had attempted fewer than
four suicides in the past three years and one
for those who had attempted more than
four suicides in the past three years. For
each stratum the patients were assigned by
random allocation” (pp. 1241-1242)
Comment: use of a computerised randomi-
sation sequence is likely to have minimised
the role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) Low risk Quote: “ [P]atientswere allocated to a group
according to the number in an opaque,
sealed envelope. The allocation sequence
was provided by a statistician uninvolved in
the assessment of patients” (p. 1241). Study
authors further note that “The allocation
list was stored in tamper proof envelopes in
a locked cabinet, accessible only to autho-
rised staff ” (p. 1242)
Comment: Use of sealed, tamper-proof en-
velopes stored in a locked cabinet would
ensure adequate allocation concealment
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “A specially trained research psy-
chologist, blind to allocation group, as-
sessed the outcome by telephone” (p. 1242)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “At the end of the 13 month fol-
low-up period we assessed all the included
participants, regardless of whether their as-
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signed telephone intervention had taken
place” (p. 1243)
Comment: of the 605 participants, 89 (14.
7%)didnot complete the intervention, and
121 (20.0%) were lost to follow-up at 13
months for the following reasons: i) died;
ii) unstated reasons
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Van der Sande 1997a
Methods Allocation: randomisation using a computer generated series of random numbers
Follow-up period: 12 months
N lost to follow-up: 0/274 (0%) for repetition data
Participants Inclusion criteria: i) admitted to hospital following an attempted suicide; ii) able to
understand and write Dutch; iii) living in the hospital catchment area
Exclusion criteria: i) engaged in habitual wrist cutting of minor severity; ii) currently ad-
mitted as a psychiatric inpatient; iii) currently in prison; iv) diagnosed with an substance
addiction; v) requires recurrent consultations with a liaison psychiatrist during a stay of
more than 2 days on a somatic ward
Numbers: Of the 274 participants, 140 were allocated to the experimental arm and 134
were allocated to the control arm
Profile: 57.7% (n = 158) were female, 63.9% (n = 175) were multiple repeaters, 28.1%
(n = 77) were diagnosed with a mood disorder
Source of participants: patients admitted to hospital following a suicide attempt
Location: Utrecht, the Netherlands
Interventions Experimental: brief psychiatric unit admission to a specialist unit for the treatment of
suicide attempters for a period of 1-4 days. Participants were then offered outpatient
treatment based on Hawton and Catalan’s problem-solving approach (Hawton 1987b)
. Treatment specifically focused on encouraging participants to: i) discuss the reasons
behind the current suicide attempt; ii) discuss these reasons with family, partner, or both
if required; iii) contact the unit on discharge in the case of a suicidal crisis; iv) change
their ability to cope with future problems. 24-hour emergency access to unit was offered
throughout the duration of outpatient treatment
Control: TAU. For around 25% (n = 34) this involved admission to an inpatient unit,
whilst for the remaining 75% (n = 100), this involved referral to outpatient services
Therapists: 1 psychiatrist, 2 community psychiatric nurses, and 9 psychiatric nurses
Type of therapy offered: problem-solving therapy
Length of treatment: not specified
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Van der Sande 1997a (Continued)
Outcomes Included: i) suicide reattempts according to self report, hospital records, or both; ii)
suicide; iii) compliance; iv) depression; v) hopelessness
Excluded: i) anxiety; ii) sleep disorder; iii) psychiatric hospitalisation; iv) phobic anxiety;
v) somatisation; vi) obsession-compulsion; vii) interpersonal sensitivity; viii) hostility
Notes Sources of funding: “This study was supported by grant OG 92-023 of the National
Health Insurance Council (Ziekenfonds-Raad)” (p. 40)
Declaration of author interests: none stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Envelope[s] contained a number
obtained from a list of random numbers
generated by computer” (p. 36)
Comment: Use of a computerised randomi-
sation sequence is likely to have minimised
the role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) Low risk Quote: “The nurse on duty in the experi-
mental ward performed the randomisation
by opening the next from a series of sealed
and opaque envelopes” (p. 36)
Comment: Use of sealed, tamper-proof en-
velopes stored in a locked cabinetwould en-
sure adequate allocation concealment from
all except the nurse on duty
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “Patients assigned to the experimen-
tal treatment were informed about the ex-
periment” (p. 36). Additionally, “patients
in the control group were sent written in-
formation about the experiment” (p. 36)
Comment: As patients were aware of the
trial, it is likely they were also aware of
which treatment arm they had been allo-
cated to
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “The nurse on duty in the experi-
mental ward performed the randomisation
by opening the next from a series of sealed
and opaque envelopes” (p. 36)
Comment: suggests that nurses were aware
of allocation. However, no details on blind-
ing of other personnel blinding were pro-
vided
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Van der Sande 1997a (Continued)
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: no details on outcome assessor
blinding provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All comparisons were made on an
’intention to treat’ basis, regardless of how
long (or even whether) patients had re-
ceived the treatment assigned” (p. 37)
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Van Heeringen 1995
Methods Allocation: randomisation using an open randomisation list
Follow-up period: 12 months
N lost to follow-up: 125/516 (24%) for repetition of SH data
Participants Inclusion criteria: i) over 15 years old; ii) resident in catchment area
Exclusion criteria: i) currently receiving inpatient medical treatment
Numbers: of the 516 participants, 258 were allocated to the experimental arm and 258
were allocated to the control arm
Profile: 43% (n = 222) were female, 30% (n = 155) were multiple repeaters, 15% (n
= 77) were diagnosed with mood disorder, 2.7% (n = 14) were diagnosed with anxiety
disorder
Source of participants: patients treated in an A&E department following a suicide attempt
Location: Ghent, Belgium
Interventions Experimental: compliance enhancement involving home visits to those participants who
did not keep to scheduled outpatient appointments in addition to TAU. Reasons for not
attending appointments were discussed and the patient was encouraged to attend future
treatment sessions
Control: outpatient appointments only.Non-compliant participants did not receive home
visits
Therapist: community nurse.
Type of therapy offered: assertive outreach and compliance enhancement.
Length of treatment: not specified.
Outcomes Included: i) repetition of SH according to self report, with collateral report from GPs,
relatives or both, if the participant could not be contacted; ii) suicide; iii) compliance
Excluded: none
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Van Heeringen 1995 (Continued)
Notes Sources of funding:“This study was supported by a grant from the National Fund for
Scientific Research (NFWO, grant no. 3.0061.86)” (p. 969)
Declaration of author interests: no details provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “Patients were randomly allocated .
. . using a randomization list” (p. 964)
Comment: As the numbers table was open,
it is possible there may have been bias in
the generation of the random sequence
Allocation concealment (selection bias) High risk Comment: As the numbers table was open,
it is possible there may have been bias in
the concealment of allocation
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
High risk Comment: no details on outcome asses-
sor blinding were provided. However, most
outcomemeasures, were either self reported
or reported by relatives, GPs or both.Given
the nature of this trial, participants, rela-
tives, and GPs could have known group al-
location
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: Of the 516 participants, 125
(24.2%) were lost to follow-up. Reasons
given for dropouts included: i) refused fol-
low-up assessment (n = 97); ii) moved from
catchment area without leaving a forward-
ing address (n = 22); iii) death following
a somatic illness (n = 2); iv) admitted to
hospital with a terminal illness (n = 2); v)
imprisoned (n = 2). No details on whether
intention-to-treat analyses were conducted
was provided, however
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
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absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Waterhouse 1990
Methods Allocation: randomisation using sequentially numbered sealed envelopes
Follow-up period: 16 weeks
N lost to follow-up: 0/77 (0%) for repetition of SH data
Participants Inclusion criteria: i) aged over 16 years old
Exclusion criteria: i) immediate medical or psychiatric treatment needs
Numbers: Of the 77 participants, 38 were allocated to the experimental arm and 39 were
allocated to the control arm
Profile: 62% (n = 48) female. 36% (n = 28) were repeaters. Mean age of 30 years
Source of participants: patients admitted to an A&E department for SH
Location: York, UK
Interventions Experimental: general hospital admission excluding additional treatment or counselling.
“Hospital admission consisted of little more than a bed, without further referral to other
helping agencies” (p. 238)
Control: discharge from hospital
Therapist: none
Type of therapy offered: hospital admission
Length of treatment: median length of admission was 17 hours
Outcomes Included: i) repetition of SH according to GP interview, hospital records, or both; ii)
suicidal ideation; iii) hopelessness
Excluded: i) depression; ii) psychiatric admission; iii) time off work; iv) social isolation;
v) somatic concerns; vi) daily routine; vii) social behaviour assessment schedule; viii) GP
questionnaire
Notes Sources of funding: no specific sources of funding were provided for this trial
Declaration of author interests: “John Waterhouse was in receipt of a research grant from
the Yorkshire Regional Health Authority” (p. 241)
Other: As depression data had been combined with anxiety data, this outcome was not
included in the present review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomisation took place . . .
using sequentially numbered sealed en-
velopes” (p. 237)
Comment: Although it is likely the random
sequence was adequately generated, with-
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out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Low risk Quote: “Randomisation took place . . .
using sequentially numbered sealed en-
velopes” (p. 237)
Comment: No mention of whether the en-
velopes were opaque or not, although they
probably were
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
that personnel (e.g., hospital staff, GPs) are
likely to have known which participant was
receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
High risk Quote: “Follow up interviews . . . were per-
formed one week after the attempt by one
of the authors . . . who was not blind to the
patient’s treatment group” (p. 237)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: Of the 77 participants, 4 (5.2%)
dropped out after 1 week and a further
21 (28.4%) dropped out by 16 weeks. No
details provided on whether intention-to-
treat analyses were conducted, however
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Wei 2013
Methods Allocation: randomisation using a computerised randomisation programme
Follow-up period: 3, 6, and 12 months
N lost to follow-up: 77/239 (32.2%) at 3-month follow-up; 123/239 (51.5%) at the 6-
month follow-up; 151/239 (63.2%) at the 12-month follow-up
Participants Inclusion criteria: i) older than 15 years; ii) admitted to emergency departments following
a suicide attempt; iii) have at least 1 contact person to provide collateral reports on
suicidal behaviour, etc; iv) able to understand the trial procedures; v) able to provide
written informed consent
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Exclusion criteria: none stated
Numbers: Of the 239 participants, 82were allocated to the cognitive therapy intervention
arm, 80 were allocated to the telephone intervention, and 77 were allocated to the control
arm
Profile: 76.1% (n = 182) were female; 45.2% (n = 108) were diagnosed with any psychi-
atric disorder
Source of participants: patients admitted to emergency departments following a suicide
attempt
Location: Shenyang, Liaoning Province, China
Interventions Experimental: there were 2 experimental arms in this trial: i) cognitive therapy, and ii)
telephone intervention. Cognitive therapy involved sessions of cognitive therapy as well
as supporting patients to reconnect with family and friends. The telephone intervention
involved psychological support based on reassurance and emphatic reasoning, and col-
laborative problem-solving therapy
Control: “ [P]atients in the control group did not receive any interventions” (p. 109)
Therapist: Therapists had more than 5 years clinical work experience.
Type of therapy offered: i) cognitive-behavioural therapy; ii) telephone contact
Length of treatment: 3 months
Outcomes Included: i) repetition of SH; ii) suicide; iii) suicidal ideation; iv) depression
Excluded: i) quality of life
Notes Sources of funding: “This project was part of the ’Small Grants Program to Improve the
Quality and Implementation of Suicide Research in China’ which was supported by the
China Medical Board of New York (grant number 05-813)” (p. 113)
Declaration of author interests: no details provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “[P]articipants . . . were randomly
assigned . . . using a computerized random-
ization program” (p. 109)
Comment: Use of a computerised randomi-
sation sequence is likely to have minimised
the role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment provided
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
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Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: no details on blinding of out-
come assessors provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “All analyses were conducted using
the intent-to-treat (ITT) principle . . . ” (p.
110)
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
Weinberg 2006
Methods Allocation: randomisation by asking participants to choose between 2 similar envelopes
Follow-up period: 8 months
N lost to follow-up: 0/30 (0%) for repetition of SH data
Participants Inclusion criteria: i) female; ii) aged 18-40 years; iii) diagnosedwith borderline personality
disorder; iv) history of repetitive SH with at least 1 episode during the month before
enrolment
Exclusion criteria: i) diagnosed with comorbid psychosis; ii) judged to be at an elevated
risk of suicide; iii) diagnosed with substance abuse; iv) history of attempted suicide (only
those engaging in repetitive SH were eligible for inclusion in this trial)
Numbers: Of the 30 participants, 15 were allocated to the experimental arm and 15 to
the control arm
Profile: 100% (n = 30) were female
Source of participants: recruited from the community via advertisements in local newspa-
pers, clinical services at a hospital, and from individuals participating in a longitudinal
study
Location: Boston, MA, USA
Interventions Experimental: manual assisted cognitive treatment involving of 6 sessions aimed at eval-
uation an attempt, developing crisis skills problem-solving skills, developing cognitive
techniques for emotional, and negative thinking management, and outlining relapse
prevention strategies
Control: TAU
Therapists: primary investigator acted as the therapist
Type of therapy offered: cognitive behavioural therapy
Length of treatment: 2 months
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Outcomes Included: i) repetition of SH according to self report; ii) suicidal ideation; iii) suicide
Excluded: i) severity of SH
Notes Souces of funding: ”This study was supported by a Young Investigator Aware from the
Borderline Personality Disorder Research Foundation (I.W.)“ (p. 482)
Declaration of author interests: no details provided
Other: All participants were also simultaneously participating in additional treatment
throughout the duration of this trial
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ”Subjects were randomly assigned“
(p. 485)
Comment: Correspondence with authors
further clarified that ”subjects were asked
to choose between 2 similar envelopes con-
taining either manual assisted cognitive be-
haviour therapy or non-manual assisted
cognitive behaviour therapy.“
Allocation concealment (selection bias) Low risk Comment: correspondence with authors
clarified that subjects choose between 2
similar envelopes
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: ” . . . interviewers were blind to base-
line ratings and to participants’ group al-
location at post-treatment assessments and
6-month follow-up“ (p. 487)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: Although ”[a]ll MACT participants
completed 6 sessions of MACT. Two TAU
group participants were not available for
the post-treatment assessments (p. 485).
Nevertheles, “[a]ll participants were inter-
viewed at the 6 months follow up” (p.485),
suggesting that intention-to-treat analyses
were undertaken
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Selective reporting (reporting bias) Unclear risk Comment: We had to request data on sui-
cides from authors, suggesting that selec-
tive reporting bias may have been present
Other bias Low risk Comment: no other apparent sources of bias
Welu 1977
Methods Allocation: randomisation using a table of random numbers
Follow-up period: 4 months
N lost to follow-up: 1/120 (1%) for repetition of SH data
Participants Inclusion criteria: i) over 16 years old
Exclusion criteria: i) student living in university accommodation; ii) resident in a care-
giving institution or institutionalised at the time of the index episode of SH
Numbers: Of the 120 participants, 63 were allocated to the experimental arm and 57 to
the control arm
Profile: 60% (n = 72) were multiple repeaters
Source of participants: patients admitted to an A&E department following an episode of
SH
Location: Pittsburgh, PA, USA
Interventions Experimental: special outreach programme involving a community mental health team
contacting participants immediately after discharge to arrange weekly/bi-weekly home
visits
Control: TAU involving a psychiatric consultation at request of the treating physician.
Participants were also given a next day appointment for evaluation at the community
mental health team centre. Any further contact after discharge was at the participant’s
request
Therapist: 4 nurses, 3 social workers, and 2 community workers
Type of therapy offered: special outreach involving a variety of treatments
Length of treatment: 4 months
Outcomes Included: i) repetition of SH according to one or more of: self report, hospital records,
collateral informant report
Excluded: i) extent of follow-up coverage; ii) type and frequency of contacts; iii) purposive
accidents; iv) excessive use of alcohol; v) drug misuse
Notes Sources of funding: “This investigation was supported by ResearchGrantMH19491 from
the National Institute of Mental Health” (p. 17)
Declaration of author interests: no details provided
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Quote: “Random assignment was worked
out in advance from a table of random
numbers” (p. 20)
Comment: Use of a random numbers table
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment provided
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this trial means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the trial means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: no details provided on outcome
assessor blinding
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: of the 120participants, 6 (9.5%)
in the experimental arm and 26 (45.6%) in
the control arm were lost to follow-up for
unstated reasons. Intention-to-treat analy-
ses were not attempted, however
Selective reporting (reporting bias) Unclear risk Comment: no reason to suspect that all out-
comes were not measured; however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: no other apparent sources of bias
A&E: accident and emergency;BPD: borderline personality disorder;CBT: cognitive behavioural therapy;DBT: dialectical behavioural
therapy; DSM-IV (TR): Diagnostic and Statistical Manual of Mental Disorders, fourth edition (text revision); ITT: intention-
to-treat; MACT: manual-assisted cognitive therapy; NSSI: non-suicidal self-injury; PST: problem-solving therapy; PTSD: post-
traumatic stress disorder; SCID-II: Structured Clinical Interview for DSM-IV Axis II Personality Disorders; SH: self-harm; SSRI:
selective serotonin reuptake inhibitors; TAU: treatment as usual.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Almeida 2012 Participants were not required to have engaged in SH prior to trial entry
Aoun 1999 Non-randomised clinical trial
Bannan 2010 Correspondence with authors suggested bias in both allocation and allocation concealment to the
intervention and control groups
Bartman 1979 Method of allocation to intervention and control groups unclear
Bateson 1989 Non-randomised clinical trial
Berrino 2011 Non-randomised clinical trial
Carter 2013 Reports on 5-year outcomes, rather than within the 2-year time frame
Cebrià 2013 Non-randomised clinical trial
Chen 2013 Correspondence with authors revealed that information on non-fatal repetition of SH could not
be disaggregated from information on completed suicide. Additionally, the study did not collect
data on the secondary outcomes included in this review
Chowdhury 1973 Correspondence with authors revealed that participants were alternately allocated to the interven-
tion and control groups
Christensen 2014 Database of RCTs
Comtois 2011 Correspondence with authors confirmed that not all participants engaged in self-harm in the 6
months prior to randomisation
Crawford 1998 Non-randomised clinical trial
Currier 2010 Participants were not required to have engaged in SH prior to trial entry
Davidson 2006 Participants could have engaged in SH at any point within 1 year prior to trial entry, rather than
within 6 months
De Leo 2007 Participants could have engaged in SH at any point, rather than within 6 months
Evans 1998 Conference proceedings
George 2014 Participants not required to have engaged in SH prior to trial entry
Ghahramanlou-Holloway 2012 Review
Gunnarsdottir 2010 Non-randomised clinical trial
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Harned 2010 RCT of a psychosocial intervention for SH patients that only presents data from the intervention
arm
Hatcher 2005 Non-randomised clinical trial
Hellerstein 2003 Conference proceedings
Horrocks 2002 Letter to the editor
Kapur 2013b Non-randomised clinical trial
Lamprecht 2007 Non-randomised clinical trial
Liberman 2001 Letter to the editor
Links 1999 Non-randomised clinical trial
Links 2003a Non-randomised clinical trial
Low 2001 Non-randomised clinical trial
Martin 2013 Non-randomised clinical trial
McMain 2007a Non-randomised clinical trial
McQuillan 2005 Non-randomised clinical trial
Montgomery 1983 RCT of a pharmacological intervention for SH patients
Morley 2014 Participants were not required to have engaged in SH prior to trial entry
Ono 2008 Non-randomised clinical trial
Pham-Scottez 2010 Non-randomised clinical trial
Raj 2001 Non-randomised clinical trial
Razzaque 2013 Non-randomised clinical trial in which only 3 participants were enrolled
Ruchlewska 2013 Participants not required to have engaged in SH prior to trial entry
Sambrook 2007 Non-randomised clinical trial
Strum 2012 Correspondence with authors confirmed that not all participants engaged in SH in the 6 months
prior to randomisation
Sáiz 2014 Correspondence with authors confirmed that not all participants were randomised to the inter-
vention or control groups; some chose to receive the intervention treatment
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Tarrier 2008a Review
Termansen 1975 Non-randomised clinical trial
Trembley 2013 Review
Van Spijker 2010 Participants were not required to have engaged in SH prior to trial entry
Vitiello 2009 Not all participants were randomised to the intervention or control groups; some chose to receive
the intervention treatment
Warren 2004 Participants were not required to have engaged in SH prior to trial entry
Winter 2007 Non-randomised clinical trial
Wullimier 1979 Non-randomised clinical trial
Zhang 2013 Participants could have engaged in SH at any point within 1 year of trial entry, rather than within
6 months
RCT: randomised controlled trial; SH: self-harm.
Characteristics of studies awaiting assessment [ordered by study ID]
Andreasson 2016
Methods Allocation: 2-arm, parallel group randomisation
Design:single centre (outpatient psychiatric clinic)
Setting:community
Follow-up period: 52 weeks
Location: Copenhagen, Denmark
Participants Males and females, 18-65 years of age, meeting 2 or more criteria for a diagnosis of borderline personality disorder
according to the DSM-IV, who made a suicide attempt within 1 month of inclusion into the trial, and are able to
provide informed consent
Interventions Participants randomised to the experimental group will receive either 16 weeks of dialectical behaviour therapy
(DBT) or 16 weeks of Collaborative Assessment andManagement (CAMS) of suicidality alongside CAMS-informed
supportive psychotherapy
Outcomes Primary outcome: number of subsequent episodes of self-harm and suicide attempts at 17, 28, and 52 weeks follow-
up
Secondary outcomes: scores on the Hamiliton Depression Rating Scale (HDRS), BDI, BSSI, the Suicide Attempt Self
Injury Interview (SASII), Beck Hopelessness Scale (BHI), Barratt Impulsivity Scale (BIS), the Zanarini Borderline
Personality Scale (ZBPS), the State Trait Anger Scale (STAS), and Rosenberg’s Self Esteem Scale measured at 16, 28,
and 52 weeks follow-up
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Notes Dr. Kate Andreasson very kindly provided unpublished information relating to this trial
Armitage 2016
Methods Allocation: individual randomisation
Design: single centre
Setting: hospital
Location: Kuala Lumpur, Malaysia
Participants Males and females admitted to Kuala Lumpur Hospital following an episode of self-harm (ICD-10 X60-X84,
intentional self-harm13) between 1 March 2010 and 28 February 2011
Interventions Implementation intentions to reduce suicidal ideation and behaviour
All participants were initially presented with a brief statement designed to encourage them to plan not to self-harm:
‘We want you to plan not to self-harm. Research shows that you are much more likely to be successful in your intention not
to self-harm if you can identify critical situations and appropriate responses’.
Following this statement, participants were randomised to one of three groups:
(i) volitional help sheet with implementation intentions (11 critical situations and 11 appropriate responses) (N=75)
;
(ii) self-generating implementation intentions, without help (N=78);
(iii) a control condition (the volitional help sheet, but no instruction on how to form implementation intentions,
participants were simply asked to identify critical situations and appropriate responses that might be useful to them)
(N=73)
Outcomes Primary outcomes: suicidal ideation and behaviour (revised Suicidal Behaviours Questionnaire); depression (BDI-II)
; motivation to avoid self-harm
Notes Personal communication between KH and Rory O’Connor
Gysin-Maillart 2016
Methods Allocation: individual randomisation using shuffled sealed envelopes.
Design: single centre (hospital-based recruitment).
Setting: emergency unit of a university general hospital.
Location: Bern, Switzerland.
Participants Males and females, 18 years of age and older, admitted to the emergency unit of a university general hospital following
a suicide attempt for which there is evidence of an intent to die. Those with a history of multiple episodes of self-
harm (i.e., indicative of probable borderline personality disorder pathology), serious cognitive impairment, psychosis,
insufficient ability to communicate in German, or those resident outside of the hospital catchment area will be
excluded from participation
Interventions Individuals randomised to the intervention group will receive between three and four weekly sessions of between 60-
90 minutes in length of face-to-face psychosocial therapy delivered according to the ASSIP manual (Gysin-Maillart
2013; Michel 2015) involving a narrative interview, cognitive restructuring, and crisis safety planning. Additionally,
participants in the intervention group will receive one letter every three months for a total of 24 months reminding
them of the importance of safety planning during times of crisis
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Outcomes Primary outcomes: suicide reattempts according to hospital records during the 24 month follow-up period
Secondary outcomes: scores on the 11-item Penn Helping Alliance Questionnaire, the Beck Depression Inventory, and
the Beck Scale for Suicidal Ideation during the 24 month follow-up period
Notes
Linehan 2015
Methods Allocation: randomisation using a computerised adaptive minimisation procedure whereby participants were matched
using 5 primary prognostic variables: i) age; ii) number of prior ’suicide attempts’; iii) number of prior NSSI episodes;
iv) number of psychiatric hospitalisations within the past year; v) depression severity
Follow-up period: 12 months
N lost to follow-up: 0/99 (0%) for repetition of NSSI and ’suicide attempts’
Participants Inclusion criteria: i) 18-60 years; ii) female; iii) met criteria for borderline personality disorder; iv) at least 2 ’suicide
attempts’ or episodes of NSSI over the past 5 years; v) at least 1 ’suicide attempt’ or episode of NSSI within the 8
weeks prior to entering the study; vi) at least 1 ’suicide attempt’ in the previous year. Due to difficulties in reaching
recruitment targets, the authors relaxed inclusion criteria towards the end of the recruitment period to include 1
participant who had engaged in an episode of NSSI in the 8-week period prior to entering the study but who did
not have a prior history of NSSI and 5 participants who did not have a history of repeated episodes of NSSI but who
did make a ’suicide attempt’ within the past year
Exclusion criteria: i) met criteria for a current psychotic or bipolar disorder; ii) diagnosed with a seizure disorder
requiring the use of medication; iii) currently undergoing treatment for another life-threatening condition (e.g.,
anorexia nervosa); iv) an IQ score of less than 70 on the Peabody Picture Vocabulary Test-Revised
Numbers: of the 99 participants 33 were allocated to the DBT + skills training arm, 33 were allocated to the DBT +
individual therapy arm, and 33 were allocated to the DBT standard protocol arm
Profile: 99 (100%) were female, 95 (95.9%) had a lifetime diagnosis of major depression, 87 (87.9%) had a lifetime
diagnosis of any anxiety disorder, and 69 (69.7%) had a lifetime diagnosis of a substance use disorder
Source of participants: healthcare practitioners
Setting: Seattle, WA, USA
Interventions Experimental: This trial involved 2 experimental arms. The first, ’DBT + skills training’, incorporated a manualised
standard case management protocol, group-based skills training sessions, and telephone coaching as required; it was
designed to resemble the DBT standard protocol with the omission of all sessions of individual-based psychotherapy.
The second, ’DBT + individual therapy’, incorporated individual-based therapy, an activity-based support group,
and telephone coaching as required; it was designed to resemble the DBT standard protocol with the omission of all
sessions of group-based skills training
Control: DBT standard protocol incorporating sessions of individual-based psychotherapy, group-based skills training,
and telephone coaching as required
Therapists: specially trained to provide either experimental or control therapy
Type of therapy offered: dialectical behaviour therapy with skills training and dialectical behaviour therapy with
individual-based psychotherapy
Length of treatment: 1 year
Outcomes To be included: i) repetition of SH (requires correspondence from study authors as to whether it is possible to aggregate
episodes of NSSI and ’suicide reattempts’); ii) depression; iii) suicidal ideation; iv) adherence with treatment
Excluded: i) anxiety; ii) importance of reasons for living
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Notes
BDI: BeckDepression Inventory;BSSI: Beck Scale for Suicidal Ideation;DBT: dialectical behaviour therapy;MINI:Mini International
Neuropsychiatric Interview; NSSI: non-suicidal self-injury; TAU: treatment as usual.
Characteristics of ongoing studies [ordered by study ID]
Agyapong 2013
Trial name or title Text message intervention to reduce repeat self-harm.
Trial registration number:NCT01823120.
Methods Allocation: single blind, parallel assignment, randomisation
Design:single centre
Setting: community
Location: Dublin, Republic of Ireland
Follow-up period: 3 months
Participants Inclusion criteria: males and females, 18 years of age and older, presenting to the emergency department
following an episode of self-harm, with a mobile phone and familiar with text messaging
Exclusion criteria: those who do not provide consent to participate, who do not have a mobile phone or are
unfamiliar with text messaging, who are admitted to psychiatric inpatient facilities following assessment in the
emergency department, who require admission to a medical ward for more than 48 h, or who are unavailable
at any point during the 3-month follow-up period
Interventions Those randomised to the intervention arm will receive daily text messages for 1 month, followed by 1 message
every 2 days for the second month, followed by 1 message per week for the third month following discharge
from the emergency department. Text messages will target the relief of mood symptoms and will provide
advice on strategies for coping with suicidal thoughts. Messages will also provide patients with a mobile phone
number for the Samaritans. All messages will encourage participants to contact the Samaritans in times of
crisis
Outcomes Primary outcome measures: proportion of patients repeating self-harm and scores on the Suicide Behaviors
Questionnaire
Secondary outcome measures: number of repeat episodes of self-harm per person, scores on the Modified Scale
for Suicidal Ideation, scores on the Positive and Negative Suicide Ideation Inventory, scores on the Beck
Hopelessness Scale, and scores on the Global Assessment of Functioning
Starting date March 2013.
End date: March 2014.
Contact information Name: Dr Vincent Agyapong.
Affiliation: Department of Psychiatry, Trinity College Dublin, Republic of Ireland
email: israelhans@hotmail.com
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Notes We made three attempts to contact Dr Agyapong to confirm these details; however, we received no response.
We therefore extracted information for this trial from the ClincialTrials.gov record
Andover 2008
Trial name or title Treatment for Non-Suicidal Self-Injury in Young Adults (T-SIB)
Trial registration number:NCT01018433.
Methods Allocation: Single-blind, parallel assignment, randomised
Design: single centre
Setting: outpatient clinic
Location: Bronx, NY, USA
Follow-up period: 3 months
Participants Inclusion criteria: males and females, aged 18-29, with a history of engaging in NSSI (with or without an urge
to self injure) within the month prior to randomisation
Exclusion criteria: those with psychotic symptomatology or severe suicidal ideation
Interventions Participants randomised to the experimental group will receive 9 sessions of therapy to reduce both the
frequency and severity of non-suicidal self-injury
Outcomes Primary outcome measures: frequency and severity of NSSI
Secondary outcome measures: scores on the Beck Depression Inventory (BDI), the Beck Anxiety Inventory
(BAI), the McLean Screening Instrument for Borderline Personality Disorder, the College Student Inventory,
the Social Problem Solving Inventory-Revised (SPSI-R), the Symptom Checklist-90-Revised (SCL-90-R),
and the University of Rhode Island Change Assessment (URICA)
Starting date September, 2008.End date: July, 2013.
Contact information Name: Prof. Margaret Andover.Affiliation: Department of Psychology, Fordham University.email:
moodbehavior@fordham.edu
Notes We made three attempts to contact Prof Andover to confirm these details; however, we received no response
and so were unable to confirm whether all participants either engaged in deliberate self-harm ormade a suicide
attempt within six months prior to randomisation. Additionally, we were unable to confirm whether the trial
was ongoing. We extracted information for this trial from the ClinicalTrials.gov record
Berrouiquet 2015
Trial name or title SIAM: Suicide Intervention Assisted by Messages.
Trial registration number:NCT02106949.
Methods Allocation: randomised.
Design: multicentre.
Setting: recruitment from hospital settings, treatment provided in the community
Location: Brest, Rennes, Nates, Lille, Angers, Tours, and Vannes, France
Follow-up period: 6 and 13 months.
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Participants Inclusion criteria: males and females, 18 years of age or older, who attempt suicide and are admitted to the
emergency department and/or psychiatric unit of one of seven participating hospitals, who are hospitalised
for no more than 7 days, and are able to be contacted by mobile telephone
Interventions Those randomised to the intervention group will receive 9 textmessages, one within 48 hours of discharge, one
a days 8 and 15, and one at months 1,2,3,4,5, and 6. Content of these messages will address validation, recall
of the discharge treatment agreement, and outreach via a continuing care intervention program. Messages
will also provide participants with information on their treating doctor’s name and contact information (GP
or psychiatrist as appropriate), as well as dates of scheduled appointments (as applicable). Information on a
crisis telephone number, available 24/7, will also be included
Outcomes Primary outcomes: number of subsequent suicide attempts at the 6 month follow-up assessment
Secondary outcomes: number of subsequent suicide attempts at the 13 month follow-up assessment, number
of deaths by suicide at the 6 and 13 month follow-up assessments, and the number self-reporting suicidal
ideation at the 6 and 13 month follow-up assessments
Starting date June, 2014.
Anticipated end date: not specified.
Contact information Name: Dr Sofian Berrouiguet (Principal Investigator)
Affiliation: Hôspital Cavale Blanche, Brest, France.
email: sofian.berrouiguet@chu-brest.fr
Notes
Brimes 2007
Trial name or title Effectiveness of Standard Emergency Department Psychiatric Treatment Associated With Treatment Delivery
by a Suicide Prevention Center
Trial registration number:NCT00641498.
Methods Allocation: randomised
Design: multicentre
Setting: dedicated outpatient suicide prevention centres
Location: Toulouse, France
Follow-up period: 2 years
Participants Inclusion criteria: males and females, 18 years of age and older, who have made a suicide attempt by self-
poisoning, who have a Glasgow score of 15, and who are currently receiving standard psychiatric treatment
Exclusion criteria: unable to speak French; admitted to inpatient facilities will be excluded from participation
Interventions Participants randomised to the intervention arm will receive sessions of individual supportive psychotherapy
delivered in a dedicated outpatient suicide prevention centre. No further details on the content, number, or
duration of these sessions is reported
Proposed N = 405
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Outcomes Outcome measures: frequency of subsequent suicidal behaviour and death by suicide during the 2-year follow-
up period
Starting date March, 2007.
End date: October, 2011.
Contact information Name: Dr. Philippe Birmes.
Affiliation: University Hospital, Toulouse, France.
email: birmes.p@chu-toulouse.fr
Notes We made 3 attempts to contact Dr Birmes to confirm these details; however, we received no response and
so were unable to confirm whether all participants either engaged in deliberate self-harm or made a suicide
attempt within 6 months prior to randomisation. Additionally, we were unable to confirm whether the trial
was ongoing. We extracted information for this trial was extracted from the ClinicalTrials.gov record
Brown 2014
Trial name or title Community-based cognitive therapy for suicide attempters
Trial registration number: NCT00081367.
Methods Allocation: randomised
Design: multicentre
Setting: recruitment from hospital settings, treatment provided in community mental health clinics
Location: Philadelphia, PA, USA
Follow-up period: unclear
Participants Inclusion criteria: males and females, 16 years of age or older, who attempt suicide within 48 h of presenting
to an emergency department or trauma care unit, who are able to speak English, and are able to understand
the nature of the trial, and who provide written informed consent
Interventions Those randomised to the intervention group will receive 10 weekly sessions of cognitive therapy in addition
to enhanced usual care
Outcomes Primary outcomes: number of subsequent suicide attempts, scores on a measure of suicidal ideation, scores on
a measure of depression, and scores on a measure of hopelessness
Starting date April, 2004
Data collection completed: September 2009
Contact information Name: Prof Gregory Brown (Principal Investigator)
Affiliation: Department of Psychiatry, University of Pennsylvania
email: gregbrow@mail.med.upenn.edu
Notes Prof Gregory Brown very kindly provided unpublished information relating to this trial
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Collinson 2014
Trial name or title MIDSHIPS: Multicentre Intervention Designed for Self-Harm using Interpersonal Problem-Solving
Trial registration number: ISRCTN54036115.
Methods Allocation:stratified block random allocation with minimisation
Design: single-centre (hospital-based recruitment by a specialist Self Harm Assessment Team within the Leeds
and York NHS Trust)
Setting: clinic rooms, GP practices, or both
Location: Leeds and York, UK
Participants Males and females, 18 years of age and older, who present to hospital following an episode of self-harm are
eligible to participate in this trial. Both first time self-harmers and those with more extensive self-harming
histories will be included. Individuals diagnosed with any psychiatric disorder are also eligible to participate
N= 60
Interventions Individuals randomised to the intervention group will receive 4-6 one-hour weekly problem-solving therapy
sessions aimed at helping patients to identify problems and to provide them with strategies for resolving these
and future problems more constructively
Outcomes Primary outcomes: repetition of self-harm necessitating hospital admission within 6 months of randomisation,
attendance at therapy sessions as measured by the Health and Social Care Information Centre, scores on the
General Health Questionnaire and the EuroQol-5D, and other health economics data
Starting date January, 2012.
Completed: July, 2015.
Contact information Name: Dr David Owens (Principal Investigator)
Affiliation: University of Leeds.
email: d.w.owens@leeds.ac.uk
Notes Dr David Owens very kindly provided unpublished information relating to this trial. Additionally, Dr Owens
provided the following notes pertaining to the this trial: “Funded by theNational Institutes of Health Research
(NIHR) Research for Patient Benefits (RfPB) program. The planned application for the full (multicentre)
trial (will be made) to the Health Technology Assessment (HTA) (program) in late 2014.”
Davidson 2009
Trial name or title ENGAGE - Meeting mental health needs of complex comorbid patients attending A&E following a suicide
attempt. A pilot study
Trial registration number:NCT00980824.
Methods Allocation: single blind randomisation
Design: single-centre (community)
Setting: postdischarge patients followed up in the community
Follow-up period: 3 months
Location: Glasgow, UK
Participants Inclusion criteria: males and females, 18 years of age and older, who were admitted to a general hospital
following an episode of self-harm or a suicide attempt, and who score above the threshold for personality
disorder using the SAPAS will be included in this trial. Those with substance misuse, defined as scoring
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Davidson 2009 (Continued)
above the threshold for substance misuse according to the AUDIT or the DAST, will not be excluded from
participation
N = 20
Interventions Those randomised to the experimental group will receive 6 sessions of Manual-Assisted Cognitive Therapy
(MACT), a brief focused therapy to address self-harm and to promote engagement with services. ENGAGE
is designed to help patients to identify problems that lead to self-harming behaviour or attempted suicide and
to assist patients in using problem-solving therapy to resolve these problems. Emphasis will also be placed
on encouraging engagement and on facilitating contact with specialist substance misuse, personality disorder
treatment, or both, as appropriate
Outcomes Primary outcomes: scores on measures of depressed mood, anxiety, and suicidality at baseline and after 3
months of follow-up
Starting date November 2009
End date: December 2010
Contact information Name: Prof Kate Davidson (Principal investigator)
Affiliation: University of Glasgow
email: kate.davidson@glasgow.ac.uk
Notes Prof Davidson kindly very kindly provided unpublished information relating to this trial. Additionally, Prof
Davidson provided the following notes pertaining to this trial: “Pilot study to assess feasibility to recruit a
sample of these complex patients to a randomised controlled trial of MACT following an index episode of
self-harm. There is preliminary support that MACT could be an acceptable and effective intervention in
patients with personality disorder and substance misuse.”
Hatcher 2016b
Trial name or title Ottawa Suicide Prevention in men pilot study (OSSUPilot): A cluster-randomised trial of a smart phone
assisted problem-solving therapy in men who present to hospital with intentional self-harm
Trial Registration Number: NCT02718248.
Methods Allocation: cluster randomisation with emergency departments being the unit of randomisation
Design: multicentre (hospital emergency department facilities).
Setting: postdischarge patients followed up in the community.
Follow-up period: 1 year.
Location: Ontario, Canada.
Participants Inclusion criteria: males, 18 years of age and older, presenting to hospital-based emergency department facilities
following an episode of intentional self-harm
Exclusion criteria: females, and those younger than 18 years
N expected: 1200 participants: 600 in each arm
Interventions Participants randomised to the intervention group will receive 6 sessions of face-to-face problem-solving
therapy, 1 additional follow-up session, and smartphone assisted problem-solving therapy embedded in a
quality improvement programme (CHESS app) over an approximate 2-month follow-up period
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Hatcher 2016b (Continued)
Outcomes Primary outcome: re-presentation to hospital for any reason over a 1-year follow-up period
Secondary outcomes: re-presentation to hospital for intentional self-harm over a 1-year follow-up period, suicide
Starting date April 2016
Proposed End Date: September 2018
Contact information Name: Dr Simon Hatcher (Principal investigator)
Affiliation: University of Ottawa
email: shatcher@uottawa.ca
Notes Dr Hatcher very kindly provided unpublished information relating to this trial
Huang 2013
Trial name or title Efficacy of dialectical behavior therapy in patients with borderline personality disorder
Trial registration number:NCT01952405.
Methods Allocation: randomised
Design: single centre (hospital-based)
Setting: hospital
Location: Taipei, Taiwan
Participants Inclusion criteria: males and females, aged 18-60, meetingDSM-IV criteria for borderline personality disorder,
and who engaged in at least 2 episodes of suicidal or non-suicidal self injurious behaviour in the past 5 years
with at least 1 episode occurring in the 3 months preceding randomisation
Exclusion criteria: those diagnosed with bipolar I disorder, delirium, dementia, mental retardation, or a diag-
nosis of substance dependence within the preceding 30 days
Interventions Participants randomised to the intervention group will receive sessions of dialectical behaviour therapy over
a 12-month follow-up period
Outcomes Primary outcome: frequency of suicide attempts as measured by the Suicide Attempt Self Injury Interview at
4, 8, and 12 months
Secondary outcomes: scores on the Borderline Symptom Checklist (BSL-23), the Patient Health Questionnaire
(PHQ-9), the SCL-90-R, BSSI, BHS, Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form
(Q-LES-Q SF), the Clinical Global Impressions-Severity (CGI-S) and Improvement (CGI-I), and the Brief
Disability Questionnaire (BDQ) at 4, 8, and 12 months
Starting date September 2013.
Proposed End Date: August 2016.
Contact information Name: Hui-Chun Huang (Assistant Investigator)
Affiliation: Mackay Memorial Hospital
email: aihch@yahoo.com.tw
Notes Hui-Chun Huang very kindly provided unpublished information relating to this trial
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Leybman 2014
Trial name or title Commitment and Motivation in a Brief DBT Intervention for Self Harm
Trial registration number:NCT02354183.
Methods Allocation: single blind randomisation
Design: single-centre
Setting: centre for addiction and mental health
Location: Canada
Participants Inclusion criteria: males and females, with borderline personality disorder, 18-80 years of age, with at least 3
self-harm episodes (either suicidal or non-suicidal) in the past 5 years, including at least 1 in the past eight
weeks
N expected: 120
Exclusion criteria: evidence of organic brain syndrome or mental retardation
Interventions A 1-hour orientation session consisting of DBT commitment strategies plus psychoeducation. Therapists
will also use commitment strategies to discuss goals related to self-harm. The psychoeducation will consist of
information about DBT’s biosocial theory and about why people self-harm. All participants will complete a
DBT skills training group after their orientation
Outcomes Primary outcome: change in autonomous and controlledmotivation (Autonomous and ControlledMotivation
for Treatment Questionnaire)
Secondary outcomes: change in frequency and severity of self-harmbehaviour (Deliberate Self-Harm Inventory)
Starting date April 2015
Proposed End Date: April 2016
Contact information Name: Michelle Leybman
Affiliation: Centre for Addiction & Mental Health, Canada
Email: michelle.leybman@camh.ca
Notes
Liu 2007
Trial name or title Effect of Psychosocial Treatment by the Case Manager in Patients After a Suicide Attempt
Trial registration number:NCT00664872.
Methods Allocation: single blind randomisation
Design: single centre, hospital-based intervention
Setting: hospital
Follow-up period: 6 and 12 months
Location: Taipei, Taiwan
Participants Inclusion criteria: males and females, 18 years of age and older, who engaged in at least 1 episode of self-harm
within 6 months prior to randomisation
Interventions Participants randomised to the intervention group will receive 6 sessions of a proactive psychosocial interven-
tion for a 4-month period. Each session will last approximately 30 min and will consist of telephone or face-
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Liu 2007 (Continued)
to-face contact with the case manager at regular, scheduled intervals or when clinically necessary. Psychother-
apy will consist of both cognitive-behavioural and problem-solving therapy and will be delivered by trained
psychologists
Outcomes Primary outcomes: the proportion of patients who self-report a subsequent episode of self-harm or a suicide
attempt at the 6- and 12-month follow-up and the number of suicides at the 6- and 12-month follow-up
Secondary outcomes: treatment attendance and adherence at the 6- and 12-month follow-up periods, types
and number of contacts with healthcare services at the 6- and 12-month follow-up periods, scores on suicidal
ideation as measured by the BSSI at the 6-month follow-up period, scores on depression as measured by the
HRSD, and the 21-item BDI over the 6-month follow-up period, and patient satisfaction with treatment at
the 6- and 12-month follow-up assessments
Starting date August, 2007.
End date: July, 2008.
Contact information Name: Dr. Shen-Ing Liu.
Affiliation: Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan
email: maryliuyip@gmail.com
Notes Dr Liu very kindly provided unpublished information relating to this trial
McMain 2015
Trial name or title DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical &Cost Effectiveness of a
6 mo. Treatment (FASTER-DBT)
Trial registration number:NCT02387736.
Methods Allocation: single blind randomisation (outcomes assessor)
Location: Greater Toronto or Vancouver area, Canada
Participants Inclusion criteria: males and females, aged 18-40 years, diagnosed with borderline personality disorder, with
at least 2 self-harm episodes (either suicidal or non-suicidal) in the past 5 years, including at least 1 in the
past 8 weeks; with absence of 8 or more standard weeks of DBT in the past year
Exclusion criteria: meets the DSM-IV criteria for a psychotic disorder; with an IQ of less than 70; with chronic
or serious physical health problem requiring hospitalization within the next year
N expected: 240
Interventions Compare 6 months v 12 months of DBT.
Outcomes Primary outcome: change in frequency and severity of suicide and self-harm behaviours over time as measured
by the Suicide Attempt Self-Injury Interview (SASII)
Secondary outcomes: changes in health care use as measured by the Treatment History Interview-2 (THI-
2); general functioning as measured by the Euroqol-5D; BPD symptoms as measured by the Borderline
Symptom List-23 (BSL-23); general psychopathology and symptoms, as measures by the Symptom Checklist
90 Revised (SCL-90R); anger as measured by the State-Trait Anger Expression Inventory-2 (STAXI-2);
depression as measured by the Beck Depression Inventory-II (BDI-II); interpersonal functioning as measured
by the Inventory of Interpersonal Problems-64 (IIP-64)
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McMain 2015 (Continued)
Starting date February 2015
End date: March 2019
Contact information Name: Shelly McMain
Affiliation: Centre for Addiction and Mental Health, Simon Fraser University
email: not given - contact: mariana.mendozaalvarez@camh.ca
Notes
O’Connor 2011
Trial name or title Improving Care Provided to Patients Treated in a Level 1 Trauma Center Post-suicide Attempt
Trial registration number:NCT01355848.
Methods Allocation: single blind randomisation
Design: single centre (hospital-based), pre-post design
Setting: acute inpatient medical setting
Location: Seattle, WA, USA
Participants Inclusion criteria: males and females, of any age, who are admitted to a medical or surgical ward following a
suicide attempt. Those with psychiatric diagnoses will not be excluded from participation
Interventions Those randomised to the experimental group will receive a brief intervention consisting of a stepped care
protocol, including building rapport, functional analysis of suicidal behavior, and crisis planning for medically
admitted suicide attempt survivors in addition to usual care
Outcomes Primary outcome: scores on the Patient Satisfaction Questionnaire post-intervention
Secondary outcomes: scores on the BSSI, Self Injury, Readiness to Change, and Reasons for Living scales post-
intervention
Starting date May, 2011.
End date: June, 2013.
Contact information Name: Prof. Stephen O’Connor (PI).
Affiliation: Western Kentucky University.
email: stephen.oconnor@wku.edu
Notes Prof Stephen O’Connor very kindly provided unpublished information relating to this trial
O’Connor 2012
Trial name or title A help sheet to reduce self-harm among people admitted to hospital for self-harm
Trial registration number: ISRCTN99488269.
Methods Allocation: randomised
Design: single centre (hospital based)
Setting: hospital
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O’Connor 2012 (Continued)
Location: Edinburgh, Scotland
Participants Inclusion criteria: males and females, 16 years or older, admitted to the Royal Infirmary of Edinburgh with
self-harm, who have a history of prior self-harm including both hospital-treated and non-hospital-treated
episodes, and those with suicidal intent associated with the present attempt necessitating admission to the
Royal Infirmary of Edinburgh
Exclusion criteria: those under 16 years of age, with no history of self-harming behaviour prior to the present
episode, those with no reported suicidal intent associated with the present episode, those unfit for interview,
those unable to provide informed consent, those for whom English is not their first language, those par-
ticipating in other research at the Royal Infirmary of Edinburgh, and those who present to the emergency
department but who are subsequently discharged without hospital admission
N= 518: 259 in each arm of the trial
Interventions Individuals randomised to the experimental group will receive TAU in addition to completing the Volitional
Help Sheet with the assistance of a research assistant. A carbon copy of this sheet will also be produced so
that participants can take home a copy of the Volitional Help Sheet to refer to as necessary. Approximately 2
months post-baseline, individuals randomised to the experimental group will receive a similar “booster” help
sheet and a covering letter explaining that the Volitional Help Sheet can be completed again if required
Outcomes Primary outcomes: repetition of self-harm necessitating hospital admission to any hospital in Scotland during
the 6-month follow-up period, number of re-presentations to hospital for self-harm during the 6-month
follow-up period, and cost-effectiveness of the VolitionalHelp Sheet, asmeasured by the estimated incremental
cost per episode of self-harm or suicide averted
Secondary outcomes: Time to re-presentation to any hospital in Scotland with self-harm during the 6-month
follow-up period measured in weeks, months, or both
Starting date April, 2012.
Proposed End Date: April, 2015.
Contact information Name: Prof. Rory O’Connor (PI).Affiliation: The University of Glasgow.Email:
Rory.OConnor@glasgow.ac.uk
Notes Prof Rory O’Connor very kindly provided unpublished information relating to this trial. Additionally, Prof
O’Connor provided the following to describe the theoretical basis, content, and purpose of the Volitional
Help Sheet: “The intervention takes the form of a help sheet (Armitage 2008), which is developed from
three well established theoretical perspectives and previous research: Gollwitzer’s concept of Implementation
Interventions (Gollwitzer 1993), Prochaska and DiClemente’s trans-theoretical model (Prochaska 1983),
IntegratedMotivational-VolitionalModel of suicidal behaviour (IMV;O’Connor 2011) and previouswork on
self-harm (e.g., O’Connor 2006; O’Connor 2009; Hawton 2006). In essence, the help sheet is a behavioural
change technique which encourages participants to link critical situations in which they are tempted to self-
harm with alternative responses/solutions.”
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O’Connor 2014
Trial name or title Pilot study of a brief intervention for medically hospitalised suicide attempt survivors
Trial registration number: NCT02414763.
Methods Allocation: single blind randomisation
Design: single centre (hospital-based), longitudinal design
Setting: level 1 trauma centre
Location: Nashville, TN, USA
Participants Inclusion criteria: males and females over 17 years of age, who are admitted to a medical or surgical ward
following a suicide attempt. Those with psychiatric diagnoses will not be excluded from participation
Interventions Those randomised to the intervention group will receive a brief intervention of a stepped care protocol,
including building rapport, functional analysis of suicidal behavior, and crisis planning for medically admitted
suicide attempt survivors in addition to usual care
Outcomes Primary outcomes: Scores on the Patient Satisfaction Questionnaire, the Readiness to Change, Reasons for
Living, Perceived Burdensomeness, Thwarted Belongingness, Acquired Capability, and Scale for Suicidal
Ideation scales post-intervention. In addition, investigators will assess repetition of suicide attempts and non-
suicidal self-injury post-intervention
Starting date Proposed start date: October 2014
Proposed end date: September 2016
Contact information Name: Prof Stephen O’Connor (Principal investigator)
Affiliation: Western Kentucky University
email: stephen.oconnor@wku.edu
Notes Prof Stephen O’Connor very kindly provided unpublished information relating to this trial
Pham-Scottez 2009
Trial name or title Effectiveness of a 24 hour phone line on the rate of suicide attempts in borderline patients
Trial registration number:NCT00603421.
Methods Allocation: single blind, parallel assignment, randomisation
Design: multicentre.
Setting: in- and outpatient clinics
Location: various locations around Paris, France
Follow-up period: 1 year
Participants Inclusion criteria: males and females, aged 18-40 years, diagnosed with borderline personality disorder, treated
as in- or outpatients at 1 of the trial recruiting centres (Hôpital St Anne and Hôpital Cichin Centre de
Recherche Clinque Paris), and able to provide written informed consent
Exclusion criteria: those below18 or over 40 years of age, those diagnosedwith schizophrenia or a severe somatic
disorder, those who refuse consent to participate, and those already participating in another intervention trial
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Pham-Scottez 2009 (Continued)
Interventions Participants randomised to the intervention arm will receive 1 year of access to a 24 h crisis phone line
monitored by a team of psychiatrists with experience treating borderline personality disorder patients in
addition to TAU
Outcomes Primary outcome measure: annualised rate of suicide attempts
Secondary outcome measure: annualised rate of self injurious behaviour
Starting date February 2009.
Estimated end date: September 2014
Contact information Name: Dr Alexandra Pham-Scottez
Affiliation: Centre Hôspitalier Sainte Anne
email: a.pham@ch-sainte-anne.fr
Notes We made 3 attempts to contact Dr Pham-Scottez to confirm these details; however, we received no response
and so were unable to confirm whether all participants either engaged in deliberate self-harm or made a
suicide attempt within 6 months prior to randomisation. We extracted information for this trial from the
ClinicalTrials.gov record
Sayal 2015
Trial name or title RCT of the Clinical and Cost Effectiveness of Cognitive Behaviour Therapy (CBT) Delivered Remotely
Versus Treatment as Usual in Adolescents and Young Adults With Depression Who Repeatedly Self-harm
(eDASH)
Trial registration number:NCT02377011.
Methods Allocation: single-blind randomisation
Design: single centre
Setting: hospital
Location: Chesterfield Royal Hospital NHS Foundation Trust
Participants Inclusion criteria: males and females, aged 16-30 years; within 96 hours of last self-harmpresentation (self-harm
as defined by NICE criteria); with >2 self-harm episodes; with high levels of unipolar depressive symptoms
(BDI-2 score of 17 or more)
Exclusion criteria: clinical judgement of high level of suicide risk, other risk to self or others requiring other
urgent approaches; other severe mental illness; currently receiving structured psychological therapy
N expected:120
Interventions Problem solving cognitive behaviour therapy (PS CBT) will be delivered remotely by means of telephone or
video calling by a cognitive behaviour therapist in addition to their usual care
Outcomes Primary outcome measure: Beck Depression Inventory ((BDI-II) at 6 months
Secondary outcome measures: Beck Depression Inventory (V2); Patient Health Questionnaire 9 (PHQ-9);
Beck hopelessness scale; Columbia Suicide Severity Rating Scale (CSSRS); social functioning (Work and
Social Adjustment Scale (WSAS)); quality of life (EQ-5D); cost effectiveness (modified version of the CSRI)
; qualitative interviews. All measured at 12 months
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Sayal 2015 (Continued)
Starting date January 2014.
Estimated end date: December 2017
Contact information Kapil.sayal@nottingham.ac.uk
Notes
Vaiva 2011
Trial name or title ALGOS.
Trial registration number:NCT01123174.
Methods Allocation: single-blind randomisation
Design: multicentre.
Setting: 23 community mental health centres
Follow-up period: 6 and 14 months
Location: various locations around France
Participants Inclusion criteria: males and females, over 18 years of age, who present to emergency departments following
an episode of attempted suicide
Exclusion criteria: multiple repeaters, those with 4 or more suicide attempts in the preceding 3 years
Expected N: 900
Interventions Using the ALGOS algorithm, a decision tree concerning the type of contact a participant should receive based
on his or her number of previous suicide attempts, first-time attempters randomised to the experimental
group will receive a crisis card. Those with 1-3 previous suicide attempts in the preceding 3 years, on the other
hand, will receive telephone contact on the 10th and 21st day following the most recent suicide attempt, and
postcard contact for 5 months
Outcomes Primary outcome: number of participants who subsequently make a suicide attempt during the follow-up
period
Secondary outcomes: number of deaths by suicide, scores on the BSSI, psychopathology as assessed by scores
on the MINI, number of health care contacts, and a medico-economic assessment of the costs of ALGOS
Starting date February, 2010.
Proposed end date: April, 2014.
Contact information Name: Prof. Guillaume Vaiva (PI).
Affiliation: Centre Hospitalier Régional Universitaire de Lille.
email: guillaume.vaiva@chru-lille.fr
Notes Prof Guillaume Vaiva very kindly provided unpublished information relating to this trial
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van den Bosch 2013
Trial name or title Intensified, Inpatient Adaptation of Dialectical Behavior Therapy (DBT) REDBT
Trial registration number:NCT01904227.
Methods Allocation: randomised, open label
Design: single centre
Setting: inpatient and outpatient (different arms of trial - Jelgersma Treatment Centre, or the outpatient DBT
programs of Rivierduinen)
Location: Netherlands
Participants Inclusion criteria: males and females, aged 18 to 40 years, with severe borderline personality disorder( > 24 on
the BPDSI), admitted to hospital with suicidal and/or self-harming behavior in the year preceding the start
of DBT treatment, including the last month preceding baseline measurement
Exclusion criteria: IQ < 80; a chronic psychotic condition; bipolar disorder; hard drug abuse that requires
inpatient detoxification; forced treatment framework; DBT in the year preceding intake
Expected N: 150
Interventions Inpatient DBT v outpatient DBT
Outcomes Primary outcome: change in number of suicide attempts/self-harming acts.
Secondary outcomes: change in severity of borderline symptomatology (BPDSI).
Starting date February 2012
Proposed end date: April 2015 (no longer recruiting)
Contact information Name: Louisa M van den Bosch
Affiliations: Rivierduinen, Centre for Personality disorders Jelgersma
Email: n/a
Notes
Walker 2012
Trial name or title Women Offenders Repeat Self-Harm Intervention Pilot II.
Trial registration number: ISRCTN18761534.
Methods Allocation: randomisation by minimisation
Design: multicentre (3 closed-category prisons)
Setting: closed-category prisons housing a mixture of remand and sentenced prisoners
Follow-up period: 3 and 6 months
Location: Cheshire, Derby, and Yorkshire, UK
Participants Inclusion criteria: female prisoners, 18 years or older, remanded or sentenced to any 1 of 3 prisons for any
offence, who have a history of repeated self-harming behaviour with at least 1 incident within the month
prior to randomisation, and are currently on an Assessment, Care in Custody and Teamwork (ACCT). As
the trial does not discriminate between the severity and frequency of self-harming behaviour, previous self-
harming behaviour can range from superficial cuts to ligaturing
Expected N: 120
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Walker 2012 (Continued)
Interventions Participants randomised to the experimental groupwill receiveweekly sessions of psychodynamic interpersonal
therapy for a minimum of 6 weeks. Those randomised to the control group will receive active control
comprising a weekly session of time out of their cell to play card games, read magazines, listen to music,
or to discuss practical topics (e.g., developing financial management skills) with research assistants. Women
randomised to this group are specifically instructed that they cannot discuss emotive topics with research
assistants
Outcomes Primary outcome: scores on Beck’s Scale for Suicidal Ideation immediately post-treatment (3 months) and at
6 months
Secondary outcomes: scores on Beck’s Depression Inventory and Beck’s Hopelessness Inventory immediately
post-treatment (3 months) and at 6 months. Additionally, information on both the frequency and severity
of self-harm and thoughts of self-harm immediately post-treatment (3 months) and at 6 months will be
measured using the Self Harm Incidents Questionnaire. Lastly, information on satisfaction with treatment
will be assessed immediately post-treatment (3 months) using the Intervention Satisfaction Questionnaire
Starting date June, 2013.
Proposed end date: June, 2015.
Contact information Name: Dr. Tammi Walker.
Affiliations: Institute of Brain, Behaviour and Mental Health (University of Manchester) and School of Social
and International Studies (University of Bradford)
Notes Dr Tammi Walker very kindly provided information relating to this trial
AUDIT: Alcohol Use Disorders Identification Test; BHS: Beck Hopelessness Scale; BSSI: Beck scale for suicidal ideation;DAST: drug
abuse screening test; DSM-IV: Diagnostic and Statistical Manual for Mental Disorders, fourth edition; MACT: manual-assisted
cognitive therapy; SAPAS: Standardised Assessment of Personality: Abbreviated Scale; SCL-90-R: Symptom Checklist-90-Revised.
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D A T A A N D A N A L Y S E S
Comparison 1. Cognitive behavioural therapy (CBT)-based psychotherapy vs. treatment as usual (TAU)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Repetition of SH at 6 months 12 1317 Odds Ratio (M-H, Random, 95% CI) 0.54 [0.34, 0.85]
1.1 Individual psychotherapy 11 1083 Odds Ratio (M-H, Random, 95% CI) 0.52 [0.36, 0.75]
1.2 Group-based
psychotherapy
1 234 Odds Ratio (M-H, Random, 95% CI) 1.35 [0.75, 2.41]
2 Repetition of SH at 12 months 10 2232 Odds Ratio (M-H, Random, 95% CI) 0.80 [0.65, 0.98]
2.1 Individual psychotherapy 9 1799 Odds Ratio (M-H, Random, 95% CI) 0.74 [0.59, 0.94]
2.2 Group-based
psychotherapy
1 433 Odds Ratio (M-H, Random, 95% CI) 1.04 [0.67, 1.61]
3 Repetition of SH at 24 months 2 105 Odds Ratio (M-H, Random, 95% CI) 0.31 [0.14, 0.69]
3.1 Indivdual psychotherapy 2 105 Odds Ratio (M-H, Random, 95% CI) 0.31 [0.14, 0.69]
4 Repetition of SH at final follow-
up
17 2665 Odds Ratio (M-H, Random, 95% CI) 0.70 [0.55, 0.88]
4.1 Individual psychotherapy 16 2232 Odds Ratio (M-H, Random, 95% CI) 0.66 [0.53, 0.84]
4.2 Group-based
psychotherapy
1 433 Odds Ratio (M-H, Random, 95% CI) 1.04 [0.67, 1.61]
5 Frequency of SH at final follow-
up
6 594 Mean Difference (IV, Random, 95% CI) -0.21 [-0.68, 0.26]
5.1 Individual psychotherapy 5 161 Mean Difference (IV, Random, 95% CI) -0.66 [-1.71, 0.40]
5.2 Group-based
psychotherapy
1 433 Mean Difference (IV, Random, 95% CI) -0.06 [-0.32, 0.20]
6 Depression scores at 6 months 11 1668 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-0.50, -0.10]
6.1 Individual psychotherapy 10 1434 Std. Mean Difference (IV, Random, 95% CI) -0.33 [-0.56, -0.11]
6.2 Group-based
psychotherapy
1 234 Std. Mean Difference (IV, Random, 95% CI) -0.13 [-0.39, 0.13]
7 Depression scores at 12 months 7 1130 Std. Mean Difference (IV, Random, 95% CI) -0.36 [-0.64, -0.07]
7.1 Individual psychotherapy 7 1130 Std. Mean Difference (IV, Random, 95% CI) -0.36 [-0.64, -0.07]
8 Depression scores at 24 months 2 225 Std. Mean Difference (IV, Random, 95% CI) -0.22 [-0.48, 0.05]
8.1 Individual psychotherapy 2 225 Std. Mean Difference (IV, Random, 95% CI) -0.22 [-0.48, 0.05]
9 Depression scores at final follow-
up
14 1859 Std. Mean Difference (IV, Random, 95% CI) -0.31 [-0.48, -0.14]
9.1 Individual psychotherapy 13 1625 Std. Mean Difference (IV, Random, 95% CI) -0.35 [-0.54, -0.16]
9.2 Group-based
psychotherapy
1 234 Std. Mean Difference (IV, Random, 95% CI) -0.13 [-0.39, 0.13]
10 Hopelessness scores at post-
intervention
3 360 Mean Difference (IV, Random, 95% CI) -1.50 [-3.62, 0.61]
10.1 Individual psychotherapy 2 47 Mean Difference (IV, Random, 95% CI) -4.23 [-8.71, 0.25]
10.2 Group-based
psychotherapy
1 313 Mean Difference (IV, Random, 95% CI) -0.80 [-2.17, 0.57]
11 Hopelessness scores at 6
months
4 968 Std. Mean Difference (IV, Random, 95% CI) -0.36 [-0.58, -0.13]
11.1 Individual psychotherapy 3 734 Std. Mean Difference (IV, Random, 95% CI) -0.48 [-0.63, -0.33]
11.2 Group-based
psychotherapy
1 234 Std. Mean Difference (IV, Random, 95% CI) -0.05 [-0.31, 0.21]
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12 Hopelessness scores at 12
months
3 539 Mean Difference (IV, Random, 95% CI) -1.89 [-2.97, -0.81]
12.1 Individual psychotherapy 3 539 Mean Difference (IV, Random, 95% CI) -1.89 [-2.97, -0.81]
13 Hopelessness scores at final
follow-up
7 1017 Std. Mean Difference (IV, Random, 95% CI) -0.31 [-0.51, -0.10]
13.1 Individual psychotherapy 6 783 Std. Mean Difference (IV, Random, 95% CI) -0.38 [-0.60, -0.16]
13.2 Group-based
psychotherapy
1 234 Std. Mean Difference (IV, Random, 95% CI) -0.05 [-0.31, 0.21]
14 Suicidal ideation scores at post-
intervention
3 360 Mean Difference (IV, Random, 95% CI) -2.52 [-5.60, 0.56]
14.1 Individual psychotherapy 2 47 Mean Difference (IV, Random, 95% CI) -5.92 [-11.98, 0.14]
14.2 Group-based
psychotherapy
1 313 Mean Difference (IV, Random, 95% CI) -1.50 [-3.50, 0.50]
15 Suicidal ideation scores at 6
months
6 1011 Std. Mean Difference (IV, Random, 95% CI) -0.32 [-0.51, -0.13]
15.1 Individual psychotherapy 5 777 Std. Mean Difference (IV, Random, 95% CI) -0.41 [-0.55, -0.27]
15.2 Group-based
psychotherapy
1 234 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.28, 0.24]
16 Suicidal ideation scores at final
follow-up
8 1131 Std. Mean Difference (IV, Random, 95% CI) -0.28 [-0.47, -0.09]
16.1 Individual psychotherapy 7 818 Std. Mean Difference (IV, Random, 95% CI) -0.35 [-0.55, -0.15]
16.2 Group-based
psychotherapy
1 313 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.24, 0.20]
17 Proportion with improved
problems at 6 months
2 231 Odds Ratio (M-H, Random, 95% CI) 2.81 [1.50, 5.24]
17.1 Individual psychotherapy 2 231 Odds Ratio (M-H, Random, 95% CI) 2.81 [1.50, 5.24]
18 Proportion with improved
problems at final follow-up
2 211 Odds Ratio (M-H, Random, 95% CI) 3.03 [0.74, 12.41]
18.1 Individual psychotherapy 2 211 Odds Ratio (M-H, Random, 95% CI) 3.03 [0.74, 12.41]
19 Problem-solving scores at post-
intervention
2 328 Std. Mean Difference (IV, Random, 95% CI) 0.15 [-0.07, 0.36]
19.1 Individual psychotherapy 1 15 Std. Mean Difference (IV, Random, 95% CI) 0.29 [-0.79, 1.37]
19.2 Group-based
psychotherapy
1 313 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.08, 0.36]
20 Problem-solving scores at 6
months
4 949 Std. Mean Difference (IV, Random, 95% CI) 0.33 [0.08, 0.58]
20.1 Individual psychotherapy 3 715 Std. Mean Difference (IV, Random, 95% CI) 0.45 [0.30, 0.60]
20.2 Group-based
psychotherapy
1 234 Std. Mean Difference (IV, Random, 95% CI) 0.02 [-0.24, 0.28]
21 Problem-solving scores at final
follow-up
5 958 Std. Mean Difference (IV, Random, 95% CI) 0.26 [0.02, 0.50]
21.1 Individual psychotherapy 4 724 Std. Mean Difference (IV, Random, 95% CI) 0.35 [0.04, 0.66]
21.2 Group-based
psychotherapy
1 234 Std. Mean Difference (IV, Random, 95% CI) 0.02 [-0.24, 0.28]
22 Suicide at final follow-up 15 2354 Odds Ratio (M-H, Random, 95% CI) 0.66 [0.29, 1.51]
22.1 Individual psychotherapy 14 1921 Odds Ratio (M-H, Random, 95% CI) 0.69 [0.29, 1.67]
22.2 Group-based
psychotherapy
1 433 Odds Ratio (M-H, Random, 95% CI) 0.47 [0.04, 5.25]
238Psychosocial interventions for self-harm in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 2. Interventions for multiple repetition of self-harm (SH)/probable personality disorder vs treatment
as usual (TAU) or other alternative forms of psychotherapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Repetition of SH at post-
intervention
9 Odds Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Group-based emotion-
regulation psychotherapy vs
TAU
2 83 Odds Ratio (M-H, Random, 95% CI) 0.34 [0.13, 0.88]
1.2 Mentalisation vs TAU 1 134 Odds Ratio (M-H, Random, 95% CI) 0.35 [0.17, 0.73]
1.3 DBT-oriented therapy
vs Alternative forms of
psychotherapy
1 24 Odds Ratio (M-H, Random, 95% CI) 0.05 [0.00, 0.49]
1.4 DBT vs TAU 3 267 Odds Ratio (M-H, Random, 95% CI) 0.59 [0.16, 2.15]
1.5 DBT vs treatment by
expert
1 97 Odds Ratio (M-H, Random, 95% CI) 1.66 [0.53, 5.20]
1.6 DBT prolonged exposure
vs DBT standard exposure
1 18 Odds Ratio (M-H, Random, 95% CI) 0.67 [0.08, 5.68]
2 Repetition of SH at 6 months 1 Odds Ratio (M-H, Random, 95% CI) Subtotals only
2.1 DBT prolonged exposure
vs DBT standard exposure
1 18 Odds Ratio (M-H, Random, 95% CI) 0.67 [0.08, 5.68]
3 Repetition of SH at 12 months 3 Odds Ratio (M-H, Random, 95% CI) Subtotals only
3.1 DBT vs. TAU 2 172 Odds Ratio (M-H, Random, 95% CI) 0.36 [0.05, 2.47]
3.2 DBT vs treatment by
expert
1 97 Odds Ratio (M-H, Random, 95% CI) 1.18 [0.35, 3.95]
4 Repetition of SH at final follow-
up
3 Odds Ratio (M-H, Random, 95% CI) Subtotals only
4.1 DBT vs TAU 3 247 Odds Ratio (M-H, Random, 95% CI) 0.57 [0.21, 1.59]
5 Frequency of repetition of SH at
post-intervention
9 Mean Difference (IV, Random, 95% CI) Subtotals only
5.1 Group-based emotion-
regulation psychotherapy vs
TAU
2 83 Mean Difference (IV, Random, 95% CI) -12.76 [-34.92, 9.
40]
5.2 Mentalisaiton vs TAU 1 134 Mean Difference (IV, Random, 95% CI) -1.28 [-2.01, -0.55]
5.3 DBT-oriented therapy
vs Alternative forms of
psychotherapy
1 24 Mean Difference (IV, Random, 95% CI) -4.83 [-7.90, -1.76]
5.4 DBT vs TAU 3 292 Mean Difference (IV, Random, 95% CI) -18.82 [-36.68, -0.
95]
5.5 DBT vs treatment by
expert
1 97 Mean Difference (IV, Random, 95% CI) -14.85 [-37.64, 7.
94]
5.6 DBT prolonged exposure
vs DBT standard exposure
1 18 Mean Difference (IV, Random, 95% CI) -0.25 [-2.47, 1.97]
6 Frequency of repetition of SH at
6 months
1 Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 DBT prolonged exposure
vs DBT standard exposure
1 18 Mean Difference (IV, Random, 95% CI) 0.34 [-0.61, 1.29]
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7 Number completing full course
of treatment
3 Odds Ratio (M-H, Random, 95% CI) Subtotals only
7.1 Mentalisation vs TAU 1 134 Odds Ratio (M-H, Random, 95% CI) 0.93 [0.43, 2.02]
7.2 DBT-oriented therapy vs
TAU
1 24 Odds Ratio (M-H, Random, 95% CI) 3.0 [0.53, 16.90]
7.3 DBT prolonged exposure
vs DBT standard exposure
1 26 Odds Ratio (M-H, Random, 95% CI) 1.14 [0.22, 5.84]
8 Depression scores at post-
intervention
8 Mean Difference (IV, Random, 95% CI) Subtotals only
8.1 Group-based emotion-
regulation psychotherapy vs
TAU
2 83 Mean Difference (IV, Random, 95% CI) -9.59 [-13.43, -5.75]
8.2 Mentalisaiton vs TAU 1 134 Mean Difference (IV, Random, 95% CI) -3.88 [-6.82, -0.94]
8.3 DBT-oriented therapy
vs Alternative forms of
psychotherapy
1 24 Mean Difference (IV, Random, 95% CI) -9.16 [-14.79, -3.53]
8.4 DBT vs TAU 2 198 Mean Difference (IV, Random, 95% CI) -2.37 [-6.52, 1.78]
8.5 DBT vs treatment by
expert
1 89 Mean Difference (IV, Random, 95% CI) -3.0 [-6.27, 0.27]
8.6 DBT prolonged exposure
vs DBT standard exposure
1 18 Mean Difference (IV, Random, 95% CI) -3.70 [-10.59, 3.19]
9 Depression scores at 6 months 1 Mean Difference (IV, Random, 95% CI) Subtotals only
9.1 DBT prolonged exposure
vs. DBT standard exposure
1 18 Mean Difference (IV, Random, 95% CI) -4.30 [-9.68, 1.08]
10 Depression scores at 12 months 1 Mean Difference (IV, Random, 95% CI) Subtotals only
10.1 DBT vs treatment by
expert
1 81 Mean Difference (IV, Random, 95% CI) -1.80 [-5.40, 1.80]
11 Suicide ideation scores at post-
intervention
2 Mean Difference (IV, Random, 95% CI) Subtotals only
11.1 DBT-oriented therapy
vs Alternative forms of
psychotherapy
1 24 Mean Difference (IV, Random, 95% CI) -7.75 [-14.66, -0.84]
11.2 DBT vs treatment by
expert
1 89 Mean Difference (IV, Random, 95% CI) -1.00 [-13.69, 7.69]
12 Suicide ideation scores at 12
months
1 Mean Difference (IV, Random, 95% CI) Subtotals only
12.1 DBT vs treatment by
expert
1 81 Mean Difference (IV, Random, 95% CI) -7.82 [-18.38, 2.74]
13 Suicide at post-intervention 3 Odds Ratio (M-H, Random, 95% CI) Subtotals only
13.1 DBT vs TAU 3 317 Odds Ratio (M-H, Random, 95% CI) 3.0 [0.12, 76.49]
14 Suicide at 6 months 1 Odds Ratio (M-H, Random, 95% CI) Subtotals only
14.1 DBT prolonged exposure
vs DBT standard exposure
1 26 Odds Ratio (M-H, Random, 95% CI) 0.16 [0.01, 4.41]
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Comparison 3. Case management vs treatment as usual (TAU) or other alternative forms of psychotherapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Repetition of SH at post-
intervention
4 1608 Odds Ratio (M-H, Random, 95% CI) 0.78 [0.47, 1.30]
1.1 Case management plus
assertive outreach vs TAU
3 843 Odds Ratio (M-H, Random, 95% CI) 0.82 [0.38, 1.78]
1.2 Case management plus
assertive outreach vs enhanced
usual care
1 765 Odds Ratio (M-H, Random, 95% CI) 0.67 [0.40, 1.10]
2 Suicide at post-intervention 4 1757 Odds Ratio (M-H, Random, 95% CI) 0.95 [0.57, 1.57]
2.1 Case management plus
assertive outreach vs TAU
3 843 Odds Ratio (M-H, Random, 95% CI) 1.77 [0.36, 8.68]
2.2 Case management plus
assertive outreach vs enhanced
usual care
1 914 Odds Ratio (M-H, Random, 95% CI) 0.88 [0.52, 1.51]
Comparison 4. Treatment adherence enhancement approaches vs treatment as usual (TAU) or other alternative
forms of psychotherapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Repetition of SH at 12 months 2 Odds Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Adherence enhancement
vs TAU
1 391 Odds Ratio (M-H, Random, 95% CI) 0.57 [0.32, 1.02]
1.2 Continuity of care
by the same therapist vs
other alternative forms of
psychotherapy
1 136 Odds Ratio (M-H, Random, 95% CI) 0.28 [0.07, 1.10]
2 Depression scores at 12 months 1 Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Continuity of care
by the same therapist vs
other alternative forms of
psychotherapy
1 127 Mean Difference (IV, Random, 95% CI) -1.40 [-4.24, 1.44]
3 Suicide at 12 months 2 Odds Ratio (M-H, Random, 95% CI) Subtotals only
3.1 Adherence enhancement
vs TAU
1 391 Odds Ratio (M-H, Random, 95% CI) 0.85 [0.28, 2.57]
3.2 Continuity of care
by the same therapist vs
other alternative forms of
psychotherapy
1 136 Odds Ratio (M-H, Random, 95% CI) 0.62 [0.10, 3.82]
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Comparison 5. Remote contact interventions vs treatment as usual (TAU)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Repetition of SH at post-
intervention
8 Odds Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Postcards vs TAU 4 3277 Odds Ratio (M-H, Random, 95% CI) 0.87 [0.62, 1.23]
1.2 Emergency cards vs TAU 2 1039 Odds Ratio (M-H, Random, 95% CI) 0.82 [0.31, 2.14]
1.3 GP letter vs TAU 1 1932 Odds Ratio (M-H, Random, 95% CI) 1.15 [0.93, 1.44]
1.4 Mobile telephone-based
psychotherapy vs TAU
1 68 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Repetition of SH at 12 months 4 Odds Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Postcards vs TAU 2 2885 Odds Ratio (M-H, Random, 95% CI) 0.76 [0.57, 1.02]
2.2 Emergency cards vs TAU 1 827 Odds Ratio (M-H, Random, 95% CI) 1.19 [0.85, 1.67]
2.3 Telephone contact vs TAU 1 172 Odds Ratio (M-H, Random, 95% CI) 1.00 [0.45, 2.23]
3 Repetition of SH at final follow-
up
7 Odds Ratio (M-H, Random, 95% CI) Subtotals only
3.1 Postcards vs TAU 4 3277 Odds Ratio (M-H, Random, 95% CI) 0.88 [0.62, 1.25]
3.2 Telephone contact vs TAU 3 840 Odds Ratio (M-H, Random, 95% CI) 0.74 [0.42, 1.32]
4 Frequency of SH at post-
intervention
3 Mean Difference (IV, Random, 95% CI) Subtotals only
4.1 Postcards vs TAU 3 1097 Mean Difference (IV, Random, 95% CI) -0.07 [-0.32, 0.18]
4.2 Postcards vs TAU (males
only)
3 401 Mean Difference (IV, Random, 95% CI) -0.00 [-0.13, 0.12]
4.3 Postcards vs TAU (females
only)
3 695 Mean Difference (IV, Random, 95% CI) -0.04 [-0.29, 0.20]
4.4 Postcards vs TAU (history
of prior SH)
3 339 Mean Difference (IV, Random, 95% CI) -0.09 [-0.68, 0.51]
4.5 Postcards vs TAU (no
history of prior SH)
3 758 Mean Difference (IV, Random, 95% CI) 0.23 [-0.32, 0.77]
5 Frequency of SH at 12 months 2 Mean Difference (IV, Random, 95% CI) Subtotals only
5.1 Postcards vs TAU 2 984 Mean Difference (IV, Random, 95% CI) -0.19 [-0.58, 0.20]
5.2 Postcards vs TAU (males
only)
2 336 Mean Difference (IV, Random, 95% CI) 0.03 [-0.11, 0.16]
5.3 Postcards vs TAU (females
only)
2 647 Mean Difference (IV, Random, 95% CI) -0.22 [-0.62, 0.18]
5.4 Postcards vs TAU (history
of prior SH)
2 296 Mean Difference (IV, Random, 95% CI) -0.64 [-2.07, 0.80]
5.5 Postcards vs TAU (no
history of prior SH)
2 688 Mean Difference (IV, Random, 95% CI) -0.07 [-0.22, 0.09]
6 Suicide at post-intervention 5 Odds Ratio (M-H, Random, 95% CI) Subtotals only
6.1 Postcards vs TAU 4 3464 Odds Ratio (M-H, Random, 95% CI) 1.86 [0.61, 5.72]
6.2 Mobile telephone-based
psychotherapy vs TAU
1 68 Odds Ratio (M-H, Random, 95% CI) 3.09 [0.12, 78.55]
7 Suicide at 12 months 1 772 Odds Ratio (M-H, Random, 95% CI) 0.41 [0.08, 2.15]
7.1 Postcards vs TAU 1 772 Odds Ratio (M-H, Random, 95% CI) 0.41 [0.08, 2.15]
8 Suicide at final follow-up 2 Odds Ratio (M-H, Random, 95% CI) Subtotals only
8.1 Telephone contact vs TAU 2 821 Odds Ratio (M-H, Random, 95% CI) 0.70 [0.11, 4.33]
242Psychosocial interventions for self-harm in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 6. Other mixed interventions versus treatment as usual (TAU) or other alternative forms of psy-
chotherapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Repetition of SH at final follow-
up
2 Odds Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Intensive outpatient
intervention vs TAU
2 245 Odds Ratio (M-H, Random, 95% CI) 0.65 [0.15, 2.85]
A D D I T I O N A L T A B L E S
Table 1. Proportion of the sample with a history of self-harm prior to the index attempt
Reference History of SH prior
to index episode
(%)
Fleischmann 2008 21.1
Hawton 1981 32.3
Hawton 1987a 31.2
Hassanian-Moghaddam 2011 34.2
Hvid 2011 38.3
Vaiva 2006 8.9a
Van Heeringen 1995 29.8
Waterhouse 1990 36.4
aProportion with more than four previous episodes of SH over the three-year period preceding trial entry.
Table 2. Methods used for the index episode of self-harm in included studies
Reference Methoda
Self poisoning
(any)
n (%)
Self poisoning
(pesticides)
n (%)
Self injury (any)
n (%)
Combined self-
poisoning and self-
injury
n (%)
Unspecified
n (%)
Beautrais 2010b 250 (76.7) - 64 (19.6) - 15 (4.6)
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Table 2. Methods used for the index episode of self-harm in included studies (Continued)
Bennewith 2002 7,733 (89.7) - 158 (8.2) - 41 (2.1)
Brown 2005 70 (58.3) - 33 (27.5) - 17 (14.2)
Carter 2005 772 (100) - - - -
Clarke 2002b 442 (94.6) - 25 (5.3) 8 (1.7) -
Crawford 2010c 74 (71.8) - 25 (24.3) - -
Evans 1999a 808 (97.7) - - - 19 (2.3)
Gibbons 1978 400 (100) - - - -
Guthrie 2001 119 (100) - - - -
Harned 2014 - - 26 (100) - -
Hassanian-
Moghaddam 2011
2300 (100) - - - -
Hatcher 2011 471 (85.3) - 81 (14.7) - -
Hatcher 2015 532 (77.8) - 125 (18.3) 27 (3.9) -
Hatcher 2016a 115 (68.9) - 41 (24.5) 11 (6.6) -
Hawton 1981 96 (100) - - -
Hawton 1987a 80 (100) - - -
Husain 2014b 65 (29.4) 167 (75.6) 4 (1.8) - -
Kawanishi 2014b 707 (77.3) - 332 (36.3) - 42 (4.6)
McAuliffe 2014d 161 (37.2) - 57 (13.2) - 4 (0.9)
Morgan 1993 207 (97.6) - - - 5 (2.4)
McLeavey 1994 39 (100) - - - -
Torhorst 1987 141 (100) - - - -
Torhorst 1988 80 (100) - - - -
Vaiva 2006 605 (100) - - - -
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Table 2. Methods used for the index episode of self-harm in included studies (Continued)
Van der Sande
1997a
232 (84.7) - - - 42 (15.3)
Van Heeringen
1995
463 (89.7) - - - 53 (10.3)
Waterhouse 1990 77 (100) - - - -
Welu 1977 - 120 (100) - -
aRefers to the methods used for the index episode.
b Percentages are greater than 100% because participants may have used multiple methods.
c The remaining four (3.9%) participants used multiple, unspecified methods.
d Methods of self-harm for the remaining 211 (48.7%) participants were not provided.
Table 3. Major categories of psychiatric diagnoses in included studies
Refer-
ence
Psychiatric diagnosisa
Major
depres-
sion
n (%)
Any
other
mood
disor-
der
n (%)
Any
anxi-
ety dis-
order
n (%)
Any
psy-
chotic
disor-
der
n (%)
Post-
trau-
matic
stress
n (%)
Any
eat-
ing dis-
order
n (%)
Alco-
hol
use dis-
order/
depen-
dence
n (%)
Drug
use dis-
order/
depen-
dence
n (%)
Sub-
stance
use dis-
order/
depen-
dence
n (%)
Adjust-
ment
disor-
der
n (%)
Bor-
derline
per-
sonal-
ity dis-
order
n (%)
Any
other
per-
sonal-
ity dis-
order n
(%)
Allard
1992
130(86.
7)
- - - - - - - 79 (52.
7)
- - 68 (45.
3)
Bate-
man
2009
75 (56.
0)
103
(76.9)
82 (61.
2)
19 (14.
2)
37 (27.
6)
- - 72 (53.
7)
- 134
(100)
b
Beau-
trais
2010
No information on psychiatric diagnosis reported
Ben-
newith
2002
No information on psychiatric diagnosis reported
Brown
2005
92 (77.
0)
- - - - - 36 (30.
0)
48 (40.
0)
82 (68.
0)
- - -
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Table 3. Major categories of psychiatric diagnoses in included studies (Continued)
Carter
2005
No information on specific categories of psychiatric diagnosis reportedc
Ced-
ereke
2002d
- 91 (42.
1)
- - - - - - - 62 (28.
7)
- -
Clarke
2002
- 98 (56.
0)e
60 (34.
0)e
12 (3.0) - - 26 (41.
0)f
- - - - -
Craw-
ford
2010
No information on psychiatric diagnosis reported
David-
son
2014
- - - - - - - - - - 17 (85.
0)
20
(100)
Dubois
1999
- - - 43 (42.
1)
- - - - 13 (12.
7)
- - -
Evans
1999a
707/827 (85.5) diagnosed with any major psychiatric disorder
Evans
1999b
No information on psychiatric diagnosis reported
Fleis-
chmann
2008
No information on psychiatric diagnosis reported
Gib-
bons
1978
No information on psychiatric diagnosis reported
Gratz
2006
- - - - - - - - - - 22
(100)
-
Gratz
2014
- 31 (50.
0)
38 (61.
3)
- 22 (35.
5)
8 (12.9) - - 1 (1.6) - 62
(100)
b
Guthrie
2001
No information on psychiatric diagnosis reported
Harned
2014
- 22 (83.
3)
23 (87.
5)
- - 3 (12.5) - - 11 (41.
7)
- 26
(100)
16 (62.
5)
Hassa-
nian-
No information on psychiatric diagnosis reported
246Psychosocial interventions for self-harm in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 3. Major categories of psychiatric diagnoses in included studies (Continued)
Moghad-
dam
2011
Hatcher
2011
No information on psychiatric diagnosis reported
Hatcher
2015
No information on psychiatric diagnosis reported
Hatcher
2016a
No information on psychiatric diagnosis reported
Haw-
ton
1981
No information on psychiatric diagnosis reported
Haw-
ton
1987a
No information on psychiatric diagnosis reported
Husain
2014
No information on psychiatric diagnosis reported
Hvid
2011
No information on specific categories of psychiatric diagnosis reported
Kapur
2013a
No information on psychiatric diagnosis reported
Kawan-
ishi
2014g
- 425(46.
5)
- 179(19.
6)
- - - - 45 (4.9) 191
(20.9)
- -
Liber-
man
1981
- 24
(100)
- - - - - - - - - h
Line-
han
1991
- - - - - - - - - - 44
(100)
-
Line-
han
2006
73 (72.
3)
- 79 (78.
2)
- 50 (49.
5)
24 (23.
8)
- - 30 (29.
7)
- 101
(100)
b
Maras-
inghe
2012
No information on psychiatric diagnosis reported
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Table 3. Major categories of psychiatric diagnoses in included studies (Continued)
McAuliffe
2014
No information on psychiatric diagnosis reported
McLeavey
1994
- 9 (23.1) 1 (2.5) - - - 5 (12.8) - - - - 6 (15.4)
Mc-
Main
2009
88 (48.
9)
- 135
(75.0)
- 71 (37.
4)
24 (13.
3)
- - 17 (9.4) - 180
(100)
b
Mor-
gan
1993
- 53 (25.
0)
- - - - - - - - -
Morthorst
2012
No information on psychiatric diagnosis reportedi
Pat-
siokas
1985
No information on specific categories of psychiatric diagnosis reported
Priebe
2012j
- - - - - - - - - - - 80
(100)
Salkovskis
1990
No information on psychiatric diagnosis reported
Slee
2008
- 80 (88.
9)
50 (55.
6)
- - 15 (16.
7)
- - 15 (16.
7)
- - -
Stewart
2009
No information on psychiatric diagnosis reported
Tapolaa
2010
No information on psychiatric diagnosis reported
Torhorst
1987
No information on psychiatric diagnosis reported
Torhorst
1988
No information on psychiatric diagnosis reported
Turner
2000
- - - - - - - - - - 24
(100)
-
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Table 3. Major categories of psychiatric diagnoses in included studies (Continued)
Tyrer
2003
- - - - - - - - - - - 471(98.
1)
Vaiva
2006
No information on specific categories of psychiatric diagnosis reportedk
Van der
Sande
1997a
- 86 (31.
4)
- - - - - - - 40 (14.
6)
- -
Van
Heerin-
gen
1995
- 76 (14.
7)
14 (2.7) - - - - - - - - -
Water-
house
1990
No information on psychiatric diagnosis reported
Wei
2013
No information on psychiatric diagnosis reportedl
Wein-
berg
2006
- - - - - - - - - - 30
(100)
-
Welu
1977
No information on psychiatric diagnosis reported
a All diagnoses represent current rather than lifetime diagnoses.
b As participants could be diagnosed with more than one axis II diagnosis, the absolute number of participants diagnosed with any
other personality disorder in this trial is unclear.
c Median number (interquartile range) of psychiatric diagnoses in the both the intervention and control groups was 2 (1-3). Information
on specific categories of psychiatric diagnosis; however, were not reported.
d A total of 47/216 (21.7%) of the sample were diagnosed with any psychiatric disorder other than a mood or adjustment disorder.
e Diagnosed with a possible psychiatric disorder according to cut-off scores on the Hamilton Anxiety and Depression Scale (HADS).
Out of a total of 176 participants with complete ratings on this instrument.
f Diagnosed with problematic alcohol use according to cut-off scores on the Alcohol Use Disorders Identification Test (AUDIT). Out
of a total of 63 participants with complete ratings on this instrument.
g An additional 73/914 (8.0%) were diagnosed with any other major psychiatric disorder.
h The authors state that “[m]ost patients would have been given personality disorder designations . . . including histrionic, narcissistic,
borderline, avoidant, and dependent types” (p.1127). The absolute number of participants diagnosed with any one of these personality
disorders in this trial is, however, unclear.
i A total of 14/243 (5.8%) participants had been admitted to a psychiatric inpatient ward in the four weeks prior to the index suicide
attempt. These patients were therefore likely to have been diagnosed with a current major psychiatric illness.
j Mean (standard deviation (SD)) number of axis I psychiatric disorders was 8.0 (3.1) (n = 63) and mean (SD) number of axis II
diagnoses was 3.5 (1.6) (n = 80).
k A total of 100/459 (21.8%) of participants had, however, been referred for psychiatric treatment at the time of the index suicide
attempt. These patients were therefore likely to have been diagnosed with a current major psychiatric illness.
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l A total of 166/239 (69.4%) were, however, diagnosed with a major psychiatric illness according to DSM-IV-TR criteria.
WH A T ’ S N E W
Last assessed as up-to-date: 29 April 2015.
Date Event Description
26 February 2016 New search has been performed Original review CD001764 was split into three and the searches andmethod-
ology updated
C O N T R I B U T I O N S O F A U T H O R S
KH had the idea for the review. All authors extracted data and assessed risk of bias for included trials. Both TTS and KW conducted
the statistical analyses. KH, TTS, and KW wrote the initial version of the report and all authors contributed to the writing of drafts.
All authors also approved the final version of the review for publication.
D E C L A R A T I O N S O F I N T E R E S T
KH and DG each authored three of the trials included in the review, EA authored two trials, and KvH is the author of one of the trials.
S O U R C E S O F S U P P O R T
Internal sources
• University Department of Psychiatry, Warneford Hospital, Oxford, UK.
• Oxford Health NHS Foundation Trust, Oxford, UK.
External sources
• NHS Executive Anglia and Oxford Research and Development Program, UK.
• NIHR Service Delivery and Organisation programme, UK.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In the original protocol for this review we planned to assess dichotomous outcome data (i.e., repetition of self-harm and suicide) using
the Peto odds ratio. Following revisions to iterations of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2003)
and new statistical advice, however, we have instead used the Mantel Haenzel method in this update. For this version of the review
we have been able to add data for the previously stated outcomes of interest: depression, hopelessness, problem-solving, and suicidal
ideation. We have also used the I2 statistic, rather than the Chi2 test, to summarise between-study heterogeneity in this version in light
of revisions to Higgins 2003.
We also planned to assess methodological quality of included trials by the means recommended by the contemporary version of the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2003). For this version of the review, we have therefore created
’Risk of bias’ and ’Summary of findings’ tables as per current recommendations. We have also refined the unit of analysis section, as
per current recommendations, to include Zelen designed trials and trials that report adjusted effect sizes.
We have also added four sensitivity analyses, one for trials that employedZelen’smethod of randomisation; one for trials that contributed
substantial (> 75%) levels of heterogeneity; one for trials that specifically recruited individuals diagnosed with borderline personality
disorder; and a fourth for trials that included a small minority (< 15%) of adolescent participants.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Cognitive Therapy [methods]; Depression [therapy]; Personality Disorders [therapy]; Problem Solving; Psychotherapy [∗methods];
Randomized Controlled Trials as Topic; Self-Injurious Behavior [psychology; ∗therapy]; Suicidal Ideation; Theory of Mind
MeSH check words
Adult; Humans
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